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Abstract 
The antioxidants ascorbic and uric acid have been shown to significantly interfere with the 
analytical signal of commercial blood glucose monitors. Thiol antioxidants were found to 
interfere to a lesser extent. Consequently, the selective detection of these antioxidants and 
glucose along with methods for their exclusion as interferents have been established. An 
electrochemical detection method was developed for cysteine and glutathione, being based 
upon the electrochemically initiated reaction between the thiol moieties and quinones. This was 
found to be selective for the two thiols due to their different reaction stoichiometries. 
Electrochemical techniques have also been employed to generate a novel lead copper alloy on 
a screen printed electrode surface, which was proven to oxidise glucose. After surveying a 
range of metal oxides (Cu, Fe, Mn, Mo, Ni, Pb, V, Zn), the use of manganese dioxide for the 
oxidative removal of ascorbic and uric acid samples was investigated. A potential mode of 
metal oxide inclusion in a sample pre-treatment module on a screen printed sensor has been 
developed using copper oxide. The concentrations of Cu, Pb, Mn and Ni in a pH 7 buffered 
solution required to fully oxidise the ascorbic and uric acids at 0.5 mM were found to greater 
than 6 mg 1-1. Uric acid, glucose and trace elements (Cr, Cu, Fe, Mn, Mo, Ni, Pb, Se, V, Zn) 
were measure 
-d 
in the serum, plasma and whole blood of thirty-eight type 2 diabetic (T2DM) 
and thirty-eight non diabetic (NDM) samples. Blood glucose was determined by YSI and 
Ultra TM , and serum uric acid by the InfinityTM uric acid assay. Cr, Cu, Mn, Mo, Ni, Pb, Se, V and 
Zn were measured by lCP-MS and Fe by FAAS. Only Cu, Fe, Se and Zn levels were reported, 
as the other elements were found to be below their detection limits. Mean serum uric acid 
values of both the NDM (0.312 mM) and T2DM (0.322 mM) populations were found to be in 
good agreement with reference range values of 0.15 - 0.43 mM. Considering glucose, the 
NDM values of 3.7 - 10.20 mM compared well with literature values of 3.5 - 7.8 mM. However, 
the T2DM glucose values were found to be significantly higher (two-tailed West, P<0.05). Cu, 
Se and Zn were higher (P<0.05) in the serum of the T2DM population whereas Fe was found to 
be statistically lower (P<0.001). Cu, Fe and Zn in plasma and serum (NDM) were found to be 
negatively correlated with age (P<0.05). Cu was found to be higher in females (for both NDM 
and T2DM, P<0.005), and Zn was found to be lower (NDM, P<0.05) compared with males. 
These findings are in agreement with other studies. The levels of all trace elements determined 
were below the concentration at which they were found to fully oxidise 0.5mM ascorbic and/or 
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Biosensors are used to sense physiological changes in a human's biochemistry, and hence 
yield information about the status of an individual's health. This information is useful to both the 
patient and the health care professional when monitoring the progress of a medical condition 
such as diabetes. Diabetes mellitus (diabetes) is an illness which lends itself particularly well to 
self-monitoring, and as a result a wide variety of near-patient testing devices developed for 
blood glucose analysis are available. 
The most prevalent types of diabetes are types 1 and 2 (Clark, 2004). Type 1 is also known as 
insulin dependent or juvenile onset diabetes and tends to first be identified in childhood. In this 
type of diabetes, the body is unable to produce the hormone insulin which is used to regulate 
blood glucose concentrations. Type 2 is non-insulin dependent diabetes and tends to develop 
in middle aged persons. It occurs because receptor cells in the body are less receptive to 
insulin, and hence the blood glucose concentration may not be entirely self-regulating (Hillson, 
2002). The treatment of type I diabetes is by careful monitoring of blood glucose 
concentrations and the subsequent injection of insulin. Type 2 diabetes can be controlled in a 
wide variety of ways such as (i) managing only the diet, (ii) by prescribed oral hypoglycaemic 
agents, (iii) by insulin treatment (in extreme cases), or (iv) any combination of these . However, 
the patient must still carefully monitor their own blood glucose level. 
Current estimates put the total number of diabetics at 200 million world wide, which has risen 
from 135 million in 1995, and is expected to continue to increase (Jackson, 2005). Given these 
figures, the need for development and improvement of near patient testing devices for blood 
glucose measurement is apparent. The first self testing methods for blood glucose were urine 
dip stick tests which tested for the presence of glucose in the urine. However, the presence of 
glucose in the urine means the glucose levels in the blood have risen dangerously high and 
may be sufficiently elevated so as to cause the person permanent tissue damage (Hillson, 
2002). For this reason there has been a great deal of interest in the development of devices 
known as biosensors to monitor blood glucose levels with a device capable of measuring not 
only abnormal glucose concentrations, but also normal healthy levels. These devices use a 
combination of specific biological and chemical recognition agents together with electricity, 
resulting in the capability to monitor species present in the biological fluid of interest. 
2 
1.1 The Biosensor 
The biosensor has three primary components: 
0 the biosensing element - which is the biological recognition centre, of the biosensor, 
typically comprising of an enzyme, or even a whole cell; 
* the signal transducer - which converts the action of the biosensing element into an 
electrical signal; the signal may be optical, calorimetric, or electrochemical; and 
0a mediator - that acts as an electron shuttle, which is particularly important in the case 
of enzymic blosensors (Sharp, 1990). 
The enzymes used are typically redox active, but due to their structure and shape they are 
generally unable to exchange electrons directly with an electrochemical transducer. Any 
mediator used to shuttle the electrons from the enzyme to the transducer should therefore have 
good electron transfer capabilities. 
1.1.1 Early Biosensors 
The first biosensor, known as the enzyme electrode, was developed by Clark and Lyons, and is 
illustrated in Figure 1.1 (Clark Jr and Lyons, 1962). It linked the enzyme glucose oxidase to an 
amperometric electrode to measure P02 (the partial pressure of oxygen). The oxidation of 
glucose to gluconolactone lowered the P02 in the test solution, and the resulting decrease was 
measured and found to be directly proportional to the concentration of glucose in the sample 
(Equation 1.1). 
glucose + oxygen 4 gluconolactone + hydrogen peroxide Equation 1.1 
Originally, glucose oxidase was physically entrapped between a gas permeable membrane and 
the Po2 electrode (Turner et aL, 1987; Cass, 1990; Hall, 1990). The membrane was selectively 
permeable to low molecular weight compounds, thereby allowing glucose and oxygen to pass 
through, but not proteins or macromolecules. The measurement Of P02 was difficult and was 
effectively made redundant by the development of the ability to measure hydrogen peroxide. 
The electrode was modified by using a selectively permeable membrane surrounding a 
platinum electrode, with the anode poised at +0.6 V. This responded only to the presence of 
hydrogen peroxide which is produced during the reaction. Later, overall sensor performance 
was enhanced by using a second Po2 electrode without any enzymes, which was able to 
correct for Po2 variations between samples (Updike and Hicks, 1967). 
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Chloride AgjAgCI 
electrode filling solution 
AgjAgCl Reference 
Electrode 
Pt Sensing Cathode 
Glucose oxidase 16, AMR-1- Gas Pem*at4e Membrane Irtimobilised N. 
Figure 1.1 The Clark enzyme electrode (adapted from Hall, 1990). 
Biosensor development has progressed rapidly over the years, and few of them now rely upon 
these early methodologies, and modern hand held devices for near-patient monitoring 
becoming common place. The discussion which follows serves as a survey of the 
electrochemical biosensor, from desirable properties and uses, through to descriptions of 
components and the mode of action of interfering substances. It is important to begin with a 
consideration of the biosensing component, and hence enzymes, in particular. 
1.2 Enzymes 
Enzymes are biological catalysts which speed up the rate of a reaction by lowering the 
activation energy of a reaction. There are six classes of enzyme, each class catalysing a 
specific reaction type (Devlin, 2002): 
" oxidoreductases catalyse redox reactions; 
" transferases catalyse the transfer of functional groups between molecules; 
" hydrolases transfer a donor group to water; 
" lyases add or remove water, carbon dioxide or ammonia to a molecule; 
" isomerases catalyse the conversion of cis/trans aldose/ketose isomers; and 
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0 ligases catalyse the synthesis and joining of molecules via phosphate bonds. 
Many enzymes have transition metals at their redox centre which helps to stabilise the 
transition state between reactants and products and enables redox transitions to take place 
without a major rearrangement of the protein molecule. Electrochemically active enzymes, 
which themselves are involved in electron transfer, are oxidoreductases. Many enzymes have 
been cited in the literature as being incorporated into enzyme sensors. These include, among 
others glucose dehydrogenase (Kost et al., 1998; Tang et aL, 2000) and glucose oxidase (Cass 
i 
et al., 1984; Cardosi and Birch, 1993; Harborn et al., 1997; Lowry et al., 1998; Mizutani et al., 
1998; Yang et al., 1998). In order to understand the enzymes of choice, their mode of 
operation, structure, specificity, kinetics and inhibition characteristics need to be reviewed. 
1.2.1 Enzyme Characteristics 
Enzymes are catalysts for specific substrates, which is of little surprise when their complex 
structure is considered, as shown by glucose oxidase in Figure 1.2 (Cardosi, 2006). Glucose 
oxidase is a highly specific enzyme, catalysing the oxidation of glucose to gluconolactone. The 
enzyme substrate fits perfectly into the active site of the enzyme, through the lock and key 
principle. Some enzymes have less specific binding sites, for example glucose dehydrogenase 
which is only specific to simple sugars, reacting with maltose and fructose as well as glucose 
(D'Orazio, 2003). 
Figure 1.2 Structure of glucose oxidase Figure 1.3 Plot of enzyme reaction velocity versus concentration 
(Cardosi, 2006) (adapted from Devlin, 2002) 
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As biological systems are involved, the kinetics of enzyme reactions are complex. However, 
most processes proceed via first order or pseudo first order reactions (Figure 1.3). The specific 
activity' of an enzyme explains the number of molecules that can react and therefore affect the 
reaction rate. The initial reaction rate is dependent upon the substrate concentration. As this 
increases, the velocity of reaction increases until all enzyme active2 sites are saturated with 
substrate - at this point a maximum velocity is reached as all active sites are occupied. 
1.2.2 Enzyme Inhibition, Activation and Reaction factors 
In a reversible reaction, problems exist where the product of the reaction has an equal or 
greater affinity for the enzyme compared with the substrate. In general, the inhibition of a 
reaction increases as the product concentration increases. Inhibition may be reversible or 
irreversible. If the effect of inhibition can be reversed by decreasing the concentration of the 
inhibitor, the enzyme is said to be reversibly inhibited. If once the inhibition has occurred, the 
concentration of inhibitor is decreased and the level of reticence remains unchanged, the 
enzyme is irreversibly inhibited. The inhibitor is usually similar to the substrate and is able to 
bind to the substrate binding site. It is therefore in competition with the substrate for the binding 
site. 
An activator increases the rate of the enzyme catalysed reaction; although it is a substance 
other than the enzyme or substrate. Less is known about activators than inhibitors. If enzyme 
activation is essential, the rate of conversion of substrate to product is zero without the 
activator. If it is non-essential, the reaction rate is finite. 
Enzyme specificity is attributed to the tertiary structure of the protein which is folded in a 
particular way so as to enable a substrate molecule to bind in a cavity within the enzyme. The 
level of 'differentiation enables the separation of L and D enantiomers, such that the enzyme 
will only react with the L or D form. Enzyme activity is particularly susceptible to environmental 
factors. As biological molecules, they are designed to operate at the optimum pH, ionic strength 
and temperature levels that would be found in the human body. 
1.2.3 Metals as enzyme co-factors and inhibitors 
Metals are required as cofactors for about 70% of all known enzymes. They are known to act 
as Lewis acid catalysts, e. g. zinc, iron, manganese and copper, which all have empty d orbitals 
acting as electron sinks. The metal ion can have two roles: (i) promoting catalysis by binding 
I Number of enzyme units per mg protein. 
2 The active site of an enzyme with particular amino acid side chains involved in catalysis. 
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the substrate and promoting electrophilic catalysis at the site of bond cleavage, or (ii) acting to 
stabilise reaction intermediates, and hence the reaction pathway (Devlin, 2002). The role of 
metals in inhibiting the enzyme and the affect on blood glucose sensors is discussed in section 
1.4.1. 
1.3 Electrochemistry of the Blosensor I 
Electrochemistry is a quick and accurate method of determining the concentration of electro- 
active analytes and is an ideal method for near patient monitoring in biosensor applications 
(Hall, 1990). Principally, there are three main electroanalytical techniques that can be 
employed: 
0 potentiometry (monitoring of potential at zero current flow); 
a amperometry (monitoring of current at an applied potential); and 
9 coulometry (measuring the amount of electricity passed). 
By far the most widely used techniques are potentiometry and amperometry, and of these the 
latter has been subjected to the most development work (Turner, et al.. 1987; Cass, 1990; 
Hall., 1990). Coulometry is a less useful technique in biosensors but is a powerful diagnostic 
tool for developing methods and elucidating mechanisms of reactions. 
1.3.1 Coulometric Enzyme Sensors 
Coulometry is an electrochemical technique, related to amperometry, which measures the 
amount of charge passed between the electrodes. This quantity is directly proportional to the 
oxidation or reduction occurring at the electrode surface. Coulometry utilises Faradays First 
Law as represented in Equation 1.2: 
Q=znF or Q=lt Equation 1.2 
where: Q= total charge, n= amount of substance oxidised/reduced (moles), z= number of 
electrons involved in oxidation/reduction, F= Faraday constant (96 485 C mol-1), I= current 
(amperes) and t= time (seconds). 
Coulometric devices are not very selective because the electrons monitored as the analyte 
signal are not specific to a reaction or analyte. This exemplifies their impracticality and is 
reflected in the scarcity of Coulometric devices on the market. However, one commercially 
available glucose biosensor which uses coulometric detection is the TheraSense FreeStyle@ 
(Abbott Laboratories, Illinois, USA) class of meter. 
7 
1.3.2 Potentiometric Enzyme Sensors 
The first potentiometric blosensor was developed by Clark and Lyons, and has been described 
in section 1.1.1. In potentiometry, the equilibrium potential of an indicator electrode is 
measured against a selected reference electrode using a high impedance voltarnmeter, thereby 
producing a current effectively of zero (Brett and Brett, 1998). The product of an enzyme 
reaction can often be monitored directly at a selective electrode. The construction of the 
electrode utilises a membrane in which the enzyme is immobilised and then placed over the 
electrode, or alternatively the enzyme may be directly coated onto the electrode. For example, 
urease immobilised on the surface of the electrode for the determination of urea (Chou et al., 
2005). The reaction of urease on urea produces ammonia, and therefore the concentration of 
urea can then be measured directly if a membrane selective to the ammonium ion is employed. 
However, there are disadvantages: for example the device is only accurate at the local 
electrode interface if a thermodynamic equilibrium is in existence; the kinetics are rapid and the 
signal has an exponential dependence on the electrode potential; and potentiometric 
biosensors, based on redox electrodes, are less specific than ion selective electrodes. 
Noble metal electrodes are typically used (Pt, Au, Pd) as they function as excellent electrical 
conductors and are unreactive. Platinum electrodes give repeatable results assuming the same 
electrode pre-treatment methods are employed. Factors which must be taken into account are 
the method of cleaning the electrode, the purity of the bulk material and the molecular 
morphology of the surface - all of which affect the operation of the potentiometric system 
(Turner et aL, 1987; Cass, 1990; Hall, 1990; Compton and Sanders, 1995; Brett and Brett, 
1998; Fisher, 1998). 
1.3.3 Amperometric Enzyme Sensors 
Amperometric enzyme sensors take advantage of the fact that chemical species are reduced or 
oxidised at inert electrodes when a constant potential is applied. When applied to biosensors, 
the anode of the sensor detects either the formation of a product or the consumption of a 
reactant resulting from a bioreaction of the analyte of interest close to the electrode surface. 
Typically, oxidoreductase (redox) enzymes will be involved in both mediated and unmediated 
amperometric enzyme electrodes (Turner et at, 1987; Cass, 1990; Hall, 1990). However, 
hydrolytic enzymes (alkaline phosphatase) may also be used if the product of their reaction is 
an electro-active species. The species generated are usually small molecules which may 
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sometimes be monitored directly without the need for mediators. Table 1.1 summarises 
enzymes used in amperometric biosensors, their specific substrates and the reaction products. 
Table 1.1 Redox enzymes, their specific substrates and reaction products (Hart and Wring, 1997; Devlin, 
2002). 
Redox Enzyme Specific Substrate Products 
Glucose oxidase Glucose Gluconolactone and hydrogen peroxide 
Cholesterol oxidase Cholesterol Cholest-4-en-3-one and hydrogen peroxide 
Lactate oxidase Lactate Pyruvate and hydrogen peroxide 
Pyruvate oxidase Pyruvate Acetyl phosphate and hydrogen peroxide 
Xanthine oxidase Xanthine Uric acid and hydrogen peroxide 
Lactate dehydrogenase Lactate Pyruvate and H* 
NADH dehydrogenase NADH NAD and H, 
Alcohol dehydrogenase Alcohols Ketones and H* 
Glucose dehydrogenase Glucose Gluconolactone and H+ 
Galactose oxidase Galactose Galacto-hexodialose and hydrogen peroxide 
The most important aspect of amperometric enzyme electrodes is to define the rate 
determining step and assess whether the reaction is under diffusion or enzyme kinetic control. 
The generation of the analytical signal is comprised of four stages: 
(1) the substrate is transported to the enzyme layer; 
(2) the substrate diffuses within the layer and is converted to product; 
(3) the products migrate to the transducer; and 
(4) the conversion by the transducer generates an electrical signal (Brett and Brett, 1998). 
The kinetics of the immobilised enzyme need to be considered. If the enzyme activity is 
sufficiently high, the overall rate of reaction is limited by mass transfer to the catalytic surface or 
layer, which minimises the effects of the limiting steps including: 
0 the transport of substrate through membrane; 
0 the reaction of enzyme with substrate transport of reaction products back through the 
membrane after the reaction; and 
0 the regeneration of the enzyme at the electrode surface (Brett and Brett, 1998). 
1.3.4 Electron Transfer Mediators 
Mediators are able to give enhanced electrochemical signals for otherdise poorly electro-active 
analytes. They actively participate in enzymic reactions, but are neither generated nor 
consumed, and their purpose is to provide an electrochemical mechanism for the recycling of 
the enzyme. Biosensors using this system are referred to as second generation biosensors. 
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The mediator is usually co-immobilised with the enzyme and transports electrons to the anode 
surface where it is oxidised, resulting in a cyclic reaction mechanism. As mentioned previously, 
enzymes are large protein molecules and in the case of oxidoreductases are highly suitable as 
electrochemical biosensors. However, considering the large size of the enzymes, it is easy to 
understand the difficulty they have in conducting electron transfer with a conventional solid 
electrode. Common redox mediators, their redox potential (Ei/2) value (vs AgjAgCl) and 
corresponding enzymes are summadsed in Table 1.2. 
Table 1.2 Redox mediators, their Ein value and corresponding enzymes (adapted from Chaubey and 
Malhotra, 2002). 
Mediator Em Enzymes 
1,1-dimethylferrocene 0.055 Glucose oxidase, galactose oxidase, glucose dehydrogenase 
Ferrocene 0.120 Glucose oxidase 
Vinyl ferrocene 0.205 Glucose oxidase 
Ferrocene carboxylic acid 0.230 Glucose oxidase, galactose oxidase, glucose dehydrogenase, alcohol 
dehydrogenase, NADH dehydrogenase, lactate dehydrogenase, 
xanthine oxidase, pyruvate oxidase, lactate oxidase, cholesterol 
oxidase 
Hydroxymethyl ferrocene 0.140 Glucose oxidase, cholesterol oxidase 
Hexa cyano ruthenium 0.640 Glucose oxidase 
Benzoquinone -0.006 Glucose oxidase 
Hexacyanoferrate 0.135 Glucose oxidase, cholesterol oxidase, lactate oxidase, xanthine 
oxidase, lactate dehyrogenase, NADH dehydrogenase 
Hydroquinone 0.015 Lactate oxidase 
N-methyl phenazine -0.201 Alcohol dehydrogenase 
N-ethyl phenazine -0.217 Glucose dehydrogenase 
Mediators act as electron shuttling species and allow a lower potential to be applied than that 
required for the direct oxidation of the analytes or interfering species. Examples of mediators 
include quinones (Ping, 1998), conducting organic salts (Gavalas et al., 2000), ferricyanide 
(Fingerhut, et al., 1963; Kwee, 1986) and ferrocene derivatives (Cass et al., 1984). The mode 
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Figure 1.2 Diagrammatic representation of a mediated biosensor. 
Mediators exhibit relatively fast electrode kinetics and must undergo heterogenous electron 
transfer reactions in solution. Some mediator redox couples are faster than others, for example 
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ferricyanide tends to be the slower of those mentioned above. In general, both the oxidised and 
reduced form must be chemically stable and there must be no reaction between the mediator 
and other species in solution, apart from the enzyme in question (Wang, 2001). Redox 
mediators, unlike enzymes in unmediated enzyme electrodes, do not need to be directly 
attached to the electrode. In some cases, this can ease problems encountered in 
manufacturing stages (Turner et al., 1987). 
Ferrocene (TI-bis-cyclopentadienyl iron) was first described by Cass et ai. (1984) as a highly 
efficient electron transfer mediator for a glucose oxidase enzyme sensor. Both chemical and 
electrochemical properties vary with differing ferrocene ring substituents. There are many 
advantages to using ferrocene type mediators, including the low formal potential required to 
generate the ferrocinium cation species which minimises issues associated with electro-active 
interferents. The reduced ferrocene does not react with oxygen, essential in biomonitoring 
systems, and electron transfer times between the mediator and substrate are rapid. Ferrocene 
compounds are sparingly soluble and can therefore be easily immobilised onto an electrode 
surface. With these advantages, it is clear to see why ferrocene derivatives are the mediators 
of choice for a number of systems. Unfortunately due to patent issues, only MediSense@ 
(Medisense Britain Ltd., Birmingham, UK) and collaborators are able to use ferrocenes (Hendry 
et al., 1993; Taliene et aL, 1994; Davies et al., 1995; Davis et aL, 1997). Recent developments 
involving ferrocene derivatives are reported by Patel et aL (2003) and Pandey et al. (2003). 
Both sets of workers have studied the incorporation of ferrocene within sol gels. Patel et al. 
(2003) report the use of a polyvinyl ferrocene silica gel co-polymer, incorporating glucose 
oxidase for the detection of glucose. Building a sensor in this way requires multiple 
technologies to make the construction method Viable, and indeed the sensor exhibits good 
stability and has an excellent linear range. 
Ferro/ferricyanide is also one of the most common redox couples used as mediators for 
biosensors. It has a relatively low redox potential (EO) of 0.36 V, and exhibits all the required 
features of a good mediating species. However its electron transfer kinetics are slightly slower 
than those of ferrocene and its derivatives. This can be explained by the differing ability of a 
metal cyano complex to accept or release an electron, especially in comparison with H20 as 
the ligand. In considering the aqua complex corresponding to ferri/ferrocyanide, it is apparent 
that the aqua complex (Equation 1.3) is less resistant to reduction than the 
hexacyanoferrate(III) complex (Equation 1.4): 
[Fe(H20)613+(aq) + e- --) [Fe(H20)6]2+(aq) EO = +0.77V Equation 1.3 
[Fe(CN)613-(aq) + e- -) [Fe(CN)6]4-(aq) EO = +0.36V Equation 1.4 
The cyano complex must be treated as the sum of Equations 1.5- 1.7: - 
[Fe(CN)613-(aq) + 61-120(1) --) [Fe(H20)6]3'(aq) + 6CN-(aq) Equation 1.5 
[Fe(H20)6]3+(aq) + e- 4 [Fe(H20)6]2+(aq) Equation 1.6 
[Fe(H20)612+(aq) + 6CN-(aq) --) [Fe(CN)6]4-(aq) + 6H20(l) Equation 1.7 
The replacement of the aqua ligands by cyano ligands stabilises the Fe(III) complex more than 
it stabilises the Fe(II) complex, and hence the net contributions favour the reactants in 
[Fe(CN)613-(aq) + e- 4 [Fe(CN)6]4'(aq). Therefore the Fe(III) complex is less susceptible to 
reduction than the Fe(II) complex (Shriver and Atkins, 1990). This accounts for the stability of 
the complexes. It is also important to consider the slow electrode kinetics of the 
hexacyanoferrate complex at carbon electrodes, which can be explained by considering the 
nature of the electrode surface. Carbon surfaces, such as screen printed carbon, glassy carbon 
and carbon epoxy, tend to have greatly negatively charged surfaces due to the presence of 
carbonyl, ketone, alcohol and carboxylic acid groups. The hexacyanoferrate complexes are 
negatively charged and thus there is an electrostatic repulsion between the electro-active 
species and the electrode surface. This contributes to slow electron transfer kinetics, as shown 
in Figure 1.5. 
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Figure 1.3 Hexacyanoferrate interactions with the surface of a carbon electrode (adapted from Shriver 
and Atkins, 1990). 
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In contrast, ferrocenes (apart from ferrocene carboxylic acid) are positively charged and have 
none of the same problems that are associated with ferri and ferrocyanide. Despite their 
disadvantages, hexacyanoferrates are widely used in biosensors particularly those involved in 
glucose sensing. Considerable work has been carried out into their incorporation into thin films, 
and current biosensor technologies still use this redox couple as it is ideal for modelling 
systems (Jaffari and Pickup, 1996; Jaffari and Turner, 1997; Alonso et aL, 1999). 
1.3.5 Immobilisation and Sensor Construction 
Early enzyme immobilisation techniques involved simple entrapment of the enzyme behind a 
membrane of low molecular weight permeability. This is exemplified by the Clark electrode (see 
section 1.1.1) and is a technique that is still used in some commercial applications. Simple 
adsorption and covalent binding of enzymes to electrode surfaces or insoluble carriers such as 
nylon or glass yield improved stability relative to the enzyme in solution (Cardosi and Birch, 
1993; Situmorang et at, 1999; Trojanowicz and Miernik, 2001; Badea et at, 2003; Marquette 
and Blum, 2003). Other modification techniques involve the enzyme comprising part of the bulk 
electrode material, for example carbon paste electrodes (Miscoria et al., 2002). In this way the 
electrode acts as both the enzyme immobilisation matrix and electro-active surface. 
Many substances are known to adsorb enzymes. These include alumina, charcoal, clay, 
cellulose, silica gel, glass, and collagen (Turner et aL, 1987). It is therefore advantageous to 
utilise this property and immobilise an enzyme without chemical reaction. Adsorption occurs 
due to physical and chemical forces of attraction. These include: hydrogen bonds, multiple salt 
linkages, and Van der Waals forces. A disadvantage of this immobilisation technique is that the 
binding forces and enzyme activity are highly susceptible to changes in pH, temperature, ionic 
strength and the presence of enzyme substrates. 
Enzymes immobilised in a polymeric gel matrix are becoming increasingly common. Variations 
in enzyme form and size can be compensated for by varying the three dimensional degree of 
cross linking in the polymeric gel matrix. There are profound disadvantages to this technique, 
mainly due to pore size and the ability of substrates and products to diffuse through the 
membrane. However, these problems can be minimised if the right selection of matrix material 
is made. The immobilisation of glucose oxidase in a pH sensitive copolyrnerised poly(N- 
isopropylacrylamide)/acrylic acid gel has been reported (Suzuki and Kumagai, 2003). This has 
a mode of action as follows: as the gel contacts glucose Within a solution, the pH of the gel 
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decreases as a result of the enzymic reaction. As such, this decay (transient) can be used to 
detect the concentration of glucose in solution. Workers have reviewed the use of cholesterol 
oxidase immobilised in a polypyrrole hydrogel membrane (Brahim et aL, 2001), while other 
authors described the use of sol gels and organically modified silicas to immobilise enzymes 
(Fernandes et aL, 1998; Walcarius, 1998; Brahim et aL, 2002a; Chen et aL, 2002; Niu and Lee, 
2002; Tian and Zhu, 2002). These organically modified silicas (ORMOSIL) allowed 
incorporation of many different types of mediator, enzymes and cofactors into ORMOSIL 
glasses. As a result, the electrode modifiers were immobilised within an ORMOSIL glass, but 
the functionality of the modifiers was maintained. In the 1990s, bifunctional agents that induce 
cross linking reactions that can bond enzymes to solid supports were a popular research topic. 
Some bifunctional agents used for cross linking are given in Figure 1.6. 
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Figure 1.4 Bifunctional agents used in cross linking of enzymes in early blosensors (Turner et A, 1987). 
Unfortunately, cross linking the enzyme to itself is expensive and inefficient. Also there are 
immense diffusional limitations and a lack of rigidity and mechanical strength (Turner, et al., 
1987). Careful selection of bifunctional agents can lead to excellent stability with respect to 
temperature and pH factors, but this can adversely affect adsorption techniques. Alternatively, 
covalent bonding can be used to immobilise both enzymes and mediators by reacting those 
functional groups on the enzymelmediator which are not essential to their activity with 
functional groups on the supporting material. The coupling of the enzyme to the support ideally 
takes place at physiological pH and temperature and at low ionic strength. However, covalently 
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bonding of mediators can be undertaken using any reaction condition which does not degrade 
the mediator. 
Miniaturisation of blosensors, in the form of strip electrodes, enables biosensor technology to 
be employed for near patient monitoring through in-vitro or implantable devices. Strip devices 
are typically composed of a two electrode system, where the working and counter electrodes 
can be mounted in close proximity to one another. Screen printing technology is the modern 
method for creating these strip electrodes, which have a number of layers screen printed onto 
an insulated thermoplastic backbone. The electrodes are typically constructed from carbon in 
the case of the working electrode and carbon or Ag/AgCl paste in the case of the 
counter/reference, depending on suitability to application. The layer of mediator and enzyme is 
printed and the whole assembly is laminated, enabling the analyte solution to cover the working 
electrode via a capillary fill mechanism (Morris et at, 1992). 
1.4 Interferences 
Manufacturers of biosensors report an array of interferences that affect the glucose sensor. 
The primary objective of diagnostic companies is to develop innovative technologies which 
improve the accuracy and precision of the detection method, whilst easing the use of the 
sensor by the patient. It is therefore clear that interferents are a major avenue of investigation 
in biosensor development. There are two methods by which species can interfere: 
0 chemically with either the electrode directly or the mediator; or 
0 physically by affecting the physical properties of the blood. 
Antioxidants; are a major group of interferents. They are found in physiological fluids and are 
sacrificially oxidised in order to protect the surrounding tissues. By virtue of this property they 
are generally found to be easily oxidisable and therefore can interfere with electrochemical 
measurements by undergoing electrochemical oxidation. Table 1.4 provides a summary of the 
potentially interferent species, their physiological range and an indication of their 
electrochemical activity. 
1.4.1 Metal Ions as Interferents 
Various metals also interfere with biosensors, and in fact a whole industry has developed from 
using inhibition biosensors. Environmental pollutants have been monitored using biosensors, 
the principle being that the immobilised enzyme is selectively inhibited by the pollutants of 
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interest. For example nitrate reductase has been employed to rapidly identify the heavy metals 
Cd, Ni, and Pb in environmental samples (Aiken et al., 2003). In biosensors for monitoring 
analytes such as glucose, the presence of various metal ions causes inhibition of the enzyme 
and therefore interferes with the bioanalytical signal. With respect to the enzyme glucose 
oxidase, the influence of K, Na, Rb, Ng, Ca, Zr, Cd, Cr, Cu, Mn, Fe, Co Ni and Al cations on a 
polyaniline immobilised glucose oxidase sensor have been investigated. Mn2+ Was found to 
activate the enzyme by reaction with the polyaniline, and CU2+ to reversibly inhibit the enzyme, 
the other cations having negligible effect (Shaolin and Jinqing, 1995). 
Table 1.4 Biochemical interferents and antioxidants wesent in blood (Devlin. 2002 
Interferent Normal 
Range 
Units Oxidation Potential 
vs ASIASCI 
Reference 
Ascorbic acid 0.4-15 mg/dl -0.25 Sandulescu et aL (2000); Wu et aL (2000); Zen et 
aL (2000) 
a-tocopherol 64-72 mg/dI --0.73 Finckheta/. (1995); Webster (1999); Wangand 
Wang (2001); Suturovic and Madanovic (2002) 
Bilirubin 0-0.6 mgIdl Not directly active Klemm et aL (2000) 
Carotenoids 0.84.0 mg/dl - 0.43, -0.66 Finckh et at (1995); Jeevarajan and Kispert 
(1996) 
Cysteine <1 mg/dl -0.9 Forsman (1981; Grier and Andrews (1981); Chen 
(free) et at (11990); Stenken et at (1990); Sugawara et 
al. 1996; Heyrovsky and Vavricka (1999) 
Glutathione 30-60 mg/dl -0.8 Compagnone et al. (1993) 
Paracetamol 0.1-0.2 mg/dl -0.24 Vaughan et at (1991); Sandulescu et at (2000) 
Ubiquinol 10 34-86 mg/dl Not directly active Finckh et at (1995), Yamashita and Yamamoto 
(1997); Menke et at ( 2000) 
Uric acid 2.3-8.5 mgIdl -0.4 Gao et al. (1997); Kochansky and Strein (2000) 
Vitamin A 0.15-0.6 mg/dl - 0.43, -0.66 Wang (2000) 
1.4.2 Removal of Chemical Interferents 
By far the most common approach to rejecting interferents from the electrode surface is to 
employ a membrane which rejects interferents based on charge or pore size. The increasing 
use of polymers is abundantly illustrated in the literature, with work being carried out 
investigating preformed polymers and electropolymerisable polymers (Davis et al., 1996; Myler 
et aL, 1997; Ekinci et al., 1998; Guerrieri et aL, 1998; Lowry et al., 1998; Ping et al., 1998; Abel 
et al., 1999; De Benedetto et al., 1999; Gadonyte and Malinauskas, 1999; Ozden et al., 1999; 
Poyard et al., 1999; Mizutani et al., 2000; Quinto et al., 2000; Soldatkin et al., 2000; Brahim et 
al., 2002b; Reddy and Vadgama, 2002; Ward et al., 2002; Zhang and Wang, 2002; Badea et 
al., 2003; Craig and O'Neill, 2003). It is possible to retain the mediator action by incorporating it 
into the polymer background or even onto the enzyme itself, Many metal complex mediators 
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(e. g. ferricyanide) are easily entrapped in polymer films, such as polypyrrole. There is also an 
increasing use of co-ordinated mediators into polymer films - forming redox gels (Iwuoha et aL, 
1999; Liu et al., 1999; Mao and Yamamoto, 2000; Zhang and Wang, 2002). 
The advantage of using electropolymerised membranes is the control over the properties of the 
polymer by virtue of their chemistry or polymerisation technique and thickness of film. Such 
polymers include poly(m-diaminobenzene), poly(o-diaminobenzene), polyvinylpyridine, 
polyphenol, polyaniline and polypyrrole. Non electropolymerisable membrane polymers include 
cellulose acetate, nylon, polycarbonate and NafionO. 
Over a decade ago, Sasso et al. reported the use of electropolymerised 1,2-diaminobenzene 
[poly(phenylenediamine)] on platinised reticulated vitreous carbon electrodes as an anti- 
interference measure for a H202 sensitive system (Sasso et al., 1990). It was found that it was 
possible to eliminate the interferences of ascorbic acid, uric acid and cysteine, and also prevent 
the biofouling of the electrode surface by blood proteins, through rejecting interfering molecules 
based upon size. A cellulose acetate membrane has a low molecular weight cut-off and is used 
in many commercial biosensors. A widely used commercial interferent screening membrane is 
Naflon@. This membrane selectively rejects interfering anions present in blood samples, for 
example ascorbic and uric acids, carefully excluding molecules based on charge (Zhang et al., 
1994). Alternating layers of cellulose acetate (size exclusion) and Nafion@ (charge exclusion) 
have been used to yield multiple functionality. The effect of biofouling molecules and proteins 
has been tackled by Wang et al. (2000) by the electropolymerisation and co-deposition of 
glucose oxidase and heparin onto metal electrodes; such systems show no fouling and good 
biocompatibility, a particularly useful methodology for implantable blood glucose sensors. 
Zhang et aL (1994) have used a Nafion@ cellulose acetate composite membrane to remove the 
signal of paracetamol and to eliminate other interferents while still allowing H202 through to 
generate the signal. 
The employment of a chemical screening agent to remove the interfering electro-active species 
has also been used. In addition, metal oxides have been found to be ideal oxidising agents. 
Choi et aL (2002) considered various metal oxides, including lead, barium, cerium and 
manganese, where lead was found to be the best at oxidising electro-active species. Previously 
Ciu et al. (2000) discussed the use of lead oxide as an interference removing agent in glucose 
biosensors. The glucose sensor, which this methodology was tested upon, yielded a good 
linear range (0-10 mM) and was found to be insensitive to ascorbic acid, uric acid and 
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paracetamol. However, as lead oxide is toxic, it is therefore unsuitable for mass production as 
an interference removing agent, especially when the associated environmental risks have been 
considered. 
1.4.3 Oxygen 
It is clear that any biosensor based on the glucose oxidase catalysed reaction converting 
glucose to gluconolactone, regardless of the method of measurement, will have a degree of 
dependence upon the concentration of oxygen present in the sample (Equation 1.11). Oxygen 
can interfere by reoxidising the enzyme instead of the mediator, so samples rich in oxygen can 
cause a major problem. In the case of the Yellow Springs Instrument (YSI), which is the 
international standard for blood glucose analysis, the glucose concentration is determined 
through the amperometric measurement of H202. In order to minimise oxygen effects, all 
sample and calibration solutions are diluted by 1: 10 with a phosphate based buffer which is in 
equilibrium with the atmospheric partial pressure of oxygen (Po2). This fixes the oxygen 
concentration in the sample and calibration standards at a constant value (see section 2.1.8.1). 
Other approaches have been applied in order to minimise oxygen effects, for example semi- 
permeable membranes have been implemented. This membrane serves to limit the diffusion of 
the primary analyte to the enzyme layer and hence avoids saturating the enzyme which 
extends the linear range of the sensor. Polycarbonate membranes are commonly used in this 
way (Maines et al., 1996, Myler et aL, 1997), but other materials include polyvinylchloride 
(Maines et aL, 1996; Wendzinski et aL, 2003) and polyurethanes (Abel et al., 1999; Choi et aL, 
2002; Ward et al., 2002). 
1.5 Trace Elements and Transition Metals 
The effect of transition metal ions on enzymes and their possible interference in biosensors is 
an interesting area of research. The relevance of the metal ions to diabetes in this project has 
arisen from the fact that their levels in diabetic serum show significant differences from control 
(healthy persons) serum (Abou-Seif and Youssef, 2004). These metals are also known to 
interfere with the enzyme glucose oxidase, which is found in the majority of blood glucose 
sensors used by diabetic individuals. Therefore, profiling of the metal concentrations in 
diabetics is an important aspect to consider. Copper has been shown to induce oxidative 
degeneration of ascorbic acid to dehydroascorbic acid, generating hydrogen peroxide, 
correlating with the marked derangement of ascorbic acid metabolism in diabetics (Ou and 
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Wolff, 1994). Numerous authors report the trace element concentrations in diabetic persons 
compared with healthy individuals and these works are reviewed in section 6.5. 
1.6 The Future of the Biosensor 
The clinical diagnostics industry is rapidly expanding, such that by the end of 2003 its financial 
turnover totalled over US $1.5 billion (D'Orazio, 2003). However, point of care diagnostics are 
only of practical use in the medical profession if they cover a wide range of analytes in a cheap, 
reliable manner and the results are as accurate as those produced by central clinical 
laboratories. 
A major advantage of the use of biosensors is their selectivity, enabling analysis in complex 
media such as blood, saliva, sweat, urine, etc. Some instruments are invaluable in the 
continual analysis of diseases, e. g. diabetes, if used for the analysis of metabolites such as 
pyruvate, lactate, glucose, etc. A classical example is the artificial pkcreas, where continual 
blood glucose measurements are taken and the data fed back to an insulin delivery device, 
enabling administration of suitable insulin levels (Brahim et aL, 2002a). The device is non 
invasive, using a dialysis membrane to facilitate continuous monitoring. Similar devices have 
also been developed for the analysis of lipids (triglycerides, cholesterol and phospholipids), 
lactate and urea (Abel et al., 1999; Petrou et at, 2003). 
In terms of technology development, first generation biosensors used enzymes bound behind a 
membrane forming a simple product sensitive electrode, the earliest example being the Clark 
enzyme electrode (section 1.1). Second generation biosensors used the traditional enzyme 
and mediator approach at a simple electrode material, for example carbon. Third generation 
biosensors utilise enzymes immobilised in a polymer or similar type film, where the film itself 
has redox properties, and the signal is generated directly at the polymer layer in contact with 
the electrode. Fourth generation biosensors are the future, with needs being dictated by the 
consumer. The major theme is to use analyte selective substrates with simple anti-intefference 
strategies, thereby producing reusable electrochemical sensors which use no enzyme 
technology. These developments would reduce the cost of production, lengthen shelf-life and 
yield a whole new area of biosensors. The chemical development of fourth generation 
biosensors is behind the need for their production, and current research into glucose and other 
carbohydrate selective electrodes is as far as things have advanced. Electrode substrates used 
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for the analysis of such carbohydrates are copper, nickel and their alloys, which yield a catalytic 
response to the analytes in question (Milardovic et aL, 1997; Yeo and Johnson, 2000; Yeo and 
Johnson, 2001; Giovanelli et al., 2003). Utilising this catalysis could well spawn a new 
generation of glucose biosensors, and with research into other simple substrate selectivity, the 
fourth generation of biosensors is developing into a highly innovative area of research and 
development. 
1.7 Alm and Objectives 
1.7.1 Alm 
The aim of this research was to elucidate the mechanisms through which common 
physiological antioxidants can influence mediated electron transfer at amperometric 
biosensors, and develop protocols for their direct quantitation and/or exclusion, assessing the 
viability of these approaches with respect to blood glucose analysis for diabetics. 
1.7.2 Objectives 
The main objectives are: 
(1) to investigate the electrochemistry of ascorbic acid, cysteine and glutathione and their 
interaction with the mediating species - potassium ferro/ferricyanide redox mediator; 
(2) where appropriate, to develop a strategy for the electrochemical detection of thiol 
moieties; 
(3) to assess to what extent the interferents (including uric acid) interfere and where 
relevant develop generic strategies using chemical (metal oxide) or physical 
(membrane) approaches to compensate; 
(4) to investigate the properties of electrochemically generated nanoscale alloys and their 
activity in relation to glucose and the antioxidants of interest; 
(5) to broadly characterise the following metals in terms of their presence in biological 
media (serum, plasma and whole blood)in both diabetic and normal healthy individuals: 
Cu, Cr, Fe, Mn, Mo, Ni, Pb, Se, V, and Zn; and 
(6) to determine the effect of Cu, Fe, Mn, Mo, Ni, Pb, V, and Zn oxides on the interferents 
ascorbic and udc acid. 
Chapter two discusses the instrumentation and the analytical methodology that was utilised 
throughout the course of this research. 
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Chapter Two 
Analytical Techniques and Methodology 
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2.0 Introduction 
A wide variety of analytical techniques have been used throughout this work, for example 
electrochemical and spectroscopic techniques. In this chapter, electrochemical techniques are 
discussed in principle and practice referencing examples from the experimental work 
conducted, including those involved in elucidating electrochemical reaction mechanisms (see 
Chapter 3), and the electro-deposition of metallic species (see Chapter 4). 
As discussed in section 1.1, electrochemical techniques are employed extensively in blood 
glucose monitoring, lending themselves well to the detection and characterisation of the 
reaction of antioxidants with mediated electron transfer in such sensors, as discussed in 
Chapter 5 (Turner et al., 1987). 
This chapter discusses glucose monitors/meters, detailing the mode of operation of both near- 
patient testing and hospital laboratory devices. Additionally, the analysis of trace elements in 
biological fluids (blood serum, plasma and whole blood) is challenging due to the complex 
nature of the samples, and hence, this chapter dealt with the development of suitable 
preparation techniques for the analysis of samples by atomic spectroscopy methods. 
Here, flame atomic absorption spectroscopy has been used for the elemental analysis of 
buffered media from electrochemically generated samples, and diluted and digested biological 
fluids (section 2.4). Inductively coupled plasma - mass spectrometry has also been developed 
for the analysis of biological fluids following suitable sample preparation methods (section 2.5). 
Ultraviolet / visible molecular spectroscopy was utilised in chemical assays (thiols, Chapter 3) 
and enzyme assays (uric acid, Chapters 5 and 6) for the detection of antioxidants by non- 
electrochemical means. 
Suitable methods for these different analyses have been developed. A clinical investigation of 
trace element concentrations in blood fractions from diabetic patients has been conducted (see 
Chapter 6), and the analysis of the clinical samples carried out using inductively coupled 
plasma mass spectrometry. 
2.1 Electrochemical Techniques 
The electrochemical techniques used throughout this work were mainly those of voltarnmetry 
(linear sweep, square wave, and cyclic) and amperometry (fixed potential - under diffusion or 
convection control), although potentiometry has also been used to evaluate reaction 
stoichiometry (see Chapter 3). Voltarnmetry was employed as an investigative method, where 
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as chronoamperometry mimics the electrochemistry of conventional near-patient devices and is 
therefore implemented to imitate the mode of action of such sensors in a laboratory 
environment. 
2.1.1 The Electrochemical Cell 
The electrochemical cell comprises a thermostatted jacketed glass cell containing three 
electrodes with their tips immersed in the solution under analysis, as shown in Figure 2.1. The 
three electrodes are the counter electrode (CE), reference electrode (RE) and working 
electrode (WE). All three are connected to a potentiostatIgalvanostat. The analytical current 
passes between the working and counter electrodes, while the potential is maintained relative 
to the reference electrode (section 2.1.1.1). No appreciable current passes through the 
reference electrode. The lid serves to prevent contamination of the solution from the laboratory 
environment, the moveable nitrogen inlet is used to purge the solution of oxygen and the 
magnetic stirrer bar is used to mix the analytes in solution. 
CE 






ý .4 Magnetic Stirrer Bar 
Figure 2.1 Electrochemical cell as used in this work (adapted from Brett and Brett, 1998). 
2.1.1.1 Reference electrodes 
Reference electrodes (RE) are used to control the potential of the working electrode in an 
electrochemical cell. It is therefore a requirement that such electrodes have a steady constant 
independent potential as all cell potentials are measured versus the reference electrode. 
Reference electrodes work via a liquid-liquid junction, typically provided by a porous glass frit, 
ceramic junction, or another porous material. This enables a constant flow of reference 
electrolyte to be released into solution (Harris, 1999). The reference electrode must fulfil 
various criteria: (1) it must have a constant potential versus the Standard Hydrogen Electrode 
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(SHE) and this potential must be independent of the analyte solution; (2) the filling solution of 
any reference electrode must not react with the electrode; (3) the filling solution must have ions 
of equal conductance to minimise the potential at liquid-liquid junctions; (4) they must be 
reversible and have a potential which returns to equilibrium after small currents are passed 
through the cell; (5) the solid phase must not be appreciably soluble in the electrolyte; and (6) 
they must show hysteresis with temperature cycling (Compton and Sanders, 1995). 
A silver-silver chloride (AgjAgCl) reference electrode is used throughout this work (3M chloride, 
BAS Technicol, Congleton, UK), and comprises a silver wire coated with porous silver chloride 
placed in a medium containing chloride ions (Compton and Sanders, 1995). The potential of 
the electrode is established by the following reaction: 
AgCl(s) + e- ý* Ag(metal) + Cl-(aq) Equation 2.1 
where an equilibrium is established at the Ag/AgCI boundary. The activity of the Ag metal and 
AgCl are both equal to 1 as they are in the solid phase. According to the Nernst equation, the 
potential of the cell is proportional to the concentration of chloride ions (Equation 2.2): 
EAg/Ap = EOAg/Agcj - RT/F In ap. ) Equation 2.2 
where EAg/AgCI ': potential of the cell (volts), EoAgtAgc, = potential of the cell under standard 
conditions (volts), R= gas constant (8.314 J K-1 Mol-1), T= temperature (K), F= Faraday 
constant (96 485 C mol-1) and ap-) = activity of chlodde ions. 
2.1.1.2 Counter electrodes 
In the three-electrode system as utilised in this study (section 2.1.1), the purpose of the counter 
(auxiliary) electrode is to complete the circuit between the solution, potentiostat and the 
working electrode without any current being passed through the reference electrode. The 
counter electrode is formed from inert material, typically platinum or gold, and must have a 
larger surface area than the working electrode so that it can act as a sink for the electrons 
consumed or generated during the reaction at the working electrode (Fisher, 1998). 
2.1.1.3 Working electrodes 
The working electrode is the site of the electrochemical reactions and hence fouling of the 
surface by reactants or products is common place. Noble metal electrodes may have anodic 
and/or cathodic working potentials depending on the metal and the electrolyte used. For bio- 
analytical applications, glassy carbon electrodes (GCE) are typically used. This is due to their 
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wide potential range, cost and ease of cleaning. A3 mm diameter GCE has most commonly 
been used throughout this work (BAS Technicol, Congleton, UK). Working electrode surfaces 
are renewed through polishing by using a suitable abrasive material for the electrode material 
(Brett and Brett, 1998); for example, a glassy carbon electrode is polished using alumina 
powder and alumina polishing pads (Kemet International Ltd., Maidstone, UK). 
2.1.1.4 Electrode materials 
Available electrode materials for the working electrode, counter electrode and reference 
electrodes are summarised in Table 2.1 and those used in this thesis are marked with an 
asterisk *. 
Table 2.1 Electrode materials and their properties (adapted from Fisher, 1998 and Harris, 1999). 
Electrode Material Range/ Comments 
Working electrode Metals - Pt, Au, Ag, Pd, Rh, Ir, Hg Have overpotentials for Hzg) evolution 
(WE) Crystalline - sheets, rods, wires Good for a wide range of potentials, in 
Carbon - glassy*, paste, screen printed* aqueous and non-aqueous systems 
(Boron doped) Diamond Wide potential window, but expensive 
Counter electrode Pt - Wre*/foiVmesh Pt wire most common 
(CE) Hg - pools 
Graphite rods 
Reference electrode Hydrogen PtIHCIIH2 
(RE) Calomel Hg2lHg2C[2 
Silver* AgjAgCI 
Non aqueous AgjAgS 
Redox couple 
* Electrodes used in this work. 
2.1.2 Analyte Transport 
The electron transfer between the reactive species in solution and an electrode can only take 
place from a thin film of the solution located immediately next to the surface of the electrode. 
This film is typically only a few angstroms in thickness and therefore contains a limited number 
of reactive ions or molecules. For a steady current to be established through the cell it is 
necessary that this film is continuously replenished with reactant from the bulk solution by 
means of mass transport mechanisms. Concentration polarization is encountered when the 
processes of mass transport are insufficient to remove the reacted species from the film and to 
replenish it with reactive species. In electrochemical analysis, the rate of reaction is limited by 
either reaction kinetics or the physical parameter of mass transport. The magnitude of the 
current may therefore be limited by the mass transport processes associated with the 
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electrode. The three processes contributing to mass transport are diffusion, convection and 
migration (Brett and Brett, 1998). 
2.1.2.1 Diffusion 
Diffusion occurs due to the smoothing of species distribution which acts to minimise the entropy 
of a solution containing an uneven arrangement of species. The rate of diffusion is therefore 
dependent upon the concentration gradient at a specific location in a solution. For example, at 
the electrode surface, a lower concentration than the bulk of solution (i. e. a larger concentration 
differential) will cause a greater rate of diffusion of species to re-balance concentration gradient 
(Brett and Brett, 1998). 
2.1.2.2 Convection 
Convection occurs when a natural or artificial force acts on the solution. Natural convection is 
present in any solution and occurs due to thermal and density gradients. During 
electrochemical experiments such convection may be due to endo- or exo-thermic reactions 
taking place in solution, which alter both the thermal and density gradients of the solution. 
Artificially forced convection occurs as a result of the mechanical movement of the solution, for 
example by stirring, bubbling or using a rotating disk electrode (RDE). The RDE itself is rotated 
and is therefore the most convenient way of controlling convection. The RDE is known 
generically as a hydrodynamic electrode and is typically composed of a disk electrode attached 
to a conducting rod which is spun in solution with the electrode held facing vertically downward. 
The flow pattern of the solution is such that the liquid is pulled up from underneath and spread 
out sideways. The resulting limiting current is directly proportional to the electrode area, proving 
that the electrode surface is uniformly accessible to the analytes in solution and the reaction 
layer is constantly replenished (Brett and Brett, 1998). The RDE has been used throughout this 
work to provide active transport of various analytes to the electrode surface, as seen for 
glucose oxidase in section 5.5. 
2.1.2.3 Migration 
Migration is caused by the effect of an external electrostatic field on the movement of ions in 
solution. The external electric field which exists at the electrode/solution interface is able to 
exert an electrostatic force on charged species. This causes the ions to migrate either towards 
or away from the electrode. Migration during electrolysis leads to complex physical transport 
processes due to the fact that during a reaction the charged species, electrical field and 
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migratory flux will change. As a result the rate of migration will constantly alter. The effect of 
migration can be ignored if a background electrolyte is present at greater than 100 times the 
concentration of the analyte (Brett and Brett, 1998). In the presence of a background 
electrolyte, adding electrolytic ions causes a slight redistribution of anions and cations at the 
electrodelsolution interface, but the effect of this redistribution on analyte transport is minimal. 
The electrolyte helps to maintain an electrically neutral solution so electric fields do not build up 
and transport effects are also minimised so that small changes in charge as a result of 
reactions are not noticeable (Brett and Brett, 1998). 
Other benefits of the presence of a background electrolyte include: (1) high solution 
conductivity making it less resistant to current flow, i. e. not limited by bulk solution conductivity; 
(2) control of the distance of the interface over which the potential drops by means of an 
electrical double layer, having the effect of removing the potential gradient outside the narrow 
region thus preventing migration, and (3) the ionic strength of solution remains effectively 
constant, and hence the activity coefficient remains the same. This has the effect of keeping 
the electrode potential (as predicted by Nernst, Equation 2.2) and the rate of reaction constant 
(Fisher, 1998). 
2.1.2.4 Background electrolytes and buffer solutions 
Britton-Robinson (BR) buffer solution was used throughout this work to provide both a 
background electrolyte and a cell solution resistant to changes in pH. In this work, the BIR 
buffer is 0.04 M acetic, boric and phosphoric acids (Analytical Reagent Grade, Fisher Scientific, 
Loughborough, UK) and is adjusted to the required pH through the addition of concentrated 
sodium hydroxide (Analysis Grade, Sigma-Aldrich Company Ltd, Gillingham, UK). The BR 
buffer was prepared in distilled deionised water (DDW) (Elga PURELAB Ultra, Veolia Water 
Systems, High Wycombe, UK), and also contains 0.1 M potassium chloride (Analytical Reagent 
Grade, Fisher Scientific, Loughborough, UK) as a background electrolyte (Mongay and Cerda, 
1974; Lawrence et at., 2000). 
2.1.3 Instrumentation 
A gAutolab Type 11 Potentiostat (Eco-Chemie, Utrecht, Netherlands) was used throughout this 
work, which was controlled by a computer operating GPES@ software, Version 4.9. This 
potentiostat is designed for low current level applications where a low signal noise is a 
requirement. The maximum current for the device is 80 mA with a maximum potential of 12 V. 
The device is capable of carrying out a wide range of electrochemical procedures, including 
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voltammetry - square wave, cyclic and linear and stripping analysis; multiple pulse 
amperometry; potentiometry; and chronoamperometry. 
2.1.4 Amperometry 
Amperometry is the branch of electrochemistry that deals with the addition (reduction) or the 
removal (oxidation) of electrons from a molecule or atom. Oxidation or reduction processes 
cause a current to flow in the electrochemical cell when a potential is applied between the 
I 
working and reference electrodes (Fisher, 1998). 
2.1.4.1 Chronoamperometry 
Fixed potential amperometry (chronoamperometry) involves the application of a potential 
sufficient to cause a reaction to take place at the electrode surface over a period of time. The 
current then rapidly decays to a baseline value as all species at the electrode surface react. 
The process is thus controlled by diffusion. Figure 2.2 shows the capacitive and Faradaic 




Figure 2.2 Fixed potential amperometry (adapted from Fisher, 1998) 
The capacitive region arises from the rearrangement of solvent ions at the electrode-solution 
interface at the instant of applying the potential. Once this rearrangement is complete, the 
Faradaic component of the current arises from the reaction of the analýyte(s) under a diffusion 
controlled mechanism as discussed in section 2.1.2.1 (Fisher, 1998). 
2.1.4.2 Steady state amperometry 
The method of steady state (staircase) amperometry involves the monitoring of the current 
generated while a system is under active transport. A current/time plot is obtained, as shown in 
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Figure 2.3. In the absence of analyte, the system is at equilibrium and no current flows. Upon 
the injection of an electro-active species to the system, a current flows which is proportional to 
the number of electrons involved in the reaction. As the system is under active transport 
conditions, the electro-active species react quickly and then the system rests back to its 
previous transport balance, but at a higher current (Fisher, 1998). With sequential additions of 
the analyte, a staircase pattern is obtained. 
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Figure 2.3 Fixed potential amperometry (adapted from Fiorito and de Torresi, 2001). 
2.1.4.3 Applications 
Amperometry is of little investigative use in electrochemistry because electrons generated or 
consumed in the reaction cannot be attributed to electron transfer from a specific chemical 
reaction. For example, ascorbic acid oxidises at approximately 0.35 V vs. AgjAgCI so a fixed 
potential of 0.35 V would cause it to oxidise and generate an analytical signal. Uric acid 
oxidises at approximately 0.45 V vs. AgjAgCI and if a solution containing both uric and ascorbic 
acids was analysed by fixed potential amperometry at 0.45 V, the analytical signal would arise 
from the oxidation of both the uric and ascorbic acid. In this way the technique is unable to 
differentiate between analytes in solution (Wang, 2001; Dutt et aL, 2003). However, when an 
analyte sensitive device is employed, chronoamperometry is frequently used. The Faradaic 
component of the decay (see Figure 2.2) represents the analyte response and therefore 
concentration. By measurement of the current signal at a fixed time, calibrations can be 
obtained and analyte concentrations determined. This approach was employed is both 
Chapters 3 and 5. 
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2.1.5 Voltammetry 
Voltammetric techniques apply a potential to an electrochemical system and monitor the 
current response as a function of this potential. By using potential sweep techniques, different 
electro-active species in solution can be identified. Voltarnmetric techniques are applied in 
Chapters 3 to 5 of this thesis. 
2.1.5.1 Linear sweep 
In linear sweep voltarnmetry (LSV), the potential is either swept to a more positive or more 
negative potential over time (scan rate) and this induces a reaction to occur at the electrode 
surface. This reaction causes electrons to be drawn in or to be liberated giving either an 
increase or decrease in current. The current produced is proportional to the concentration of 
the analyte at the surface of the electrode. Linear sweep voltarnmetry is usually carried out 
under diffusion conditions and hence gives a current vs. potential plot which shows the limiting 
current of diffusion (Brett and Brett, 1998). 
LSV is also applied to anodic and cathodic stripping voltarnmetry (ASV and CSV). ASV 
involves the absorption of cations onto an electrode surface by applying a negative potential 
then sweeping the potential to a more positive value. A LSV profile is then obtained as the 
cations are electrochemically liberated from the surface. In CSV, which is the opposite of ASV, 
a positive potential is employed and the potential swept to a more negative value (Fisher, 
1998). 
2.1.5.2 Cyclic 
In a cyclic voltammetry sweep (CV), the forward and backward components of the sweep are 
the same as linear sweep. In conventional cases, the potential is stepped at a constant sweep 
rate from an initial potential to a final potential then back to the initial potential. The current is 
measured as a function of this potential, Figure 2.4. 
At point (A), the starting potential, no reaction occurs at the electrode surface. As the potential 
is swept towards (C), the oxidation of the analyte becomes favourable. The rate of oxidation of 
the species increases as the current increases exponentially during the electron transfer. The 
rise in current slows and reaches a maximum, which represents the surface concentration of 
oxidant/reactant, and the depletion of oxidant at the surface. The current magnitude is then 
limited by the rate of transport of the analyte to the surface of the electrode. The current falls as 
fresh material has further to migrate to the electrode surface and a zone of depletion of the 
analyte appears around it. At point (C) the potential is reversed and swept back towards point 
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(B). During the reverse sweep the current increases in magnitude again (but the opposite 
vector) as the kinetics for reduction become increasingly favourable. The high concentration of 
oxidised species held at the electrode surface by the depletion zone is therefore available for 
immediate reduction. The current then slows and reaches a maximum in a similar way to that in 
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Figure 2.4 Reversible CV (adapted from Fisher, 1998) 
2.1.5.3 Square wave 
Square wave voltammetry (SWV) applies an alternating potential based upon a typical 
staircase potential sweep (Figure 2.5). The currents for both the forward and backward pulse 
are added together, producing a voltammogram with more resolved and sharper peaks and 
elevated signal currents compared with linear sweep voltarnmetry. Square wave voltarnmetry is 
useful for identifying oxidation potentials of analytes in question and may also be used as an 




Figure 2.5 Square wave voltammetry waveform (adapted from Fisher, 1998). 
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2.1.5.4 Reversible reactions 
Reversible reactions typically have fast electrode kinetics relative to the time scale of the 
sweep. The product of the initial oxidation/reduction is then reduced/oxidised respectively on 
reversing the scan direction. Systems behave reversibly when the rate constant for the reaction 
is greater than 0.1 cm s-I and scan rates are up to IV s-1. However, usually it is not possible to 
re-oxidise/re-reduce all the products as they will diffuse away from the electrode (Fisher, 1998). 
2.1.5.5 Irreversible reactions 
Both electrochemical and chemical reactions may be irreversible. If the process is 
electrochemically irreversible, changes in scan rate will not change the CV and only an 
oxidation or reduction peak will be seen. If the process is chemically reversible, a stable 
product is formed by a chemical step after electron transfer. In this case if the scan rate is 
increased, the chemical step can be minimised and a reverse peak will be observed. The peak 
potential varies with scan rate, and kinetic limitations cause a shift in the oxidation peaks to a 
more positive potential, whilst reduction at peaks a more negative potential (Fisher, 1998). The 
electrochemical oxidation of ascorbic acid is irreversible and a CV representing the reaction 
can be seen in Figure 5.10. 
2.1.5.6 Quasi-reversible reactions 
Most electrochemical redox couples, such as ferri/ferrocyanide (section 1.3.4), fall into this 
category. Quasi-reversible systems typically have a slow electron transfer rate. In the CV of a 
quasi-reversible system, the back peak does occur but it is smaller than the forward peak. The 
kinetically controlled portion of the CV curve will be 'drawn out" and the peak current will be 
further away from the formal potential. This also occurs in the reverse peak and leads to 
greater peak separation. The peak potential position depends on the rate constant, the 
concentration of the species and the scan rate. 
2.1.6 Potentiometry 
In potentiometry, the equilibrium potential of an indicator electrode is measured versus a 
reference electrode using a high impedance potentiostat to ensure that the current path 
between the electrodes is highly resistive. Potentiometry is the method by which ion selective 
electrodes function and was first used in biosensors by Clark and Lyons, as described in 
section 1.1.1. 
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2.1.7 Screen Printed Electrodes 
Screen printed electrodes (SPE) are the material of choice for near-patient testing devices 
which require disposable electrodes. Typically, a conducting ink is printed on an insulating 
polymer support and the print shape of the ink corresponds to electrode configurations. Above 
this conducting ink layer, a variety of enzymicAndicator/mediating species can be printed 
yielding sensors that can be selective for a wide variety of analytes (Cui et aL, 2001a, b). 
Commercial applications of screen printed electrodes are numerous, including the analysis of 
lactate, cholesterol, and glucose (D'Orazio, 2003). The screen printed electrodes used 
throughout this study were prepared using proprietary technology (LifescanD Scotland Ltd. ) 
akin to that used for commercial glucose sensing strips. They consisted of a two electrode 
assembly: either 1 MM2 carbon and a AgjAgCl paste reference; or 1 MM2 carbon and 1 MM2 
carbon reference/counter electrode. Thus they are able to function as a complete 
electrochemical cell (Brett and Brett, 1998). 
2.1.8 Glucose Measurements 
In order to understand how to report glucose measurements, it is important to recognise how 
glucose partitions in the blood. Glucose distributes itself, like water, between plasma and 
erythrocytes. Although all blood fractions have the same glucose molality, they do not have the 
same concentration and this is dependent upon the water concentration of the sample. 
Biosensors using sample dilution will produce results approximately 11 % higher than the same 
whole blood direct measurement (Fogh-Andersen and D'Orazio, 1998, Parkes et aL, 2000 
D'Orazio et aL, 2005). This is explained by considering the water content of blood and relating it 
to haematocrit. Haematocrit is the proportion of erythrocytes in whole blood and is reported as 
a percentage, hence is also a measure of the water content of the blood. For a normal person 
with a haematocrit level of 43%, [H20] erythrocytes =-0.71 kg 1-1, [1-1201 plasma =-0.93 kg I- 
1. The water content of the whole sample is therefore 0.84 kg H. [H201plasma / [1-1201whole blood = 
1.11, which accounts for an 11% over estimation of the plasma measurements for normal 
healthy individuals (Jackson and Cardosi, 2002). 
2.1.8.1 Yellow Springs Instrument 
The instrument used throughout this work is the YSI 2300 STAT Plus Glucose and Lactate 
Analyzer@ (YSI Incorporated, Yellow Springs, Ohio, USA). This measures the glucose 
concentration of a sample (whole blood or plasma) amperometrically at a platinum electrode, 
and reports all results as plasma glucose concentration, based on the water content of the 
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sample. The electrode utilises glucose oxidase which is immobilised between two membrane 
layers - polycarbonate (exposed to the sample solution) and cellulose acetate (between the 
enzyme and the electrode). The sample diffuses through the polycarbonate layer which acts to 
limit substrate passage, preventing the reaction from becoming enzyme concentration limited. 
The glucose in the sample is then oxidised to gluconolactone by the enzyme and hydrogen 
peroxide is generated. The hydrogen peroxide then passes through the cellulose acetate layer 
and reacts at the electrode, generating a current directly relating to the concentration of 
glucose in the sample. Because cellulose acetate is a membrane with size exclusion 
properties, many electrochemical interferences are excluded. The linear range of the sensor is 
1.1 to 33.3 mmol 1-1 (YSI Life Sciences, 2004). The glucose concentration in the samples is 
measured by dilution: 25 pLI of sample diluted to 600 jal using a patented phosphate buffered 
diluent, which' inherently reports results based on the water content of the sample (YSI Life 
Sciences, 2004). 
2.1.8.2 One Touch Ultra Blood Glucose Monitor 
The blood glucose monitor/meter used throughout this work is the One Touch UltraTM Meter 
(Lifescan@ UK, High Wycombe, UK). This uses a1 gl sample volume which is administered to 
a screen printed electrode (strip), which contains the reagents: glucose oxidase, mediator 
(potassium ferricyanide) and other binding agents (Lifescan Inc., 1998). The linear range of the 
sensor is 1.1 to 33.3 mmol 1-1 and the 'adjusted' results are reported for a plasma calibration 
(11 % higher than whole blood values), so as to avoid confusion when comparing values with 
standard hospital methods (e. g. YSI) (Lifescan Inc., 2002). 
2.2 Molecular Spectroscopy - 
Ultraviolet I Visible Absorption Spectrometry 
Molecular spectroscopy techniques are useful when reactants, products or reaction indicators 
strongly absorb ultraviolet or visible wavelength radiation. The primary use of the method in this 
work is for the quantitative determination of antioxidants. The Ellman's assay for thiols is a 
chemical assay which generates a chromophore in the presence of thiol (RSH) groups and 
hence can detect reduced thiol antioxidants (see Chapter 3). The Infinity'm uric acid assay is an 
enzyme assay used to quantify uric acid (see Chapters 5 and 6). The principles, 
instrumentation, and the details of each assay are discussed in this section. 
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2.2.1 Pfinciples 
Ultraviolet/visible absorption spectrometry (LIV/Vis) is the measurement of the absorption of 
light in the high UV to visible range (180 - 780 nm) of the spectrum by electrons in molecules 
(Harris, 1999). This absorption is common in organic molecules with unsaturated bonds, for 
lone pairs of electrons and in transition group or lanthanide elements which have d and f 
orbitals where electron transitions can occur. These transitions give rise to characteristic 
chromophores. Absorption is defined by the Beer-Lambert Law, Equation 2.3: 
I 
log -=A= --cl 10 
Equation 2.3 
where 10 = incident radiation, I= detected radiation, A= absorbance, c-- molar absorption 
coefficient, c= concentration of analyte/chromophore and I= path length. 
2.2.2 Instrumentation 
The instruments used in this work were double beam spectrometers, namely, Unicam UVIIS, 
Unicam Helios y (Thermo Electron Corp., Hemel Hempstead, UK), and Cecil CE 7200 and 
Cecil CE 8020 instruments (Cecil Instruments Ltd., Cambridge, UK). All instruments were 
equipped with Grant stirred water baths (Grant Instruments, Shepreth, UK). A schematic 
representation of all instruments is shown in Figure 2.6. 
Beam Semi-transparent 
Source H Monochromator ýý. Sample Detector H Amplifier H Recorder 
or 
Reference Mirr 'J; ýt 
Figure 2.6 Schematic of a UVIVIs double beam spectrometer (adapted from Harris, 1999). 
All measurements were carried out using DDW in the reference cell and by base-fining the 
instrument against air. 
2.2.3 Ellman's Assay for Thiols 
The concentration of thiols was determined using Ellman's assay, which utilises the thiol 
derivative of 5,5'-dithio-bis-(2-nitrobenzioc acid) as a chromophore (Ellman, 1959). At pH 8, the 
reagent acts 1: 1 with SH groups. The molar absorption coefficient (6) at 410 nm (Xma, ) is 
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13,600 M-1 cm-1. A typical volume of 2 CM3 pH 8 BR buffer was used, with a1 cm path length 
quartz cell. The limit of detection (LOD) of a method is calculated as the concentration 
equivalent to the signal of the blank plus three times the standard deviation of the blank (Miller 
and Miller, 2000): 
s =Vý(x, -! )In -I Equation 2.4 
LOD = yb + 3sb Equation 2.5 
where s= standard deviation, x, = x value, T= mean of x, n= number of values, yb = signal of 
the blank and sb = standard deviation of the blank. The LOD for Ellman's Assay for thiols was 
found to be 0.4 [LM. 
2.2.4 Infinity'm Uric Acid Assay 
The lnfinityTm uric acid assay was used for the spectrophotometric determination of uric acid in 
the samples and is based on the methods of Trivedi et al. (1978) with a modified Trinder 
peroxide assay, using 2,4,6-Tribromo-3-hydroxybenzioc acid (TBHB). The generated quinone- 
imine species causes a change in the absorbance at 520 nm and is proportional to the 
concentration of uric acid in the sample. InfinityTM uric acid reagent was obtained from Alpha 
Laboratories UK and used according to the prescribed method: 
0 1: 50 sample: reagent ratio ( 50 pl : 2500 pl); 
0 incubation at 370C for 5 minutes; 
scan range 500-700 nm; and 
calibrate at Amax 520 nm. 
Plastibrand@ UV plastic disposable cuvettes were used for both the reference (distilled water) 
and sample beams. Although a one point calibration is prescribed by the manufacturer, this 
was not analytically viable. Therefore a separate calibration was carried out, over the repofted 
linear range of the reagent assay (0.25-1.5 mM uric acid). From these measurements a limit of 
detection (see Equation 2.5) was found to be 0.07 mM. 
2.3 Biological Sample Preparation 
Biological samples are complex matrices and require dilution or digestion prior to elemental 
analysis by inductively coupled plasma mass spectrometry (ICP-MS) and flame atomic 
absorption spectrometry (FAAS). 
36 
2.3.1 Blood Serum and Plasma Preparation 
Analysis of blood serum and blood plasma by ICP-MS and FAAS is complex and the preferable 
method of sample preparation is simply by dilution (Vandecasteele and Block, 1997). The trace 
elements of interest in the study are not present at high concentrations in blood serum and 
plasma, therefore sample preparation must be kept to a minimum. Digestion of such samples 
would likely result in the loss of many elements of interest due to the inherently high dilution 
factors involved (Barany et al., 1997). Blood serum and plasma samples require dilution in 
order to overcome problems arising from the sample matrix and also the low sample volume. 
The main difficulty with using sample dilution to overcome these problems, is that both blood 
fractions contain high amounts of protein. It is therefore important that the diluent encourages 
protein solubilisation and not precipitation, thereby preventing it from blocking the nebuliser and 
sample injector of the ICP. 
Previous studies have used 1% v/v nitric acid to dilute the samples (Vandecasteele et aL, 1993; 
Stovell, 1999; Adair, 2002). However this tends to encourage protein precipitation, particularly 
in plasma samples. An alternative is to use alkali diluents containing ammonia, 
ethylenediamine tetraacetic acid (EDTA), alcohols and/or a surfactant (Barany et aL, 1997, 
2002a, b). The components of the diluent serve a multitude of functions; the ammonia reduces 
the protein content in the sample, the ETDA stabilises the trace elements by forming a chelated 
complex, the alcohol encourages suspension of the organic content of the sample, whilst the 
surfactant promotes total dissolution and a decrease in viscosity. 
The alkali diluent (alkali blood diluent, ABID) approach was chosen for this study. The optimised 
diluent composition was 5g 1-1 25% ammonia solution, 5g 1-1 methanol (AristarO, BDH 
Laboratory Supplies, Poole, UK), 0.5 g 1-1 EDTA disodiurn salt (Anayical Reagent Grade, 
Fisher Scientific, Loughborough, UK) and 0.5 g 1-1 Triton X-100 (Laboratory Reagent Grade, 
VWR International Ltd., Poole, UK). Previous work has shown that the accuracy and precision 
of ICP-MS analysis of biological samples can be considerably improved by maintaining a 
constant dilution factor, as this minimises changes in the sample matrix (Thouet, 2003). The 
dilution factor was thus quantified by weight as outlined in Figure 2.7. 
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Blood Serum or Blood Plasma 
Accurately weigh -0.25g sample 
into Eppendorfý tube 
; F- 
actual weight of 
curately eigh -1.0 g sample 
into Eppendorflý tube 
Multiply actual weight of 
Add this mass of ABD to 
Eppendorfl tube containing 
Record mass of sample with ABD 
Dilution factor = 
mass sample + 
mass of samý-Ii 
Analyse by FAAS 
Add this mass of ABD to 
Eppendorflý tube containing 
Record mass of sample with ABD 
Dilution factor = 
mass sample + 
rnass of sampli 
Analyse by ICP-MS 
Figure 2.7 System of work for the dilution of blood serum and plasma for analysis by FAAS and lCP-MS. 
2.3.2 Whole Blood 
Whole blood is a complex mixture of salts, erythrocytes, plasma and other proteins which is it 
not possible to analyse directly by most ICP-MS instruments. It is therefore necessary to carry 
out a digestion procedure in order to generate a solution which can be subsequently analysed. 
Whole blood samples were digested in 100 CM3 Kjehldahl PyreXTM tubes (31 cm long) which 
were heated in a Tecator digestor (Perstop Analytical, Maidenhead, UK). This consisted of an 
insulated aluminium block with 12 sample positions, fitted with an accurate temperature control 
device. Only the bottom 7cm of the tubes are within the heating block, thus allowing the 
remainder of the tube to act as an air condenser for volatile substances (Rayman et aL, 1996). 
A nitric acid / hydrogen peroxide digestion method was developed from modifications of a 
previous procedure used at the University of Surrey (Heales, 2003). A flow diagram detailing 
the procedure is shown in Figure 2.8. The final dilution factor was approximately 21 -fold and no 
further dilution was required in the case of lCP-MS analysis, whereas for Fe determination by 
FAAS, a further 20-fold dilution of the digest solution was required. 
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I ml of whole blood is transferred to a pre weighed labelled Eppendorf@ 
microcentrifuge tube 
I Full tube is then weighed and mass of whole blood in the tube determined I 
Contents of Eppendorf@ tube then transferred to a dry acid washed Kjehldahl 
digestion tube. Eppendorf@ tube rinsed x5 with I ml conc. Aristar@ nitýc acid 
(BDH Laboratory Supplies, Poole, UK) and rinsate transferred to Kjehldahl tube 
I Leave tubes ovemight(>12 hrs <14 hrs) to assist protein and fat breakdown I 
I Heat to 120 OC for I hour I 
I Heat to 160 OC for 3 hours I 
Add 1 ml 30%Analyfical Reagent Grade (Fisher Scientific, Loughborough, UK) 
hydrogen peroxide to each sample 
Continue heating for a further hour at 160 OC 
I 
Turn off heating block and allow tubes to cool to mom temperature (250C) 
Transfer the contents of the Kjehldahl tubes to labelled Sterelin 0 sample 
containers (Bibby Sterilin@, Stone, UK) 
I Rinse each tube x3 with 5 ml DDW and transfer rinsate to the sample containers I 
I Record the final weight of the digest solution I 
Figure 2.8 System of work for digestion of whole blood by nitric acid I hydrogen peroxide (adapted from 
Heales, 2003). 
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2.3.3 Sample Preparation Quality Control 
When preparing the diluted blood serum and plasma samples a portion of Seronorm@ Trace 
Elements in Serum Level 1 (Lot no JI-4409) reference material (Sero AS, Billingstad, Norway) 
was also prepared. The reference material was supplied in a freeze dried condition and was 
reconstituted with 3 ml distilled deionised water (DDW). 
Digested samples were prepared in batches of 10, with the last two remaining sample tubes 
containing 1ml DDW (the digestion blank) and a reference material. The reference material for 
whole blood digestion was Seronorm@ Trace Elements in Whole Blood Level 1 (Lot no 
OK0336) reference material (Sero AS, Billingstad, Norway), which was also supplied freeze 
dried and reconstituted with 5 ml DDW. All 10 samples, digestion blank and reference material 
were treated identically throughout the digestion process. The data obtained from the analysis 
of these reference materials is provided in section 6.2.5, Tables 6.1 and 6.2 in context with data 
from the samples analysed. 
2.4 Atomic Spectroscopy - Flame Atomic Absorption Spectrometry 
Flame atomic absorption spectrometry (FAAS) has been used throughout this work to evaluate 
the elemental composition of samples, including acid digested-whole blood and ABD diluted 
blood plasma and serum samples. The instrument used was a Perkin Elmer Model AAnalyst 
400 spectrometer (Perkin Elmer, Beaconsfield, UK). 
2.4.1 Principles 
In FAAS a flame is used as an atomisation source for the analysis of the component elements 
of liquid samples by atomic absorption spectrometry. A liquid sample is aspirated into a flame, 
typically by pneumatic nebulisation. The sample is drawn up through a capillary by decreased 
pressure, created by an expanding oxidant gas at the end of the capillary; when the liquid 
meets with the gas, fine droplets of the sample liquid are formed. These are then mixed 
turbulently with additional oxidant and fuel gases, before passing into the bumer head and 
flame. Approximately 85 - 90% of the droplets are removed from the aerosol as they deposit in 
the bumer head and drain away to waste. In the flame, the solvent evaporates and the 
compounds in solution dissociate into an atomic state. 
The energy transferred to the atoms is directly proportional to the flame temperature. If it is too 
low, the sample is not atomised and if it is too high, the atoms are excited further to a state of 
ionisation. In the latter situation, the atoms are no longer in the ground state and are unable to 
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absorb energy from the light source. In this work an air/acetylene flame was used, which has a 
combustion temperature of approximately 2540 K. Light at a characteristic wavelength, which is 
dependent on the element of interest is passed through the flame and the wavelength for 
analysis is selected by the monochromator before detection. Once the species in the flame 
have atomised, the atoms of the element of interest can then absorb energy from the light 
source, promoting their ground state electrons to a singlet excited state. The absorption of light 
is directly proportional to the concentration of the element of interest, as described by the Beer- 
Lambert Law (see Equation 2.3) (Vandecasteele and Block, 1997). A schematic of FAAS 
instrumentation is shown in Figure 2.9. 





Figure 2.9 Simple schematic of a typical FAAS instrument (adapted from Vandecasteele and Block, 1997). 
The light source used in this work was a hollow cathode lamp (HCL) which comprised of a 
glass container with a quartz window. The cathode is inside a hollow cylinder covered with the 
element of interest or an alloy of the element and the container is filled with an inert gas, either 
argon or neon. When a potential of 300 V (I - 50 mA) is applied, the inert gas ionises and the 
positive ions accelerate towards the cathode. Upon striking it, some of the atoms of the 
cathode material are transformed into the gaseous state. These are then excited by collisions 
with the electrons and ions, causing them to emit their characteristic atomic emission line. The 
current applied is carefully selected to give the most intense emission but without Doppler 
broadening or self absorption wifthin the HCL itself (Vandecasteele and Block, 1997). 
2.4.2 Possible Problems Encountered in Biological Sample Analysis 
Biological fluids have both a higher dissolved salt content and higher viscosity compared to a 
simple nitric acid matrix or water samples. They therefore suffer from matrix effects resulting 
from both physical (viscosity) and chemical effects (dissolved salt content). 
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2.4.2.1 Interferences 
Spectral interferences occur when the absorption or emission of an interfering element/species 
overlaps or is close to the wavelength of the element of interest. However this only tends to 
occur when the separation between wavelengths is less than 0.01 nm. In order to minimise the 
effect of spectral interferences, wavelengths have been selected which are the least 
susceptible to interference (Welz and Sperling, 1999). Matrix interferences may either be 
physical or chemical. 
Typical physical interferences can arise from dissolved or suspended solids and as a result of a 
difference in the viscosity of a sample in relation to the calibration standards. This affects the 
rate of sample uptake as well as the nebulisation process. The best way to correct for physical 
interferences is to matrix-match the calibration standards to that of the samples (Vandecasteele 
and Block, 1997). Methods for the determination of zinc in 4-fold diluted blood serum suggest 
the preparation of standards containing 50 g 1-1 glycerol to correct for viscosity effects (Burtis 
and Ashwood, 2001). However, where this is not suitable, the method of standard addition 
may be used to identify and correct for any matrix effects. The method of standard addition was 
used in this investigation to evaluate matrix effects in diluted and digested blood samples, see 
section 2.4.5. 
Chemical matrix effects occur when compounds of low volatility are formed in the flame, 
typically by anions combining with the element of interest, and hence eliminating the proportion 
of free atoms of the sample in the flame and subsequent detection. In flames where oxygen is 
readily available, refractory metal oxides are formed making these metals (e. g. iron) highly 
susceptible to this type of interference. This is particularly the case with blood fractions which 
have high iron concentrations (blood plasma and serum typically 1 mg 1-1, whole blood 400 mg 
1-1). This effect may be minimised by adding a releasing agent, which binds preferentially to the 
anions present, releasing the element of interest; or by adding a protective agent (e. g. EDTA) 
which forms a stable but volatile compound of the element of interest (Vandecasteele and 
Block, 1997). 
lonisation interferences also occur when a sample contains easily ionised elements of interest. 
In particular, the number of atoms in the ground state is therefore diminished and hence the 
analyte signal reduced. This is the case with biological samples which tend to contain high 
concentrations of sodium. Importantly, all chemical effects are easily corrected for by matrix- 
matching calibration standards or reagent blanks (Welz and Sperling, 1999). 
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2.4.2.2 Limitations 
There are several limitations of FAAS, aside from the interferences that affect analysis. It is a 
single element technique which is very useful if only one or two elements are to be determined 
per sample. Analyses are also fairly rapid (-15 seconds / sample). However, the sample 
volume requirement for solution nebulisation is quite high - requiring 2 to 3 CM3 per element. 
The elemental detection limits are also higher than for other atomic spectroscopy techniques 
(Vandecasteele and Block, 1997). 
2.4.3 FAAS Operating Conditions 
A Perkin Elmer Model AAnalyst 400 spectrometer (Perkin Elmer, Beaconsfield, UK) was 
available for use, which is a computer controlled spectrometer, operating Winlab 32 for AATm 
software. This instrument is equipped with a true double beam Echelle monochromator optical 
system with a segmented solid state detector. Calibration standards were prepared such that 
six standards, including the blank, were within the linear calibration range. For example, lead 
has a linear range of 0 to 7.5 mg 1-1, and the standards prepared were 0,0.5,1,3,5 and 7.5 mg 
1-1. All standards were prepared by the dilution of 10000 mg 1-1 stock standards (Aristar@ BDH 
Laboratory Supplies, Poole, UK) using either 1% nitric acid (Adstar@ grade, BDH) or ABID. 
Where the diluent for the standards was not the same as the sample, a reagent blank of the 
sample matrix was analysed. 
2.4.4 Calibration Curves 
The calibration curves were obtained using Microsoft@ ExcelTm using the calibration standard 
intensity values obtained by the instrument plotted against the actual elemental value (mg 1-1). 
The resultant curves were used to determine the amount of analyte in each sample. Examples 
of typical calibration curves obtained for copper and lead by the Perkin Elmer AAnalyst 400 
spectrometer are shown in Figure 2.10. Also highlighted on a calibration curve is the 
calculated linear regression equation and the Pearson's product moment correlation coefficient 
(R2). The regression line for the least squares line fit can be calculated as follows (Miller and 
Miller, 2000): 
2: 1( X, - 30( YI-N 
Slope= m (XI 2 Equation 2.6 
Intercepi =c=ý- mY 
Equation 2.7 
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The Pearson's correlation coefficient of the line, R2, is calculated as follows (Microsoft@) 
ExcelTM , 2003): 1 (xi - g)( Y, - Y) 
R Equation 2.8 
- Fy--(X, -w (Y' -W V7 
Where m=slope, xi= x value, i= mean of x values, yi= y value, mean of y values, c 






Copper Calibration Curve 
CCU] Img 1-1 
Figure 2.10 Typical FAAS calibration curves for copper and iron. 
For each element, the limit of detection (LOD) was calculated, using Equation 2.5. Table 2.2 
summarises the analytical figures of merit for the Perkin Elmer AAnalyst 400 spectrometer, with 
reported calibration ranges for each wavelength selected and the calculated limit of detection. 
Table 2.2 Conditions and analytical figures of merit for FAAS analysis by Perkin Elmer AAnalyst 400 
spectrometer, vvith calculated limits of detection. 
Element Matrix ). / nm Slit I nm Calibration Range I mg 1-1 Limit of Detection mg 1-1 
Ca 1% HN03 422.67 2.7/06 0-3 0.43 
cu 1% HN03 324.75 2.7/0.8 0-5 0.18 
Fe 1% HN03 248.33 1.8/0.6 0-5 0.10 
Fe ABD 248.33 1.8/0.6 0-3 0.10 
Mn 1% HN03 279.48 1.8/0.6 0-2 0.11 
Na 1% HN03 589.00 1.8/0.6 0-0.5 0.05 
Ni 1% HN03 232.00 1.8/1.35 0-5 0.06 
Pb 1% HN03 217.00 2.7/1.35 0-7.5 0.11 
Zn 1% HN03 213.86 2.7/1.8 0-3 0.05 
1% HN03 A as described in 2.3.1 
ABD diluent as described in section 2.3.1 
2.4.5 Method of Standard Addition 
The method of standard addition was applied to diluted blood serum and plasma samples 
(Figure 2.7), and digested whole blood samples (section 2.3.2), as they provide the most 
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complex matrices (Vandecasteele and Block, 1997). The method of standard addition involves 
the addition of known increasing amounts of analyte to a sample, thus generating a pseudo- 
calibration in the sample matrix. The concentration of the sample can be determined by 
extrapolating a least squares line fit to the point where the y intercept is zero and the 
correlating point on the x axis is the modulus of the sample concentration. This is illustrated in 
Figure 2.11 for a digested whole blood sample (iron concentration from calibration = 1.10 mg I- 
1; concentration from standard addition = 1.28 mg 1-1), and a diluted blood serum sample (iron 
concentration from calibration = 0.11 mg 1-1; concentration from standard addition = 0.10 mg 1-1). 
Standard Addition to Digested Whole Blood Standard Addition to Elood Serum 
0300 -0,150 - 
0.200 0.100 
01 y=0,0873x +0 112 (4 0.1 0,050 
Sampke C=onc entration 
.S1.28 mgtl 
yz0.1057x + OV08 
Sample Concentration = 0.10 
ý0.000 
-- ------ 
21012 -0 . 25 0.75 
[Fe] added Im gl4 IN] added I mg L-I 
Figure 2.11 Standard addition curves for the determination of iron by FAAS in a digested whole blood 
sample, and a diluted blood serum sample. 
This method was conducted for 8 samples: 4 digested whole blood; 2 diluted blood serum and 
2 diluted plasma, The concentrations determined by the method of standard addition were 
evaluated versus the concentrations determined from the calibration by means of a paired Mest 
(Miller and Miller, 2000): 
dN6n- / Sd Equation 2.9 
where t= tca1c, ý= mean of difference between pairs of values, n= number of values and Sd = 
standard deviation of the difference between pairs of values. The calculated value for t (t.,,: ) 
was found to be 1.66 and the critical value for t (6it) was 1.89 at the 95 % confidence interval 
(P<0.05) for 7 degrees of freedom (n = 8). Thus tcaic< tcrit so the null hypothesis is retained, 
indicating that there is no statistical difference between values obtained from the calibration 
curve and the method of standard addition at the P<0.05 level. It can therefore be concluded 
that the calibration matrix is adequately matched to the sample matrix. 
2.4.6 Quality Control 
Quality control charts were used in the identification of instrument drift throughout the analysis 
run. Two check solutions, a blank and a standard solution (QC) from the middle of the 
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calibration range (e. g, if analysing from 1 to 5 mg 1-1, a check solution of 2.5 mg 1-1 would be 
used) were analysed after at least every 10 samples throughout the whole analysis run. This 
was done for the determination of every element using FAAS. An example of a quality control 
chart can be seen for zinc in Figure 2.12. The x axis represents the analysis sequence 
number, with the actual values obtained for the check solution represented as single points, 
and the mean from the whole day represented as a single line. Lines for ±1 and ±2 SID 
(standard deviation) are also represented (see Equation 2.4). From Figure 2.12 the zinc levels 
I 
for 40 samples lie within ±1 SID of the mean value. 












Figure 2.12 FAAS quality control chart for zinc. 
2.4.7 Drift Correction 
Analysis of alkali blood diluent samples tended to result in instrument drift due to the high salt 
content affecting the nebulisation process. An example of the quality control chart, similar to 
that in Figure 2.12, can be seen for iron in Figure 2.13, It is clear that the non-drift corrected 
data deviates unsatisfactorily, yielding data greater than 2 standard deviations different to the 
mean. Drift correction was achieved by correcting the raw data for each block of 10 samples 
after the blank-QC sequence. This involved dividing the blank intensity by the QC intensity and 
multiplying by the intensity of the sample. The resulting corrected QC data can be seen in 
Figure 2.13 for comparison, showing that this method of correction brings the QC data to an 
acceptable level of within one standard deviation of the mean value. 
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Figure 2.13 FAAS quality control chart for iron. 
2.4.8 Quality Control - Spike Recoveries 
Spike recovery experiments were conducted for iron by spiking diluted samples with 0.1 mg 1-1 
iron. Samples analysed in this way were digested whole blood samples and diluted blood 
serum and blood plasma samples. The % recovery of the spike was calculated as follows 
% Recovery r. [SpiKOU sample] - isample] IX 100 Equation 2.10 
[Spike] 
where [spiked sample] = the concentration of the spiked sample, [sample] = the concentration 
of the sample, and [spike] = the concentration of the spike added to the sample. Average % 
recoveries were 103.4 ± 6.8% (n=4) for digested whole blood and 98.9 ± 0.5% (n=4) for diluted 
blood plasma and serum. 
2.4.9 Precision 
The precision of determinations can be evaluated in terms of the relative standard deviation 
(%RSD), which is calculated as follows: 
S %RSD=-x]00 Equation 2.11 
.V 
where s= standard deviation of determinations and x-= mean value of determinations. %RSD 
values of <± 5% indicate a good level of precision (Prichard et al., 1996). Each FAAS intensity 
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reading is reported as the mean of three individual intensity readings and the %RSD calculated 
for each sample. Typical %RSD values for a set of FAAS analyses are 1.5 ± 0.9 % (n= 63). 
2.5 Atomic Spectroscopy - 
Inductively Coupled Plasma Mass Spectrometry 
Inductively coupled plasma mass spectrometry (ICP-MS) is a multielement technique first 
established by the Houk group at Iowa State University and Date and Gray at the University of 
Surrey. The instrument used throughout this work is the Finnegan Mat SOLA ICP-MS 
(Finnegan Corp., Hemel Hempstead, UK) which is equipped with a quadrupole mass analyser. 
2.5.1 Principles 
In ICP-MS, the sample is introduced into the plasma as an aerosol, where it is desolvated, 
vaporised and ionised. A small proportion of the sample is then extracted into the mass 
analyser system, which is under a vacuum of 10-5 mbar, through differentially pressurised 
vacuum stages. Within the system, the mass analyser separates elemental ions on a mass- to- 
charge ratio (m/z). The ion counts are then acquired by either the Faraday Cup bulk detector or 
the Channeltron Electron Multiplier. Each area of the instrument will be considered in turn; 
sample introduction, the inductively coupled plasma, sampling interface, ion beam focusing 
unit, mass spectrometer and data acquisition. Figure 2.14 shows a schematic of the Finnegan 
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Figure 2.14 Schematic of Finnegan Mat SOLA ICP-MS instrument (Dudding, 2000). 
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2.5.2 Instrumentation 
2.5.2.1 Sample introduction 
There are typically three modes of sample introduction into the inductively coupled plasma 
(ICP): pneumatic nebulisation (PSN), electrothermal vaporisation (ETV); and hydride 
generation (HG). Only PSN was utilised in this work. In PSN, a peristaltic pump (Gilson 
Minipuls 3, Gilson Inc., Middleton, USA) is used to deliver a liquid sample to a nebuliser at a 
constant rate (1.1 ml min-'). As a high velocity gas stream (argon) collides with a low velocity 
liquid stream (sample) the nebuliser produces a fine aerosol. This is then transported by the 
nebuliser gas into the spray chamber. The purpose of the spray chamber is two fold; it forms a 
condensation surface for the very fine particles of the aerosol, whilst allowing the larger 
particles to gravitate towards the surfaces, hence controlling the size of the particles reaching 
the plasma (Vandecasteele and Block, 1997). In this work, a concentric type nebuliser was 
used. 
2.5.2.2 The inductively coupled plasma 
The ICP is a well characterised high temperature source, which is highly suited to atomisation 
and ionisation elements in a sample (Vandecasteele and Block, 1997). The plasma is simply a 
stabilised ionised inert gas, in this case argon, which stabilises at a temperature in the range of 
8000 - 10000 K. The plasma torch is constructed of 3 concentric quartz tubes. Between the 
outer most and middle tubes, coolant or plasma gas. flows tangentially to the orifice of the torch, 













At the top of the torch, radio frequency (RF) power is applied via an induction coil forming an 
oscillating magnetic field. The plasma then forms when a spark of electrons from an igniter is 
introduced into the coolant gas. The electron source causes the plasma to form which is then 
stabilised by the magnetic field. The gas stream from the nebuliser punches a hole in the 
centre of the plasma, where the sample is then carried through and is vaporised, atomised and 
ionised. At a temperature of 7500 to 8000 K and an electron density of 1015 cm-3, singly 
charged positive ions are formed for 50 elements with an efficiency of greater than 90%. 
2.5.2.3 Sampling interface 
The sampling interface of the SOLA transports the sample from the ICP to the mass analyser 
unit. The interface must transport ions from a high temperature and atmospheric pressure to 
the mass spectrometer system which operates at ambient temperature and a pressure of 1.5 x 
10-5 mbar. This is achieved by a series of cones with a pressure drop between each pair of 
cones, the first being the sampler cone which sits approximately 10 mm from the plasma 
induction coil. This has an aperture of 1.1 mm and "samples" the stream of ions. Next is the 
skimmer cone, With an aperture of 0.8 mm, which serves to further narrow the ! on stream. The 
pressure in this area of the sampling interface is 2 to 3 mbar. The third is the accelerator cone 
which has an aperture of 1.0 mrn and a negative charge applied to it which enables the ions to 
be focused into the mass analyser, under a pressure of 1.5 x 10-5 mbar. 
2.5.2.4 Ion beam focusing unit 
The SOLA is equipped with a series of electrostatic lenses. These enable the ions to be 
focused into the quadrupole mass analyser by simply altering the potential of the lenses. The 
slightly off axis entry to the lens arrangement in the SOLA minimises the effect of photonic 
discharge caused by the plasma and hence the background ion counts (seen in Figure 2.16) 











Figure 2.16 The ICP-MS ion beam focusing unit (Dudding, 2000). 
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The optimisation of the lenses across the whole mass range is essential, as different ions with 
differing masses will have different kinetic energies, and hence varying paths through the 
system. By optimisation, a suitable isotope can be chosen from the analyte range to optimise 
the lenses without an appreciable loss in sensitivity. 
2.5.2.5 Mass spectrometer 
The SOLA instrument is equipped with a quadrupole mass analyser consisting of four 
hyperbolic shaped rods, where pairs are connected by either RF or DC voltages and produce 
an electric field. By altering the voltage characteristics of the rods, the m/z ratio of the ions can 
be matched over the whole mass range and at any one time only one m/z emerges to be 
detected. Fortunately, the speed of this scan does not limit the rate of analysis and the method 
remains simultaneous. Typical resolution for this type of instrument is 0.7 to 0.8 atomic mass 
units (amu), and is limited by the stability of the electric field and the spread of ion energies. 
2.5.2.6 Data acquisition 
The data acquisition system in the SOLA occurs off-axis through the use of either the 
Channeltron electron multiplier or the Faraday Cup. The multiplier has a high negative potential 
applied to it which attracts the ions. Upon impact of the ions with the multiplier surface, one or 
more secondary electrons are ejected which then in turn collide again and so on. These are 
then accelerated down the multiplier tube by a potential gradient. Although this detector is 
sensitive, with a relatively long life and low background counts, it is not suited to the analysis of 
high ion count rates. For this reason the instrument is equipped with a Faraday Cup bulk 
detector, which is an analogue detector compriised of a metal plate and is able to measure the 
ion current directly. It has poorer sensitivity than the multiplier, but is able to measure higher ion 
count rates and its lifetime is greater than that of the majority of components of the instrument. 
2.5.3 Interferences 
Intefferences affecting lCP-MS analysis may be either spectroscopic or non-spectroscopic. As 
these interferences have the potential to cause major analysis problems they are considered in 
detail With reference to the elements of choice in this work. 
2.5.3.1 Spectroscopic 
Isobaric interferences occur where equal mass isotopes of different elements occur in the 
sample, e. g. 58Fe+ (0.28% abundance) and 58Ni+ (68.3% abundance). Only monoisotopic, 
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elements such as 27AI+ and 55Mn+, do not cause this interference. Polyatomic interferences 
occur due to the presence of molecular ions with an equal mass to the isotopes analysed. They 
arise from a mixture of the plasma gas, sample and matrix ions. For high mass elements, MO+, 
MOH+ and ArM+ species may exist and, under certain plasma conditions, they may be stable 
enough to cause interferences. A different effect occurs when doubly charged ions exist in an 
ionised sample, for example 206Pb2+. When this ion is separated and detected on a mass to 
charge basis, the 103Rh+ isotope is detected. Table 2.3 summarises the typical spectroscopic 
interferences affecting the elements of interest in the blood sample matrices analysed, as well 
as internal standard candidates (section 2.5.5.1). The internal standard isotopes selected are 
not normally present in the sample, and cover the same mass range as the analytes, and are 
relatively free of spectroscopic interferences. 
Given the information in Table 2.3, the following isotopes were chosen for analysis: 5'V+, 53Cr+, 
55Mn+, 58Ni+, 63CU+, 68Zn+, 82Se+, 98MO+, 206pb+f 207Pb+ and 20BPb+, with the following isotopes as 
internal standards: 59CO+, 74Ge+, 1151n+ and 209Bi+. 
2.5.3.2 Non-spectroscopic 
The sample matrix causes a wide range of non-spectroscopic effects on the signal intensity 
and is particularly prevalent when analysing high concentrations of dissolved solids (-1%). The 
effect may cause either suppression or enhancement of the analyte signal. Firstly, the analysis 
of samples containing salts of low volatility causes salt deposition on the apertures of the cones 
which may restrict the flow of the ions through the cones. Even if deposition does not occur, the 
analysis of samples containing high levels of salts causes many other effects, particularly 
ionisation suppression (Olivares and Houk, 1986). 
The introduction of easily ionised elements to the plasma contributes strongly to the electron 
density of the plasma, i. e. depletes the plasma of available electrons to ionise elements of 
interest. This shifts the ionisation equilibrium, causing the analyte ions to be ionised to a lesser 
extent. 
Another effect is the space charge effect which is caused by the positive ion density occurring 
at the cones from matrix ions. This accumulation has the capability to repel analyte ions 
(Gillson et aL, 1988). The lighter analyte elements are the most severely affected by the space 
charge effect, causing expulsion from the beam, but heavier elements also have a strong 
influence due to their ability to better repel the lighter elements (Vandecasteele and Block, 
1997). 
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Table 2.3 Interferences affecting the analytes of Interest and Internal standards, where the selected 
isotopes are shown in BOLD (adapted from Vandecasteele and Block, 1997). 
Isotope Isobaric Interferences Polyatomic Interferences (% abundance ) (% abundance) 
V 50V* (0.25) 5OTi* (5.4), 5OCr (4.35) 34S160- 36Ar14N- 35CI15N+ 36S14N+ 32Sl8()+, 33S170+ . 
5'V* (99.75) 34SI66Fýf 35CI16b+, 38Arl 3C+, 
ýXrMN+, 36kl4NH-, 37CI14N*, 36S15N+v 33S180. 
34SI70- 
Cr 5OCr+ (4.35) 5OTi* (5.4), 50V* (0.25) 34S'60* 36Ar14N+ ' 35CI15N- ' 36S14N+ 32SI8()+, 33SI70+ 
52Cr, (83.8) 35CI160ý+ I 4OAr12C+ I 36k160+, 376015N+ 3 34S180. I 36S160- , -18Arl4N+, 36Arl5NH-, 37CI170+ 
53Cr+ (9.5) 37CI16()-, 38k15N*, 3BArl4NH*, 36Sk170-, 36k'60H+j 35CI170H+1 35CI180-, 36S170-, 
4OAr13C+ 
54Cr, (2.3M 54Fe* (5.8) 
_ --L 
37CI16OH-, 4OArl4N+, 38Arl5NH*, 36MBCý, 38Ar160*, ! S6rl7QH- 37GI17()- 
Mn 55Mn+ 0 00) 4OArl4NH- 39K16C)-, 37CIISO+ 160H 
I, 
4OArl5N*, 38ArVoý 36k'BOH,, 38Ar 37CI17op-, 
23Na32S+, 
NI 58Ni+ (68-3) 58Fe+ (0.28) 23Na35CI*, 4OAr18O-, 40Ca'80+, 40Ca'70H+, 42Cal6o., 4OAr17OH- 
6ONi* (26.1) 44Cal6C)+, 23Na37CI-, 43Ca160H+ 
6'Ni+(1.13) 44Ca'60H+ 
62Ni+ (3.59) 23Na39K+, 46Cal6()r- 
64Ni+ 0.91)_ 
__! 
4Znýjjq. q) 32 L6Qe 32S; C 
CO 59CO+ (100) 43CaI60- 42Ca16OH* 2CJ4Mg35CI-, 36Ar23Na,, 4OAr16OH* 
Cu 63CU* (69.2) 31PI60e, 4Ok23Na+, 23Na4OCa-, 46Ca'60H*, 36kl2Ci4NH*, 14N12C37Cl- I 16012C35CI. 65CU* (30.8) 32S1602H+, 4OAr25Mg-, 4OCa'60H*, 36Arl4N2H-, 32S33S- . 32SI6017()-, 33S160ro 12C16037CI- 
I 
12C18035CI. 
Zn 64Zn+ (48.6) 64Nil (0.91) 32S160f, 31PI602H+, 48Ca160+, 32S2-, 31PI6017()+, 34S1602+, 36kl4N2+ 
66Zn* (27.9) 34S1602+, 33S1602H-, 32SI60180+0 32S170g+1 33S160170+, 32S34S-, 33S2* 
67Zn* (4.1) 35CI160e, 33S34S-1 34SI602H+, 32S1601801-1-, 33S34S+, 34S16Oi7O+, 33S160180+. 
32SI7018()+, 33S1702+, 35CI1602+ 
68Zn+ (18.8) 36S160r, 34SI60180+ 
I 
4OAi4N2+, 35CI16017C)-, 34S2+, 36Ar32S-, 34S1702-, 33S170180-, 
32S18O2+, 32S36S+ 














73Ge+ (7.8) 36Ar2H+ ' 37C[1802-, 36Ar37C[-, 38Ar35C[* ' 4GAr33S- 
74Ge+ (36.5) 74Se+ (0.9) 40Ar34S*, 36Ar38Ar- , 37CI37CI-, 38Ar36S* 
76Ge* (7. 76Se* (9.0) 36Ar4OAr+, 38Ar38Ar 40Ar36S+ 
Se 74Se+ (0.9) 74Ge+ (36.5) 37Cl2+, 36Ar38Ar+, 38k36S*, 4OAr34S* 
76Se* (9.0) 76Ge* (7.8) 4OAr36Ar *' 38Arr 
77Se+ (7.6) 4Ok37CI*, 36Ar4OkH*, 38Ar2H*. 12C19F14N16O2+, 
78Se+ (23.6) 78Kr+ (0.35) 4Ok38Ar+, 38Ar4OCa+ 
8OSe+ (49.7) 8OKr+ (2.25) 4Ok2+, 32S160r 
12C35CI2-, 34Sl6O3- 4OAr2H2* 
MO 92MO+ (14.8) 92Zr, (17.2) 
94Mo* (9.25) 94Zr+ (117.4) 39K2160- 
95Mo- (115.9) 4OAr39K16O- 
96Mo+ (16.7) 96Zr, (2.8), 96Ru* (5.52) 39K41KI6(),, 
97MO- (9.55) 4Ok2i6OH*, 4OCa216OH*, 40AOIK16(y 




In 1131n* (4.3) 113Cd* (12.2) 
. 
MW ( 5.7) 






Instrumental parameters, such as the size of the cone apertures, the carrier gas flow rate, the 
RF power and sample uptake rate also influence the presence and magnitude of spectroscopic 
effects. It is therefore important that for each different sample matrix, the instrument is 
optimised and non-spectroscopic (matrix) effects are characterised and, where appropriate, 
corrected for. In this work four methods for correcting matrix effects are used: 
0 sample dilution; 
0 matrix matching, whereby matrix matched standards are used. This is typically only 
suitable for simple matrices such as waters and digested samples; 
* the method of internal stanclardisation. In this method, a known amount of a non 
endogenous element is added to all samples and standards. During analysis, the 
internal standard elements are affected by the matrix in the same way as the analyte 
elements. It is therefore important that the mass range of the internal standards covers 
the same as the analyte range. The signal of the analyte elements in the samples and 
standards is divided by the internal standard signal and the ratio is used to correct the 
ion count signals (Adair, 2002). This therefore enables correction for both random and 
systematic variations; and 
0 the method of standard addition is used to correct for unknown matrix effects, where a 
known concentration of anaýte is added to the sample and hence suffers the same 
effects. 
2.5.4 Instrumentation Optimisation - Finnegan Mat SOLA ICP-MS 
It is cited in the literature that the major instrumental factors affecting ICP-MS analysis are the 
forward power (RF) applied, the nebuliser gas flow rate and the scan parameters. The forward 
power and scan parameters of the SOLA have been investigated previously and therefore 
optimisation was not carried out in this work (Stovell, 1999; Adair, 2002). The selected 
parameters are listed in Table 2.4. However, the concentric nebuliser chosen for this work is 
not well-characterised and therefore the nebullser flow rate was optimised. 
Table 2.4 Measurement parameters selected for the Finnegan Mat SOLA ICP-MS. 
Measurement Parameters 
Detector Electron Multiplier 




Analyte Isotopes 51V-, 53Cr-, 55Mn- , 58Ni*, 
63CU-, 68Zn*, 82Se*, 98Mo+1 206Pb+, 207Pb* I 208Pb* Internal Standard Isotopes 59co*1 74Ge+1 '151n-, 2MBi+ 
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2.5.4.1 Optimisation - nebuliser flow rate 
A 100 ýtg 1-1 solution of all analyte and internal standard elements was measured at various 
nebuliser flow rates. Figure 2.17 is a three dimensional mesh plot obtained when plotting the 
element mass (x axis) versus the nebuliser flow rate (ml min-') (y axis) and ion count rate (z 
axis). The contour plot shows increased ion count rates of the nebulisation sample solution 









Figure 2.17 Ion count rate, versus element mass and nebuliser flow rate for optimisation of the SOLA ICP- 
MS nebuliser flow rate. 
2.5.4.2 Optimisation -washout 
A 50 pg 1-1 solution of Cu, Cr, Mo, Mn, Ni, Se, Pb, V and Zn was aspirated into the plasma for 
a duration of 5 minutes and analysed. Then a washout solution of the diluent (either 1% nitric 
acid or ABD) was then aspirated and analysed repeatedly using the analysis parameters listed 
in Table 2.4. The time taken for the count rate to decrease to the blank level was noted. This 
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2.5.4.3 Optimisation - sample analysis parameters 
The sample uptake rate, when analysing biofluids, has been well characterised by previous 
work and is known to be 90 seconds for a pump rate of 10 rpm, for 1: 10 diluted samples 
(Stovell, 1999; Adair, 2002). Given this information and the optimised washout time, a standard 
sample analysis run procedure was established, as summarised in Table 2.5. 
Table 2.5 Run procedures for the different sample matrices on the Finnegan Mat SOLA ICP-MS. 
Optimised Run Procedure 
Sample uptake time / mins 2 
lCP-MS run procedure duration / mins 3.5 
Washout time / mins 5 
Total analysis time per sample / mins 10.5 
Daily maintenance when analysing biofluids is extensive, involving the cleaning of the sampler 
and skimmer cones before analysis. Their installation affects the ion beam properties, and 
therefore before each day of analysis the ion lenses were tuned to optimise the signal intensity 
of the analyte elements by monitoring the response on 1151n+ as this is in the centre of the mass 
range. Tables 2.6 lists the instrument properties relating to the SOLA. Table 2.7 lists the 
optimised instrument parameters including typical values for the lens settings. 
Table 2.6 SOLA instrument properties. 
Instrument Properties 





Table 2.7 Typical SOLA hardware and tuning settings. 
Hardware Settings 
Incident Power 1.5 kW Focus 7.63 
Reflected Power 0W Match 5.05 
Coolant Flow 16 1 min-' Pole Sias 2.96 
Intermediate Flow 1.21 min-' Filter 9.9 
Nebuliser Pressure 1.95 bar Interspace 10 
Pump Speed 10 rpm Discriminator 0.4 
Resolution 32 Multiplier voltage 4.5 
Y-steer 6.2 Spectrum/Integral Spectrum 
Y-defiection 4.55 Vacuum 1 0.0 X 10-3 mbar 
X-deflection 5.85 Vacuum 2 2.6 x 100 mbar 
Extraction 2.8 Vacuum 3 1.5 x 10-5 mbar 
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2.5.5 Analysis Procedures and Calculations 
The data output from the SOLA in terms of intensity value (counts per second) for each isotope 
was printed via a computer. The intensity values were then entered into a Microsoft@ Excellm 
spreadsheet and the data evaluated as follows: 
" internal standard (IS) corrected; 
" blank corrected - for standards using either 1% HN03 or ABD or a digestion blank for 
digested samples; 
" calibration curves plotted and the resultant least squares fit line obtained for each 
element (see Equations 2.6 and 2.7); 
" Pearson's correlation coefficients obtained for each least squares line fit (Equation 2.8) 
" sample intensity fifted to the least squares line fit (Equation 2.7); and 
41 calculated concentration corrected for dilution volume and mass of sample and 
reported as either Itg 1-1 or mg 1-1. 
2.5.5.1 Internal standard correction 
The use of internal standards to correct for changes in sample composition has been discussed 
in section 2.5.3.2. The internal standard isotopes and the analytes they were used to correct 
for are listed in Table 2.8. 
Table 2.8 Internal standard isotopes and the corresponding analyte element isotopes they are used to 
correct for. 
Internal Standard Isotope Analyte Element Isotope Corrected by Internal Standard Isotope 





209Bi* 206Pb-, 207Pb*. 20BPb* 
Inherent changes in the instrument throughout sample analysis occur and cause the instrument 
to drift, i. e. not stay constant throughout the analysis of samples. The use of internal standards 
was used to correct for such drift as well as small changes in sample matrices. An internal 
standard of constant concentration can either be added to all standards, blanks and samples or 
run on-line. The signal for the internal standard can then be monitored at the same time as the 
elements of interest. The appropriate internal standards were chosen and serve to represent 
the analyte mass range, thus a solution containing 100 pg 1-1 59CO, 74Ge, 1151n and 209Bi 
prepared from 10000 mg 1-1 Aristar@ standards (BDH, Poole, UK) in either ABD or 1% HN03 
was used on-line with all sample solutions. Figure 2.19 shows a plot of the signals of the 
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Figure 2.19 Plot of the signals of the internal standard 59Co* and the analyte 63Cu+ over a period of 
analysis. 
A drift in signal that cannot be attributed to analyte concentration can be seen as an increase 
or decrease in internal standard value. By means of calculating the ratio of the internal 
standard signal to the average internal standard signal, a correction can be made; and this is 
used to correct for each analyte in turn as follows: 
average IS signal ,x analyte signal = corrected analyte signal Equation 2.12 
IS signal for sample. 
The corrected analyte signal along with the corrected internal standard signal has been plotted 
versus analysis time in Figure 2.20. Any deviation in the analyte signal due to instrument drift 
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Figure 2.20 Plot of the corrected signals of the internal standard 59Co+ and the analyte 63CU+ over a period 
of analysis. 
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In some cases it was appropriate to correct for the internal standard signal using the ion counts 
produced within a 'block' of analysed samples. Figure 2.21 shows a plot of the signals of the 
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Figure 2.21 Plot of the signals of the internal standard 59Co+ and the analyte 63CU+ over a period of 
analysis, vAth block sections A-D marked. 
21: 36 
Block A was considered first, as this contains the calibration data. The analyte signals in this 
block were corrected as in Equation 2.12, using the average signal of that block only. Thus an 
average IS signal for block A was determined. Block B, then C then D were corrected in the 
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Figure 2.22 Plot of the block corrected signals of the internal standard 59Co+ and the analyte 63CU+ over a 
period of analysis, Wth block sections A-D marked. 
In order for all data to be corrected so that the internal standard signal is the same as block A, 
which contains the calibration, the ratio of block A to block B, C or D ("n") was calculated and 
multiplied by the corrected data. Thus the methodology can then be applied for any number of 
blocks, and is shown by Equation 2.13. 
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Block "n" average IS signal x analyte signal x rblock A average corrected signal 




The resultant data is shown in Figure 2.23. Hence a chart similar to Figure 2.20 was produced 
showing all analyte data corrected according to the same internal standard signal, but with the 
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Figure 2.23 Plot of the corrected signals of the internal standard 59Co* and the analyte 63CU+ over a period 
of analysis. 
2.5.5.2 Calibration 
The instrument was calibrated before analysis using 0,5,10,25,50 and 100 ýtg 1-1 multi 
element mixed standards prepared from 10000 mg 1-1 Aristaro single element standards (BDH, 
Poole, UK) for Cu, Cr, Mn, Mo, Ni, Pb, Se, V, and Zn, diluted using the matrix matched diluent 
(11 % HN03 or ABID). 
The calibration curves were obtained using Microsoft@ ExceITM for the IS corrected signal 
counts obtained by the instrument plotted against the actual elemental value (ýLg 1-1). The 
resultant curves were used to determine the amount of analyte in each sample. Examples of 
typical calibration curves obtained for lead, selenium and zinc are shown in Figure 2.24. Also 
highlighted on these curves are the calculated linear regression equation and Pearson's 
correlation coefficient (R2), calculated as in Equations 2.6 to 2.8. All lead determinations were 
made as a sum of the signals from 206Pb, 207Pb and 208Pb, due to the low ion count rates at the 
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Figure 2.24 SOLA ICP-MS calibration curve for 68Zn+, 82Se+ and Pb (as the sum of 206Pb+, 207Pb, 208Pb+). 
2.5.5.3 Limit of detection 
The limit of detection (LOD) for analytes measured by the SOLA was calculated by Equation 
2.5. Values obtained for each matrix are set out in Table 2.9. 
Table 2.9 LOD for all i3otopes in the ABD and 1% HN03matrices, a3 determined by the SOLA lCP-MS. 
Anal)qe BD LOD " 1-1 1% HN03 LOD gg 1-1 
51v. 0.8 2.4 
53Cr+ 2.5 42 
55Mn+ 2.34 4.2 
58Ni* 54.45 12.6 
63CU- 9.5 11.2 
68Zn+ 27.2 19.6 
82Se+ 2.8 3.1 
98mo+ 1.7 1.3 
Pb 10.1 2.9 
2.5.6 Analysis of Biological Fluids 
2.5.6.1 Method of standard addition to investigate matrix effects 
The method of standard addition has been described in section 2.4.5 and was applied to both 
digested whole blood samples and diluted blood serum and plasma samples. Figure 2.25 
shows the standard addition curves for copper and selenium in a digested whole blood sample. 
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Figure 2.25 Standard addition curves for the determination of copper and selenium by SOLA ICP-MS in a 
digested whole blood sample. 
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The copper concentration determined by calibration was 38.7 ýtg 1-1 and the concentration from 
standard addition was 45.2 ýtg 1-1. The selenium concentration determined by calibration was 
6.1 [tg 1-1 and the concentration from standard addition was 12.6 ýLg 1-1. The method of standard 
addition was carried out for four digested whole blood samples. The values obtained from both 
the calibration and the method of standard addition are summarised in Table 2.10. 
Table 2.10 Digested whole blood sample concentrations obtained from the SOLA ICP-MS from calibration 
I and method of standard addition calculations. 
Sample Method Isotopic Concentration 
/ lag 1-1 
51V+ 53Cr, 55Mn+ 58Ni+ 63CU+ 68Zn+ 82Se+ 98Mo+ SUM Pb 
1 Calibration <LOD 57.8 63.7 167.8 43.9 232.6 5.3 <LOD 2.4 
Std addition <LOD 45.6 53.2 155.2 50.7 280.5 11.5 <LOD 3.1 
2 Calibration <LOD 51.9 56.1 83.5 44.1 211.0 3.3 <LOD 2.9 
Std addition <LOD 67.3 47.6 88.8 47.4 240.6 9.3 <LOD 3.3 
3 Calibration <LOD 66.0 74.4 118.8 34.9 281.3 4.6 <LOD 3.1 
Std addition <LOD 67.4 91.7 162.5 58.1 434.6 10.7 <LOD 5.2 
4 Calibration <LOD 61.9 67.3 131.6 38.7 462.3 6.1 <LOD 4.1 
Std addition <LOD 54.1 66.3 155.8 45.2 590.0 12.6 <LOD 4.8 
LOD = limit of detection (see Table 2.9) 
Figure 2.26 shows the standard addition curves for Cu and Se in diluted blood plasma. The 
copper concentration determined by calibration was 142.6 lag 1-1, and the concentration from 
standard addition was 126.6 4g 1-1. The selenium concentration determined by calibration was 
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Figure 2.26 Standard addition curves for the determination of copper and selenium by SOLA ICP-MS in a 
diluted blood plasma sample. 
The method of standard addition was carried out for two diluted blood plasma samples and one 
diluted blood serum sample. The concentrations obtained from the calibration and the method 
of standard addition are summarised in Table 2.11. 
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Table 2.11 Diluted blood plasma and serum sample concentrations obtained from the SOLA ICP-MS from 
calibration and method of standard addition calculations. 























2 Calibration 1.6 17.9 <LOD <LOD 60.3 62.7 10.3 <LOD <LOD 
Plasma Std addition 3.6 46.5 <LOD <LOD 46.5 70.6 14.4 <LOD <LOD 
3 Calibration 1.5 20.2 <LOD <LOD 139.8 69.8 10.7 <LOD <LOD 
Serum Std addition 4.0 48.0 <LOD <LOD 137.0 84.9 11.3 <LOD <LOD 
LOD = limit of detection (see Table 2.9) 
A Paired Mest (see Equation 2.9) was conducted to evaluate any statistical difference between 
the calculations obtained from the calibration or the method of standard addition. The 
calculated value for t (6c) was found to be 1.91 and the critical value for t (6. ) was 2.14 at the 
95 % confidence interval (P<0.05) for 14 degrees of freedom (n = 15). Thus 6"< 6 so the null 
hypothesis is retained, indicating that there is no statistical difference between values obtained 
from the calibration curve and the method of standard addition at the P<0.05 level. It can 
therefore be concluded that the calibration matrix is adequately matched to the sample matrix. 
2.5.6.2 Quality control - spike recoveries 
Quality control analysis was undertaken for the SOLA lCP-MS procedures by means of spike 
recovery experiments. Each sample was spiked with 50 Vg 1-1 V, Cr, Mn, Ni, Se, Mo and Pb; 
and 500 gg 1-1 Cu and Zn. The recoveries were then calculated according to Equation 2.10. 
Values obtained for digested whole blood samples are given in Table 2.12 and for diluted blood 
plasma in Table 2.13. Acceptable percentage spike recovery values are between 75% and 
125% (Prichard et aL, 1996). All values obtained for the SOLA lCP-MS fall within 90-110% 
which indicates good analyte recovery. 
Table 2.12 Spike recovery values for digested whole blood samples by the SOLA ICP-MS. 
average ± range (n=4)] 
51v+ 53Cr#, 55Mn+ 58Ni+ 63C U+ 6BZn+ 82Se+ 98MO+ Pb 
Average % 99.5 99.8 97.2 99.9 99.5 99.1 101.1 100.3 99.2 
+/-% 1.2 1.2 4.45 1.2 1.1 2.2 3.4 0.9 1.0 
Pb as the sum of 2mPb*, 207Pb* and 208Pb*. 
Table 2.13 Spike recovery values for dil uted blood serum samples by the SOLA ICP-MS. 
average ± range (n=4)] 
5IV+ 53Cr+ 55Mn+ 58Ni+ 63CU+ 6OZn+ 82Se+ 98MO+ Pb 
Average (n=3) 100.1 98.7 102.8 100.3 100.5 99.89 103.6 100.2 99.9 
1.0 3.5 3.7 0.7 0.3 0.6 7.5 1.6 0.9 
Pb as the sum of 206Pb-, 207Pb+ and 208Pb* 
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2.5.6.3 Precision (repeatability) 
The precision of the method was evaluated by repeated analysis of the same sample 
throughout a period of analysis, generating a ±%RSD value (see Equation 2.11). The data 
obtained for copper, zinc and selenium are listed in Table 2.14. 
Table 2.14. Copper, zinc and selenium data for the repeated analysis of diluted blood serum and digested 
whole blood, where n= number of determinations. 
Element Matrix n Average % ±RSD 
63CU- ABD 7 88.6 2.7 
1% HN03 4 25.5 3.6 
68Zn* ABD 7 73.1 2.8 
1% HN03 5 27.4 3.9 
82Se* ABD 7 5.2 5.4 
1% HN03 5 27.2 6.1 
The %RSD values for determinations of serum in ABD are lower than those of digested whole 
blood (1% HN03 matrix). This difference can be attributed to the dilution factors: 10-fold for 
serum and plasma using ABD and 20-fold for digested whole blood using DDW. The precision 
levels for copper and zinc were good (<±5 %RSD), whereas they were acceptable for selenium 
(<±6.5 %RSD). 
2.5.7 Analytical Methodology- Perkin Elmer Elan DRC 11 ICP-MS 
A portion of the blood sample population (section 6.2.1) was analysed by a Perkin Elmer Elan 
DRC 11 ICP-MS, which combines a dynamic reaction collision cell and dynamic band pass 
technology. The dynamic reaction collision cell means that as well as standard mode analysis, 
the quadrupole reaction cell can be purged with a variety of gases, e. g. ammonia and methane, 
which are used to remove polyatomic interferences. This lowers the detection limits for most 
elements in ultrapure acid solutions to low or sub ng 1-1 levels. 
2.5.7.1 Instrument optimisation 
Instrument optimisation was carried out by an automated run procedure. This adjusts the x and 
y steer, the nebullser flow rate and the lens voltage. Instrument details and optimised 
parameters are listed in Table 2.15. 
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Table 2.15 Optimised parameters for Perkin Elmer Elan DRC 11 ICP-MS. 
Instrumental Parameters Elan DRC 11 lCP-MS 




Cone Pt tipped Ni 
Incident Power 1.35 kW 
Reflected Power 0W 
Coolant Flow 15 1 min-' 
Intermediate Flow 0.8 CM3 min-' 
Nebuliser Flow (standard mode) 1.02 CM3 min-' 
Nebuliser Flow (DRC mode) 0.99 CM3 min-' 
Lens Voltage 7.20 V 
2.5.7.2 Methods 
All calibration standards and samples were prepared by a 50 fold dilution using the alkali blood 
diluent described in 2.3.1, which in this case also contained the internal standards rhodium and 
indium at a concentration of 50 ýtg 1-1. The isotopes monitored for each element and the 
collision cell modes utilised are listed in Table 2.16. The concentrations obtained for a variety of 
reference materials were then compared with certified values and recommended collision cell 
modes calculated. These are also shown in bold in Table 2.16. 
The calibration range for blood serum, plasma and whole blood was 0.05 ýtg 1-1 to 50 Rg 1-1. 
However the Fe range was changed to 50 - 10000 Rg 1-1 to accommodate the higher Fe 
concentrations expected in whole blood. 
Table 2.16 Conditions for the quadrupole reaction cell in the ELAN DRC 11 lCP-MS, chosen parameters 
selected in bold. 
Element Standard Mode NH3 Collision cell CH4 Collision cell 
v 51v+ 51v* 
Cr 52Cr+ 52Cr+ 
Mn 55Mn+ 55Mn+ 
Fe 57Fe+ 56Fe+ 56Fe+ 
Ni 60Ni* 6ONi+ 
Cu 63CU+ 65CU+ 63CU+ 
Zn 66Zn* 68Zn* 64Zn* 
Se 82Se+ 78Se+ 78Se+ 
Mo 95MO+ 98mo+ 
Pb 208Pb+ 
Rh 103Rh* 
In 1151n* 1151n* 1151n* 
2.5.7.3 Instrument d(ift 
The Elan DRC 11 lCP-MS has the capability to allow samples to be analysed using a greater 
dilution factor than the SOLA. This has the effect of improving instrument stability with a 
65 
reduced risk of clogging the nebuliser, injector and cones. Figure 2.27 shows a plot of the 
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Figure 2.27 Plot of the signals from the Elan DRC 11 lCP-MS of the internal standard 103Rh+ and the analyte 
68Zn+ over a period of analysis. 
The drift in internal standard signal is marginal and the relative standard deviation of the 103Rh+ 
signal is only ± 4.0%. Internal standard correction was applied to the data, as discussed in 
section 2.5.5.1 (Equation 2.12). Figure 2.28 shows a plot of the corrected signals of the internal 
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Figure 2.28 Plot of the corrected signals from the Elan DRC 11 ICP-MS of the internal standard 103Rh* and 
the analyte 68Zn+ over a period of analysis. 
2.5.7.4 Limit of detection 
The limit of detection (LOD) for the isotopes measured by the Elan DRC 11 lCP-MS was 
calculated according to Equation 2.5, the same method as for the AAnalyst 400 spectrometer 
and the SOLA. The calculated LODs are listed in Table 2.17. 
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Table 2.17 LOD for all isotopes as determined by the ELAN DRC 11 ICP-MS. 
Isotope Collision cell mode LOD gg 1-1 
51v. Standard 0.4 
60Ni, Standard 0.4 
63CU- Standard 0.02 
68Zn- Standard 1.6 
82Se* Standard 0.5 
98MO. Standard 0.4 
208Pb* Standard 0.3 
52Cr- Ammonia 0.5 
55Mn* Ammonia 0.1 
56Fe* Methane 0.6 
2.5.7.5 Accuracy 
The accuracy of the Elan DRC 11 lCP-MS was evaluated by the analysis of the NIST 1640 
Trace Elements in Natural Water Standard Reference MateriaR (NIST, USA). The certified 
ranges and measured values are listed in Table 2.18. 
Table 2.18 Certified values for the elements of interest in NIST 1640 Standard Reference Materials and 
values determined by the ELAN DRC 11 lCP-MS. 
51V* 52Cr4 55Mn* 56Fe* 60Ni* 63CU+ 68Zn* 82Se* 98MO+ 208Pb* 
Certified Min gg 1-1 12.62 37.00 120.40 32.70 26.60 84.00 52.10 21.45 46.49 27.75 
Sq_Ljfied Max. "ý' 13.36 40.20 122.60 35.90 28.20 86.40 54.30 22.47 47.01 29.03 
Measured pq 1-1 14.1 45.8 128.7 34.2 27.6 78.2 62.3 22.1 46.4 28.4 
All values are within the certified reference range except those determined for 5'V+, 52Cr+, 55Mn+ 
and 68Zn+. With these elements the determined values are slightly greater than the certified 
maximum values however the difference is not sufficient to question the accuracy of the 
method. A Paired Mest (see Equation 2.9) was conducted to compare the average certified 
value with the measured value for each isotope. The calculated value for t (6c) was found to 
be 1.16 and the critical value for t (6t) was 2.26 at the 95 % confidence interval (P<0.05) for 9 
degrees of freedom (n = 10). Thus 6c< 6-t so the null hypothesis is retained, indicating that 
there is no statistical difference between the certified values and determined values for the 
reference material NIST 1640 at the P<0.05 level. 
2.5.8 Summary of lCP-MS Methodology 
The methodology for the analysis of biological samples by both the SOLA ICP-MS and the 
ELAN DRC 11 ICP-MS has been established. Both instruments were shown to yield good levels 
of accuracy and precision. In Chapter 6 (section 6.2.5) biological reference materials are 
evaluated using the methodology described in this chapter so as to provide a quality control 
evaluation for blood samples taken from diabetic and non-diabetic individuals. 
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2.6 Blood Sample Collection 
Blood samples were required for trace element analyses and the measurement of blood 
glucose levels and serum urate. Cornelis et aL (1995) reviewed the possible sources of 
contamination and precautions for blood sample collection. They suggested that all stages of 
sample collection should be evaluated with respect to contamination studies, namely: collection 
containers, anticoagulants and needles. In this work such factors are reviewed in this section. 
Cornelis et al. (1995) also recommended that careful separation procedures for acquiring 
serum and plasma samples are adopted, such that no haemolysis of the sample occurs. For 
this reason any separations conducted in this work were carried out directly according to the 
manufacturer's instructions. 
2.6.1 Samples Required 
Three types of samples were required: trace elements were determined in blood serum, 
plasma and whole blood; uric acid in blood serum; and blood glucose in whole blood. 
2.6.2 Evaluation of Collection Containers 
Evacuated blood collection tubes are the sample collection devices of choice for the majority of 
healthcare professionals. There are two major manufacturers - Vacuette@ and Vacutainer@ and 
both have previously been used for trace element work at the University of Surrey (Stovell, 
1999; Adair, 2002), hence they were chosen as the sample collection devices of choice in this 
work. 
Six types of Vacutainerl& (BD Diagnostics, Oxford, UK) were obtained for assessment of 
suitability to the study, listed in Table 2.19 and shown in Figure 2.29. 
Table 2.19 VacutainersOD characterised for sample collection 
Sample Type VacutainerO Type Additives Tube Code 
rum Serum Separation Tube Clot Activator SST 11 Plus 
Serum Serum Separation Tube Advanced Clot Activator SST 11 Advance 
Plasma K3ETDA Plasma Separation Tube K3ETDA Anticoagulant K3E PST 
Plasma Lithium Heparin Plasma Separation Tube Lithium Heparin Anticoagulant LH PST 
Whole blood Sodium EDTA Whole Blood Trace Elements Na-ETDA Anticoagulant EDTA TE 
Whole blood Sodium Heparin Whole Blood Trace Elements Sodium Heparin Anticoagulant NH TE 
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Figure 2.29 Vacutainers@ evaluated in the study (Left to right: SSTII Plus, K3E, PST, ETDATE, SST 11 
Advance, LH PST, NH TE). 
The contamination due to the tubes was evaluated using synthetic blood serum. Synthetic 
blood serum was first developed by Vanhoe et aL (1999) for use as the blank when analysing 
trace elements in blood serum. The synthetic serum has the same amount of calcium, 
chlorine, sodium and sulphur as human serum. 
The synthetic blank was prepared as follows from Analar@ reagent grade materials (BDH, 
Poole, UK) in 1% HN03 (Aristar@); 
0.57gl-'Ca(NO3)2-4H20; 
6.0 g 1-1 NaCl; 
3.3 g 1-1 NaNO3; and 
6.6 g 1-1 cysteine - HCI - 
H20. 
A second preparation of this synthetic serum was then spiked with 0.2 gg 1-1 Cr and V, 2 ýtg 1-1 
Mn, Mo, Ni and Pb, 100 gg 1-1 Se and 1000 gg 1-1 Cu and Zn added, in order to mimic the 
typical trace element composition of blood serum. Both the spiked and un-spiked synthetic 
serum are acidic and able to leach metals from plastic and glass surfaces, thereby making 
them ideal for a study of the contaminants present in the sample collection tubes. Although 
they do not represent ideal biological samples, they have been evaluated by previous workers 
to show information of merit (Adair, 2002). 
Each Vacutainer@ was evaluated in quadruplicate for both synthetic serum and spiked synthetic 
serum. A5 ml aliquot of the test solution was added to each tube, then inverted four times and 
left to stand for 4 hours. The samples were then combined and transferred to ElkayTM metal- 
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free 15 ml polypropylene sample tubes for storage until analysis. The evaluation of 
contamination was carried out using the SOLA lCP-MS as described in section 2.5.5. The data 
obtained for the synthetic serum is shown in Table 2.20, where the data has been blank- 
corrected using the synthetic serum. 
Table 2.20 SOLA lCP-MS data for the evaluation of trace element contamination from VacutainersO using 
synthetic serum, all data synthetic serum blank corrected. 
Difference* in elemental concentration I gg 0 
VacutainerO Sample V Cr Mn Ni CU Zn Se Mo Pb 
K3E Plasma 0.7 0.7 15.8 84.5 -33.4 804.9 30.3 -9.1 4 
LH Plasma 2.1 1.2 2.7 84.1 -40.9 207.4 17.3 -8.3 -6.8 
SST 11 Plus Serum 0.2 0.1 1.7 50.4 -22 101.6 6.2 -3 -3.1 
SST 11 Advance Seurm -0.3 0 1.2 35.1 -9 105.7 20 5.2 4.1 
EDTA TE Whole blood 1.8 1.5 1.9 78.7 -90.2 -9.6 17 -7.9 -2.9 
NH TE Whole Blood 1.2 1.6 1 69.3 -27.3 -19.2 17.1 -8.1 -6.9 
* Difference calculated as (synthetic serum from vacutainer - synthetic serum) elemental values. 
The data obtained from the SOLA lCP-MS for the spiked synthetic serum study is shown in 
Table 2.21, where the data has been blank-corrected using the spiked synthetic serum. 
Table 2.21 SOLA lCP-MS data for the evaluation of trace element contaminabon from Vacutainers@ using 
spiked synthetic serum, all data spiked synthetic serum blank-corrected. 
_ Difference in elemental concentration I ýLg 1-1 
VacutainerO Sample v Cr Mn Ni CU Zn Se MO Pb 
K3E Plasma -3.7 -5.85 10 -2.7 -161.3 606.4 -8.9 -3.9 -7.8 
LH Plasma -1.1 . 1.45 -1.8 8.4 -84.5 183.1 -7.6 -5.1 -6.7 
SST 11 Plus Serum -1.9 -4.25 -0.4 7.6 -96.5 16.3 -22.2 -3.5 -8.5 
SST 11 Advance Seurm -1.3 -0.75 0.8 108.2 -85.4 49.7 -8.7 15.6 4 
EDTA TE Whole blood -36.5 -7.55 -8 -32.4 -263.5 -253.9 -33.2 -5.5 -11.4 
NH TE Whole Blood -1.1 4.55 -1.4 10.9 -70.4 -44 -15.3 -3.8 0.55 
* Difference calculated as (synthetic serum from vacutainer -synthetic serum) elemental values. 
The conclusions drawn from the data in Tables 2.20 and 2.21 can be surnmarised as follows: 
0 very little difference in concentration was found for Cr, Mn, Pb and V for all 
Vacutainerss; 
0 Se was found to be elevated in the K3E PST Vacutainer4D, but not in the other 
Vacutainerss which all show similar levels (typical difference -17 ýtg 1-1); 
a Cu levels decreased in all Vacutainers@, but this effect was least with SST 11 Advance, 
NH TE and LH PST; 
a Ni concentrations in synthetic serum show very little difference; 
a Ni concentrations of spiked synthetic serum from Vacutainers@ containing heparin as 
an anticoagulant show nickel contamination; and 
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0 Zn levels are elevated to concentrations equal to those of Zn in blood fractions in 
samples from K3E Vacutainers@ý the other tubes show some variation, but this is less 
significant and the tubes showing least variation are NH TE and LH PST, little 
difference is seen between SST 11 and SST 11 Advance samples. 
For these reasons, SST 11 Advance, NH TE and LH PST were used as the Vacutainers@ of 
choice for trace element measurements in serum, plasma and whole blood. 
2.6.3 Sample Storage 
For trace element determinations in blood samples, it is necessary to ensure that the samples 
are separated and stored as soon after collection as possible (Cornelis et aL, 1995). The 
separation of blood serum and blood plasma was carried out according to the procedure 
detailed in Appendix B, namely centrifugation of serum and plasma collection tubes at 2000 xg 
for 10 minutes, between 30 and 120 minutes after collection by venous puncture. 
Ideal storage tubes are metal free polypropylene tubes, which are capable of withstanding the 
recommended < -180C storage condition (Cornelis et aL, 1995; Subramanian, 1995). In this 
work, ElkayTM metal-free 15 CM3 polypropylene sample tubes (Elkay Laboratory Products ( UK) 
Ltd., Basingstoke, UK) were used to store the samples at a temperature of -200C after 
collection and separation, prior to analysis (Adair, 2002, Stovell, 1999). As recommended, 
polypropylene pipette tips were used to transfer the samples from collection tube to the storage 
vessels (Cornelis et aL, 1995). 
2.6.4 Needles 
Two types of needles have been investigated for use in the study, namely the Vacutainer@ 
needle (BD Diagnostics, Oxford, UK) and the Vacuette@ collection set with luer adapter 
(Greiner Bio-One Ltd, Stonehouse, UK). Both are designed for use with evacuated blood 
collection tubes and the principle of operation is also the same. The needle has a sharp point at 
both ends, the shorter end being covered by a rubber sheath. The longer end is used for 
venous penetration and the shorter end is used to pierce the rubber stopper of the vacuum 
tube. The sheath over the shorter needle enables the withdrawal of several tubes of blood 
(multi-draw). The Vacutainer@ needle is a straight through needle, where as the Vacuefte@) 
collection set has a section of tubing between the two needles. In this study, a 21 gauge needle 
was used (0.8 mm lumen), see Figure 2.30. 
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Figure 2.30 Venous puncture needles - Vacuette@ (left), Vacutainer@ (right). 
The risk of trace element contamination from the needles was assessed using the same 
synthetic serum and spiked synthetic serum solutions described previously in section 2.6.2. In 
duplicate, three aliquots; of 5 CM3 of each solution were drawn through the needle and into the 
Vacutainers@. The duplicates were then pooled and analysed by the SOLA ICP-MS for the 
elements of interest. The data generated was evaluated by a Student t- test, (95% confidence 
interval (P<0.05), 16 degrees of freedom) and the data summarised as follows: 
no statistical difference between the synthetic serum from each needle type 
(Tcalc = 0.372 <Tit = 2.120); and 
no statistical difference between the synthetic serum from each needle type 
(Tcaic = 0.008 <Tcrit = 2.120). 
It can therefore be concluded that either needle may be used for trace element determinations. 
In summary, the two, the Vacutainer@ needle was chosen as this was the recommended needle 
for use with the Vacutainer@ tubes. 
2.6.5 Venous Puncture 
Venous blood samples were taken with the donor in a sifting position, in accordance with 
current NHS guidelines. This involves inspecting the veins, applying a tourniquet and checking 
the vein to be punctured (which should be firm and bouncy). The venous puncture is then 
carried out by inserting the needle (bevel side up) into the vein at an angle of 30 to 45 degrees. 
The collection device is then applied to the other end of the needle and the vacuum withdraws 
the blood sample from the arm. The Vacutainer@ system is designed such that the blood flow 
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will decrease when the Vacutainer@ is at a full capacity. Once all the samples have been taken, 
the tourniquet is released and a portion of cotton wool applied over the needle. The needle is 
then withdrawn and pressure is applied to the puncture site using the cotton wool. Clotting 
should occur within 30 to 60 seconds, when a sticking plaster should be placed over the site. 
2.6.6 Protocol 
The sample collection protocol has arisen from the investigation of the sampling equipment, 
and also the requirements for venous blood collection in agreement with the ethical permission 
granted for the work, which can be found in Appendix B. The standard operating procedure for 
the collection of blood samples used throughout this work can be found in Appendix B. 
2.7 Summary 
The analytical techniques and methodology described throughout this chapter provide a full 
range of tools which can be used to investigate the effect of antioxidants and trace elements on 
blood glucose sensors. 
The electrochemical techniques including voltammetric, potentiometric and amperometric are 
used throughout chapters 3 to 5 for the investigation antioxidants 
The operation of the standard laboratory YSI blood glucose sensor and conventional blood 
glucose monitors (Lifescans UltraTm) for self monitoring by diabetics has been discussed 
(section 2.1.8). The Ultra TM meter has been used throughout this work to determine the glucose 
concentration of samples prepared in BR buffer and whole blood. The linear range of both 
sensors covers the normal physiological range, negating the need for any sample dilution. 
UVNis spectroscopic techniques have been used to evaluate the antioxidant composition of 
samples, and Ellman's assay for thiols and the InfinityTM uric acid assay for uric acid have been 
optimised (section 2.2) 
The influence of the trace element composition of blood on blood glucose sensors, such as 
Ultra TM , prescribed the need to develop suitable sample collection (section 2.6) and preparation 
(section 2.3) methods. 
The sample collection method was evaluated With respect to trace element contamination of all 
equipment used to obtain the samples and resulted in the choice of 3 types of Vacutainer@ to 
obtain the samples, namely the SST 11 Advance for serum, the LH PST for plasma and the TE 
NH for whole blood. The samples were then separated according to the developed protocol 
and stored in metal-free ElkayTM tubes at -200C until analysis. Sample preparation methods for 
blood plasma and serum were developed and involved the dilution of the samples 10-fold With 
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an alkali diluent comprising 5g 1-1 25% ammonia solution, 5g I-' methanol, 0.5 g 1-1 EDTA 
disodiurn salt and 0.5 g 1-1 Triton X-100. Whole blood samples were digested using an 
established method using nitric acid / hydrogen peroxide under reflux conditions (Heales, 
2003). 
The elemental composition of prepared blood samples was determined by FAAS (section 2.4) 
and lCP-MS (section 2.5). Each of these elemental techniques has been evaluated with 
respect to analysis parameters, interferences, calibration, correction methods and quality 
control and the figures of merit for both methods were reported in their respective sections 
(sections 2.4 and 2.5). Biological sample reference materials were analysed in tandem with 




Selective Detection of Antioxidants: 




The aim of this work was to investigate the amperometric response of the physiologically 
relevant thiols cysteine and glutathione in the presence of benzoquinone, to investigate the 
reaction between the thiol and the quinone by electrochemical means, and to evaluate the 
potential for transferring the developed methodology to screen printed electrode sensors. 
Thiols are biologically significant electrochemically active antioxidants. Despite being 
electrochemically active they require high potentials to be applied for their measurement This 
makes their electrochemical detection challenging, hence the analysis of thiols is typically 
restricted to spectroscopic assays or chromatographic techniques as reviewed in Table 3.1. 
Table 3.1 Available methods for thiol detection in biological fluids. 
Method Detection Sample Analyte Reference 
Fluorimetry Fluorimetry CSF* Cysteine, Patsoukis and Georgiou (2005) 
Glutathione, 
N-Acetylcysteine 
Fluorimetry Fluorimetry Plasma Glutathione Wang et al. (2005) 
Uv / vis LIVNIS Plasma Cysteine, Ellman (1959) 
Glutathione, 
Homocysteine 
RP -HPLC Fluorescence Whole blood Cysteine, Bramanti et a/. (2005) Glutathione, 
Homocysteine 
CE Fluorescence Plasma Cysteine, Carru et al. (2004) 
Glutathione 
HPLC LIV Plasma Cysteine, Bald et al. (2004) 
Glutathione, 
Homocysteine 
Isocratic Fluorescence Plasma Cysteine, Tcherkas and Denisenko (2001) 
RP-HPLC Homocysteine 
* Cerebrospinal fluid 
3.0.1 Biological Significance of Thiols 
Normal concentrations of plasma thiols are shown in Table 3.2. These physiological 
concentrations of the plasma thiols, cysteine (CSH) and glutathione (GSH) are known to be 
significantly depleted under conditions of oxidative stress, i. e. where there is a disturbance in 
the antioxidant/pro-oxidant balance. This condition is a predominant status in individuals 
suffering from diabetes, especially those exhibiting complications which include neuropathy, 
nephropathy, peripheral vascular disease and retinopathy (Lang et al., 2000; West, 2000; 
VanderJagt et al., 2001). 
Table 3.2 Normal plasma thiol concentrations for healthy Individuals (Halliwell and Gutteridge, 2002). 




Plasma thiols are antioxidants and act to protect the body from reactive oxygen species by 
sacrificial oxidation of themselves to the corresponding disulphide, as illustrated in Schemes 
3.1 and 3.2. 





Scheme 3.1 Oxidation of cysteine to cystine. 
H2N, 










Scheme 3.2 Oxidation of glutathione (GSH) to the disulphide (GSSG). 
The correlation of diminished plasma reduced thiol concentration (PSH) with clinical conditions 
has been researched by Elhadd et aL (1999), West et aL (2000) and Lang et al. (2000) and has 
been proven to be a useful measurement. Unfortunately there is no rapid method for the 
analysis of PSH, as current techniques require sample transportation to a central facility, 
followed by analysis, typically by the methods listed in Table 3.1. 
3.0.2 Electrochemical Methods for Thiol Determination 
Numerous electroanalytical strategies have been employed to aid the quantification of the 
various thiols, with the majority utilising voltarnmetric and potentiometric methodologies. Direct 
oxidation of the target analytes at bare electrodes has largely been superseded by the use of 
electrode modifiers, such as metallophthalocyanines (O'Shea and Lunte, 1994; Qi and Baldwin, 
1996; Zhang et al., 1999), mixed valence hexacyanometallates (Zhou and Wang, 1994; Cataldi 
et al., 1998; Shi et ah, 1999) or quinone intermediaries (Lawrence et al., 2000, White et ah, 
2001; White et al., 2002). These are either immobilised in or at the electrode substrate, or 
added to the analysis solution as the basis of an assay. The various merits and limitations 
possessed by these approaches have been reviewed (White et al., 2002). More recently, Joshi 
et al. (2004) have investigated the encapsulation of quinones within ORMOSILs for the 
detection of thiols. They reported a detection limit of 18 nM for cysteine and 36 nM for 
glutathione validated against standard spectrophotometric methodologies. Recent work using 
electrochemical mediatorlindicator species for thiol detection is summarised in Table 3.3. 
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Table 3.3 Electrochemical methods for the detection of thiols. 
Thiol Mediator/Indicator Method Reference 
Cysteine, homocysteine NN-dimethylphenylene- Voltammetry Lawrence at al. (2000) 
1,4-diamine (LSV, CV) 
Cysteine, homocysteine, o-Quinone Voltarnmetry Lawrence eta/. (2001) 
Glutathione (LSV, CV) 
Cysteine Benzoqinone Voltammetry Higneftet al. (2001) 
(LSV, CV) 
Cysteine Various quinones Voltarnmetry White et al. (2001) 
Cysteine, N-acetylcysteine, N, N-diethyl-p- Voltarnmetry Nekrassova etaL (2002) 
Hornocysteine, glutathione, phenylenediamine (LSV, CV) 
Captopril 5,5-dithiobis-2-nitrobenzoic 
acid 
cysteine, glutathione Hydroquinone Potentiornetry Digga et al. (2003) 
Glutathione Benzoquinone Potentiornetry Gracheva et al. (2004)* 
Glutathione, thiolated albumin Naphthoquinone Potentiornetry Yonge et al. (2004)* 
Cysteine Naohthoauinone Potentiornetrv Moorino et al. (2005)* 
* Post-dates the experimental work in this section, CV = cyclic voltammetry, LSV = Linear sweep voltarnmetry 
3.0.3 Mechanistic Approaches 
The electrochemical generation of quinoid intermediates and their subsequent reaction with 
sulphydryl thiols (RSH) have emerged as some of the more promising approaches and have 
been shown to provide a generic route through which the reduced thiols can be quantified 
(White et al., 2001). There are three possible mechanisms through which the quinone species 
could interact with reduced thiols and these are highlighted in Scheme 3.3. 
Firstly, the electro-g en e rated quinone component (1) could interact through simple redox inter- 
conversion of the thiol to the corresponding disulphide and hydroquinone (11) derivative (Path 
1). However nucleophilic addition of the thiol species to the electro-generated quinoid structure 
(1) has been proposed, which subsequently leads to the production of a chemically reduced 
adduct (Path 2,111). Secondly, re-oxidation (Path 3,111 --- . IV) at the electrode leads to an 
amplification of the oxidative current which can be correlated to the thiol concentration of the 
analysis medium. 
RSSR 2 RSH RSH 
H0 OH 0 
SR SR 
G) HIo OH 0 
(11) L: l (111) (IV) 
Scheme 3.3 Possible reaction pathways for thiols in benzoquinone mediated systems. 
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Alternatively, exploiting the direct reaction where the electro-initiation stage is removed, the 
amperometdc analyfical signal would arise simply from the re-oxidation of the hydroquinone- 
thiol conjugate (111). This would eliminate the need for potentiometry, simplifying the mode of 
action of the sensor and also its construction. 
3.1 Experimental Details 
All reagents were of the highest grade available and used without further purification. All 
solutions and subsequent dilutions were prepared daily using deionised water. Electrochemical 
measurements were conducted using a pAutolab computer-controlled potentiostat. An initial 
cell volume of 10 CM3 was generally used and the measurements recorded at a temperature of 
20oC ± 20C. A three-electrode system was used throughout and was comprised of a GCE 
working electrode, a Pt wire counter electrode and a AgjAgCl reference electrode. Rotating disk 
experiments were conducted using the electrode configuration detailed above and a BAS RDE- 
1 system operating at 5000 rpm at a fixed potential of +OAV was utilised for the steady state 
amperometric measurements. Square wave voltammetry was also conducted using the RIDE 
GCE (25 CM3 cell volume, frequency 50 Hz, initial potential +0.5 V, final potential -0.5 V, ) with 
each scan conducted in triplicate with the electrode polished (1 pm alumina, Buehler, UK) and 
sonicated between each measurement (see section 2.1). Screen printed electrodes were 
prepared using proprietary technology (Lifescan@ Scotland Ltd.. ) akin to that used for 
commercial glucose sensing strips and consisted of a two electrode assembly (JMM2 carbon 
and a AgjAgCI paste electrode). Unless specified otherwise, the electrochemical solutions 
consisted of Britton-Robinson buffer, as described in section 2.1.2.4. 
3.2 Results and Discussion 
3.2.1 Amperometric Response of Thiols 
The steady state response of glutathione at a rotating GCE (GC-RDE) poised at +0.4 V in pH 7 
Britton-Robinson buffer is shown in Figure 3.1. Increasing aliquots of the thiol (50 0,0.01 M) 
were added to the solution and are indicated by the arrows, but it can be seen that there is very 
little change in the amperometric trace. The experiment was repeated with benzoquinone 
(200 gM) added to the solution prior to the addition of the thiol. A low current was observed in 
the initial stages as the mediator is already present in the oxidised form. The addition of the 
thiol to the solution, however, resulted in consecutive increases in the current that were 
substantially greater than those observed in the absence of the quinone. It was anticipated that 
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upon introducing the thiol component to the solution, nucleophilic addition to the quinone 
occurs resulting in the production of the hydroquinone-thiol conjugate (Lawrence et al., 2001). 
The increase in the current was attributed to the re-oxidation of the conjugate as shown in 
Scheme 3.3 (Path 3 111 --+ IV). 
Figure 3.1 Steady state amperometric responses of a glassy carbon electrode (+0.4 V, 5000 rpm) to 
consecutive additions of 20 jaM glutathione in the presence and absence of 200 gM 
benzoquinone in pH 7 buffer. 
The potential for this process to be exploited as the basis of an electroanalyfical approach was 
briefly assessed through increasing the concentration of the quinone. The steady state 
response of glutathione (20 ýLIVI additions) recorded at the GC-RDE in the presence of 2 mM 
benzoquinone is shown in Figure 3.2. Increments of 20 ýM glutathione were added and it can 
be seen that providing the quinone is in massive excess, as in this case, a linear response to 
thiol concentration could be achieved, with a correlation coefficient (R2) of 0.9999 (Equation 
2.8). A detection limit of 0.4 ýLIVI (Equation 2.5) was found and falls within a range that is 
appropriate to the monitoring of extra-cellular glutathione concentrations of approximately 1-2 
ýW (Elhadd et aL, 1999; Lang et al., 2000; West 2000; VanderJagt et al., 2001). 
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Figure 3.2 Steady state amperometric linear response of a glassy carbon electrode (+0.4 V, 5000 rpm) to 
consecutive additions of 20 jaM glutathione in the presence of 2 mM benzoquinone. 
3.2.2. Reaction Stoichiometry and Mechanistic Rationalisation 
A differential in the responses obtained from the reactions of benzoquinone with cysteine and 




Figure 3.3 Quantitative analysis of the steady state responses of a glassy carbon electrode (+0.4 V) to 
increasing additions of glutathione and cysteine in the presence of 200 ýN benzoquinone (BQ). 
This illustrates a 1: 1 stoichiometry for the reaction of glutathione With benzoquinone, ruling out 
path I and supporting path 2 (Scheme 3.3). The reaction stoichiometry for cysteine was found 
to be 1: 2 (thiol: quinone). 
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The discrepancy in the reaction stoichlometries was investigated further by considering the 
potentiometric response of an equi-molar (200 ýLM) hydroquinone/benzoquinone solution to 
increasing aliquots of cysteine. The reaction of the thiol with benzoquinone to yield the reduced 
form of the conjugate (IV) depletes the concentration of quinone and thereby leads to an 
increase in the hydroquinone/benzoquinone ratio. This subsequently leads to a decrease in the 
electrode potential which can be related to concentration of benzoquinone, and therefore also 
the concentration of the thiol. 
The data obtained from the addition of 12 RM aliquots of cysteine to the hydroquinone/ 
benzoquinone system, every 60 s, is shown in Figure 3.4a. A quantitative representation of the 
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Figure 3.4 (A) Steady state potentiometric response of a glassy carbon electrode towards 200 gM 
hydroquinone/ benzoquinone after the addition of cysteine (12.5 AM aliquots). 
(B) Experimental/ theoretical comparison of the response assuming ai cysteine :2 
benzoquinone reaction stoichlometry. 
The theoretical electrode response is included for comparison and serves to confirm the 1 
cysteine to 2 benzoquinone reaction stoichiometry, which can be attributed to chemical 








Scheme 3.4 Path 3 of Scheme 3.3 indicating ring closure with cysteine being the ring adduct. 
The condensation of the amino group with the quinone carbonyl (Scheme 3.4, structure V) has 
been proposed (Digga et al., 2003) and has subsequently been investigated (Gracheva et al., 
2004; Gracheva et al., 2005). The role of the amino group in controlling the reaction 
stoichiometry was corroborated by examining the response to N-Acetyl cysteine, shown in 
Figure 3.5. The presence of the blocking substituent on the nitrogen resulted in an 
amperometric response that mirrored that of glutathione, with a 1: 1 reaction stoichiometry 




Figure 3.5 N-Acetyl Cysteine. Figure 3.6 Comparison of the reaction st6ichiometries of cysteine, 
glutathione (GSH) and N-acetyl cysteine. 
The failure of glutathione to undergo the intra-molecular reaction despite the presence of a 
terminating primary amino group can be attributed to the fact that it is incapable of forming the 
six member ring (Scheme 3.4, V) and while the peptide contains a cysteinyl residue, its amino 
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group is bound within the peptide linkages and therefore unavailable for reaction with the 
quinone carbonyl. 
The complexity of the thiol: benzoquinone interaction was investigated further through 
examining the square wave voltammograms (SWV) resulting from the consecutive additions of 
thiol to a solution containing 200 gM benzoquinone. The resulting scans are compared in 
Figure 3.7 for cysteine and glutathione. 
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Figure 3.7 Square wave voltammograms detailing the response of a glassy carbon electrode to the thiols 
in the presence of benzoquinone. 0-400 gM cysteine (Cy, red) and 400 ýLM Glutathione (GSH, 
Blue). 
The initial SQV (commencing from +0.25 V and terminating at -0.5 V) produced a single redox 
process (403 V) corresponding to the reduction of benzoquinone. Upon the addition of 
cysteine (100 ýM aliquots) to the solution, a multitude of signals were produced indicating that 
there are a number of intermediates present both in the solution and adsorbed at the electrode 
surface. The voltammograms recording the introduction of excess glutathione (400 ýW) to fresh 
benzoquinone markedly contrasts the response to cysteine in that a single redox process was 
observed. This indicates that the proposed reaction outlined above in Scheme 3.3 holds for 
glutathione; however for cysteine the process is more complex. 
3.2.3 Interference-free Thiol Detection at Screen Printed Electrodes 
3.2.3.1 Interference from thiols 
Given that cysteine will be present along with glutathione in both whole blood and plasma, it is 
clear that the mixed response resulting from the interaction of cysteine with benzoquinone 
could lead to an ambiguous signal, and therefore the target sample matrix must be chosen to 
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suit this ap' roach. For example, glutathione is the predominant thiol within erythrocytes (mM p 
concentrations) and therefore it could be envisaged that the contribution of cysteine to the 
signal will be negligible when detecting the presence of reduced thiols in whole blood, and thus 
would still be capable of providing a clinically relevant response (Devlin 2002). 
3.2.3.2 Electrochemical interference 
The potential required for the re-oxidation of the conjugate is approximately +0.2 V vs AgJAgCl 
and may promote the oxidation other species within physiological fluids, typically ascorbate or 
urate (Kayamod et aL, 2000; Dutt et aL, 2005). Selection of an indicating quinone, other than 
benzoquinone, can allow the detection potential to be positioned within a region where there 
will be little interference from the oxidation of other electro-active species. This is highlighted in 
Figure 3.8 where a cyclic voltammograrn (CV) detailing the response of a GCE to 125 ýLM 
naphthoquinone in the presence of 500 gM ascorbic acid is detailed. The oxidation and 
reduction of the quinone occur at -0.18 V and -0.21 V respectively and are sufficiently resolved 
from the oxidation of ascorbate (+0.22 V). The Us of benzoquinone is also included in Figure 
3.8 for comparison (dashed line), and the overlap of the oxidative peaks of ascorbate and the 
quinone are shown clearly. 
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Figure 3.8 Cyclic voltammogram recorded at a glassy carbon electrde the presence of 125 gM 
naphthoquinone and 500 gM ascorbic acid (pH7). The response to 125 AM benzoquinone 
(dashed line) has been included for comparison. 
3.2.3.3 Chronoamperomet(ic response at the GCE 
Chronoamperog rams of the response of a GCE to increasing concentrations of glutathione (15 
gM aliquots) in the presence of 125 gM naphthoquinone are shown in Figure 3.9. The potential 
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of the electrode was fixed at 0V which lies between the quinone and ascorbate oxidative 
processes (Figure 3.8), and thus the reaction of the thiol with naphthoquinone results in the 
production of the corresponding conjugate with the analytical signal arising from its re-oxidation 
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Figure 3.9 Chronoamperometric responses of a Figure 3.10 Comparison between the response to 
glassy carbon electrode (fixed at OV) to glutathione and ascorbic acid within 
increasing concentrations of the naphthoquinone system. 
glutathione (15 pM increments) in the 
presence of 125 pM naphthoquinone. 
The linear response of the chronoamperometric method was evaluated with respect to the 
analyte glutathione and the interferent ascorbic acid, as shown in Figure 3.10. The operating 
potential does not induce any appreciable error from the presence of physiologically relevant 
concentrations of ascorbate (Devlin, 2002) and the linear response to glutathione is over a 
physiologically relevant range (Table 3.2). 
3.2.3.4 Chronoamperometric response at the screen printed electrode 
The chronoamperometric methodology was adapted to screen print electrodes (SPEs) shown 
in Figure 3.11, whose disposability and inherent low cost would be more amenable to near 
patient monitoring applications. The electrode is comprised of a screen printed carbon working 
electrode and a AgjAgCl paste referencelcounter electrode. While the electrode composition 
and performance of such electrodes are generally poorer than those of glassy carbon, it can be 
seen from the Us shown in Figure 3.12 that resolution between the naphthoquinone and 
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Figure 3.11 Screen printed electrode 
used in this work. 
Figure 3.12 Cyclic voltarnmogram of 125 tLM 
naphthoquinone and 500 RM ascorbic acid 
(pH 7) recorded at a screen printed 
electrode operating under a two electrode 
configuration. Scan rate: 50 mVs-1. 
The chronoamperometric response of the screen printed electrode assemblies (fixed at +0.2 V 
vs SPE AgjAgCl) to increasing concentrations of glutathione (20 ld additions of sample directly 
onto the strip - connecting both electrodes) are shown in Figure 3.13. A linear response (R2 = 
0.9168, Equation 2.8) was observed (inset Figure 3.13) and effectively mirrors the profiles 
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Figure 3.13 Two electrode chronoamperometric response of individual screen printed electrodes (fixed at 
+0.2V) to increasing concentrations of glutathione. 15 ýLM increments). Sample volume: 20 PL 
Inset: Quantitative representation of the current - concentration relationship with the 
analytical signal taken at 40 s. 
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3.3 Conclusion 
An amperometric approach to the detection of biologically significant thiols has been 
developed. The utilisation of naphthoquinone as a mediating/indicating species has enabled 
the detection of glutathione at +0.2 V, thus eliminating the need for the application of a high 
potential, and hence reducing the effect of interferents present in physiological fluids. The 
methodology has been applied to commercially available carbon screen printed electrodes, 
which gave a linear response to glutathione over the biologically significant range. The total 
response time is far superior to the standard laboratory techniques currently used and is less 
than 40 seconds. 
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Chapter Four 
Engineering Chemically Selective Substrates 
- Alloying at the Electrode Surface 
89 
4.0 Introduction 
Fourth generation biosensors rely upon analyte-specific electrode substrates which require no 
biological recognition agent or electron transfer mediator and as a result their manufacture is 
much simpler. The aim of this work was to investigate the properties of electrocatalytic metals, 
such as copper, and to develop novel electrode materials from such metals which may have an 
application in fourth generation biosensors. 
4.0.1 Electrocatalytic Metals 
Transition metal electrodes are known to catalyse the oxidation of biomolecules 
electrochemically (Yeo and Johnson, 2000). The reaction of glucose and similar carbohydrates 
at the copper electrode is of particular interest. It has been proposed by Marioli and Kuwana 
(1993) that the copper(II) 4 copper(III) redox couple can function to produce a similar 
response to that of electron transfer in carbohydrate oxidation, via the oxy hydroxide species in 
alkaline media. However, there is still some controversy over the actual reaction mechanism. 
Better agreement is found with reference to nickel electrodes and carbohydrate oxidation (Yeo 
and Johnson, 2001). Fleischman et al. (1972) proposed that the following stages take place in 
alkaline media: 
Ni(OH)2 + OH- -) NiO(OH) + H20 + e- Equation 4.1 
NiO(OH) + RH 4 Ni(OH)2 +R- Equation 4.2 
NiO(OH) +R-4 Ni(OH)2 + Products Equation 4.3 
where R- is the reactive reduced carbohydrate and RH is the stable oxidised carbohydrate. 
Similar mechanisms have been proposed for copper induced-oxidation of carbohydrates in 
alkaline media (Torto et aL, 1999). Copper is the more researched of the two metals, primarily 
due to the toxicological hazards associated with the use of nickel. The various uses of copper 
electrodes are summarised in Table 4.1. 
Table 4.1 Uses of copper electrodes. 
Electrode* Analyte Analysis Method References 
Copper on gold Glucose Amperometric Casella et at (1997) 
Copper microelectrode Carbohydrates Electrophoresis Colon et at (1993) 
COE Sugars, organic Acids Electrophoresis Fu and Fang (2000) 
COE Monosaccharides, alditols Voltarnmetry Luo and Baldwin (1995) 
Copper on GCE Polyhydroxyl compounds Amperometric 
Prabhu and Baldwin 
(1989) 
COE Ethanol Amperometric PaIxao et at (2002) 
COE Mono and di-saccharides Amperometric Torto et at (199 9) 
COE Amino acids and peptides Electrophoresis Ye and Baldwin (1994) 
COE Mannitol, xylose, laculose ElectroDhoresis Wrinq et at (1997) 
*CDE = copper disc electrode 
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4.0.2 Alloys 
Electrochemically, alloys or intermetallics yield an interesting electrode substrate as they 
frequently exhibit unique properties dissimilar to those of the component metals. There are two 
modes of alloy formation: 
0 prefabricated machined alloy rod; and 
0 electrodeposition of component metals from a mixed solution onto an electrode surface 
(Yeo and Johnson, 2001). 
Examples of the electrocatalytic properties of both types of alloy are summarised in Table 4.2. 
Table 4.2 Allov electrodes and their uses. 
Metals Mode of alloy formation Analyte References 
Electrodeposition Carbohydrates Casella et al. (1999) 
Ni-Cu glucose, glycine Yeo and Johnson (2000) 
Machined Glucose, glycine, Yeo and Johnson (2001) cysteine 
Cu-Cd Electrodeposition Jovic et aL (1991) 
Cu-Mn Machined Amino acids, Mho and Johnson (2001) carbohyrdates 
Ni-Cu, Fe- Machined Glucose Yeo and Johnson (2000) Cu, Mn-Cu 
Cu / Cu-Co Electrodeposition Uhlemann et aL (2003) 
Co-W Electrodeposition Aravinda et aL (2000) 
Ni-W, Ni-Mo Electro-less deposition Hydrogen Lu et al. (2003) 
Ni-Ti Electrodeposition Carbohydrates Luo and Kuwana (1994) 
From Table 4.2 it can be seen that the alloys used for the detection of biomolecules contained 
copper or nickel or both. The concept of electrodeposition (deposition under applied potential) 
and electroless deposition (deposition under no applied potential) have also been reviewed. 
Electroless deposition, also known as electrostatic accumulation, is clearly more favourable as 
it requires no current to flow through the electrode. 
4.1 Experimental Details 
The cell solutions used were prepared from either NaOH (Analytical Reagent Grade, Fisher 
Scientific, Loughborough, UK) or HN03 (Aristar@ Grade, BDH Laboratories, Poole, UK), 
although tissue culture medium (Dulbecco's Eagles Medium, Sigma-Aldrich Company Ltd, 
Poole, UK) was used to mimic biological systems. Solutions of glucose, the antioxidants and 
CUS04, Mg(N03)2, Ca(N03)2, Sr(N03)2 and Pb(N03)2 were prepared from >99.7% purity 
powders (Sigma Aldrich Company Ltd, Poole UK). Ba, Cd, Co, Cr, Cu, Fe, Mn, Mo, Ni, Pb Sb, 
Sn and W 10000 mg 1-1 lCP-MS stock solutions (Aristar@ BDH Laboratories, Poole, UK) 
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provided the metal source for ASV and alloy studies when a potential was applied. All solutions. 
and dilutions were prepared using distilled deionised water (DDM. 
4.1.1 Electrochemical Measurements 
Electrochemical measurements were carried out using a computer controlled ýL-Autolab Type 11 
potentiostat. Measurements were generally carried out using an initial cell volume of 15 CM3 at 
a temperature of 20 ± 20C. A three electrode assembly was used throughout, comprising of a 
silver/silver chloride reference electrode (3 M, BAS Technicol, UK), a platinum wire counter 
electrode, and a working electrode, as described in section 2.1.1. Three different working 
electrodes were used during the course of the work: 
" glassy carbon (GCE) (3 mm diameter, BAS Technicol, UK); 
" copper disc (CDE) (3 mrn diameter, BAS Technicol, UK); and 
" screen printed carbon (SPE) (Surface Area 1.52 CM2, Lifescan@ Scotland., Inverness, 
UK). 
4.1.2 Flame Atomic Absorption Spectrometry 
Flame atomic absorption spectrometric analysis (FAAS) was carried out using a Perkin Elmer 
AAnalyst 400 Atomic Absorption Spectrophotometer, utilising an air: acetylene flame as detailed 
in section 2.4. The parameters used for copper and lead analysis have been reported in Table 
2.2, section 2.4.3 Measurements were determined in triplicate and the average results 
reported. Typical relative standard deviation (RSD) values for these analyses were <± 2.5%. 
4.1.3 Active Deposition of Metals 
Active metal accumulation was carried out using a 15 CM3 cell volume comprising 0.1 M HN03, 
which was degassed using nitrogen for 5 minutes prior to each experiment. Aliquots (3.3 mg 1-1) 
of 1000 mg 1-1 ICP-MS stock solutions were added to the cell. Between each addition the cell 
solution was thoroughly mixed. ASV was then conducted by applying a potential of -1.5 V to the 
working electrode for 60 seconds and then sweeping the potential to +0.5 V. To produce an 
alloy, subsequent aliquots (3.3 mg 1-1) of a different 1000 mg 1-1 ICP-MS stock solution were 
added and the process repeated. To evaluate any electrocatalytic activity with blomolecules, 
the electrode surface had to be prepared for analysis. This was done by removing the electrode 
from the solution and rinsing it with DDW while a -1.5 V potential was applied and then 
changing the cell solution to 0.1 M NaOH and cycling the potential from -1 V to +1 V ten times. 
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4.1.4 Passive Deposition of Metals 
Passive metal accumulation was carried out in a stirred 10 CM3 10 mM solution of the metal 
salt, either CUS04 or Pb(N03)2. The working electrode was placed in the metal salt solution 
while the reference and counter remained in 15 CM3 0.1 M HN03. When a specified time (either 
5,10 or 15 minutes) had elapsed the working electrode was removed from solution and a 
potential of -1 V was applied. It was placed in the 0.1 M HN03 cell for 60 seconds. The 
electrode was removed from the solution while the potential was still applied, so as to ensure 
the metal was not dissolved from the surface by the nitric acid. To generate an alloy, the exact 
same process was repeated using a different metal salt solution. 
4.1.5 Investigation of Electrode Properties 
The analysis of biomolecules required the cell solution to be changed to 0.1 M NaOH. The 
working electrode was then cycled from -1 V to +1 V ten times. Investigation of the oxidation of 
biomolecules by the working electrode was also conducted in a cell containing 0.1 M NaOH. To 
determine the presence of an alloy at the electrode surface, the electrodes were immersed in 
15 CM3 0.1 M HN03 at a fixed potential of -1 V and the potential was then swept using square 
wave voltarnmetry (SWV) from -1 V to +0.5 V. The anodic stripping voltammograms (ASV) 
generated showed characteristic peaks corresponding to the component metals and alloy if 
present. An example for a copper lead alloy can be seen Figure 4.12, section 4.2.3. 
4.2 Results and Discussion 
To evaluate the reactions of the biomolecules at modified screen printed electrodes, their 
reactions at a copper disc electrode (CIDE) were first investigated. The antioxidants did not give 
any response at the CDE, whereas an oxidative peak was observed in the presence of 
glucose, corresponding to the oxidation of glucose by the oxy/hydroxyl species on the electrode 
surface (Equations 4.1 - 4.3), as reported below. Anodic stripping voltammetry at the screen 
printed electrode was conducted for various metals and of these antimony, bismuth, copper 
and lead were found to give a measurable response. The potential for these metals to produce 
an alloy under active (section 4.1.3) and passive (section 4.1.4) conditions has also been 
investigated. The electrochemical evidence of passive (electrostatic) metal accumulation on the 
screen printed electrode surface has been corroborated by FAAS methods (Table 4.5, section 
4.2.7). The method for generating the passively deposited alloy was optimised. The 
electrochemical activity of the alloy electrode towards glucose was also evaluated. 
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4.2.1 Reaction of Biornolecules at Copper Electrodes 
Copper has been reported to respond catalytically to a number of biornolecules as previously 
discussed in section 4.0.1 and as such was the first electrode substrate investigated. It was 
essential to characterise the response of the analytes glucose, uric acid, ascorbic acid and 
cysteine at a conventional copper electrode so that the electrochemical activity of other 
copper/alloy electrodes generated in this work could be compared and contrasted. Figure 4.1 
shows the cyclic voltammogram (CV) resulting from cycling the copper electrode in alkaline 
media and it clearly illustrates the characteristic shape of a CV generated by a copper 
electrode (Luo and Baldwin, 1995). The CV response of this electrode to ascorbic acid, 
cysteine, glutathione and uric acid is shown in Figures 4.2 to 4.5. 
Copper was then actively deposited on a screen printed electrode (SPE) containing an Ag/AgCI 
paste reference electrode according to the procedure in section 4.1.3, producing a copper 
modified SPE (CuSPE). The CV obtained in 0.1 M NaOH is shown in Figure 4.6, where the 
oxidative peak at approximately +0.38 V and the reductive peak at +0.08 V correspond to the 













Figure 4.2 Cyclic voltammogram response of a 
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Figure 4.3 Cyclic voltarnmogram response of a 
copper disc electrode to glucose. 
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Figure 4.4 Cyclic voltammogram response of a 
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Figure 4.5 Cyclic voltammogram response of a Figure 4.6 Blank cyclic voltammogram of a copper 
copper disc electrode to uric acid. modified screen printed electrode in 0.1 
M NaOH. 
The response of the CuSPE to glucose (Figure 4.7) was also found to replicate the 
manufactured copper electrode well (Figure 4.3), indicating that the electrodeposited electrode 
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Figure 4.7 Response of the copper modified screen printed electrode to sequential additions of 0.25 mM 
glucose in 0.1 M NaOH. 
4.2.2 The Electrode Surface 
Screen printed electrodes used for blood glucose monitoring are manufactured by screen 
printing conducting carbon ink followed by ink containing the mediating species and the 
enzyme and is completed with an insulating layer on the top (Lifescan Inc., 1998). The screen 
printed electrodes used in this study consisted of only the conducting carbon ink screen printed 
layer and were prepared using the same process as those for blood glucose monitoring. It was 
hypothesised that the screen printed carbon surface was comprised of carboxylic acid and 
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similar functional groups, such that, when hydrated, they produce a negatively charged surface 
as shown in Figure 4.8. 
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Figure 4.8 The proposed negative nature of the screen printed carbon electrode surface. 
The existence of the negative charge at the surface was investigated using the group 11 metals 
magnesium, calcium and strontium and the ferri/ferrocyanide redox couple. This redox couple 
is known to show slow electron transfer kinetics at negatively charged surfaces, as discussed 
previously in section 1.3.4. The slower the electron transfer kinetics, the more negative the 
electrode surface and the greater the separation of the oxidation (Epa) and reduction (Epc) 
peaks as seen by cyclic voltarnmetry (Fisher, 1998). By adding group 11 cations, the negative 
electrode surface could be neutralised and evidence was provided by monitoring the peak 














Figure 4.9 Model of the electrode surface in the presence of group 11 metal cations. 
Magnesium, strontium and calcium cations were added to a cell containing 0.1 M NaOH and 10 
mM potassium ferrocyanide with a screen printed electrode as the working electrode. The peak 
to peak separation was calculated as (Epa-Epc), and has been plotted versus the 
concentration of the cation in Figure 4.10. The closer the value of (Epa-Epc) to 59/n (where n= 
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Figure 4.10 Data from cyclic voltammogram titration experiments plotted as peak separation of the 
ferritferrocyanide redox couple, versus concentration of group 11 metals Ca, Mg and Sr. 
From Figure 4.10 it can be seen that the addition of the group 11 cations resulted in a decrease 
in the (Epa-Epc) values. It was found that for the same concentration of the metal added, the 
peak to peak separation decreased in the order of Ca2+>Mg2+>Sr2+. 
This order relates to the electron affinity (EA / eV) of the metal (Shriver and Atkins, 1999). It 
also indicates that calcium bonds to the electrode surface strongly and is the most efficient at 
neutralising the negative surface charge, followed by magnesium and strontium. It is therefore 
evident that the hypothesised negative nature of the screen printed electrode surface does 
exist. 
4.2.3 Metal Candidates - ASV and Alloying 
In order to establish which metals produced a detectable ASV signal, a series of ASV 
experiments were conducted for various metals, namely antimony, bismuth, cadmium, 
chromium, cobalt, copper, iron, lead, manganese, molybdenum, nickel, tin and tungsten. These 
metals were selected because they are all known to produce an ASV peak at standard 
electrode materials (Brett and Brett, 1998), but have not been characterised at the screen 
printed carbon electrodes used in this work. The cell comprised 10 CM3 0.1 M HN03 and to the 
cell was added a 500 Ial aliquot of the 1000 mg 1-1 ICP-MS standard for the metal. A potential of 
-1.0 V was then applied and swept to +1.0 V. Any peaks observed during the ASV sweep were 
recorded and their peak potential noted. The results are listed in Table 4.3. 
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Table 4.3 ASV peak potential results for metals investigated at the SPE. 
Metal Peak potential V (vs. AgjAgCI) 
Antimony 0.00 
Bismuth -0.03 
Cadmium No peak 
Chromium No peak 
Cobalt No peak 
Copper 0.10 
Iron No peak 
Lead -0.50 
Manganese No peak 
Molybdenum No peak 
Nickel No peak 
Tin No peak 
Tungsten No peak 
Table 4.3 shows that antimony, bismuth, copper and lead are the only metals investigated 
which show an ASV peak at the SPE. No peak was observed for cadmium, chromium, cobalt, 
iron, manganese, molybdenum, nickel, tin or tungsten which can be attributed to the fact that 
the screen printed electrode surface has much poorer homogeneity. 
For this reason, only antimony, bismuth, copper and lead were investigated further. Evidence 
for alloy formation is seen as a separate ASV peak between the peaks of the ASV component 
metals, as shown later in Figure 4.12. The ASV profiles for antimony, copper and bismuth were 
found to overlap, as shown in Figure 4.11. 
F. '- 
Potential IV 
Figure 4.11 Anodic stripping voftammetry profiles for Pb, Bi, Sb and Cu at 50 mg 1-1, illustrating the overlap 
of Bi, Sb and Cu peaks. 
Given the information in Figure 4.11, it was not possible to differentiate between the peaks of 
antimony and bismuth and hence the presence of an alloy of these metals could not be 
investigated. 
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An intermetallic species was produced at the SPE from lead and copper according to the active 
deposition procedure outlined in section 4.1.3. This intermetallic, or alloy, was investigated by 
ASV as outlined in section 4.1.5 and showed a peak at -0.35 V, which is clearly observed in 
Figure 4.12. 
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Figure 4.12 Square wave voltammograms showing the anodic stripping voltarnmetry signal at the screen 
printed electrode for Pb at -0.5 V, Cu at +0.10 V, and the PbCu alloy at -0.35 V with increasing 
concentration (50 mg 1-1 aliquots). 
Potentiostat fixed at -1.0 V for 60 seconds then swept at 0.05 V s-I from . 1.0 V to +1.0 V. 
It was found that the alloy was only generated when the metals were deposited in the order of 
lead then copper. It was hypothesised that the accumulated lead atoms on the electrode 
surface acted as nucleation centres for copper deposition, and this was where the alloy formed. 
4.2.4 Optimisation of Alloy Production 
The lead-copper alloy found (shown in Figure 4.12) was produced at an SPE using a relatively 
high concentration mixture of copper and lead (50 mg 1-1 aliquots). It was also important to 
confirm whether an alloy could be produced using lower metal concentration solutions (<5 mg I- 
1). A lower concentration active deposition study was carried out as outlined in section 4.1.3, 
with lead added first and copper second (0.5 mg 1-1 aliquots). The presence of an alloy was 
investigated using the procedure described in section 4.1.5 and the SWVs from this experiment 










Figure 4.13 Square wave voltammograms of Pb, Cu and the PbCu alloy intermetallic formation with 
increasing concentration (0.5 mg 1-1 aliquots) at the screen printed electrode. 
Potentiostat fixed at -1.0 V for 60 seconds then swept at 0.05 V s-I from -1.0 V to +1.0 V. 
Figure 4.13 clearly indicates that an alloy was produced when using low concentrations of 
copper and lead (0.5mg 1-1 aliquots). When looking at the lead, copper and alloy peaks at such 
a low concentration the inhomogeneity of the electrode surface can be seen to affect the SWV 
producing a noisy signal, evident in the region of -0.8 V to -0.6 V. 
As discussed previously, the screen printed carbon surface has a negative charge (section 
4.2.2). This means the surface is ideal for electroless (electrostatic) accumulation of metals and 
therefore has the capability to generate alloys. Hence, the electrostatic accumulation of copper 
and lead at screen printed electrodes was investigated. The electrode was first immersed in a 
10 mM solution of Pb(N03)2 and then in a 10 mM solution Of CUS04 according to the procedure 
outlined in section 4.1.4. The anodic stripping voltarnmetry profile obtained is shown in Figure 
4.14 along with the comparative profile obtained by depositing the metals at a negative 
potential (active deposition, section 4.1.3). 
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Figure 4.14 Square wave voltammograms of Pb, Cu and the PbCu alloy intermetallic formation by passive 
accumulation from 10 mM solutions Of CUS04 and Pb(N03)2 at the screen printed electrode 
(Passive Alloy at SIDE) and from 5 mg 1-1 Pb and Cu lCP-MS standards at -1.0 V (Active Alloy at 
SPE). The alloy in both SWV profiles is highlighted in green. 
Potentiostat fixed at -1.0 V for 60 seconds then swept at 0.05 V s-I from -1.0 V to +1.0 V. 
Figure 4.14 clearly shows the presence of lead at -0.5 V, copper at +0.10 V and the PbCu alloy 
at -0.35 V (highlighted green in the diagram) under passive conditions (section 4.1.4). It can 
also be seen that the SWV profile under passive conditions mimics that of the active conditions 
(section 4.1.3). Thus the negative nature of the screen printed electrode surface was able to 
accumulate lead and copper and produce an alloy of these two metals, 
There were two variables which related to alloy production 
0 time of exposure in salt solution; and 
a response of the alloy to glucose. 
These factors were investigated and the electrode was characterised according to whether an 
alloy was found to be present (increase in the current at -0.35 V compared to the background) 
and whether the electrode gave rise to an oxidative response to glucose as determined by 
cyclic voltammetry, and shown in Figure 4.7, section 4.2.7. The findings of these investigations 
are surnmarised in Table 4.4. 
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Table 4.4 ODtimisation of allov Droduction with resDect to time. 
Time in 10 mM 
Pb(N03)2 I mins 
Time in 10 mM 
CuSO4 I mins 
Was an alloy found by 
ASV? 
Was the electrode 
catalytic for glucose? 
0 0 No No 
5 5 No No 
10 10 Yes Yes 
15 15 No Yes 
5 15 No Yes 
5 10 No Yes 
10 5 No No 
10 15 No Yes 
15 5 No No 
15 10 Yes Yes 
ASV = anodic stripping voltarnmetry 
Table 4.4 shows that all electrodes with a copper deposition time of at least 10 minutes were 
found to be catalytic for glucose, which was likely to be due to the higher concentration of 
copper (approximately 0.11 mg deposited on the electrode surface) as determined in section 
4.2.7. However, only two electrodes were found to produce a clearly definable alloy, namely, 
the electrode exposed to lead for 10 minutes and then copper for a further 10, and the 
electrode exposed to lead for 15 and then copper for a further 10. This corroborates the 
hypothesis that lead is required at the electrode surface before copper, so that when the 
copper is deposited the alloy forms in the vicinity of the lead deposits. If this was not the case, 
an alloy would be generated where copper was deposited first. 
In the interest of time economy, only the 10 minute lead 10 minute copper electrode 
(1OPb1OCu) was used for further investigations. Time economy is essential when the 
commercial viability of the modified electrodes is considered. The ability for the electrodes to be 
manufactured and modified on a large scale as quickly as possible is the most desirable 
outcome. 
4.2.5 Catalytic Response of PbCu Alloy 
The electrochemical activity of the 1OPb1OCu SPE alloy electrode to various biomolecules was 
evaluated as described in section 4.1.5. This involved the preparation of the electrode by 
cycling the potential ten times between -1.0 V and +1.0 V in a cell containing 0.1 M NaOH and 
then the subsequent addition of the biomolecule which was again investigated by cyclic 
voltammetry (-1.0 V to +1.0 V). The cyclic voltammograms obtained for the oxidation of glucose 
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Figure 4.16 Calibration obtained from the CV response of 1OPbIOCu SPE to glucose additions (0.5 mM 
aliquots). 
The CV profiles for the oxidation of glucose at the 1 OPb1 OCu electrode clearly show the anodic 
oxidation peak (Figure 4.15). The oxidation peak was found to increase With increasing glucose, 
concentration and this response was linear over the range of 2 to 5 mM. 
The response of this electrode to glucose was also compared with two modified screen printed 
electrodes: one with passively deposited copper for 10 minutes (passive copper) and another 
actively deposited lead (bulk lead) for 10 minutes (sections 4.1.3 and 4.1.4). A third unmodified 
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SPE was also used, along with a bulk copper electrode, namely the copper disc electrode 
evaluated in section 4.2.1. A calibration plot similar to Figure 4.16, comparing the responses of 
each of these electrodes is shown in Figure 4.17. 
71 
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Figure 4.17 Plot showing the peak current response of various electrodes to the presence of glucose. 
The data in Figure 4.17 shows that the bulk copper (copper disc) electrode was found to be the 
most responsive to glucose, yielding the highest peak currents. The linear analysis range for 
this electrode was found to be the same as the 1OPb1OCu electrode, namely 2 to 5W The 
second highest current response to glucose was observed for the passive lead copper alloy 
(1OPb1OCu) electrode, as described previously. Interestingly, despite the passive copper 
electrode having the same exposure time to copper as the 1OPb1OCu electrode, it shows a 
negligible response to glucose. 
The response of both the bulk lead and blank unmodified electrode were comparable to that of 
the passive copper electrode, i. e. negligible, thus verifying that these electrodes do not cause a 
measurable oxidation of glucose. 
The oxidative response of the 1 OPb1 OCu electrode to glucose indicated that the alloy electrode 
shows a better response compared to that of the other passively deposited copper containing 
electrode. It was expected that the passive copper electrode would exhibit an oxidative 
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response in the presence of glucose; however, this was not found to be the case. It is therefore 
clear that the alloy itself or the arrangement of the copper on the electrode surface gave rise to 
the desired response in the presence of glucose. 
The response of the 1OPb1OCu modified SPE to cysteine and uric acid was also studied. 
Cysteine was investigated because it is known to react at some copper electodes (Ye and 
Baldwin, 1994), despite the fact that it was not found to be oxidised by the copper disc 
electrode used in this study (see Figure 4.4, section 4.2.1). Udc acid was evaluated because it 
is not known to react at a copper electrode surface, but is known to react directly at a screen 
printed carbon surface (Dutt et aL, 2005). The cyclic voltammograms obtained using the 
procedure outlined in section 4.1.5 are shown in Figures 4.18 (cysteine) and 4.19 (uric acid). 
-02 00 02 04 0.6 0.8 
Potential /V 
Figure 4.18 Cyclic vobmmograms showing 50 
l. LM additions of cysteine to 
1OPbIOCu screen printed electrode 
in 0.1 M NaOH. 
-0.2 0.0 0.2 0.4 0.6 0.8 
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Figure 4.19 Cyclic voltarnmograms showing 50 
gM additions of uric acid to 
1OPb1OCu screen printed electrode 
In 0.1 M NaOH. 
Figure 4.18 shows the oxidative response of the 1OPb1OCu electrode to cysteine at +0.3 V. 
Carbon electrodes are known to poorly oxidise cysteine so the presence of oxidation at the 
alloy electrode indicates that this oxidation occurs in the same manner as a copper electrode. 
Figure 4.19 shows the oxidative response of the 1OPbIOCu electrode to uric acid. An oxidation 
peak was observed at approximately +0.025 V. Uric acid is not known to oxidise at copper 
electrodes, but is known to oxidise at carbon electrodes (Dutt et al., 2005). Therefore the 
presence of an oxidation peak indicates that the oxidation occurs at the areas of the SIDE 
surface where the alloy did not exist. This suggests that the alloy does not form uniformly 
across the SPE surface. 
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4.2.6 Response of Electrodes in Tissue Culture Medium 
Cyclic voltarnmetry studies were carried out in a cell consisting of glucose free tissue culture 
medium (Dulbecco's Eagles Medium) prepared in 0.1 M NaOH. Various working electrodes 
were used, namely the blank SPE, the actively deposited lead (bulk lead) electrode 
(electrodeposition of lead for 10 minutes as described in section 4.1.3, and the 1OPb1OCu 
modified SPE. Figure 4.20 shows the response at +0.65 V to 1 mM additions of glucose to the 
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Figure 4.20 Glucose calibration obtained by plotting the peak current for glucose oxidation at various 
working electrodes in tissue culture medium. 
Figure 4.20 shows that in the presence of tissue culture medium, only the bulk copper 
electrode was found to oxidise glucose. The linear calibration range for this electrode was 
found to be 1 to 4 mM. 
The oxidative response of the 1OPb1OCu electrode was found to be poorer in the presence of 
tissue culture medium, with the peak current approximately 20-fold lower than that in the cell 
containing 0.1 M NaOH. No linear response to glucose was observed and there was negligible 
difference between the 1 OPb1 OCu electrode and the blank electrode. 
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Amino acids present in the tissue culture medium are able to complex metals (Luo et aL, 199 1). 
With respect to the data in Figure 4.20, it can be inferred that the electrochemical activity of the 
alloy was inhibited by such complexation. The bulk copper electrode gave an oxidative 
response to glucose in the presence of the tissue culture medium, although the peak current 
was reduced from that in a cell containing only 0.1 M NaOH (see Figure 4.17). This indicates 
that the reactive copper electrode surface was partially, but not completely, inhibited by the 
tissue culture medium. As such, the 1 OPb1 OCu modified SPE was found to be suitable for the 
determination in biological fluids. 
4.2.7 Spectroscopic Quantitative Verification of Metal Deposition 
A set of 12 screen printed electrodes (total surface area 18.2 CM2), was immersed in 10 mM 
solutions of the metal salt (Pb(NO3)2 or CUS04) for a specified period of time (5,10 or 15 
minutes). The electrodes were then gently rinsed twice with DDW to remove all non bound 
species. The electrodes were then thoroughly rinsed with 0.1 M HN03 to leach the metallic 
species from the surface. The rinsate solution was then diluted to a total volume of 25 CM3 and 
analysed by FAAS according to the procedures outlined in sections 2.4 and 4.1.2. The data 
obtained from these experiments is summarised in Table 4.5. 
Table 4.5 Perkin Elmer AAnalyst 400 data of the concentrations of Cu and Pb acquired at the SPE surface 
by electrostatic accumulation of the metals from 10mM solutions Of CUS04 and Pb(N03)2. 
Time exposed to metal solution (mins) Cu I mg I- 
,I 
Pb / mg 1-1 
5 1.49 0.79 
10 5.34 1.65 
15 2.88 1.82 
The results show an increasing accumulation of the metal on the electrode surface with 
increasing exposure time. However, this accumulation reaches its optimum concentration at 10 
minutes for copper and 15 minutes for lead. In summary, a 10 minute exposure time was found 
the more favourable condition for metallic accumulation and alloy formation (section 4.2.4). 
This data also corroborates the ASV data obtained for passively accumulated metals, indicating 
that the metals copper and lead are readily accrued on the electrode surface. 
4.3 Conclusions 
The metals copper and nickel and their alloys are known to oxidise glucose and other 
carbohydrates and have been used extensively for their detection in chromatographic and 
electrophoretic systems (section 4.0.2). Although the reactions of glucose, ascorbic acid, 
cysteine, glutathione and uric acid at a copper disc electrode were all characterised by cyclic 
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voltammetry (section 4.0.2), only in the presence of glucose was an oxidation peak observed 
(see Figure 4.7). 
The aim of this work was to produce an alloy by electrostatic accumulation of the metal on the 
screen printed electrode surface. Anodic stripping voltammetry studies conducted on various 
metals with antimony, bismuth, copper and lead gave amperometric responses at the screen 
printed electrode, as listed in Table 4.4. An alloy was found in the presence of copper and lead 
(Figure 4.11) when the metals were deposited under an applied potential (active conditions, 
section 4.1.3). 
The electrode was hypothesised to have a negatively charged surface and this was proven 
using group 11 metal cations and the ferri/ferrocyanide redox couple, as reported in section 
4.2.2. This negative electrode surface was found to accumulate copper and lead under the 
passive conditions described in section 4.2.4, verified by both anodic stripping voltammetry 
(Figure 4.14) and flame atomic absorption spectrometry (section 4.2.7). Only when the metals 
were deposited in the order of lead and then copper was an alloy was formed (section 4.2.4). 
The production of this alloy was optimised with respect to both the peak current of the alloy by 
anodic stripping voltammetry and the catalytic response to glucose. By these means the 
optimum alloy was produced after 10 minutes deposition in a 10 mM solution of Pb(N03)2 
followed by 10 minutes in a 10 mM solution Of CUS04 (section 4.2.4). 
This screen printed electrode modified by the presence of the alloy was found to oxidise 
glucose, cysteine and uric acid. It was also shown that glucose and cysteine were oxidised by 
the alloy itself, while uric acid, which is not known to react at a copper electrode, was oxidised 
at the bare screen printed electrode surface. The response of the electrode to glucose was 
linear over the range of 2 to 5 mM (section 4.2.5). However, it was found that the electrode 
responded poorly to glucose in the presence of tissue culture medium and therefore was not 
suited to the analysis of glucose in biological fluids (section 4.2.6). In biological fluids, the 
electrode response would also be affected by cysteine and uric acid. As such this electrode 
was found to be suited to the analysis of glucose in samples which do not enclogenously 
contain such amino acids or uric acid. 
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Chapter Five 
Biofluid Interactions with Metal Oxides: 




Antioxidants; are known to be electrochemically active and thereby can be possible interferents 
in electrochemical blood glucose monitoring (Dutt et at, 2005). Methodologies developed by 
previous workers to eliminate such interference fall into two categories: firstly the screening of 
antioxidants by membranes based on either their size or charge (Brahim et al., 2002) or, 
secondly, their pre-oxidation so that they are not electrochemically active (Xu et al., 2004). 
The aim of this work was to explore the electrochemistry of the antioxidants, and their 
interferent effect on blood glucose sensors (section 5.2.1). After establishing these facts, the 
reactions of the relevant antioxidants with transition metal oxides were characterised (section 
5.3). In terms of the metal oxides found to have an effect, their optimum concentrations for 
complete antioxidant removal were determined (section 5.3.3), and any interaction with sensor 
components evaluated (sections 5.4 and 5.5). A possible mode of sensor modification 
comprising a sample pre-treatment area has been developed for the effective removal of 
ascorbic acid as an interferent in biosensors (section 5.6). Finally, the interaction of the most 
effective metal oxide with antioxidants in biological fluids has also been assessed (section 5.7). 
5.0.1 Oxidation of Antioxidants 
Physiologically, antioxidants are easily oxidisable compounds. They are oxidised more easily 
than cells of the body and therefore protect the cells from damage caused by pro-oxidants. 
Every one of the antioxidants of interest oxidises by a slightly different mechanism, all of which 
can be induced electrochemically. The function and electrochemically initiated oxidation of 
each antioxidant (ascorbic acid, uric acid, cysteine and glutathione) are considered in turn. 
5.0.1.1 Ascorbic acid 
Ascorbic acid (vitamin C or AA) is a well-cited antioxidant and biologically acts as a reducing 
agent in the hydroxylation of lysine and proline in the formation of prontocollagen (Devlin, 
2002). In vitro, ascorbic acid acts chemically to reduce ferric iron to ferrous iron, to aid 
absorption in the digestive system. The oxidation of ascorbic acid (AA) to dehydroascorbic acid 
(DHAA) is represented in Figure 5.1. 
HO OH 0 
+ H20 +2 H+ +2 
HO'ýý o0 HO"ý oýO 
0H0H 
Figure 5.1 Oxidation of ascorbic acid (adapted from Devlin, 2002). 
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5.0.1.2 Uric acid 
Uric acid (UA) is a product of puriine degradation in humans and is present physiologically as 
an antioxidant. It is known to chelate iron and copper in vivo, and also to protect haem proteins 
from oxidation by hydrogen peroxide (Halliwell and Gutteridge, 2002). The oxidation of uric acid 
and its subsequent degradation to allantoin is featured in Figure 5.2. 
HN -2H* -2a- 
.,: 
k 1 >=O 
0NN 
+2H1 +2e- 










Figure 5.2 Electrochemically initiated oxidation of uric acid (adapted from Dryhurst, 1987). 
Uric acid is oxidised in a2 electron, 2 proton process, yielding a reactive di-imine species. This 
undergoes nucleophilic attack from water, producing an imine alcohol, which reacts with a 
second water molecule and undergoes intra-molecular degradation to allantoin (Dryburst, 
1987). 
5.0.1.3 Cysteine 
Cysteine (CSH) is a sulphur containing amino acid, which is easily oxidised to the disulphide 
cystine, as shown in Figure 5.3 (Devlin, 2002). Besides having a structural role in proteins, 
cysteine also has an important role as an antioxidant. The oxidation from cysteine to cystine 
occurs readily within physiological fluids under conditions of oxidative stress. This oxidative 
stress may be induced by transition metal ions, in particular copper is known to be complexed 
with this thiol (Halliwell and Gutteridge, 2002). 










Figure 5.3 Oxidation of cysteine (adapted from Halliwell and Gutteridge, 2002). 
5.0.1.4 Glutathione 
Glutathione (GSH) is a simple tripeptide which can undergo a similar oxidation reaction to that 
of cysteine and be oxidised to a disulphide as shown in Figure 5.4 (Devlin, 2002). Glutathione 
is actively involved in a number of oxidation reactions in the body, primarily complexing harmful 
transition metal ions and binding to toxic substances such as paracetamol, in order to reduce 
their toxicity and efficiently metabolise them (Devlin, 2002; Halliwell and Gutteridge, 2002). 
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Figure 5.4 Oxidation of glutathione (adapted from Halliwell and Gutteridge, 2002). 
5.0.1.5 Elimination of antioxidant based interferences 
Anti-interference strategies to eliminate antioxidant effects in biosensors are numerous, 
employing membranes to screen out molecules based on both charge and size. Recent work 
detailing their application to glucose sensors in particular is detailed in Table 5.1 
Table 5.1 Antioxidant anti-interference strateoies emDloved in Qlucose biosensors. 
Antioxidant Anti-interference strategy Reference 
Ascorbic acid Polypyrrole Adeloju and Moline (2001) 
MnO2 Xu et aL (2004)* 
Ascorbic acid and uric acid Nitroceullulose Cui et aL (2001) 
Pre-oxidising cell Gavalas et al. (2000) 
3-aminopropyltdethoxysilane 
perfluorocarbon polymer 
and Naflon@ Matsumoto et aL ( 200 1) 
Polyurethane, polyethersulfone, 
cellulose acetate and Naflon@) Ward et al. ( 2002) 
Lead dioxide in cellulose acetate Zhang and Wang (2002) 
Ascorbic acid, cysteine and uric acid Poly(o-phenylenediamine) Xu and Chen (2000) 
Ascorbic acid and cysteine Polypyrrole Brahim et al. (2002) 
' Post-dates this work 
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5.0.2 Transition Metal Oxides of Interest 
The metals of interest in this work are copper, iron, lead, manganese, molybdenum, nickel, 
vanadium and zinc. All of these exhibit variable oxidation states, despite the fact that it is likely 
that only one will be stable. As an example, in the case of zinc, the most stable oxidation state 
is +2 with all common zinc compounds formed in this valency. 
Metal oxides able to undergo reduction are expected to be good oxidising agents thereby 
making them suitable for oxidation of the antioxidant. The oxidation state of the metal oxides 
used in this work should therefore permit reduction of the oxidation state number. The 
properties of the oxides are listed in Table 5.2. 
Table 5.2 Prooerties of metals and metal oxides of interest (Cotton et aL. 1988: Shriver and Atkins 1999). 









Cu [Ar] 4s' 3d10 1,2,3 
CU20 I No Mild base CUO 11 No 
Fe [Arl 4S2 3d6 2,3,4,5,6 FeO Fe203 11 III 
No 
Yes Amphoteric 
MnO 11 No 
Mn [k] 4S2 3d5 2,3,4,5,6,7 Mn203 III Yes Strong acid 
Mn02 IV Yes 
Mo [Kr] 4d5 5s' -2,0,1,2,3,4, 
M002 IV Yes Strong acid 5,6 M003 A Yes 
N! [Ar] 4S2 3d8 2,3.4 NiO 11 No Mild base 





V203 III Yes 
V [Ar] 4S2 3d3 2,3,4,5 V204 IV Yes Amphoteric 
V205 V Yes 
Zn LAr] 4S2 3d10 2 ZnO 11 No Amphotedc 
Considering those which are able to be reduced, there are any number of likely candidates. 
However, it is important to note that the reaction that takes place with the metal oxide may be a 
simple matter of oxidation by complexation with the metal. For this reason no metal oxides, 
regardless of their lack of prospective reduction, can be ruled out for subsequent investigation. 
5.0.3 Biomolecule interaction with Metals and Their Oxides 
Considering only the transition metals of interest, a review by Davies (1992) is a key piece of 
information for consideration. This review details the complexation and oxidation of ascorbic 
acid with transition metals. Ascorbic acid is known to form stable complexes with Mn2+, Ni2+, 
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Figure 5.5 Ni-ascorbic acid complex (Davies, 1992). 
Similar chelated species exist with the other ions, but may differ slightly, With more ascorbic 
acid molecules complexed. This complexation will alter the redox potential and may therefore 
render the ascorbic acid not electrochemically active. Also reviewed by Davies (1992) is the 
transition metal induced oxidation of ascorbic acid, which is achieved by complexes of groups 
6,7,8,9,10 and 11. However this is not recorded to occur with the oxides of these metals. 
The first work detailing the use of lead dioxide to prevent ascorbic and uric acid interference in 
biosensors; was carried out by Cui et aL (2000). This involved lead dioxide being incorporated 
within a nitrocellulose membrane at a strip electrode modified for glucose detection. In this 
study, the combination of the nitrocellulose membrane and lead dioxoide was found to be 
effective in removing uric acid, ascorbic acid and paracetamol interferences from the biosensor. 
However this study was carried out in buffered solution, and not in a physiological fluid. 
Choi et aL (2002) have used this knowledge to develop an amperometric biosensor using an 
insoluble oxidant as an interference removing agent. They assess the oxides Ba02, Ce02, 
Mn02 and Pb02. They found Pb02, bound within a hydrophilic polyurethane membrane, 
exhibited the best antioxidant removal performance. 
Further work with Pb02 has been carried out by Zhang and Wang (2002) who immobilised the 
oxide in a cellulose acetate membrane at a modified glassy carbon electrode. This 
arrangement was found to oxidise ascorbic acid in blood serum samples and yield intefference- 
free measurements. 
Shin et al. (2001) developed a similar system for a blood serum enzymatic creatinine 
biosensor, which effectively eliminated ascorbic acid, uric acid and paracetamol, However, it is 
unclear whether this was due to the hydrophilic polymer or to the lead dioxide. A summary of 
research carried out by various groups considering the interactions of transition metal 
compounds and their reactions with biomolecules is given in Table 5.3. 
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Table 5.3 Literature review of transition metals and their reactions with biomolecules. 
Metal Complex Biornolecule References 
Cu Cuo Ascorbic acid and uric acid Karousos et al. (2005)* 
Glucose Xie and Huber (199 1); Luque et al. 
(2005) 
CU20 Ascorbic acid and cysteine Dursun and Nisli (2004) 
Glucose, ribose, galactose, Xie and Huber (199 1) 








Ni Nickel Oxide 
Nickel nanoparficles 
lactose, sucrose, maltoses, 











Glucose, glycine, lactic acid, 
ethylamine and ethanol 
Glucose 
Glucose, fructose, sucrose and 
lactose 
Hasebe et al. (1998) 
Freire and Kubota (2002) 
Luo, et al. (2004) 
Yin et al. (2001) 
Turkusic et al. (2000) 
Schachl et al. (1997) 
Kosminsky et aL (2003) 
Mafatle and Nyokong (1996) 
Mederos et al. (1998) 
Luo et al. (199 1) 
Stitz and Buchberger (1994) 
You et al. (2003) 
Pb Pb (11) Uric acid Gandouret a/. (1994) 
v VM oxo diperoxo Cysteine Ballistre6 et al. (2000) 
complexes 
Post-dates this work 
Manganese dioxide nanoparticles have also been used to eliminate ascorbic acid interference 
by Xu and co-workers (2004). The Mn02 particles were immobilised in a Chitosan@ film at a 
glucose oxidase modified gold electrode. When using buffered solutions, this arrangement was 
found to remove ascorbic acid interference in glucose sensing. The oxidation of ascorbic acid 


















mnu + zmn2U3 
Figure 5.6 Oxidation of ascorbic acid by Mn02 (adapted from Turkusic et A, 2000). 
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Chemical Oxidation 
of Ascorbic Acid 
Uric acid has been found to be oxidised in a similar way (Figure 5.7) and is described by 
Beyene et aL (2004). 
Uric Acid Allantoin 
0 Chemical Oxidation 
of Uric Acid H OýN 





Mn02 y MnO + zMn201 
Figure 5.7 Uric acid oxidation by Mn02 (adapted from Beyene, et aL, 2004). 
From this information, it can be proposed that Pb02 and/or Mn02 would be a suitable target 
metal oxide for the subsequent study, although the other metals do have compounds which are 
known to react with antioxidants. 
5.1 Experimental Details 
Unless otherwise stated, the following experimental details refer only to the work detailed in this 
chapter. The methodology to which the experimental techniques are applied is discussed within 
each sub-section of the chapter in context with the corresponding results. 
5.1.1 Blood Glucose Monitors 
Two types of blood glucose monitors were used in this study; both commercially available and 
manufactured by Lifescan@ Scotland Ltd.. 
0 FastTake TM 
o carbon screen printed working and counter electrodes, with a screen printed silver 
chloride reference electrode; 
o 3jd sample volume. 
UltraTm 
o screen printed carbon for all electrodes; 
11il sample volume. 
Both types of electrodes are manufactured by Lifescan@ Scotland Ltd., and contain a screen 
printed enzyme - mediator layer containing glucose oxidase (GOD) and potassium 
ferricyanide. Their mode of action is identical: 
0 the sample is applied to the end of the electrode; 
0 the sample is drawn up through the capillary within the strip; 
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* the sample contacts the electrodes, and 
0a potential of -+0.4 V is applied to measure glucose. 
The difference between the two electrodes is simply the sample volume and the reference 
electrode potential. The UltraTm meter has been described previously in section 2.1.8.2. 
5.1.2 Electrochemical Measurements 
Electrochemical measurements were carried out using a ýýAutolab Type 11 potentiostat as 
outlined in section 2.1.3. A standard three electrode configuration was used throughout with a 
Pt wire counter electrode, a AgjAgCl reference electrode and either a glassy carbon (GCE) 
(section 2.1.1.3) or a Pt rotating disc (PtRDE) working electrode (section 5.5.1). The cell utilises 
a pH 7 Briitton Robinson Buffer (section 2.1.2.4) with O. IM KCI as a background electrolyte, 
unless otherwise stated. 
Solutions of glucose, potassium ferrocyanide and the antioxidants ascorbic acid, cysteine, 
glutathione and uric acid were prepared from >99.7% purity powders (Sigma Aldrich Company 
Ltd, Poole UK); and glucose oxidase solutions were prepared from BioChemika powder 
(activity -150 units mg-1 (Fluka, Sigma Aldrich Company Ltd, Poole UK). Metal oxides were 
obtained at greater than 97% purity and used without further modification (Sigma Aldrich 
Company Ltd, Poole, UK). Cu, Fe, Mn, Mo, Ni, Pb, V and Zn 10000 mg 1-1 ICP-MS stock 
solutions (Aristar@ BDH Laboratories, Poole, UK) were diluted using DDW to 1000 mg 1-1 and 
used for mediator and enzyme studies. All solutions and dilutions were prepared using distilled 
deionised water (DDM. 
5.1.3 Atomic and Molecular Spectrometry 
Both Flame Atomic Absorption spectrometry (FAAS) and UVNisible (UV/Vis) spectrometry 
were used in this section of the work. FAAS was carried out using the Perkin Elmer AAnalyst 
400 instrument described in section 2.4. The concentrations of copper, iron, lead, manganese, 
nickel and zinc in various samples were determined according to the parameters listed in Table 
2.2. The UVIVis InfinityTm uric acid assay was used to determine the uric acid concentration of 
blood serum and plasma samples. The method utilises a modified Trinder peroxide assay for 
the enzymic detection of uric acid (, %max 520 nm) (Trivedi et al., 1978). The linear range of the 
method is 0.25-1.5 mM, with a limit of detection found to be 0.07 mM. Further information 
regarding the technique can be found in section 224. 
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5.2 Interferents in Blood Glucose Monitoring Technology 
The purpose of this section of work was two-fold. Firstly to determine the oxidation 
characteristics of the antioxidants ascorbic acid, cysteine, glutathione and uric acid, and 
secondly to investigate the effects of the presence of these antioxidants on the measurement of 
glucose by electrochemical blood glucose monitors. 
5.2.1 Methodology 
The electrochemistry of the antioxidants ascorbic acid, cysteine, glutathione and uric acid at a 
physiological pH (pH 7) was investigated using square wave voltarnmetry (SWV) at a glassy 
carbon electrode, as described in section 2.1.5.3. 
The effect of the antioxidants ascorbic acid, cysteine, glutathione and uric acid on glucose 
readings by the Ultralm meter was evaluated using the following solutions: 
a4 mM (74 mg dl-1) glucose 
04 mM (74 mg dl-1) glucose and 0.5 mM ascorbic acid 
04 mM (74 mg dl-1) glucose and 0.5 mM cysteine 
04 mM (74 mg dl-1) glucose and 0.5 mM glutathione 
04 mM (74 mg dl-1) glucose and 0.5mM uric acid 
which were all prepared in pH 7 Britton Robinson buffer (BR) and analysed in triplicate. A 
concentration of 4 mM glucose was selected as this is a low physiological glucose 
concentration and thus will enable any interference caused by the antioxidants to be clearly 
observed. 
The data generated was evaluated by the Parkes Error Grid (Parkes et aL, 2000). This error 
grid has been designed to assess the extent to which blood glucose monitor readings differ 
from the genuine glucose content of a sample and any clinical significance of this difference. 
The grid is broken down into zones each corresponding to a clinical action (difference iq 
glucose between real value and observed value) and the clinical outcome (influence of this 
difference on the health of the individual). These zones are surnmarised in Table 5.4. 
Table 5.4 Parkes Error Grid zones (adaz)ted from Parkes et A, 2000). 
Zone Clinical Action Clinical Outcome 
A No effect no effect 
B Altered little or no effect 
C Altered likely to affect 
D Altered significant medical risk 
E Altered dangerous consequences 
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5.2.2 Results 
5.2.2.1 Electrochemistry of the interferents 
The electrochemical activity of ascorbic acid, cysteine, glutathione and uric acid was evaluated 
by square wave voltammetry. A potential sweep from -0.2 V to +1.0 V was applied to a 0.5 mM 
solution of each antioxidant in Britton Robinson Buffer (pH 7). The results are shown In Figure 
5.8. 
Potential N 
Figure 5.8 Square wave voltammograms at the glassy carbon electrode of ascorbic acid (AA), cysteine, 
(Cy) glutathione (GSH) and uric aicd (UA) at 0.5 mM in Britton Robinson buffer (pH 7). 
From Figure 5.8 it can be seen that uric acid has the highest peak current (-30 IAA, +0.32 V), 
followed by ascorbic acid (-2 A +0.1 V) and cysteine (-2 A +0.7 V) and glutathione (+0.6 
V, -0.5 pA). As discussed in section 3.2.1 the thiols are particularly unresponsive at an 
unmodified electrode surface, which is reflected in the low peak currents obtained in Figure 5.8. 
The detection potential for ferro/ferricyanide, which is the electron transfer mediator in both the 
UltraTm and FastTakeTm blood glucose monitors, is +0.4 V which corresponds to the oxidation 
potential of the mediator. At this potential the antioxidants ascorbic and uric acid are oxidised 
and therefore have the potential to contribute to the analytical signal. However, cysteine and 
glutathione are not oxidised at this potential and are therefore unlikely to contribute to the 
analytical signal. 
5.2.2.2 Blood glucose monitor data 
The blood glucose monitor (UltraTm) readings for the samples detailed in section 5.2.1 are listed 
in Table 5.5. 
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Table 5.5 Glucose reading results from the UltraTM meter for a variety of antioxidant solutions where 
glucose was present at 4 mM and the antioxidants at 0.5 mM. 
Solution Glucose 1 Glucose 2 Glucose 3 Mean glucose 
/mm Imm /mm /W (mg dl-')* 
Glucose 4.0 3.8 4.0 3.9(70.8) 
Glucose + ascorbic acid 4.7 5.1 5.0 4.9(88.8) 
Glucose + cysteine 4.3 4.2 4.2 4.2(76.2) 
Glucose + glutathione 3.8 3.8 3.7 3.8(67.8) 
Glucose + uric acid 5.4 5.7 5.6 5.6000.2) 
*Glucose concentration (mg dl-1) is converted to mM by multiplying by 0.055 
The data in Table 5.5 was then plotted as actual glucose concentration versus the Ultra TM 
blood glucose monitor determined glucose concentration on a Parkes Error Grid (Figure 5.9). 
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Figure 5.9 Parkes Error Grid of the actual glucose concentration versus the Ultra Tm blood glucose reading 
for solutions comprising 4 mM glucose, 4 mM glucose + 0.5 mM ascorbic acid, 4 mM glucose + 
0.5 mM cysteine, 4 mM glucose + 0.5 mM glutathione and 4 mM glucose + 0.5 mM uric acid. 
The Parkes Error Grid shows that there is a bias resulting in the over estimation of glucose 
when ascorbic acid, cysteine and uric acid are present at 0.5 mM in a4 mM glucose solution. 
The bias was calculated and Parkes Error Grid zones observed and this information is 
surnmarised in Table 5.6. 
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Table 5.6 Glucose reading results from the UltraTM meter for a variety of antioxidant solutions where 
glucose was present at 4 mM and the antioxidants at 0.5 mM. 
Antioxidant Mean glucose Mean Ultra TM value Bias Zone Clinical outcome 
- 
(0.5 mM') I mM (m2 di-1) I mM (mg dl-1) I mM (mg dl-1) 
None 3.9(70.8) 3.9(70.8) 0.0(0.0) A No effect 
Ascorbic acid 3.9(70.8) 4.9(88.8) 1.0(18.0) A No effect 
Cysteine 3.9(70.8) 4.2(76.2) 0.3(5.4) A No effect 
Glutathione 3.9(70.8) 3.8(67.8) -0.1(-3.0) A No effect 
Uric acid 3.9(70.8) 5.6(100.21 1,7(29.4) B Little or no effect 
Note: Glucose concentration (mg dl-1) is converted to mM by multiplying by 0.055 
Given the information in Table 5.6 it is clear that although all antioxidants contributed some 
bias, only the presence of uric acid yielded an observed glucose (Ultralm) value in zone B 
where there is an altered clinical effect and outcome. The uric acid presented so much of an 
interferent that it produced a bias of +1.7 mM in blood glucose readings. This would have the 
most effect with glucose concentrations at a hypoglycaemic level, where the over estimation 
has the potential to cause the meter to read a normal glucose result, and for an individual to 
unknowiingly enter a hypoglycaemic state. Consequently, uric acid is a significant interferent. 
5.2.2.3 Paired Mest 
The data in Table 5.6 was also evaluated by means of a Paired Mest (Equation 2.9) where the 
replicate values for the 4 mM glucose solution were compared with the values for the 4 mM 
glucose solution with 0.5 mM ascorbic acid, cysteine, glutathione, or uric acid. The data 
generated is summarised in Table 5.7. 
Table 5.7 Summary of Paired Rest results comparing 4 mM glucose solution and 4 mM glucose solution 
with 0.5 mM antioxidant. 
Antioxidant 
(0.5 MM) n Law tcrft 
(P<0.05) D of F** Null hypothesis 
Ascorbic acid 3,3 5.77 4.30 2 Reject 
Cysteine 3,3 5.19 4.30 2 Reject 
Glutathione 3,3 1.88 4.30 2 Accept 
Uric acid 3,3 11.24 4.30 2 Reject 
P=Probability, **D of F= degrees of freedom 
The Paired Mest data indicates that the null hypothesis was rejected for the glucose solution 
containing ascorbic acid, cysteine and uric acid at the 95% confidence interval (P<0.05 level), 
but accepted for the solution containing glutathione. This indicates that ascorbic acid, cysteine 
and uric acid antioxidant solutions produce significantly different results compared to the 
glucose solution without these antioxidants. 
121 
5.2.4 Discussion 
Given the data from both the Parkes Error Grid (section 5.2.2.2) and the Paired Mest (section 
5.2.2.3), it is clear that a4 mM glucose solution containing 0.5 mM glutathione does not 
present any clinically or statistically significant interference to the UltraTm blood glucose meter 
at the P<0.05 level. This is as expected, as the oxidation potential for glutathione is higher than 
the detection potential used in the sensor (section 5.2.2.1) However, a4 mM glucose solution 
containing 0.5 mM ascorbic acid or cysteine does cause statistically different glucose readings. 
In the case of ascorbic acid this causes a1 mM bias (see Table 5.6) and for cysteine causes a 
0.3 mM bias. Neither of these were found to yield data outside of zone A of the Parkes Error 
Grid (Figure 5.9) A statistically significant (P<0.05) difference (bias of 1.7 mM) was observed 
for uric acid at 0.5 mM in a4 mM glucose solution, which gave rise to a result in zone B of the 
Parkes Error Grid (Figure 5.9). Uric acid therefore presents the most prominent source of 
interference in this blood glucose sensor. It was decided that ascorbic acid and uric acid would 
be the interferents to target in prevention of their interaction Within the blood glucose monitor. 
5.3 Metal Oxides 
It has been mentioned in section 5.0.3 that some metal oxides including Pb02 and IVIn02 have 
been used to remove antioxidant-based electrochemical interference in blood glucose monitors 
(Cui et aL, 2000; Choi et al., 2002). However, in both cases the metal oxides were immobilised 
within a membrane and as a result it is not clear whether the antioxidants were screened by the 
metal oxide or the membrane. 
In this work, it is desirable that the metal oxides found to oxidise the interferents are suited to 
incorporation into screen printed biosensors. Consequently, the reaction of the following metal 
oxides with the antioxidants ascorbic and uric acid was evaluated: CUO, CU20, FeO, Fe03, 
W02, W203, M002, M003, NiO, PbO, Pb02, V203, V204, V205 and ZnO. Those found to have 
a beneficial effect on the sensor have been evaluated further with respect to the efficiency of 
their reactions. 
5.3.1 Metal Oxide Selection 
The metal oxides CuO, CU20, FeO, Fe03, Mn02, Mn203, M002, M003, NiO, PbO, Pb02, V203, 
V204, V205 and ZnO have been evaluated in terms of their ability to oxidise antioxidants. This 
was characterised by the use of the UltraTm blood glucose meter (section 2.1.8), cyclic 
122 
voltarnmetry (section 2.5.2) and the Perkin Elmer Analyst 400 flame atomic absorption 
spectrometer (section 2.4). 
5.3.1.1 Methodology 
The metal oxide interaction with antioxidants was investigated using pH 7 BR buffer. A set of 
samples containing were prepared: 
e glucose at 4 mM; 
* glucose at 4 mM with 0.5 mM ascorbic acid (glucose+ AA); and 
e glucose at 4 mM with 0.5 mM uric acid (glucose + UA). 
A fixed volume of 5 CM3 of each solution was added to 0.25g of the metal oxides (CuO, CU20, 
FeO, Fe03, Mn02, Mn203, M002, M003, NiO, PbO, Pb02, V203, V204, V205 and ZnO), This 
ratio of volume to mass was selected as it represents the volume of blood: solid reactant ratio 
used in the UltraTm blood glucose monitor strip electrodes. The samples were then gently 
agitated for a period of 5 minutes. These samples were then filtered using Sartodus Minisart@ 
<2 micron pore size syringe filters (Sartorius Ltd, Epsom, UK) to remove the metal oxide 
powder from the sample solution. The filtered samples were then compared with a portion of 
the original sample which was not reacted with the metal oxide. The methods for comparison 
were: 
9 blood glucose monitor/meter (BGM) analysis (UltraTm meter) (section 2.1.8); and 
0 electrochemical determination of ascorbic acid or uric acid. 
The samples were also analysed by FAAS (sections 2.4 and 5.1.3) to evaluate the potential of 
the antioxidant solution to leach the metal into solution from the solid oxide. 
Each sample (before and after reaction with the metal oxide) was analysed in triplicate by blood 
glucose meter and the data evaluated in terms of the following categories: 
1. elevation where the average result of antioxidant-containing solutions after metal oxide 
treatment was more than 0.5 mM greater than before metal oxide treatment; 
2. no change where the average results of antioxidant-containing solutions before and 
after metal oxide treatment were within 0.5 mM of each other, 
3. reduced to >OK where the average results of antioxidant-containing solutions after 
metal oxide treatment were more than 0.5 mM lower than before but more than 0.5mM 
higher than the non antioxidant-containing solutions; 
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4. reduced to OK where the average results of antioxidant-containing solutions after 
metal oxide treatment were within 0.5mM of the non antioxidant-containing solutions; 
and 
5. reduced to <OK here the average results of antioxidant containing solutions after metal 
oxide treatment were more than 0.5mM lower than the non antioxidant-containing 
solutions. 
The concentrations of the antioxidants were evaluated using cyclic voltarnmetry (CV, section 
2.1.5.2) utilising a glassy carbon working electrode. The oxidation peak current for the 
antioxidant, before and after reaction with the metal oxide, was determined. Any reduction in 
peak current after reaction with the metal oxide indicated that the metal oxide was capable of 
oxidising the antioxidant. The amount of antioxidant remaining was expressed as a percentage 
which was calculated as follows: 
% Antioxidant remaining= [(IA-1m)11A]xlOO Equation 5.1 
Where 1A = peak current of antioxidant solution and Im = peak current of the antioxidant solution 
after reaction with the metal oxide. An example can be seen in Figure 5.10, next section, which 
shows a CV of ascorbic acid before and after reaction with CuO. 
It was noted that uric acid has the potential to 'foul' the electrode surface. However, with blank 
subtraction, the effect of the fouling did not compromise the response of the electrode. The 
electrode surface was refreshed between the antioxidant solutions by polishing the electrode 
surface using fine alumina powder (Sigma Aldrich Company Ltd, Poole, UK). 
Each solution was also analysed by FAAS as detailed in sections 2.4 and 5.1.3. The data from 
the antioxidant solutions reacted with metal oxide was blank subtracted using the antioxidant 
solution prior to reaction with the metal oxide. As a result the net increase in metal content of 
the sample was obtained. Due to the non availability of a nitrous oxide flame, molybdenum and 
vanadium could not be determined using the Perkin Elmer AAnalyst 400 FAAS instrument. 
5.3.1.2 Results 
The reduction of the concentration of the antioxidant in solution after treatment with the metal 
oxides was evaluated by cyclic voltarnmetry as described in section 5.3.1.1 (Equation 5.11). An 
example cyclic voltammograrn showing ascorbic acid before and after treatment with CuO is 
given in Figure 5.10. The decrease in the anodic (oxidative) peak for ascorbate (Figure 5.10) 
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Figure 5.10 Cyclic voltammogram of the 4mM glucose + 0.5mM ascorbic acid solution before and after 
treatement With CuO. 
Table 5.8 lists the findings of evaluating the 4mM glucose solutions with 0.5mM ascorbic and 
uric acid by UltraTm blood glucose monitor, according to the categories listed in section 5.3.1. 
Also included in the Table is the corresponding FAAS and % antioxidant remaining data 
(section 5.3.1) 
Table 5.8 Summary of blood glucose monitor (UltraTM), AAnalyst 400 and % antioxidant remaining data for 
4mM glucose + either 0.5mM ascorbic or uric acid samples. 
Metal Oxide 00000000 00 
Q) cv CC00 L) LA. LL. mmm2 IL m 
Ascobric Acid Samples 
Elevation 
No Change 
Reduced to > OK 0 0 0 
Reduced to OK 
Reduced to < OK 
Metal by FAAS 
1 mg 1-1 
5.6 1.5 0 0 12.8 0.3 N/A N/A 31 0.1 1.8 N/A N/A NIA 0.5 
% Antioxidant 
0 5 92 87 37 5 96 67 4 40 0 62 30 18 92 
remaining 
Uric Acid Samples 
Elevation 0 0 0 9 0 0 
No Change 
Reduced to > OK 
Reduced to OK 
Reduced to < OK 
Metal by FAAS 
/ mg 1-1 
9.4 40.1 0.1 5.2 0 1.9 N/A N/A 49 1.2 0.7 N/A NIA N/A 0.1 
% Antioxidant 
96 99 95 98 77 5 100 89 5 91 17 46 96 81 97 
remaining 
Considering the data in Table 5.8 for ascorbic acid, the folloWing metal oxides were excluded 
from the study as they either caused an elevation or yielded no change in the blood glucose 
monitor (UltraTm) results as defined previously: 
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a FeO, Fe203, M002, and V203. 
However, the blood glucose monitor (UltraTm) results for the followilng metal oxides all showed 
a reduction as defined previously: 
0 CUO, CU20, MnO2, Mn2O3, M003, NiO, PbO, Pb02, V204, V205and ZnO. 
Only eight metal oxides were found to efficiently oxidise ascorbic acid, as indicated by the % 
antioxidant remaining (<15%) 
0 CUO, CU20, MnO2, NiO, and Pb02. 
Whereas considering uric acid, the following metal oxides were disqualified from the study as 
they either caused an elevation or yielded no change in blood glucose monitor (UltraTm) results 
as defined preViously: 
e Mn203, MO02, M003, Pb02, V204 V205 and ZnO 
The following metal oxides all caused a reduction in the blood glucose monitor (UltraTm) results 
as defined previously: 
0 CUO, CU20, Fe203, FeO, Mn02, NiO, PbO, V203, and ZnO. 
However, of these oxides, only Mn02, NiO, PbO were found to effect a decrease in uric acid 
concentration. It was also found that ascorbic and uric acid solutions reacted with CuO and NiO 
had the most leachability resulting in elevated levels of the respective metals into solution. 
5.3.1.3 Discussion 
The influence of metal oxides on the measurement of 4mM glucose solutions containing 0.5mM 
ascorbic or uric acid has been evaluated. Some metal oxides were found to lower the Ultra TM 
blood glucose monitor readings and not affect the antioxidant concentration (e. g. M003 and 
ZnO). Some metal oxides were even found to elevate the blood glucose monitor readings 
without affecting the antioxidant concentration (e. g. FeO andMO02). These differences may be 
caused by a number of factors which have the potential to affect the monitor, and not just the 
presence of the antioxidant. For example elevation may occur due to direct reduction of the 
mediator by metal oxide, which would give rise to an increase in oxidation current (elevation of 
signal). Conversely, a portion of the metal from the oxide may become soluble and be able to 
move through the electrode capillary and cause inhibition of the enzyme. Considering the data 
in Table 5.8, it was decided that CuO andCU20should be further investigated in relation to 
ascorbic acid oxidation, and Mn02, NiO, and Pb02in relation to both ascorbic and uric acids. 
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5.3.2 Metal Oxide Efficiency 
An important factor in developing a strategy to remove antioxidant interferences using metal 
oxides is to determine the efficiency of antioxidant oxidation by each metal oxide. The simplest 
way to do this was to investigate the proportion of metal oxide required to completely oxidise 
ascorbic acid and uric acid under identical conditions. From the results in section 5.3.1, CuO 
and CU20 were evaluated in relation to ascorbic acid oxidation, and Mn02, NiO, and Pb02 in 
relation to both ascorbic and uric acid. 
5.3.2.1 Methodology 
The following solutions were used to evaluate the efficiency of CuO, CU20, Mn02, NiO, and 
Pb02 for antioxidant oxidation: 
e glucose at 4 mM with 0.5 mM ascorbic acid (glucose+ AA); and 
9 glucose at 4 mM with 0.5 mM uric acid (glucose + UA). 
A 5CM3 aliquot of each solution was reacted with approximately 0.01,0.02,0.03,0.04,0.05, 
0.06,0.07,0.08,0.09 and 0.10g of the metal oxide. These samples were then gently agitated 
for a period of 5 minutes and then filtered using Sartorius Minisart@ <2 micron pore size syringe 
filters (Sartorius Ltd, Epsom, UK) to remove the metal oxide powder. Each sample was 
analysed using cyclic voltarnmetry to monitor the current of the oxidation peak of the 
antioxidant. 
5.3.2.2 Results 
The blank corrected peak current for the oxidation peak of each reacted solution was then 
plotted against the mass of the metal oxide reacted. An example can be seen for the NiO- 








Figure 5.11 Plot of blank corrected peak current versus mass NiO reacted with 0.5 mM uric acid. 
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The mass required for the complete oxidation of 0.5mM ascorbic acid or uric acid was 
calculated from the intercept of the line of best fit with the x axis (where y=O). The results are 
listed in Table 5.9. 
Table 5.9 Mass of metal oxides reouired to oxidise ascorbic or uric acid in a 5CM3 0.5mM solution 
Oxide Mass required to oxidise 
ascorbic acid/ g 
Mass required to oxidise 
uric acid Ig 
Cuo 0.090 N/A* 
CU20 0.006 N/A* 
Mn02 0.013 0.018 
NO 0.004 0.095 
Pb02 0.007 0.026 
*N/A not studied as not found to oxidise uric acid in section 5.3.1. 
From Table 5.9, the efficiency of the oxidising agents with respect to ascorbic acid was 
NiOý'CU20ý'PbO2ý'MnO2ý'CuO; and with respect to uric acid was MnOPPbOPMO. For Mn02, 
Pb02 and NO the mass required to oxidise uric acid was also found to oxidise ascorbic acid. 
This is because ascorbic acid is more easily oxidised than uric acid, which is reflected in its low 
oxidation potential (Figure 5.8, section 5.2.2.1). 
5.3.3 Discussion 
The interaction of a total of 15 metal oxides (CuO, CU20, FeO, Fe03, Mn02, Mn203, M002, 
M003, NiO, PbO, Pb02, V203, V204, V205 and ZnO) has been evaluated with respect to their 
ability to oxidise ascorbic and uric acids. Firstly the UltraTm blood glucose meter has been used 
to determine the concentration of glucose in a solution with no antioxidants present, the 
concentration of the same solution with 0.5 mM ascorbic or uric acid, and the same antioxidant 
solution after reaction with the metal oxides. Secondly, the amount of antioxidant remaining (% 
remaining, Equation 5.1) after the solution was reacted with the metal oxides was determined 
electrochemically using cyclic voltarnmetry (section 5.3.1.1). 
The oxides CuO, CU20, Mn02, NiO, and Pb02 were found to be the most effective at oxidising 
ascorbic acid, and of these, Mn02, NiO, and Pb02 at oxidising uric acid also (section 5.3.2). 
However, both ascorbic and uric acids were able to leach these metals into solution. 
Consequently, they would become mobilised in the solution within the sensor and any reaction 
of the metals with the ferri/ferrocyanide redox mediator and the enzyme glucose oxidase must 
be evaluated. 
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5.4 Reactions of Cu, Mn, Ni and Pb with the Ferrocyanide Mediator 
The interaction of copper, manganese, nickel and lead in solution with the mediating species 
(ferri/ferrocyanide) within the sensor may be unfavourable. Consequently the reaction of these 
metals with the mediator has been investigated. 
5.4.1 Methodology 
The electrochemical activity of the mediator can be easily monitored using cyclic voltarnmetry. 
The standard cell configuration with a glassy carbon electrode described in section 51.2 was 
used, Increasing aliquots of 15.7 pM of the metal (from diluted ICP-MS stock solutions, section 
5.1.2) were added to a1 mM solution of ferrocyanide. The potential sweep was from -0.1 V to 
+0.4 V at 50 mV s-1. 
5.4.2 Results 
Cyclic voltammograms detailing the response of a glassy carbon electrode to ferrocyanide in 
the presence of increasing concentrations of a free metal ion (15.7 pM additions to a 10 CM3 
cell) are shown in Figures 5.12 to 5.15. 
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Figure 5.12 Cyclic voltarnmograms of 15.7 pM Cu to Figure 5.13 Cyclic voltammograms of 15.7 pM Mn 
1mM ferrocyanide. to 1mM ferrocyanide. 
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Figure 5.14 Cyclic voltammograms of 15.7 pM Ni Figure 5.15 Cyclic voltammograms of 15.7 pM Pb 
to I mM ferrocyanide. to 1mM ferrocyanide. 
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The heights of the oxidation and reduction peaks were found to decrease markedly upon the 
addition of the copper ion. This was then evaluated in the presence of 0.1 M citrate, which is 
present as a buffering agent in the mediator screen printing ink (section 5.1.1). In contrast, the 
influence of increasing copper on the ferrocyanide response in the presence of 0.1 M citrate 
(pH 7) was found to be negligible as the % change in analytical signal peak current was found 
to be approximately zero, as shown in Figure 5.16 
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Figure 5.16 Change of analytical signal of 1 mM ferrocyanide with 87.5 pM additions of copper in the 
absence and presence of 0.1 M citrate. 
Manganese addition caused precipitation in the solution thereby 'fouling' the electrode surface. 
It is this which is seen in the cyclic voltammograrn (Figure 5.13), and can be assumed not to 
affect the sensor as the blood glucose monitor data was not compromised (Table 5.8, section 
5.3.1.2). Nickel addition caused a decrease in the peak height of the signal also, but there was 
no precipitation in solution. This is likely to be due to the fact that Ni2+ readily becomes 
complexed with the ferrocyanide and chemically alters the redox characteristics of the 
mediator. However, for this to occur the nickel and ferrocyanide need to be in solution and the 
electrode potential must be cycled. In the sensor this does not occur, and therefore this effect 
will not compromise the sensor signal. 
In the case of lead, there is very little change in the mediator redox signal and the small shift 
can be attributed to the fact that each lead addition also relates to a small 1% HN03 addition. 
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5.4.3 Discussion 
Manganese, nickel and lead were found not to have a detrimental effect on the electrochemical 
signal of the ferri/ferrocyanide redox mediator (Figures 5.12 to 5.15). Consequently, the fact 
that these metals are easily leached into solution from their oxides would not compromise the 
electrochemistry used in the blood glucose monitor. However, the situation with copper is more 
complex. Copper was found to inhibit the mediator (Figure 5.12), but in the presence of 0.1 M 
citrate, this did not occur (Figure 5.16). Citrate is present as a component of the mediator 
screen printed layer, and consequently copper oxides could be used to modify the sensor and 
a decrease in the analytical signal relating to the presence of copper should not be observed. 
5.5 Reactions of Cu, Mn, Ni and Pb with Glucose Oxidase 
The copper, manganese, nickel and lead leached into solution by the antioxidants have the 
potential to inhibit the screen printed enzyme in the sensor (glucose oxidase), as well as the 
mediator. In this section of work the interaction of the metal with glucose oxidase has been 
investigated, and, where necessary, protocols developed to prevent any undesirable 
interaction. 
5.5.1 Methodology 
Rotating disk experiments were conducted using a BAS RIDEA system coupled to ýL-Autolab 
Type 11 potentiostat (section 2.1.3). In this instance the working electrode was a 3mm diameter 
Pt disc working electrode, rotating at 5000 rpm. A cell volume of 25 CM3 was used, with the 
working electrode poised at +0.8V for the measurement of hydrogen peroxide as a result of the 
oxidation of glucose by glucose oxidase (Equation 1.1). The reaction mixture within the cell 
comprised a solution of 1g 1-1 glucose oxidase in Britton Robinson buffer (pH 7). 
5.5.2 Results 
5.5.2.1 Manganese, nickel and lead 
The rotating disc electrode (RDE) response to the reaction mixture within the cell was 
monitored by chronoamperometry. Five aliquots of glucose (50 ýW) were added to the cell, and 
then four aliquots of the metal (17.5 [W). Figure 5.17 shows the RIDE chronoamperometric 







Figure 5.17 Chronoamperometric response for glucose additions (50 pM) followed by additions of lead, 
nickel and manganese (17.5 gM) a Pt RDE (5000 rpm, +0.8 V) in the presence of glucose 
oxidase in pH7 Britton Robinson buffer. 
Figure 5.17 shows the overlaying of the three sets of data and clearly the results imply the 
replication of the response to glucose between experiments. The subsequent addition of lead 
to the solution caused no change to the analytical signal, and reinforces the suitability of Pb02 
as an anti-interference device. Nickel additions show a small decrease and the enzyme is 
quantitatively, but minimally, inhibited. This suggests that nickel oxide is unsuitable as an anti- 
interference strategy. The addition of manganese to the solution yielded a more interesting 
response. The current decreased logarithmically with each addition, suggesting that the 
electrode surface was 'fouled' in the presence of manganese. This effect was investigated 
further by carrying out a glucose calibration at the manganese-treated electrode and comparing 
it with a freshly polished electrode, shown in Figure 5.18. 
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Figure 5.18 Comparison of Mn fouled Pt RDE and clean polished Pt RDE (5000 rpm, +0.8 V) and their 
response to glucose in the presence of glucose oxidase in pH 7 Britton Robinson buffer. 
The data in Figure 5.18 shows a significant depletion in the signal, and strengthens the case for 
manganese in solution fouling the electrode surface. However, in the sensor a much lower 
detection potential is employed. As discussed in section 5.3, the use of Mn02 did not show any 
deleterious effect on the UltraTM meter response and it can be concluded that the data yielded 
by such a sensor does not appear to be in anyway affected by this type of electrode surface 
destruction. 
5.5.2.2 Copper 
The chronoamperometric response of a platinum RDE working electrode (poised at + 0.8 V) in 
the presence of glucose oxidase as a function of increasing additions of glucose (50 pM) in pH 
7 buffered solution is shown in Figure 5.19. The current increases with increasing glucose as 
the hydrogen peroxide (released as a consequence of the enzymic reaction) is oxidised at the 
electrode surface. The experiment was then repeated, but in this instance, Cu was added to 
the solution prior to commencing the analysis. The presence of the copper ions was found to 
significantly depress (in the presence of 0.76 mM Cu) or completely inhibit (3.15 mM Cu) the 
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Figure 5.19 Ch ronoamperog rams for glucose additions (50 gM) in the presence of Cu (0 mM, 0.79 mM and 
3.15 mM) to a Pt RDE (5000 rpm, +0.8 V) in the presence of glucose oxidase in pH7 Britton 
Robinson Buffer. 
The ability of whole blood to extract the copper ion from the CuO particles was assessed to 
determine the likely concentration of copper to be released within a typical blood sample 
aliquot. It was found that a 20 pl sample of whole blood applied to 10 mg of CuO effectively 
released 4.12 mM of copper into solution. Extrapolating this result to the data, would indicate 
that this level of Cu would completely inhibit the glucose oxidase reaction. It must be 
acknowledged that the data presented in Figure 5.19 represents the influence of Cu in a simple 
buffer regime. It could be anticipated that the chelation of the cupric ion by the amino acid / 
peptide components of blood would preserve enzymatic activity. This was assessed through 
repeating the steady state (chronoamperometric) amperometric detection of glucose, but in a 
tissue medium buffered at pH 7. The response of the system to (a)tissue culture medium and 
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Figure 5.20 Chronoamperograms for glucose additions (50 gM) in the presence of Cu (0 mM, 0.79 mM and 
3.15 mM) to a Pt RDE (5000 rpm, +0.8 V) in the presence of glucose oxidase in tissue culture 
medium prepared in pH 7 Britton Robinson Buffer. 
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In simple Britton Robinson buffer, 3.15mM copper completely inhibits the enzyme, whereas in 
tissue culture medium containing the same concentration of copper, this inhibition is markedly 
reduced. This is due to the amino acids and peptide components of the tissue culture medium 
chelating the Cu and preventing the enzyme from complete inhibition. 
It was found that the introduction of a large excess of 0.1 M citric acid could remove the 
deleterious effect of the copper. The influence of copper (1.57 mM) on the enzyme response in 









Figure 5.21 Comparison of the steady state amperograms for glucose additions (50 pM) in the presence of 
Cu at 1.57 mM to Pt RDE (5000 rpm, +0.8 V) in the presence of glucose oxidase in 0.1 M pH 7 
citrate buffer and citrate buffered tissue culture medium. 
From Figure 5.21, it is apparent that there is no deviation in the signal between the two cell 
solutions. It can therefore be shown that the presence of 0.1 M citrate within the sensor can 
effectively prevent copper from inhibiting the enzyme. 
5.5.3 Summary 
Rotating disc electrode studies of the reaction of glucose oxidase with glucose and copper, 
nickel, manganese and lead were used to evaluate whether any metals had a detrimental effect 
on the enzyme. The data in Figure 5.17 indicated that lead gave an ideal response, with no 
change in the amperometric signal. Manganese was found to 'foul' the electrode surface at 
such a high potential, so cannot be assigned either an ideal or inhibitory response. Nickel was 
found to quantitatively inhibit the enzyme and was therefore not found to be suitable for use in 
sensor modification. Copper was found to inhibit the enzyme when present at a physiological 
concentration, although this could be prevented by the introduction of a complexation agent in 
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the form of 0.1 M citrate. This was found to hold true in both a Britton Robinson buffer regime 
and a tissue culture medium. 
Other factors also have to be considered, such as biocompatibility and environmental factors, 
and this is where the case for the use of Pb02 and NiO becomes unfavourable. Lead 
compounds are physiological and environmental toxins, and nickel compounds are known to be 
carcinogenic. For a combination of all of these factors, manganese dioxide was selected as the 
metal oxide of choice for an ascorbic and uric acid anti-interference strategy. Ideally this would 
involve the incorporation of the oxide into a suitable sample pre-treatment system for the 
screen printed electrodes used with blood glucose monitors. 
5.6 Copper Oxide Sensor Fabrication 
Sensor fabrication was developed using the copper (11) oxide (CuO) particles, although it 
should be noted that the methodology described is readily applicable to the other metal oxides 
described in this work. The particles used in this part of the study were characterised using a 
scanning electron microscope (SEM) in order to determine the approximate particle size as 
shown in Figure 5.22. It was concluded that the particles would be best suited to use in sample 
pre-treatment methods, and a suitable approach has been developed. 
Figure 5.22 Scanning Electron Microscope image of CuO particles showing particle size of 2-20 ýLm. 
5.6.1 Sensor Construction 
A copper oxide sponge was produced utilising MelolinO (Smith and Nephew Healthcare Ltd., 
Hull, UK) which can then be used as a sample pre-treatment device prior to sample uptake into 
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the screen printed electrode. The mode of action of the sponge is shown in Figure 5.23a, 
where the sample passes through the permselective layer to the polyester binder material 
where the ascorbate is oxidised to dehydroascorbic acid. The sponge is then squeezed (Figure 
5.23b) and the sample passes up the screen printed electrode (SPE) capillary where it makes 
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Figure 5.23. (A)The model of the movement of analyte through the permselective membrane to react with 
the CuO particles, and 
(B) the subsequent squeezing of the Melolin@ sponge forcing the analyte up the capillary 
channel to contact the electrode. 
The SEM images indicate that CuO was immobilised behind a Melolin@ permselective 
membrane as shown in Figure 5.24 and within the polyester binder material forming as shown 
in Figure 5.25. Inspection showed that a random particle distribution was found, with little 
clumping, thus ensuring the maximum surface area for the ascorbate to react. This 
arrangement effectively formed a sponge which was utilised for the pre-treatment of samples 
before analysis at the aforementioned screen printed electrode. 
Figure 5.24 Melolinlý Membrane. Figure 5.25 Melolin" immobilised CuO particles. 
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5.6.2 Sample Analysis at the Modified Screen Printed Electrode 
Chronoamperometry, with the potential poised at +0.8V, was used to determine the efficacy of 
the sample pre-treatment area. Screen printed electrodes were obtained from the Glucose 
meter FastTake Tm (Lifescan& Inc. ) and interfaced with the potentiostat (R-Autolab Type 11, as 
described in seýtion 2.1.3). All solutions were prepared in 0.1 M citrate buffer in order to mimic 
the complexing ability of proteins and amino acids found in physiological fluids. A2 mM 
glucose solution and 2 mM glucose spiked with 0.5 mM ascorbate solution was analysed 
before and after sample pre-treatment using the modified sensor. The chronoamperometric 
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Figure 5.26 Chronoamperograms of glucose response (2 mM) and glucose 2 mM spiked with 0.5 mM 
ascorbic acid at the screen printed electrode and utilising the Melolino CuO processing 
sponge before analysis at the screen printed electrode. 
The data in Figure 5.26 shows a significant signal elevation in the presence of ascorbate. This 
suggests the antioxidant interferes directly at the SPE causing an increase in the amperometric 
signal. The sample pre-treatment sponge was then utilised to sieve out the interferents at a 
molecular level, with the same solutions being analysed again. 
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5.6.3 Discussion 
An effective pre-oxidation device for the removal of ascorbic acid interference in blood glucose 
monitors has been developed. This employed a CuO modified absorbent sponge through which 
the sample passed before being analysed at the screen printed electrode. Analysis of ascorbic 
acid spiked glucose samples found that the glucose solution gave an identical response both 
with and without the sample pre-treatment sponge while the sample spiked with ascorbate and 
passed through the sponge gave an identical response to the glucose only solutions. Thus the 
sponge served to effectively remove the antioxidant and give an interference-free glucose 
measurement. 
5.7 Manganese Dioxide for Total Antioxiclant Removal 
Manganese dioxide has been resolved to be the most effective metal oxide for oxidising 
ascorbic and uric acids present as electrochemical interferents in glucose solutions analysed 
by blood glucose sensors. Other metal oxides have been excluded from further investigation on 
the grounds of either: 
0 not being able to oxidise ascorbic and/or uric acid (section 5.3); 
0 undesirable interaction with either the ferri/ferrocyanide redox mediator or glucose 
oxidase (e. g. NiO, sections 5.4 and 5.5); 
0 only being able to oxidise ascorbic acid (e. g. CUO, CU20, section 5.3); or 
a undesirable environmental or toxicological effects (e. g. NiO, Pb02, section 5.5). 
With a possible mode of sensor modification developed, it only remained to investigate Mn02 
with real biological fluids, namely blood plasma and serum. 
5.7.1 Methodology 
Manganese dioxide was obtained in a fine granular form, <1 0 micron (Sigma Aldrich Company 
Ltd., Poole, UK). A similar approach to that applied to the initial investigations was applied 
(section 5.3.1), whereby the oxide was mixed with the sample solution and then filtered to 
remove the oxide particles. However, blood serum, plasma and whole blood were not found to 
be suitable for filtration due to their high protein content. A different method for separating the 
solid manganese dioxide from the biofluid was developed. This involved the centrifugation of a 
well-mixed sample/manganese dioxide solution such that the solid was collected at the bottom, 
and the supernatant, when analysed by blood glucose meter, yielded interference-free data. 
Unfortunately, this methodology could not be evaluated using whole blood, as the 
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centrifugation would cause the separation of the blood into the components of plasma, platelets 
and red blood cells. However this method was highly suited to plasma and serum analysis. 
5.7.2 Samples 
Samples of blood plasma were obtained from a 25 year old female volunteer immediately prior 
to conducting the experiments. Blood serum was obtained from a pooled serum in-house 
reference material. Each serum / plasma sample was spiked with glucose to elevate the 
glucose level such that it was in the optimum range for BGM analysis (between 4 and 12 mM). 
The samples were then spiked with 0.5mM ascorbic or uric acid. A 500 PI aliquot of the blood 
serum / plasma was added to 0.03 g Mn02 in an EppendorfTM tube (Eppendorf UK Limited, 
Cambridge, UK). This was gently agitated for 1 minute and then centrifuged at 4000 rpm for 5 
minutes. The supernatant was then removed for analysis. 
5.7.3 Results 
5.7.3.1 UltraTm blood glucose monitor data 
The data obtained from the analysis of the plasma samples by UltraTm blood glucose monitor is 
shown in Table 5.10. The average results for three replicates are listed, along with the relative 
standard deviation (%RSD, Equation 2.11). For all sets of replicates the %RSD was less than 
±5%, indicating that the method had a good level of precision. 
Table 5.10 UltraTO results for blood plasma samples spiked with either 0.5 mM ascorbic or uric acid before 
and after reaction with WON 
UltraTO results before Mn02 treatment S l UltraTm results after Mn02 treatment amp e Rep I Rep 2 Rep 3 Mean %RSD Rep I Rep 2 Rep 3 Mean %RSD 
Plasma 6.3 5.9 5.9 6.0 3.8 5.1 4.9 5.1 5.0 2.3 
Plasma + AA 7.2 7.3 7.2 7.2 0.8 4.9 4.9 4.7 4.8 2.4 
Plasma + UA 7.3 7.2 7.5 7.3 2.1 4.7 4.6 4.8 4.7 2.1 
A Paired Mest (Equation 2.9) was conducted on the data given in Table 5.10 to evaluate 
whether there was any statistical difference between the plasma samples before and after 
reacting with Mn02. For ascorbic acid, a value of tcaic = 1.73 < twit = 2.78 (P<0.05) (4 degrees of 
freedom) was obtained. Whereas, for uric acid a value of 6, c = 1.94 < 6-t = 2.78 (P<0.0) (4 
degrees of freedom) was calculated. In both cases, the null hypothesis was accepted at the 
P<0.05 level (95% confidence interval) indicating no statistical difference between the unspiked 
solution and any of the samples after reaction with Mn02. All samples after treatment were 
found to contain approximately 4.8 mM glucose. 
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The data obtained from the analysis of the blood serum samples by UltraTm BGM is reported in 
Table 5.11 and the average results for three replicates and %RSD values are included 
Table 5.11 UltraTm results for blood serum samples spiked with either 0.5 mM ascorbic or uric acid before 
and after reaction with MnO2. 
Sample UltraTm results before Mn02 treatment/ mM UltraTm results after Mn02 treatment I mM 
Rep 1 Rep 2 Rep 3 Mean %RSD Rep I Rep 2 Rep 3 Mean %RSD 
Serum 9.3 9.7 9.8 9.6 2.8 8.7 8.8 8.8 8.8 0.7 
Serum + AA 10.8 10.2 10.6 10.5 2.9 8.8 9.3 8.8 9.0 3.2 
Serum + UA 10.7 10.6 10.9 10.7 1.4 8.9 9.0 8.8 8.9 1.1 
Again, a Paired Mest was conducted to evaluate whether there was any statistical difference 
between the serum samples and after reacting with the Mn02. Similarly to the plasma samples, 
no statistical difference was found between any of the samples after Mn02 treatment. For uric 
acid, tcalc = 1.31, tit = 2.78 (P<0.05) (4 degrees of freedom) and for ascorbic acid 6ý = 2.00, 
tcrt = 2.78 (P<0.05) (4 degrees of freedom). After reacting with Mn02 all serum samples were 
found to have a glucose concentration of approximately 8.9 mM. 
It can be seen that in both the un-spiked plasma and serum samples the glucose reading is 
lowered after reaction with Mn02. This was attributed to the oxidation of the antioxidants 
present in the biological fluids. To confirm this, a study using the Infinity TM uric acid assay was 
conducted. 
5.7.3.2 Uric acid removal in serum and plasma - InfinityTm uric acid assay 
The Infinity uric acid assay was carried out as prescribed in sections 2.2.5 and 5.1.3. Each 
blood serum or blood plasma sample and a serum or plasma sample spiked with 0.5mM uric 
acid was analysed using the InfinityTM uric acid assay. The determinations were carried out in 
triplicate (n=3) and the results (mean and % RSD) are reported in Table 5.12 
Table 5.12 Infinity'rm uric acid data for blood plasma and serum samples with and without 0.5 mM uric acid 
added before and after Mn02 treatment. 
Sample 
Infinity TM UA data before Mn02 treatment/ mM InfinityTM UA data after Mn02 treatment I mM 
Rep 1 Rep 2 Rep 3 Mean %RSD Rep 1 Rep 2 Rep 3 Mean %RSD 
Plasma 0.192 0.191 0.193 0.192 0.5 0.079 0.08 0.08 0.080 0.7 
Plasma + UA 0.796 0.798 0.795 0.796 0.2 0.105 0.106 0.107 0.106 0.9 
Serum 0.181 0.182 0.183 0.182 0.5 0.086 0.086 0.087 0,086 0.7 
Serum + UA 0.635 0.638 0.637 0.637 0.2 0.109 0.111 0.112 0.111 1.4 
The background uric acid concentration was found to be in the range of 0.2 mM in both the 
plasma and serum samples. This uric acid value was found to decrease to a level of 
141 
approximately 0.1 mM (0.08-0.11 mM) after manganese dioxide treatment. Given this 
information and the fact that the meter readings of samples reacted with Mn02 are lower than 
those from before, it may be suggested that this can be attributed to the oxidation of 
endogenous uric acid in the sample. 
The data for the plasma and serum samples spiked with uric acid indicate that before Mn02 
treatment the uric acid concentration was elevated to approximately 0.7 mM. Considering the 
concentrations of samples after Mn02 treatment, all samples are lowered to a concentration of 
between 0.08 and 0.11 mM. These values are below the linear range of the InfinityTM uric acid 
method (0.25 - 1.5 mM) and close to the limit of detection (0.07 mM). The concentration of all 
post Mn02 samples therefore should be represented as <0.25 mM. 
5.7.4 Summary 
The data generated in this section has confirmed the ability of Mn02 particles to oxidise 
ascorbic and uric acid in blood plasma and serum samples. This has been evaluated with the 
UltraTm blood glucose monitor and the Infin4Tm uric acid assay (section 5.7.1). It was found 
that the particles were highly effective at removing the interference generated by ascorbic and 
uric acid in both plasma and serum samples. This was confirmed by a Paired West, which 
found no statistical difference between any samples (those with and without ascorbic and uric 
acid spiked at 0.5 mM) after reaction with the Mn02 particles (P<0.05) (section 5.7.2). It was 
noted that the glucose measurement by the UltraTM meter was higher with the un-spiked 
sample before Mn02 treatment compared with after. This was found to be due to the oxidation 
of endogenous uric acid present in the sample, confirmed by the InfinityTm uric acid assay 
(section 5.7.3). 
5.8 Conclusions 
The extent to which the antioxidants uric acid, ascorbic acid, cysteine and glutathione interfere 
with blood glucose monitors has been evaluated (section 5.1). This data has been assessed by 
using the Parkes Error Grid which categorises the interference by clinical effect, and also by 
using a Paired Mest. In both cases it was found that cysteine and glutathione do not exhibit a 
sufficient level of interference to be of relevance in the study (section 5.1.2). For this reason 
only ascorbic acid and uric acid have been investigated. The literature relating these 
antioxidants to transition metals and their compounds has been reviewed and it was found that 
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manganese dioxide and lead dioxide were likely to be the most effective at oxidatively 
removing antioxidants such as ascorbic and uric acid (section 5.0.3). However, the interactions 
of these and other metal oxides with the antioxidants ascorbic acid and uric acid have been 
evaluated (section 5.3). The methods used in the study include electrochemical measurements, 
UVNis spectrometry, FAAS and the use of the UltraTm blood glucose monitor. 
Two approaches have been employed for investigating the final application of the oxides within 
blood glucose monitors using screen printed electrodes. Firstly copper (11) oxide was evaluated 
as a sample pre-treatment methodology for screening out ascorbic acid in blood glucose 
sensing (section 5.6). Secondly manganese dioxide was investigated as a strategy for both uric 
acid and ascorbic acid oxidation (section 5.7). These approaches would ideally be combined in 
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Blood glucose monitoring is an essential criterion for individuals suffering from diabetes 
mellitus, especially in type 2 or non-insulin dependent cases (Clark, 2004). Many trace 
elements have been investigated in relation to diabetes (Abou-Self and Youssef, 2004) using 
blood serum, plasma (Ward and Pim, 1984) or whole blood (Ekmeckloglu, 2001). Several of 
these trace elements (copper, iron, lead, manganese, molybdenum, nickel, vanadium and zinc) 
were studied in Chapter 5 in order to consider their interaction as metal oxides with 
antioxidants. It has been shown that ascorbic acid has a limited yet measurable effect on blood 
glucose measurements as determined by sensors using mediated electron transfer (section 
5.2.3). Similarly, uric acid has been shown to be a more significant interferent (section 5.2.3). 
This study was designed to evaluate the effect of trace elements and uric acid on blood 
glucose sensing in a human population. Specifically, the UltraTm glucose measurements were 
investigated in relation to YSI glucose, serum uric acid and the trace elements to see if there 
was any influence or correlation. Type 2 diabetics were chosen due to the importance of blood 
glucose monitoring in controlling their condition. In designing the study it was considered to be 
important to review the scientific and medical literature so as to gain an understanding of the 
concentration and physiological function of glucose, uric acid and trace elements in biological 
fluids, such as blood (serum, plasma and whole). Furthermore, special attention was given to 
any published data relating to type 2 diabetic and selected control individuals. 
6.1 Diabetes Mellitus 
Diabetes mellitus is a disease which results from the inability of the body to control blood 
glucose levels. There are two main types of diabetes. Type 1 diabetes tends to occur in young 
individuals and is a result of the islets of Langerhans in the pancreas failing to produce insulin. 
Untreated, this leads to hyperglycaemia. The treatment for type 1 diabetes is by insulin 
injection and this type of diabetes is therefore also known as insulin-dependent diabetes 
(Hillson, 2002). Type 2 diabetes is most prevalent in mature individuals and is also known as 
maturity (age) onset diabetes. This occurs in individuals whose body tissues are not able to 
respond to the insulin released by the pancreas. This also leads to hyperglycaernia. Treatment 
of type 2 diabetes involves a combination of the following: diet control, oral hypoglycaernic 
agents and insulin, although insulin is only used in the most severe cases (Hillson, 2002). 
Treatment for both types of diabetes is monitored by the diabetic themselves using blood 
glucose meters. 
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To understand the effects of diabetes mellitus it is important to consider the way in which the 
body metabolises glucose. The islets of Langerhans are endocrine glands which are 
responsible for releasing the hormones insulin and glucagon which control glucose metabolism. 
Insulin stimulates glucose uptake from the blood into the liver and muscle cells. Ultimately, 
glucose in the liver is converted to glycogen for storage. This lowers the blood glucose 
concentration. The hormone glucagon stimulates the breakdown of the glycogen in the liver, 
releasing glucose. As a result, these hormones homeostatically control the concentration of 
glucose in blood, which also controls the concentration in other body tissues (Taylor and Jones, 
1996). 
The kidneys and liver are the two organs actively involved in controlling glucose metabolism. 
The liver is able to synthesise glucose from amino acids, glycerol and lactate in a process 
known as gluconeogenesis, as well as being the site of glycogen storage and breakdown as 
previously mentioned. The kidneys are responsible for the ultrafiltration and reabsorption 
process which controls the transport of water, proteins, amino acids, glucose, urea, uric acid, 
creatinine and inorganic ions from the blood through to the urine. Glucose, amino acids, 
vitamins, sodium and chloride are actively reabsorbed as required. As such the kidneys are 
able to control the content, pH and water content of the blood (Jones, 1998). 
In both types of diabetes, the lack of insulin or response to insulin causes blood glucose levels 
to climb to a hyperglycaernic level. This challenges the reabsorption of glucose by the kidneys 
and when the renal glucose threshold is reached, some of the glucose passes through into the 
urine along with more salts and fluid, so causing dehydration. This gives rise to the classic 
symptoms of diabetes of increased thirst and urination. The blood glucose concentration 
plummets as a consequence of glucose excretion in the urine. Because insulin is not able to 
stimulate the uptake of glucose and its conversion to glycogen by the liver, there is no glycogen 
present for the glucagons to act on. This leads to hypoglycaernia. As a result gluconeogenesis 
occurs and this leads to a build up of keto-acids in the blood and a decrease in the pH of the 
blood (Taylor and Jones, 1996). This stress on the kidneys and the liver causes a state of 
altered homeostasis which is pivotal in the onset of diabetic complications such as 
nephropathy, neuropathy and retinopathy (Marshall, 2000). 
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6.2 Experimental Details 
6.2.1 Sample Population 
Diabetic patients were recruited from the Diabetic Lipid Clinic held at the Clinical Investigation 
Unit of the Royal Surrey County Hospital. The control population was recruited from volunteers 
at the University of Surrey who did not suffer from any metabolic disorders, such as diabetes 
and hyperuricaernia, and were age and sex-matched to the individuals of the diabetic 
population. In total, 8 non-diabetic or control (NDM) and 37 type 2 diabetic (T2DM) patients 
were recruited to take part in the study, yielding 38 non-diabetic sample sets (20 male, 18 
female) and 38 type 2 diabetic sample sets (23 male, 15 female). 
6.2.2 Ethical Considerations 
The study was reviewed by both the South West Surrey Local Research Ethics Committee 
(South West Surrey LREC) and the University of Surrey Ethics Committee. Details of the ethics 
permission granted can be found in Appendix B. All individuals participating in the study gave 
written permission to be involved. 
6.2.3 Sample Preparation 
No sample preparation methods were required for blood glucose or serum uric acid 
measurements. For trace element measurements, blood serum and plasma samples were 
prepared as outlined in section 2.3.1, namely diluted 10-fold (w/w) with the alkali blood diluent 
(ABD) as described in section 2.3.1, and whole blood samples were digested using a nitric acid 
and hydrogen peroxide digestion method as stated in section 2.3.2. It should be noted that in 
some cases there was insufficient volume to enable analysis; thus, the number of samples for 
each analyte was not the same. 
6.2.4 Sample Analysis 
Whole blood samples were analysed for glucose by the YSI 2300 STAT Plus Glucose and 
Lactate AnaWer@ and the UltraTm meter as described in section 2.1.8. Serum uric acid 
measurements were carried out using the Infinity'm uric acid assay (section 2.2.4). 
For trace element analysis, the prepared samples were analysed by SOLA lCP-MS for Cr, Cu, 
Mn, Mo, Ni, Pb, Se, V and Zn, and for Fe by FAAS (AAnalyst 400) (section 2.4). Analysis of 
the diabetic and control individual blood fractions found that the Cr, Mn, Mo, Ni, Pb, and V 
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concentrations were all below the detection limit (Table 2.9). As a result only the data for Cu, 
Fe, Se and Zn in blood serum, plasma and whole blood is reported and evaluated. 
6.2.5 Quality Control for Trace Element Measurements 
The quality control of trace element measurements by SOLA ICP-MS and AAnalyst 400 FAAS 
was evaluated by the analysis of certified reference materials, namely Seronorm Trace 
Elements in Serum Lot No JL4409 and Seronorm Trace Elements in Whole Blood Lot No 
OK0337. 
6.2.5.1 Quality control - serum measurements 
For the serum/plasma analysis method (section 2.5), Seronorm Trace Elements in Serum Lot 
No JL4409 (Sero AS, Billingstadt, Norway) was prepared in accordance with the prescribed 
instructions, namely reconstitution of the material by the addition of 3 ml distilled deionised 
water (DDM to the freeze-dried reference serum. The reconstituted reference material and the 
calibration standards were then prepared in the same way, namely by 10-fold (w1w) dilution 
with the alkali blood diluent (ABID). Values were obtained for copper, selenium and zinc (quality 
control for iron values was evaluated by an inter-method comparison, see section 6.2.6). These 
values served both to validate the method of dilution using the ABD (section 2.3.1), and also to 
evaluate the accuracy and precision of the method. The results, certified values and results of a 
Student Mest to evaluate any statistical difference between the data obtained and the certified 
value are summarised in Table 6.1. 
Table 6.1 Measured and certified values of trace elements determined by the SOLA ICP-MS for Seronorm 
Trace Elements in Serum reference material, Lot No JI. 4409. 
Element Mean (SD) Range RSD n* 
Certified value (range) t tcdt / pg 1-1 / pg 1-1 +% I gg 1-1 cwc (P<0.25L 
cu 1016(35) 957-1072 4 10 1060 (997-1123) 3.95 2.26 
Se 81(11) 66-98 13 10 72.8 (66.7-78.9) 2.50 2.26 
Zn 848(62) 749-960 7 10 849 (768-930) 0.04 2.26 
*degrees of freedom = n-1 
The mean values obtained by the SOLA lCP-MS using the ABD sample preparation method 
compare well with the certified reference material values. No statistical difference was found for 
the serum zinc measurements compared to the reference values (P<0.05). Although the null 
hypothesis is not retained for copper or selenium at the P<0.05 level (95% confidence limit), it 
is retained at the P<0.001 level or 99.9% confidence limit (tcaic = 4.78). This confirms that the 
ABD sample preparation method is fit for purpose. The relative standard deviation (RSD) 
148 
values for the copper and zinc data are less than ±1 0% indicating good precision. However the 
RSD value for selenium is ±13%. This low level of precision is due to the selenium levels of 
blood serum being such that when diluted for analyses, the values are at or just above the limit 
of detection. 
6.2.5.2 Quality control - whole blood measurements 
The certified reference material Seronorm Trace Elements in Whole Blood Lot No OK0337 
(Sero AS, Billingstadt, Norway) was digested (section 2.3.2) and then analysed by AAnalyst 
400 for Fe and by SOLA lCP-MS for the remaining trace elements. The calibration blank and 
standards were matrix-matched by preparation in 5% Aristar@ HN03 (v/v). The data obtained 
were used to validate the methods of sample digestion and analysis. The results, certified 
values and Student Mest data calculated to evaluate any statistical difference between the data 
obtained and the certified value are summarised in Table 6.2. 
Table 6.2 Measured and certified of trace elements determined by the SOLA lCP-MS and AAnalyst 400 
instruments for Seronorm Trace Elements in Whole Blood reference material, Lot No OK0337. 
Element I 
units Mean (SD) Range RSD (± %) n* 
Certified value tcalc tcdt 
&(range) or b(SD) (P<0.05) 
cu / Ag 1-1 656(24) 643-699 4 5 695 b(30) 3.62 2.78 
Fe / mg 1-1 434(42) 364-467 2 5 435 b(l 6) 0.60 2.78 
Se I lag 1-1 71(3) 69-76 4 5 72 a(68-75) 0.61 2.78 
Zn/pgF' 4804(103) 4677 -4921 9 5 4777 b(198) 0.11 2.78 
* degrees of freedom =n-1 
It can easily be seen that all experimentally determined values are similar to the certified 
values. This was confirmed by a Student Mest, where the values of iron, selenium and zinc 
were not found to be statistically different at the P<0.05 level. The values for copper were found 
to be statistically different at the P<0.05 level, but not at the P<0.02 level (tcrit=3.75). This 
indicates that the digestion procedure for whole blood, followed by analysis by the SOLA ICP- 
IVIS and AAnalyst 400 instruments produces accurate concentrations of copper, iron, selenium 
and zinc. The relative standard deviation (RSID) values for all the elements are less than ±10% 
indicating good levels of precision. 
6.2.6 Inter-method Comparison 
An inter-method comparison was conducted to validate the blood serum and plasma iron 
measurements. The methods used were FAAS (Perkin Elmer AAnalyst 400, section 2.4) and 
lCP-MS (Perkin Elmer Elan DRC 11, section 2.5.7). The sample preparation procedure for both 
methods was by dilution using the alkali blood diluent (ABD) with a 4-fold dilution for FAAS and 
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50-fold for lCP-MS (section 2.3.1). Blood serum and plasma samples from four individuals were 
analysed by both methods and the values generated evaluated by means of a Paired Mest 
(Equation 2.9). The data obtained from the methods are shown in Table 6.3. 
Table 6.3 Blood serum and plasma iron data obtained by the AAnalyst 400 FAAS and Perkin Elmer Elan 
DRC 11 lCP-MS instruments and the findinas of a Paired Mest used to comDare the data. 
Blood Surrey Analyst 400 FAAS Perkin Elmer Elan lCP-MS 
fraction n Mean I pg 1-1 SD / gg 1-1 Mean I jig V SDI gg 1-1 
Laic t-ft (p) 
Serum 4 620 105 483 54 3.98 3.18 (<0.05) 
Plasma 4 0.848 0.269 0.979 0.25 7.04 3.18 (<0.05) 
* Degrees of freedom =n-1 
A statistical difference was observed between the two methods at the 95% confidence interval 
(P<0.05), but no statistical difference was observed at the P< 0.005 level (tue 8.05). 
Consequently, the values obtained by the FAAS were comparable to those of the lCP-MS, for 
which the analytical figures of merit have previously been determined (section 2.5.7). 
6.2.7 Inter-laboratory Comparison 
An ICP-MS inter-laboratory comparison was carried out using the SOLA ICP-MS at the 
University of Surrey and the Perkin Elmer Elan DRC 11 1CP-MS at Perkin Elmer, Beaconsfield, 
UK. The serum, plasma and whole blood samples from four control individuals were prepared 
for analysis by the sample preparation methods for both techniques (sections 2.3.1 and 2.3.2). 
The elemental concentrations of copper, selenium and zinc were evaluated by both lCP-MS 
instruments and a summary of the data and findings of a Paired Mest (Equation 2.9) used to 
compare the values are summarised in Table 6.4. 
Table 6.4 Results from a Paired West used to compare trace element results determined at the University 
of Surrey and at Perkin Elmer. For all values of tcaic, tcrft=3.18 (P<0.05). 
Element Blood Surrey SOLA ICP-MS Perkin Elmer Elan lCP-MS 
raction n - Mean Ig g 1-1 SD / gg 1-1 Mean I gg 1-1 SD / gg 1-1 
tcalc 
Cu Serum 4 1041 231 1066 208 1.226 
Plasma 4 952 221 1066 208 2.936 
Whole 4 735 182 765 135 0.582 
Se Serum 4 171 36 117 15 4.811 
Plasma 4 1.63 68 120 14 1.596 
Whole 4 112 14 129 30 2.076 
Zn Serum 4 982 109 730 42 3.460 
Plasma 4 881 256 924 180 0.644 
Whole 4 5651 452 7994 1570 2.575 
From Table 6.4 it can be seen that the SOLA and Elan DRC 11 lCP-MS values compare well for 
copper, selenium and zinc in blood serum, plasma and whole blood. This was statistically 
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evaluated using a Paired Rest and all values of tcaic were found to be less than tcrit at the 
P<0.05 level, excepting selenium and zinc in serum. For these measurements, tcaic was found 
to be less than tcnt=5.84 (P<0.001). This indicated that there was no statistical difference 
between the values obtained for the samples by the two lCP-MS instruments. 
6.2.8 Distribution of Analytes 
Essential nutrients and elements are known to follow a normal distribution in the blood samples 
of healthy individuals. Log-normal distributions are typically observed for those nutrients and 
elements which are non-essential or in individuals where there is some breakdown in 
homeostatic regulation (Adair, 2002). In this work, the essential nutrient glucose and the trace 
elements are subject to distribution analyses, whereas uric acid was not evaluated because it is 
a waste product of DNA breakdown and is not homeostatically regulated (Devlin, 2002). A 
distribution curve is said to be normal (Gaussian) if the arithmetic mean is similar to the 
median, and log-normal if the geometric mean is similar to the median (Brooks, 1972). The 
curve is also said to be normal if approximately 68% of the values lie within 1 standard 
deviation of the mean, 95% lie within 2 standard deviations of the mean, and 99.7% within 3 
standard deviations of the mean (Miller and Miller, 2000). The data were evaluated using 
Microsoft& ExcelTm. 
6.3 Glucose 
Glucose concentrations in blood are in a constant state of flux. The glucose level of an 
individual is homeostatically regulated by the hormones insulin and glucagon. As discussed in 
the previous section (6.1), diabetes mellitus (both type 1 and type 2) develops following a 
breakdown of this homeostatic regulation. A normal blood glucose concentration should be the 
same for both diabetics and non diabetics, namely 3.5 - 7.8 mM (Hillson, 2002). In healthy 
individuals this should rarely rise above 8 mM or fall below 2.5 mM (Marshall, 2000). The 
normal renal threshold for glucose (as mentioned in section 6.1) is approximately 10 mM, which 
relates to a mildly hyperglycaemic level (Hillson, 2002). However, severe cases may elevate 
blood glucose concentrations as far as 50 mM (Marshall, 2002). 
A normal fasting glucose level for a healthy individual should be less than 5.6 mM and less 
than 6.1 for a diabetic case (WHO, 2003). In a diabetic individual, blood glucose should fall to 
less than 10 mM 2 hours after food intake (WHO, 2003). Blood glucose measurements 
obtained by any method should be analysed within 4 hours of sampling as erythrocytes 
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continue to metabolise exogenously. This restriction may be avoided if the blood is centrifuged 
and the plasma extracted for analysis (Hillson, 2002). The relationship between plasma and 
whole blood glucose has been discussed previously in section 2.1.8. Blood glucose 
concentrations were determined by the YSI 2300 STAT Plus Glucose and Lactate Analyser 
and the UltraTm blood glucose meter. 
6.3.1 Sample Population 
Whole blood samples of the NDM and T2DM study populations were obtained under non- 
fasting conditions and subsequently analysed for glucose by the YSI and Ultra Tm devices. Thus 
the data generated were used to evaluate the typical non-fasting glucose levels of the 
individuals of the two study populations. The values obtained by both methods and the 
normality of their distribution are summarised in Table 6.5. 
Table 6.5 Summary data for the NDM and T2DM populations for blood glucose measurements by YSI and 
UltraTM. 
Method Population n 
Arithmetic 
Mean / mM 
Geometric 




Log-normal SDImM Range / mM 
YSI NDIVI 38 5.63 5.48 5.54 Normal 1.38 3.37-9.79 
T2DM 40 8.59 7.88 7.80 Log-normal 3.67 4.00-18.50 
Ultra NDM 38 5.60 5.49 5.33 Normal 1.23 3.67-10.20 
T2DM 40 8.59 7.90 7.92 Log-normal 3.68 4.00-19.10 
Distributions for the T2DM population using both methods of analysis were found to be log- 
normal as the geometric mean and median values were similar, as shown in Table 6.5. These 
data sets were therefore examined for statistical outliers using the Grubb's test. This is the 
statistical method recommended by ISO for the detection and rejection of statistical outliers 
from a sample population (Miller and Miller, 2000). A Grubb's test is performed by calculating a 
value of Z (Equation 6.1) and any values where Zcaic>Zait at the P>0.05 level are rejected as 
outliers (Barnett and LeVis, 1998): 
z= 
lie - suspectl Equation 6.1. 
once all outliers had been removed, the remaining data formed the NDM-rejected or T2DM- 
S 
rejected groups. No statistical outliers were found for the T2DM data obtained by both the YSI 
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Figure 6.1 Frequency distribution plots for the NDM and T2DM population data obtained using the YSI and 
Ultra Tm devices. 






where si andS2 are the standard deviations of the two populations, allocated so that the value 
of F is always ýt 1. The standard deviations of the two populations were compared for both 
methods of glucose analysis. An F-test resulted in a value of Fcaic-: 1.14 when comparing the 
NDM and T2DM YSI standard deviations and a value of Fcalc = 1.11 when comparing the 
corresponding UltraTm values. Both values of F. 1c were less than FIit 37,38 -'ý 1.71 (P<0.05) 
indicating that there is no statistical difference in the variance of glucose measurements of the 
two populations by either method. 
A two-tailed Mest was used to compare the experimental means of the two populations: 
Equation 6.3 ýn, 
n2 
where x, and X2 are the means of the two populations, nj and n, are the number of values in 
the two populations and s is the standard deviation (see Appendix A). The two-tailed Mest was 
then carried out to test whether there was a statistical difference between the NDM and T2DM 
populations for both the YSI and Ultralm glucose measurements. A statistical difference was 
found between YSI and Ultralm; t. 1, = 4.65 where t,, it = 1.99 (P<0.05) and for Ultralm tcaic = 
4.76, where tcnt = 1.99 (P<0.05) for 38 degrees of freedom. Despite the fact that the NDM 
population distribution curve for both YSI and Ultralm was found to be normal, the data were 
examined for outliers using Grubb's test (Equation 6-1) to determine whether the statistical 
difference could be attributed to outliers. The outliers found for the YSI data were the maximum 
value of 9.79 mM (Zcai, =3.01 (n=38), Z,, ýt= 3.01 (P<0.05)) and the second highest YSI glucose 
value 7.05 mM. The remaining data became the NDM-rejected YSI group. The Ultra Tm glucose 
values had only one outlier of 10.2 mM (Z. ic=3.73 (n=38), Z,, t= 3.01 (P<0.05). With this outlier 
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excluded, the remaining data was the NDM-rejected Ultralm data. The data for the NDM- 
rejected groups are summarised in Table 6.6 
Table 6.6 Summarv data for the NDM-reiected arows for blood cilucose measurements bv YSI and UltraTM 
Method Group n 
Arithmetic Geometric Median Normal I SDI Range I mM Mean I mM Mean I mM Imm Log-normal MM 
YS1 NDM-rejected 36 5.40 5.31 5.48 Normal 0.99 3.37-7.05 
Ultra NDNI-rejected 37 5.48 5.40 5.27 Normal 0.98 3.67-7.40 
The two-tailed Mest was repeated using the NDM-rejected values for both the YSI and Ultralm 
and again, a statistical difference was found at the P<0.05 level for YSI (tcalc = 4.84 (n=78), tcrit 
= 1.99) and for UltraTm (tic = 4.99 (n=78), 6t = 1.99). This indicates that this significant 
difference is not an artefact of the outliers. 
6.3.2 Pearson's Product Moment Correlation - Age 
The effect of age on glucose levels measured by YSI and Ultra TM was evaluated for the NDM 
and T2DM populations. This was carried out by calculating a Pearson Product Moment 
Correlation Coefficient (r) (Equation 6.2), and then determining the significance of the 
correlation by calculating at value (Equation 6.3) as outlined by Miller and Miller (2000): 
n ý: xy) - x)ý: y) r Equation 6.4 [nj: 
y2 Y)21 
t Equation 6.5 
where r= Pearson's product moment correlation coefficient and n= no of values used to 
determine r. The stronger the correlation, the closer r is to ±1 and the higher the t value (i. e. a 
higher confidence level, lower P value). The values obtained are summarised in Table 6.7. 
Table 6.7 Pearson's Product Moment Correlation Coefficients and significance for glucose versus age 
correlations for the NDM and T2DM populations. 
Population Correlation Degrees of freedom r Lee tcdt P 
NDIVI YSI vs age 37 0.699 7.63 3.57 <0.001 
NDIVI UltraTm vs age 37 0.739 8.68 3.57 <0.001 
T2DM YSI vs age 39 0.061 0.39 2.03 <0.05 
T2DM UltraTm vs age 39 0.094 0.61 2.03 <0.05 
Significant correlations at the P<0.001 level (tcaic > t,: (, t) were observed between age and 
glucose measurements for both the YSI and Ultralm values in the NDM population, but not for 
the T2DM population. To determine whether this level of significance was influenced by specific 
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values within the data set, the NDM-rejected group (Table 6.6) data were correlated versus 
age. The data is surnmarised in Table 6.8. 
Table 6.8 Pearson's Product Moment Correlation Coefficients and significance for glucose versus age 
correlations for the NDM- rejected group. 
Group Correlation Degrees of r teale tcrft P 
freedom 
NDM-rejected YSI vs age 36 0.688 7.69 3.58 <0.001 
NDM-rejected UltraTm vs age 37 0.747 8.79 3.57 <0.001 
Again, significant correlations (61c > 6-t (P<0.001)) between age and glucose measurements 
were found for both the YSI and UltraTm values in the NDM-rejected group indicating that age 
correlated directly to glucose measurements, and that this was not influenced by any 
population outliers. 
6.3.3 Influence of Gender 
The influence of gender on blood glucose measurements was evaluated by dividing the 
population glucose values (YSI and Ultralm) for each population (NDM and T2DM) into male 
and female groups. The values obtained are summarised in Table 6.9. 
Table 6.9 Summarv blood cilucose data for the male and female arouDs of the NDM and T2DM DODulations. 
Method Population Sex n Mean I mM SD/mM Range I mM 
YSI NDIA m 20 6.17 1.61 3.37-9.79 
YSI NDM F 18 5.04 0.74 4.11-6.51 
Ultralm NDNI m 20 6.00 1.45 3.67-10.20 
UltraTm NDM F 18 5.16 0.74 4.20-6.90 
YSI T2DM m 25 8.60 3.66 4.20-14.70 
YSI T2DM F 15 8.56 3.82 4.00-18.50 
Ultra'rm T2DM m 25 8.49 3.49 4.00-16.20 
UltraTM T2DM F 15 8.76 4.10 4.00-19.07 
The data for the male and female groups from each blood glucose method (YSI or Ultra TM) 
shown in Table 6.9 were then evaluated by an Rest to determine whether there are any 
differences in the variances of the groups. For the NDM population there was no statistical 
difference found between the male and female YSI data (Fcaic 17,19 = 0.79, F,, it = 2.20) and 
UltraTm data (Fcajd7,19 = 0.74, Fcrft = 2.20) at the P<0.05 level. Equally, for the T2DM population 
there was no statistical difference found between the male and female YSI data (Fcaic = 1.09, 
Fcrftl4,24= 2.13) and UltraTm data (Fcaic = 1.37, Fcrftl4,24= 2.13) at the P<0.05 level. 
Given that no difference was found in the sample variances, a two-tailed West was conducted 
to determine if there was any statistical difference in the values of the male and female groups 
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of the data. For the T2DM population, no statistical difference was found between the male and 
female YSI data (6, c = 0.03 (n=38), 6t = 2.02) and UltraTm data (6c = 0.21 (n=38), 6t = 2.02) 
at the P<0.05 level. Therefore in the T2DM population glucose values by either method were 
not influenced by gender. However, for the NDIVI population, the male and female glucose data 
showed a statistical difference. For the YSI measurements tcalc = 2.72 and tait = 2.02 (P<0.05) 
and Ultra TM 6c = 2.21 and tt = 2.02 (P<0.05) for 36 degrees of freedom. To determine 
whether the statistical difference found for the NDIVI population was influenced by statistical 
outliers, the NDIVI-rejected group data was evaluated. The data for this group is summarised in 
Table 6.10. 
Table 6.10 Summary blood glucose data for the male and female groups of the NDM-rejected group. 
Method Group Sex n Mean I mM SDImM Range I rnM 
YSI NDM-rejected M 18 5.77 1.08 3.37-7.05 
YSI NDM-rejected F 18 5.04 0.74 4.11 - 6.51 
UltraTm NDM-rejected M 19 5.78 1.09 3.67-7.40 
UltraTm NDM-rejected F 18 5.16 0.74 4.20-6.90 
Again, an F-test was conducted to see if there were any statistical differences in the standard 
deviations of the male and female groups. For the NDM-rejected group, no statistical difference 
was found between the male and female groups for the YSI data at the P<0.05 level (Fcalc17,17 ý 
0.53, Fait 17,17 = 2.27) and Ultrarm data (Fcalc 17,17 = 0.55, Fc6t = 2.23) and therefore a two-tailed t- 
test was carried out. A statistical difference was found between the male and female groups of 
the YSI data for the NDM-rejected group at the P<0.05 level (6c = 2.35, tC'd = 2.03 for 34 
degrees of freedom). However, no statistical difference was found between the male and 
female groups of the UltraTm data at the P<0.05 level (61c = 2.01 and ý, jt = 2.03,35 degrees of 
freedom). Re-evaluating the data at a higher probability level (P<0.01), the values of 6ic for the 
YSI and UltraTm values (Table 6.10) were found to be less than their respective tcrft values of 
2.72 and 2.72 and there was no statistical difference between the data for the male and female 
groups of the NDM-rejected group. 
6.3.4 Comparison of YSI versus Ultra TM Data 
Having established the factors which affect the glucose concentrations of an individual, the 
effect of glucose (YSI) on the signal of the UltraTm meter was evaluated. The purpose of this 
evaluation was to establish whether there is any difference in the YSI and UltraTM data sets and 
hence whether the two sets of values could be used interchangeably. The complete data set 
was evaluated (as given in Table 6.5). 
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Firstly, the standard deviations of the YSI and Ultra Tm data sets for the NDM and T2DM 
populations were compared using an F-test (Equation 6.2). For the NDM population, Fclc 37,37 
=1.26 and Fcrit 37,37= 1 . 73 and no statistical difference was found at the P<0.05 level. This was 
also the case with the T2DM population (Fcalc 37,38=1 . 
01 and Fcrit 37,38-,: 1.70, P<0.05). 
Consequently, a Paired Mest was carried out to see if there was any statistical difference 
between the values obtained by each method. For the NDM, the Paired t-test gave a tcaic value 
of 0.27 where tcalc=2.03 (37 degrees of freedom, P<0.05) and the T2DM a tcaic of 0.05 where 
tac=2.02 (39 degrees of freedom, P<0.05). These findings showed that there was no statistical 
difference between the YSI and Ultralm values for both the NDM and T2DM populations. 
Secondly, a linear correlation was plotted of YSI glucose versus Ultra TM glucose for each of the 
NDM and T2DM populations, as shown in Figure 6.2 Inspection of Figure 6.2 shows that a 
direct positive correlation is seen for both the NDM and T2DM populations. This was confirmed 
by calculating a Pearson's Product Moment Correlation Coefficient (Equation 6.2) for both the 
NDM and T2DM populations along with the significance level of the correlation (Equation 6.3). 
The NDM r--0.868 (n=38) gave tmic = 14.40 (t, it=2.431) and the T2DM r=0.933 (n=40) gave t. 1c 
=30.78 (tcrit= 3.55). Both values of tcaic were greater than tcrit at the P<0.001 level and the 












Figure 6.2 Comparison of YSI Glucose data and Ultra Tm Glucose data, where the red line corresponds to a 
value of x=y (YSI = Ultra TM ). 
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Thirdly, Bland and Altman (1986) established a method calculating the agreement between two 
clinical analytical methods. It was based on graphical and simple mathematical methods, not 
correlations. They advise caution in using Mests and correlations to determine the agreement 
between two statistical tests as these tests measure the relationship between the two methods, 
not the agreement. Furthermore, such methods also do not take into account the scale of the 
data and the results are highly dependent on the analysis range. As such the method 
established by Bland and Altman (Altman-Bland method) has been used here to verify the 
findings of the Mests and correlations. An Altman-Bland plot for the data can be seen in Figure 
6.3 where the mean value obtained for the two methods is plotted versus the difference 
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Figure 6.3 Altman-Bland plot for YSI and Ultra Tm data of the NDM and T2DM populations. 
Bland and Altman state that where 95% of the data fall between 2 standard deviations of the 
mean value (-2SD, +2SD) the two methods agree and may be used interchangeably, and this 
is the case with the YSI and Ultra Tm data for the NDM and T2DM populations (Figure 6.3). 
Finally, the data for the two populations were converted to mg dl-I and plotted on a Parkes 
Error Grid (Figure 6.4). 
The purpose of the Parkes Error Grid is to give an indication of whether the values of the two 
methods agree to a clinically acceptable level. By definition, at least 95% of the data should fall 
within zone A and no more than 5% in zone B (Parkes et aL, 2000). The zones have been 
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Figure 6.4 Parkes Error Grid illustrating the clinical significance of the differences between the YSI and 
Ultra TM glucose measurements. 
In Figure 6.4, the majority of the values (>95%) fall into zone A (no clinical action, no clinical 
outcome). However, some values (<5%) fall into zone B (altered clinical action, little or no 
clinical outcome). This indicates that the YSI and Ultra Tm data agree well and the two methods 
can be used interchangeably. 
6.3.5 Summary 
The glucose values of the NDM population compare well with the normal range described by 
Hillson (2002). However, the range of values of the T2DM population are higher, reflecting the 
poor glycaemic control of the diabetics. This was confirmed by assessing the normality of the 
distribution of values. The NDM values were found to be normally distributed whereas the 
T2DM values were log-normal. An F-test found no statistical difference (P<0.05) in the variance 
of values of the NDM and T2DM populations. A two-tailed Mest, however, found that NDM 
values were statistically lower than the T2DM values (P<0.05). To determine whether this 
finding was affected by statistical outliers in the population, a Grubb's test (Equation 6.1) was 
conducted on both NDM and T2DM values. Only the NDM population was found to have 
outliers and with these removed, the calculations were repeated with the NDM-rejected group. 
The NDM-rejected group values also were found to be statistically lower than the T2DM 
(P<0.05) (section 6.3.1). 
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Parkes Error Grid 
Correlating the data with age gave a significant positive correlation for both the NDM and NDM- 
rejected data sets (P<0.05), but not for the T2DM population (section 6.3.2). The data was also 
evaluated with respect to gender, and no statistical difference was found between the male and 
female groups of the T2DM and the NDM-rejected groups (section 6.3.3). 
The difference between the YSI and Ultralm data was evaluated to determine whether the two 
measurements may be used interchangeably. Four methods were used to compare the values 
from both the NDM and T2DM populations. Statistically, no significant difference was found 
between the YSI and UltraTm data of the NDM and T2DM populations (F-test, Paired Mest, 
P<0.05). The YSI and UltraTM values were then correlated against each other and a direct 
correlation was found for both the NDM and T2DM groups (section 6.3.4). The Altman-Bland 
method was used to evaluate the difference between the two clinical methods. All values were 
found to meet the designated criteria, and thus the two methods could be used interchangeably 
(Figure 6.3). Finally, the data was plotted on a Parkes Error Grid and more than 95% of the 
values were found to be within zone A, indicating a good agreement between the two methods 
of glucose measurement (Figure 6.4, section 6.3.4). 
The final blood glucose values used in further sections were the initial data sets - NDM and 
T2DM. 
6.4 Uric Acid 
The biological function of uric acid has been discussed previously (section 5.0.1.2. ). A review of 
the literature finds that type 1 diabetics are expected to have the most severely depleted serum 
uric acid, with a level of approximately 0.167 mM (Golemblewska et aL, 2005). The reference 
value for type 2 diabetic males is 0.320 mM and for females is 0.251 mM (Vucic et aL, 1997). 
The normal expected range for healthy individuals is 0.15 - 0.43 mM (Thermo Electron 
Corporation, 2004). The lower serum uric acid levels in diabetics can be attributed to increased 
blood glucose levels which, at a hyperglycaernic level, cause a challenge to efficient renal re- 
absorption of glucose. As a result some glucose is passed through into the urine. The inhibited 
absorption of glucose also limits uric acid re-absorption and uric acid is also passed into the 
urine, decreasing the serum uric acid concentration. This was first investigated With type 2 
diabetic subjects by Boner (1982) and Herman and Goldbourt (1982), and later confirmed to 
occur in type 1 diabetics by Golembiewska et aL (2005). Diabetes is known to induce oxidative 
stress by depleting the physiological concentrations of antioxidants including ascorbic and uric 
acids (Maxwell et aL, 1997; Marra et al., 2002). Research has shown that the decrease is most 
160 
marked in type 1 diabetics which suffer from more tissue damage as a result of oxidative stress 
(Ashour et al., 1999). In type 2 diabetic cases, antioxidant and uric acid levels are only 
marginally less than those of healthy individuals (Vucic et aL, 1997). This indicates that the 
antioxidant system is under less oxidative stress (Abou-Seif and Youssef, 2004). 
6.4.1 Serum Uric Acid Levels of Controls and Diabetic Individuals 
The serum uric acid concentrations were determined by InfinityTI, uric acid assay (see section 
2.2.4) for both the control (NDM) and type 2 diabetic (T2DM) populations. The values obtained 
are surnmarised in Table 6.11. 
Table 6.11 Summary population data for serum uric acid measurements. 
Population n Uric Acid Mean I mM Uric Acid SD I mM Uric Acid Range I mM 
NDM 38 0.312 0.087 0.126 - 0.583 
T2DM 40 0.322 0.114 0.140 - 0,666 
The standard deviation of the two populations were compared by means of an Rest and the 
following values found: Fcalc 37,39" 1.59 and Fit = 1.71 at a probability of <0.05. Fcalc was less 
than Faa and thus there was no significant difference in the variance of the two populations. A 
comparison of the values obtained for the two populations was conducted using a two-tailed t- 
test and ýaic = 0.45 was found to be less than tcnt = 1.99 (P<0.05) for 76 degrees of freedom 
with no statistical difference between the values of the two populations being found at the 
P<0.05 level, 
Comparison of this data with the reference values show that for both the NDM and T2DM 
populations the mean uric acid value ±2 standard deviations of the mean lie within the 
expected range for normal healthy individuals. This agreement and the findings of the statistical 
interpretation of the data are most similar to the findings of Vucic et al. (1997) who found 
marginally, but not statistically significant, lower uric acid values in type 2 diabetics. This 
difference could be attributed to either the small sample population size in this study or the fact 
that the patients recruited for the study were being monitored by a hospital consultant and 
hence their uric acid levels were better controlled than in individuals involved in previous 
studies. 
6.4.2 Influence of Serum Uric Acid Concentration on Blood Glucose Data 
To investigate the influence of serum uric acid on UltraTm blood glucose data (using YSI and 
Ultra TM methods), any possible differences in the correlation of serum uric acid to UltraTM and 
YSI glucose values were evaluated. A correlation plot was constructed which used the total 
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sample population (NDM + T2DM, Appendix C) for serum uric acid and glucose by both YSI 
and Ultra TM , as shown 
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Figure 6.5 Correlation of YSI and UltraTM glucose readings versus blood serum uric acid concentration. 
From Figure 6.5, it is clear that there is no obvious correlation between serum uric acid and 
blood glucose concentration determined by either the YSI or Ultra TM method. This was 
confirmed by calculating the Pearson Product Moment Correlation Coefficient (r) (Equation 6.4) 
and the significance of its value (Equation 6.5). For YSI versus serum uric acid, a value of 
r= - 0.020 was calculated, which was found not to be significant at the P<0.05 level (tcaic = 0.21, 
6it = 2.03,77 degrees of freedom). For Ultra TM versus serum uric acid, a similarly poor 
correlation was calculated at the P<0.05 level (r= 0.010, tcalc = 0.08, tc, it = 2.03,77 degrees of 
freedom). 
The data was then evaluated by partial least squares regression using Minitab@ Software to 
determine if there was a direct mathematical relationship between YSI glucose and serum uric 
acid to the Ultra TM glucose measurement. The following relationship was found: 
Ultra TM = -0.04 + 0.959 YSI + 1.02 uric acid r=0.991 
where all measurement values are in mmol 1-1. The Pearson Product Moment Correlation 
Coefficent value was r=0.991, indicating a highly significant correlation at the P<0.001 level 
(tcaic = 86.31, tcit = 3.57,77 d. f). This indicates a direct dependence of the Ultralm measurement 
on both the YSI glucose and serum uric acid concentrations, 
6.4.3 Summary 
This study found no statistical difference (two-tailed Mest, P<0.05) between the serum uric acid 
concentrations of the T2DM and NDM populations, indicating that the type 2 diabetic cases 
involved in this study did not have an altered uric acid metabolism compared to healthy 
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individuals. Also, despite the significant direct correlation found between the Ultra TM glucose 
concentration and the YSI blood glucose and serum uric acid, it should be noted that this does 
not cause a difference in the Ultra TM glucose measurements which is "clinically" or statistically 
significant (section 6.3.5) 
6.5 Trace Elements 
The trace elements considered in this study were chromium, copper, iron, manganese, 
molybdenum, nickel, selenium, vanadium, zinc and lead. All except lead are known to be 
essential trace elements for animals or humans (Adair, 2002). An essential trace element, as 
defined by Mertz (1981), is "required for maintenance of life" and a "deficiency consistently 
caused an impairment of a function from optimal to sub-optimal". The concentration of essential 
trace elements in biological fluids follows a dose response curve, Figure 6.6. 
C 
Figure 6.6 Dose response curve for essential trace elements (after Underwood and Mertz, 1987). 
When the concentration of a trace element is below the optimum level for normal physiological 
requirements, usually the person will survive although they may have a heavily impaired 
physiological response. As the trace element dose (concentration in biological fluids) increases, 
but is not at the level required for normal health, the individual is said to be deficient and 
biological functions relating to the trace element are not optimal. In normal health the dose and 
response are both optimal, although the element concentration range for this varies with each 
essential element. A toxic effect is observed as the dose increases, leading to a reduced 
response, and eventually the trace element concentrations may indeed be toxic. Under normal 
conditions in healthy individuals the concentration of essential trace elements are 
homeostatically regulated such that they are present at their optimum concentration for health 
(Adair, 2002). Each of the trace elements in this study will now be reviewed. 
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6.5.1 Chromium 
Chromium is an essential trace element and is a component of the low molecular weight 
protein chromodulin, otherwise known as the glucose tolerance factor (GTF). This important 
factor is known to potentiate the effects of insulin, presumably by allowing it to bind to cell 
receptor sites (Devlin, 2002). Individuals who are chromium deficient are known to have 
impaired glucose tolerance and decreased insulin effectiveness (Anderson et aL, 1990). 
Plasma chromium is known to increase in conditions of poor glycaemic control (Ward, 1984; 
Ward and Pim, 1984; Anderson et al., 1990; Rukgauer et al., 2001). Some reports have 
described lower chromium levels in diabetic patients compared with control subjects (Elamri et 
aL, 1994; Liu et al., 2000; Ekmekcioglu et al., 2001). The reference range for type 2 diabetics is 
0.75 - 6.8 gg 1-1 in blood plasma (Ward and Pim, 1984; Ekmekcioglu et al., 2001) and a value 
of 1.28 lag 1-1 in whole blood (Ekmekcioglu et al., 2001). The accepted reference interval in 
healthy individuals for chromium in plasma or serum is 0.038 - 0.388 ýtg 1-1 (Versieck and 
Cornelis, 1989) and for whole blood 0.08 -1.23 jig 1-1 (Caroli et al., 1994; Ekmekcioglu et al., 
2001). 
6.5.2 Copper 
Copper has many physiological properties mainly in metalloenzymes, such as cytochrome c 
oxidase and the antioxidant enzyme superoxide dismutase (Devlin, 2002). Direct effects on 
diabetics have been reported, including the exacerbation of oxidative stress by elevated copper 
levels and the potential of lower levels to be atherogenic (Thompson and Godin, 1995). The 
deprivation of copper in the diet has also been shown to affect circulating insulin and plasma 
glucose (Nielsen and Milne, 1990). The majority of investigations have reported copper 
elevations in the blood fractions of both type 1 and type 2 diabetics (Walter et aL, 1991, 
Hadrzynski, 1999; Rukgauer et aL, 2001; Abou-Self and Youssef, 2004), although some report 
a lowering of plasma copper (Ward, 1984; Ward and Pim; 1984, Rohn et al., 1993). The 
reference range of copper for type 2 diabetics is 565 - 1292 gg 1-1 in blood serum (Terres- 
Martos et aL, 1998; Navai et aL, 2003; Cooper et al., 2005), 1070 - 1226 ýLg 1-1 in blood plasma 
(Ward and Pim, 1984; Walter et al., 1991; Leonhardt et aL, 1996; Abou-Seif and Youssef, 
2004) and a value of 952 gg 1-1 in whole blood (Ekmekcioglu et al., 2001). In healthy 
individuals, the accepted reference interval for copper in plasma or serum is 560 - 1850 ýLg 1-1 
(Versieck and Cornelis, 1989) and for whole blood 962 - 1200 gg 1-1 (Hamilton et aL, 1994; 
Ekmekcioglu et aL, 2001). 
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6.5.3 Iron 
Iron is an essential component of haemoglobin and myoglobin and is required for oxygen and 
carbon dioxide transport. It is also a component of many cytochromes and is required for 
correct phagocytosis add the killing of bacteria by neutrophils. Deficiency results in anaemia, 
whereas the opposite results in haemochromatosis (Devlin, 2002). Very little research has 
been carried out into the iron concentrations in diabetic blood compared with matched control 
subjects. Those studies reporting iron data either describe no difference in plasma and whole 
blood concentrations (Fayek et aL, 1984, Ekmekcioglu et aL, 2001), or a slight depression (Liu 
et al., 2000, Mueller et aL, 2003). However, high contents of tissue iron have been reported in 
diabetics (Fraga and Oteiza, 2002). The reference range of iron for type 2 diabetics is 692 - 
1240 lag 1-1 in blood serum (Cooper et al., 2005), 1430 - 4690 lag 1-1 in blood plasma (Ward and 
Pim, 1984; Ekmekcioglu et aL, 2001) and a value of 427 mg 1-1 in whole blood (Ekmekcioglu et 
aL, 2001). The normal range for iron in the blood serum of healthy individuals is 200 - 4455 gg 
1-1 (Hamilton et aL, 1994; Ekmekcioglu et aL, 2001), in blood plasma is 1100 - 1377 gg 1-1 
(Caroli et aL, 1994; Forrer et aL, 2001) and in whole blood 408 - 490 mg 1-1 (Hamilton et aL, 
1994; Ekmekcioglu et aL, 2001). 
6.5.4 Manganese 
Manganese is an essential trace element involved in the enzymes pyruvate carboxylase, 
superoxide dismutase and numerous other metalloenzymes involved in carbohydrate 
metabolism (Devlin, 2002). Deficiency of manganese is known to impair insulin synthesis 
(Anderson et aL, 1990). The concentration of manganese in blood cells is approximately 25 
times higher than that in whole blood and is therefore more easily measured. Reports show 
that the whole blood of type 2 diabetics has lower manganese concentrations than healthy 
controls, resulting in impaired insulin synthesis (Ekmekcioglu et al., 2001). The reference range 
of manganese in type 2 diabetics is 0-1.1 pg 1-1 in blood serum (Cooper et aL, 2005), 0.6 - 
2.7gg 1-1 in blood plasma (Ward and Pim, 1984; Leonhardt et al., 1996) and a value of 7.89 [ig 
1-1 in whole blood (Walter et al., 1991; Ekmekcioglu et al., 2001). In healthy individuals, the 
accepted reference interval for manganese in plasma or serum is 0.54 - 34.5 Pg 1-1 (Versieck 




Molybdenum is an essential trace element and its main functional role in humans is in the 
enzyme xanthine oxidase, which catalyses the degradation of hypoxanthine to xanthine, and 
xanthine to uric acid (Devlin, 2002). Molybdenum concentrations in type 2 diabetic plasma have 
been reported to be elevated compared with controls and type 1 individuals (Ward, 1984; Ward 
and Pim, 1984). No information was found on the reference range for molybdenum in type 2 
diabetic blood serum or whole blood. However a reference value (average) for blood plasma of 
2.75 pg 1-1 was reported by Ward and Pirn (1984). The normal range of molybdenum in the 
plasma and serum of healthy individuals is 0.23 - 1.3 jtg 1-1 (Versieck and Cornelis, 1989) and 
in whole blood 1- 157 pg 1-1 (Caroli et al., 1994; Hamilton et aL, 1994). 
6.5.6 Nickel 
Nickel has been cited by some authors to be an essential trace element, based on studies by 
Nielsen and Ollerich (1974), Anke et aL (1974) and Sunderman (1997), although its 
physiological role has not yet been established. Few investigators have reviewed nickel in 
relation to diabetes. One study found no statistical difference between the nickel content from 
plasma of diabetic subjects and controls (Ward and Pim, 1984). No information was found on 
the reference ranges for nickel in type 2 diabetic blood serum or whole blood. However, a 
reference value (average) for blood plasma of 1.6 ltg 1-1 was reported by Ward and Pim (1984). 
In healthy individuals, the accepted reference interval for nickel in plasma or serum is 0.05 -1.3 
ptg 1-1 (Versieck and Cornelis, 1989) and for whole blood 1.1 - 5.0 ptg 1-1 (Caroli et al., 1994). 
6.5.7 Selenium 
Selenium is an essential trace element actively involved in many enzymic antioxidants - 
including glutathione peroxidase which destroys peroxides found in the cell cytosol (Devlin, 
2002). As a result of this antioxidant activity, selenium deficiency is known to exacerbate the 
complications associated with diabetes (Thompson and Godin, 1995). The selenium level of 
biological fluids has been widely used to assess human health in relation to immune function, 
cardiovascular disease and cancer (Rayman, 2000). Selenium is also known to act as an 
insulin mimic with particular potency in type 2 diabetics (Hadrzynski, 1999; Mueller et aL, 
2003), with the ability to alleviate renal and cardiac problems, while restoring glycaemic control 
(Beckett and Arthur, 2005). Reports regarding selenium concentrations in diabetic b1ofluids are 
contradictory. Higher levels are reported in both types of diabetes, compared with controls, and 
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this has been related to the increased demand for antioxidants in diabetics (Ward, 1984; Ward 
and Pim, 1984; Ekmekcioglu et aL, 2001; Rukgauer et al., 2001). Lower levels of selenium in 
diabetic subjects compared with controls have also been reported (Faure et al.; 1993, Elamd et 
al., 1994; Quilliot et al., 2001; Rajpathak et al., 2005), although these are correlated to 
pancreatic function and type 1 diabetes. The reference range for selenium in type 2 diabetics is 
75 - 115 gg 1-1 in blood serum (Cooper et al., 2005), 72.2 - 127 jig 1-1 in blood plasma (Ward 
and Pim, 1984; Ekmekcioglu et al., 2001) and a value of 71.8 mg 1-1 in whole blood 
(Ekmekcioglu et aL, 2001). In healthy individuals, the accepted reference interval for selenium 
in plasma is 15 -190 gg I -'(Versieck and Cornelis, 1989) , for serum, 15 - 168 gg 1-1 (Versieck 
and Cornelis, 1989) and for whole blood 68 -140 lag 1-1 (Caroli et al., 1994; Ekmekcioglu et al., 
2001). 
6.5.8 Vanadium 
The function of vanadium as an essential trace element is not completely understood. 
However, it is known to act as an insulin mimic, improving glucose homeostasis (Cam et at, 
2000; Goldwaser et al., 2000; Srivastava and Mehdi, 2005). It is widely acknowledged that the 
concentration of vanadium in the blood fractions is increased in diabetic persons compared to 
healthy individuals (Ward, 1984, Ward and Pim, 1984; Ekmekcioglu et al., 2001). No reference 
values for vanadium in the blood serum of type 2 diabetics were found, although a range of 2- 
11.4 ýtg 1-1 in blood plasma was reported (Ward and Pim, 1984; Ekmekcioglu et at, 2001) and 
an average value of 2.13 mg 1-1 in whole blood (Ekmekcioglu et al., 2001). In healthy 
individuals, the accepted reference interval for vanadium in plasma or serum is 0.016 - 1.3 pg 
1-1 (Versieck and Cornelis, 1989) and for whole blood 2-5 pg 1-1 (Hamilton et at, 1994; 
Ekmekcioglu et al., 2001). 
6.5.9 Zinc 
Zinc is found in over 300 metalloenzymes, including superoxide dismutases (along with 
copper), RNA and DNA polymerases (Devlin, 2002). Zinc is needed for glycogen synthesis 
therefore a deficiency results in impaired glucose metabolism (Reeves and O'Dell, 1984a, b). 
High zinc levels have been shown to inhibit insulin secretion from the pancreas (Sweeny et al., 
1990). Zinc blood concentrations in diabetic persons tend to be lower than those of healthy 
individuals (Ward and Pim, 1984; Rohn et al., 1993; Elamri et aL, 1994; Chen et aL, 1995; 
Quilliot et aL, 2001; Abou-Seif and Youssef, 2004), and this can be attributed to the depletion of 
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antioxidant defences and the prevalence of diabetic complications (Faure et al., 1993; Karahan 
et al., 2001). Hyperglycaemia has also been shown to increase u(inary zinc loss, hence 
depleting blood zinc levels (Hadrzynski, 1999). The reference range for zinc in type 2 diabetics 
is 614 - 660 gg 1-1 in blood serum (Terres Martos et al., 1998; Navai et al., 2003; Cooper et al., 
2005), 449 - 1150 gg 1-1 in blood plasma (Ward and Pim, 1984; Walter et al., 1991; Abou-Seif 
and Youssef, 2004) and 5324 mg 1-1 in whole blood (Ekmekcioglu et al., 2001). In healthy 
individuals, the accepted reference interval for zinc in plasma or serum is 120 - 2760 gg 1-1 
(Versieck and Cornelis, 1989) and for whole blood 4000 - 8000 gg 1-1 (Caroli et aL, 1994). 
6.5.10 Lead 
Lead is a neurological and nephrological toxin (Versieck and Cornelis, 1989). It has been 
shown to be elevated in diabetic subjects compared with controls (Ward and Pim, 1984), and 
may cause a decline in renal function (Hu et al., 2004). Again, no information was found on the 
reference range for lead in type 2 diabetic blood serum or whole blood. A reference value 
(average) for blood plasma of 1.6 gg 1-1 was reported by Ward and Pim (1984). The accepted 
reference interval for lead in the plasma or serum of healthy individuals is 0.6 - 37 PLg 1-1 
(Versieck and Cornelis, 1989) and for whole blood 40 - 290 ýtg 1-1 (Caroli et aL, 1994). 
6.5.11 Summary 
To summarise, the reference ranges of trace elements in healthy blood serum, plasma and 
whole blood are listed in Table 6.12 and the reference ranges for the trace elements in type 2 
diabetic serum, plasma and whole blood are given in Table 6.13. 
Table 6.12 Reported normal concentrations of essential and non-essential trace elements in biological 
fluids. 
Reported Range pg 1-1 for European Populations 
Plasma Serum Whole Blood 
Cr 0.03-0.388 0.14-0.43 0.08-1.23 
Cu 560-1850 560-1850 962-1200 
Fe 200 -4455 1100-1377 408 000 - 490 000 
Mn 0.54-34.5 0.54-34.5 6.7-11.0 
Mo 0.28-1.3 0.28-1.3 1-157 
Ni 0.050-1.3 0.05-1.3 1.1-5 
Pb 0.6-37 0.6-37 40-290 
Se 15-190 15-168 68-140 
v 0.016-1.3 0.016-1.3 2-5 
Zn 120-2760 120-2760 4000- 8000 
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Table 6.13 Reported normal concentrations of essential and non-essential trace elements in biological 
fluids for diabetics. 
Reported Range lag 1-1 for Type 2 Diabetics 
Plasma Serum Whole Blood 
Cr 0.75-6.8 - 1.28 
Cu 1070-1226 565-1461 952 
Fe 1430-4690 692-1240 427000 
Mn 0.6-2.7 0-1.1 7.89 
MO 2.75 
NI 16 
Pb 16 - 
Se 72.2-127 75-115 71.8 
v 2-11.4 2.13 
Zn 499-1150 523-1503 5324 
(- represents no data available) 
6.6 Investigation of Trace Element Interactions with Antioxidants 
6.6.1 Introduction 
The interaction of transition metal oxides with the antioxidants ascorbic acid and uric acid has 
been previously investigated (Chapter 5). Manganese, nickel and lead oxides have been found 
to oxidise both ascorbic and uric acid, while copper oxides only oxidise ascorbic acid (section 
5.3). This interaction is thought to be dependent upon the oxide particles (section 5.3). 
However, there is also a possibility that the reactions occur with both the antioxidant and metal 
as liquids. Therefore, the liquid phase reactions with selected trace elements need to be 
investigated. 
6.6.2 Methodology 
All expedments were conducted using a liAutolab Type 11 potentiostat (Biochemie, Utrecht, 
Netherlands), with a cell volume of 10 CM3 Britton Robinson Buffer at pH 7, and a three 
electrode configuration comprising of a glassy carbon working electrode, a platinum wire 
counter electrode, and a3M AgjAgCl reference electrode. The antioxidants were added to the 
cell from 10 mM stock solutions, such that the final concentrations were 0.3 mM ascorbic acid, 
or 0.5 mM uric acid, which replicates their typical physiological concentrations. At these levels 
the peak current values of the oxidation of the antioxidant was determined by cyclic 
voltarnmetry. 
6.6.3 Results 
Each metal solution was added to each antioxidant solution by increasing additions of a single 
element lCP-MS standard (Aristar@, BDH, Poole, UK). The single element standard 
169 
concentration and aliquot volume were selected such that the final level of the metal in the cell 
corresponded to normal physiological values, and with increasing additions were elevated to 
reported toxic levels. For example, the range of copper levels was from 0 to 6 ýIg ml-1, see 
Figure 6.7. The peak current of the antioxidant was plotted versus metal concentration (ýLg ml 
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Figure 6.14 shows no observed difference in the uric acid peak current with the addition of 
molybdenum. This was also found to be the case for copper, vanadium and zinc, of which 
vanadium and zinc also had no effect on the peak current of ascorbic acid. The remaining 
metals did result in a decrease in the oxidative peak current which corresponded to a decrease 
in the concentration of the antioxidant (Figures 6.7 to 6.13). This can be attributed to the 
oxidation of the antioxidant by the metal in solution, which correlates well with the results given 
in 5.3.3.2 From the data in Figures 6.7 to 6.13, the concentration of metal at which the 
antioxidants are effectively completely oxidised can be determined, see Table 6.14. 
Table 6.14 Metal concentrations at which the antioxidants are effectively completely oxidised. 
Metal Concentration required to oxidise 0.3 mM ascorbic Concentration required to oxidise 0.5 mM 
acid / I! g ml-1 uric acid/ gg ml-I 
CU 6 N/A 
Mn 10 6 
Ni 55 
Pb 22 
Given these findings, the purpose of the work was to investigate the concentration of the 
metals of interest in blood fractions from both healthy persons and diabetic subjects. Should 
the levels of the metals exceed those listed in Table 6.14, there may be an appreciable 
influence on the antioxidant concentration potentially affecting the electrochemical blood 
glucose sensor (UltraTM) used in this study. 
6.7 Diabetic Study - Copper 
6.7.1 Diabetic Study - Sample Population 
Whole blood, serum and plasma samples were obtained from both the NDM and T2DM 
populations and were analysed by SOLA ICP-MS (section 2.5), The data obtained from the 
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individuals of both populations is listed in Table 6.15, and is compared Wth literature 
information later in section 6.7.4. 
Table 6.15 NDM and T2DM DODulation data for CODDer in serum, Dlasma and whole blood. 
Fraction Population n AM I gg 1-1 GM I gg 11 
Median 
gg 1-1 
Distribution SD III I. L9 
Range I iLg 1-1 
Serum NDM 37 1032 995 1015 Log-normal 274 569-1478 
Serum T2DM 40 1032 1011 985 Log-normal 225 595-1636 
Plasma NDM 37 1029 985 964 Log-normal 301 561-1598 
Plasma T213M 40 975 945 891 Log-normal 262 602-1819 
Whole NDM 38 784 767 754 Log-normal 167 497-1131 
Whole T2DM 40 765 739 752 Loa-normal 208 411-1433 
AM = arithmetic mean, GM = geometric mean, SID = standard deviation, n= number of samples 
The mean standard deviation of the values of copper in blood serum, plasma and whole blood 
for the NDM and T2DM populations were compared using an F-test (Equation 6.2) and a two- 
tailed Mest (Equation 6.3). The values calculated are surnmarised in Table 6.16. 
Table 6.16 Nest and two-tailed Mest results for evaluation of a statistical difference between copper 
concentrations in the serum, plasma and whole blood of the NDM and T2DM populations. 
Fraction Relationship D of F Fcac Fcm D of F tCWC tCdt Sig. P 
(F-test) (P<0.05) (Mest) 
Serum NDM vs T2DM 36,39 1.48 1.72 75 0.01 1.99 NS <0.05 
Plasma NDM vs T2DM 36,39 1.35 1.72 75 0.84 1.99 NS <0.05 
Whole NDM vs T2DM 37,39 1.64 1.72 76 0.45 1.99 NS <0.05 
D of F= degrees of freedom (F-test, =n-1, t-test=n-2) 
Sig. = significance, NS = not significant,, P=probability level 
The data in Table 6.16 shows no statistical difference between the copper values in any 
fraction between the NDM and T2DM populations at the probability level of P<0.05. The 
distribution of copper in all fractions for both study populations has been shown to be log- 
normal (Table 6.15) using the criteria outlined in section 6.2.8. Consequently, the data was 
inspected for statistical outliers by means of a Grubb's test (Equation 6.1). No statistical outliers 
were found for the data of the NDM population. For the T2DM population, only whole blood and 
blood plasma data were found to have outliers. For blood plasma, the outlier values were 1819 
ýtg 1-1 and 1536 gg 1-1, and for whole blood 1433 lag 1-1. Further details can be found in 
Appendix C. Removal of these outliers resulted in the plasma T2DM-rejected and whole blood 
T2DM-rejected groups, for which the summary data are given in Table 6.17. 
Table 6.17 T2DM. reiected ciroUD data for comer in Dlasma and whole blood. 
Fraction Group n 
AM I GMI Median Distribution SD/ Range / ýLg 1-1 gg 1-1 gg 1-1 1 Pg 1-1 Aq 1-1 
Plasma T21DIVI-rejected 38 938 917 876 Log-normal 207 602-1413 
Whole UDIVI-reiected 39 748 726 738 Normal 180 411-1209 
AM = arithmetic mean, GM = geometric mean, SD = standard deviation 
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The removal of the statistical outlier of copper in whole blood for the T2DM population has 
resulted in the group distribution altering from log-normal to normal, whereas for plasma, this 
has not altered the distribution. Using the T2DM-rejected groups, the Nest and West were 
repeated. The values are summarised in Table 6.18 
Table 6.18 F-test and two-tailed Mest results for evaluation of a statistical difference between copper 
concentrations in serum. olasma and whole blood of the NDM and T2DM-reiected ciroups. 
Fraction Relationship D of F Fcaic Fcdt D of tcwc tCdt Sig. P (F-test) (t-test) 
Plasma NDM vs T2DM-rejected 36,37 2.16* 1.73 73 1.52 1.99 NS <0.05 
Whole NDM vs T2DM-rejected 37.38 1.11 1.72 75 0.92 1.99 NS <0.05 
D of F= degrees of freedom (F-test=n-1, t-test=n-2) 
Sig. = significance, NS = not significant, P=probability level 
* Null hypothesis rejected 
A statistical difference in the standard deviations of the two study populations was found for 
blood plasma values, whereas no such difference was found for the whole blood values at the 
P<0.05 level. The two-tailed Mest found no statistical difference between the values of the 
groups at the P<0.05 level. This was also found for the T2DM population. Therefore the 
presence of the outliers did not affect the results of the two-tailed Mest. 
6.7.2 Diabetic Study - Correlation of Blood Copper with Age 
To determine whether the age of an individual affected the copper concentration found in 
serum, plasma or whole blood, correlation studies were conducted. The Pearson Product 
Moment Correlation Coefficient (r) (Equation 6.4) was calculated for the copper concentrations 
of each blood fraction versus the age of the individuals from both populations (NDM and 
T2DM). The significance of the correlation was then evaluated using a t-test (Equation 6.5). 
The findings are listed in Table 6.19. 
Table 6.19 Correlation of serum, plasma and whole blood copper values with age of the NDM and T2DM 
individuals. 
Fraction Population n r tesic tcrft Sig. p 
Serum NOM 37 -0.705 7.67 3.58 S <0.001 
Serum T2DM 40 0.004 0.02 2.02 NS <0.05 
Plasma NDM 37 -0.684 7.19 3.58 S <0.00 1 Plasma T2DM 40 0.103 0.65 2.02 NS <0.05 
Whole NDM 38 -0.474 3.92 3.57 S <0.001 Whole T2DM 40 -0.021 0.13 2.02 NS <0.05 
r= Pearson's Product Moment Correlation Coefficient n= number of samples 
Sig. = significance, NS = not significant, S= significant, P=probability level 
173 
Copper was found to correlate negatively With age in the serum, plasma and whole blood of the 
NDM population (P<0.001), whereas no such correlation was observed for the T2DM 
population. 
6.7.3 Diabetic Study - Influence of Gender on Copper Concentration 
The concentration of copper in males and females has the potential to be considerably 
different, and hence influence the data of the population as a whole. Consequently, the data 
was resolved according to gender, and are shown in Table 6.20. 
Table 6.20 NDM and T2DM group data for copper in serum, plasma and whole blood as a function of 
females (F) and males (M). 
Fraction Population Gender n Mean ýLg 1-1 SD pg 1-1 Range Vg 1-1 
Serum NDM F 18 1237 194 908-1478 
Serum NOM M 19 839 182 569-1055 
Serum T2DM F 15 1180 236 818-1636 
Serum T2DM M 25 994 168 695-1398 
Plasma NDM F 18 1251 252 852-1598 
Plasma NOM M 19 819 170 561-1055 
Plasma T2DM F 15 1160 293 705-1819 
Plasma T2DM M 25 864 163 602-1281 
Whole NDM F 18 889 134 654-1039 
Whole NDM M 20 690 136 497-1131 
Whole T2DM F 15 893 233 598-1433 
Whole T2DM M 21 688 150 411-1008 
SID = standard deviation, n= number of samples 
The data were statistically evaluated by means of an Rest and a two-tailed Mest to determine 
any statistical differences between the data of males and females for each blood fraction in 
both populations. The values obtained are summarised in Table 6.21. 
Table 6.21 Nest and two-tailed Mest results for evaluation of a statistical difference between between 
copper concentrations in the serum, plasma and whole blood for the female (F) and male (M) 
groups of the NDM and T2DM populations. 
_ 
Fraction Population Relationship D of F Fcwc Fcdt D of F LAIC tedt Sig. P (F-test) (t-test) 
Serum NDM M vs F 17,18 1.14 2.23 35 6.43 3.57 S <0.001 
Serum T2DM M vs F 14,24 1.97 2.13 38 3.68 3.57 S <0.001 
Plasma NDM M vs F 17,18 2.20* 2.23 35 6.14 3.57 S <0.001 
Plasma T2DM M vs F 14,24 3.23* 2.13 38 4.12 3.57 S <0.001 
Whole NDM M vs F 17,19 1.37 2.20 36 4.51 3.57 S <0.001 
Whole T2DM M vs F 14,24 2.41 * 2.13 38 3.41 2.98 S <0.005 
D of F= degrees of freedom (F-test, =n-1, t-test=n-2) 
Sig. = significance, S= significant, P=probability level 
* Null hypothesis rejected 
From Tables 6.20 and 6.21, significant differences in the values of copper between males and 
females were found for all groups (NDM and T2DM) in serum, plasma and whole blood 
(P<0.005 T2DM whole blood, P<0.001 all other values). Inspection of the data in Table 6.20 
174 
reveals that in all cases the copper concentrations of females were higher than males. To 
determine whether the outliers removed in section 6.7.1 influenced these findings, the 
calculations were repeated. The group data for the T2DM-rejected male and female groups are 
listed in Table 6.22, and the Rest and two-tailed Mest data in Table 6.23. 
Table 6.22 T2DM-rejected group data for copper in plasma and whole blood, as a function of females (F) 
and males (M). 
Fraction Group Gender n Mean pg 0 SD gg 0 Range gg 1-1 - Plasma T21DIVI-rejected F 13 1081 213 705-141T 
Plasma T21DIVI-rejected M 25 864 163 602-1281 
Whole T21DIVI-rejected F 14 855 185 598-1209 
Whole T2DM-reiected M 21 688 150 411-1008 
SID = standard deviation, n=number of samples 
Table 6.23 Nest and two-tailed West results for evaluation of a statistical difference between copper 
concentrations in the plasma and whole blood of the male (M) and female (F) groups of the 
T2DM -rejected group. 
Fraction Group Relationship D of F Fcaic Fait D of F Laic tCM Sig. p (F-test) (t-test) 
Plasma T2DM- M vs F 12,24 1.71 2.18 36 3.50 2.99 S <0.005 rejected 
Whole T2DM- M vs F 13,24 1.52 2.15 37 3.07 2.99 S <0.005 reiected 
D of F= degrees of freedom (F-test, =n-1, t-test=n-2) 
Sig. = significance, S= significant, P=probability level 
' Null hypothesis rejected 
It can be seen from the data in Table 6.23 that the exclusion of the outliers caused the standard 
deviations of the male and female groups to no longer differ. However, it did not affect the 
results of the two-tailed Mest, with copper in the plasma and whole blood of females (T2DM- 
rejected) having statistically higher concentrations than males (P<0.05). 
6.7.4 Diabetic Study - Copper: Discussion 
Comparing the NDM population data in Table 6.15 with the reference ranges cited in Table 
6.12, it was found that the ranges determined for copper in all three blood fractions generally 
agree well with the literature values. The T2DM population data (Table 6.15) was also found to 
compare well with the reference ranges listed in Table 6.13. The copper concentrations in 
blood plasma are similar to those in blood serum, although, due to the difference in reference 
values between plasma and serum, the mean value (975 ýtg 1-1) lies below the minimum value 
of the literature range (1070 ýtg 1-1). However, all the plasma copper values do fall within the 
reference range for serum. Therefore, the reference values for plasma should be treated 
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sceptically. A reference value was found for copper in whole blood (952 Rg 1-1), and this was 
not found to compare well with the mean measured value of 765 Rg 1-1. 
The data listed in Table 6.16 show no statistical difference between the copper values in blood 
serum, plasma and whole blood of the diabetic or non diabetic population. This is in agreement 
with Leonhardt et al. (1996) and Ekmekcioglu et al. (2001). However, in blood plasma and 
whole blood, the non diabetics have slightly higher levels of copper than the diabetic 
population. This was attributed to a reduction in homeostatic regulation, and is corroborated in 
the literature by Ward (1984), Ward and Pim (1984) and Rohn et al. (1993). 
Considering the log-normal distribution found for copper in all fractions of both populations, this 
raises a concern about the normality of the NDM population. Copper is an essential trace 
element and therefore should be normally distributed in all fractions (Adair, 2002). Further 
evaluation of the data with respect to age (Table 6.19) shows that copper is negatively 
correlated with age in the NDM population. The NDM population has a lower mean age than 
the T2DM, and therefore the log-normal distribution in the NIDIVI population may be attributed to 
the weighting caused by age bias. 
The gender of an individual was also found to affect the population data, with the 
concentrations of copper in the blood fractions of females found to be statistically higher than 
males (P<0.001) (Table 6.19). A negative correlation of copper with age is expected amongst 
females, and the data was found to agree with previous studies by Barany (2002) and 
Ghayour-Mobarhan et aL, (2005). Thus the proportion of males and females in a population 
has the potential to affect the normality of the distribution. The populations used in further 
studies are the NDM and T2DM populations, that is all individuals sampled. 
6.8 Diabetic Study - Iron 
6.8.1 Diabetic Study - Sample Population 
Whole blood, serum and plasma samples of the NDM and T2DM populations were statistically 
evaluated for iron (Table 6.24. ) 
Table 6.24 NDM and T2DM DoDulation data for Iron in serum, Dlasma and whole blood. 











Serum NDIVI 36 1.075 0.985 1.041 Normal 0.439 0.295 - 2.315 Serum T2DM 38 0.736 0.687 0.689 Log-normal 0.277 0.267-1.398 
Plasma NDIVI 36 0.858 0.795 0.809 Log-normal 0.306 0.159-1.414 
Plasma T2DM 40 0.914 0.864 0.867 Log-normal 0.327 0,436 - 2.019 Whole NDIVI 38 446 443 444 Log-normal 51 335-573 
Whole T2DM 40 455 450 448 Loa-normal 70 348-674 
AM = arithmetic mean, GM = geometric mean, SD = standard deviation 
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The variance of the values for iron in each blood fraction of both study populations was 
investigated by means of an F-test (Equation 6.2) and a two-tailed Mest (Equation 6.3). The 
values are summarised in Table 6.25. 
Table 6.25 Nest and two-tailed West results for evaluation of a statistical difference between Iron in the 
serum, plasma and whole blood of the NDM and T2DM populations. 
Fraction Relationship D of F Fesic Fcrft D of F tc4c 6t Sig. P (F-test) ( t-test) 
Serum NDM vs T2DM 35,37 2.51* 1.74 72 3.99 3.43 S <0.001 
Plasma NDM vs T2DM 35,39 1.17 1.72 74 0.77 1.99 NS <0.05 
Whole NDM vs T2DM 37.39 1.53 1.71 76 0.66 1.99 NS <0.05 
D of F= degrees of freedom (F-test, =n-1, t-test=n-2) 
Sig, = significance, NS = not significant, S= significant, P=probability level 
* Null hypothesis rejected 
The data in Table 6.25 show a statistical difference in the iron values of blood serum between 
the NDM and T2DM populations at a probability level of P<0.001. The distribution of iron in the 
blood serum of the NDM population was found to be normally distributed (Table 6.24). 
However, the distribution of iron in all other fractions of both populations has been shown to be 
log-normal. Consequently, the data were inspected for statistical outliers by means of a 
Grubb's test (Equation 6.1). 
No statistical outliers were found for the plasma and whole blood data of the NDM population. 
For the T2DM population, only whole blood and blood plasma data were found to have outliers. 
For blood plasma this was 2.02 mg 1-1 and for whole blood, 674 mg 1-1. Further details can be 
found in Appendix C. Removal of these outliers resulted in the plasma T2DM-rejected and 
whole blood T2DM-rejected groups, for which the summary data is given in Table 6.26. 
Table 6.26 T2DM. reiected aroUD data for iron in Dlasma and whole blood. 
Fraction Group n 
AM I GMI Median Distribution SDI Range I mg 1-1 mg 1-1 mg 1-1 1 mg 0 mg 0 
Plasma T2DM-rejected 39 0.886 0.845 0.861 Log-normal 0.277 0.436 -1.619 
Whole T21)M-reiected 39 450 446 448 Loq-normal 61 348-579 
AM = arithmetic mean, GM = geometric mean, SD = standard deviation, n= number of samples 
The removal of statistical outliers was not found to change the distribution of iron in the plasma 
or whole blood from that of the T2DM population. Using the T21DIVI-rejected groups, the Rest 
and two-tailed Mest were repeated. The values are summarised in Table 6.27. No statistical 
difference was found in the standard deviations of the NDM and T2DM-rejected plasma and 
whole blood iron data (P<0.05). The two-tailed Mest also found no statistical difference 
between the values of the groups at the P<0.05 level. 
177 
Table 6.27 Rest and two-tailed t-test results for evaluation of a statistical difference between Iron 
concentrations in the serum, plasma and whole blood of the NDM and T2DIVI-rejected Aroups. 
Fraction Relationship D of F Fac Fcm D of LAIC tcrft Sig. P (F-test) (t-test) 
Plasma NDM vs T21DIVI-rejected 35.38 1.22 1.73 73 0.41 1.99 NS <0.05 
Whole NDM vs T2DM-rejected 37,38 1.70 1.73 75 0.29 1.99 NS <0.05 
D of F= degrees of freedom (F-test, =n-1, t-test=n-2) 
Sig. = significance, NS = not significant, P=probability level 
* Null hypothesis rejected 
6.8.2 Diabetic Study - Correlation of Iron with Age 
The age of an individual has the potential to affect the concentration of iron in blood fractions 
(Versieck and Cornelis, 1989). To evaluate whether there was an effect with the NDM and 
T2DM study populations, the iron concentration of all blood fractions was correlated with age. 
The Pearson Product Moment Correlation Coefficient (r) was calculated for the iron 
concentrations of each fraction versus the age of individuals of both populations (NDM and 
T2DM) (Equation 6.4). The significance of the correlation was then evaluated using a West 
(Equation 6.5). The findings are listed in Table 6.28. 
Table 6.28 Correlation of serum, plasma and whole blood values of iron with age in both the NDM and 
T2DM populations. 
Fraction Population n r Laic tcrft Sig. P 
Serum NDM 36 -0.332 2.37 2.03 S P<0.05 
Serum T2DM 38 0.064 0.39 2.03 NS P<0.05 
Plasma NDM 36 -0.365 2.67 2.03 S P<0.05 Plasma T20M 40 0.024 0.15 2.02 NS P<0.05 
Whole NDM 38 -0.042 0.25 2.03 NS P<0.05 Whole T2DM 40 -0.337 2.55 2.02 S P<0.05 
r= Pearson's Product Moment Correlation Coefficient, n= number of samples 
Sig. = significance, NS = not significant, S= significant, P=probability level 
Iron was found to correlate negatively with age in the serum and plasma of the NDM population 
and the whole blood of the T2DM population (P<0.05). To determine whether the correlation 
observed with the whole blood of the T2DM population was an artefact of statistical outliers, the 
correlation was re-calculated using the T2DM-rejected groups. A Pearson Product Moment 
Correlation Coefficient of -0.357 was calculated, which gave t.,, =2.71, where 6=2.02 (38 
degrees of freedom, P<0.05). Thus a significant correlation was observed and was not due to 
the statistical outlier. 
6.8.3 Diabetic Study - Influence of Gender on Iron Concentration 
Gender has the potential to affect the concentration of iron in blood (Devlin, 2002). To 
determine whether this affected the study populations, the serum, plasma and whole blood for 
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both study populations was statistically evaluated against gender. The group data for the male 
and female groups are listed in Table 6.29. 
Table 6.29 Female (F) and male M NDM and T2DM cirouo data for Iron in serum. olasma and whole blood, 
Fraction Population Gender n Mean / mg 1-1 SD /mg I-' Range / mg 1-1 
Serum NDM F 17 1.149 0.521 0.295 - 2.315 
Serum NDM M 19 1.110 0.353 0.475 - 1.749 Serum T2DM F 15 0.664 0.249 0.344 - 1.219 
Serum T2DM M 23 0.783 0.290 0.267 - 1.398 Plasma NDM F 17 0.824 0.372 0.159 - 1.414 
Plasma NDM M 19 0.888 0.238 0.595 - 1.298 Plasma T2DM F 15 0.808 0.289 0.436 - 1.619 Plasma T2DM M 25 0.978 0.338 0.462 - 2.019 Whole NDM F 18 407 32 335-446 
Whole NDM M 20 481 38 398-573 
Whole T2DM F 15 417 59 348-523 
Whole T2DM M 25 479 66 360-673 
SID = standard deviabon, n=number of samples 
The data were subsequently evaluated by means of an F-test and a two-tailed Mest to 
determine any differences between the group data of males and females for each blood 
fraction of both study populations. The values obtained are summarised in Table 6.30. 
Table 6.30 F-test and two-tailed Mest results for evaluation of a statistical difference between iron 
concentrations of the serum, plasma and whole blood of the female (F) and male (M) groups of 
the NDM and T2DM populations. 
Fraction Population Relationship D of F Fcaic Fcrft Dof F LAIC 6t Sig P (F-test) (t. test) 
Serum NDM M vs F 16,18 2.18 2.25 34 0.95 2.03 NS <0.05 
Serum T2DM M vs F 14,22 1.74 2.17 36 1.30 2.03 NS <0.05 
Plasma NDM M vs F 16,18 2.44* 2.25 34 0.69 2.03 NS <0.05 
Plasma T2DM M vs F 14,24 1.73 2.13 38 1.62 2.02 NS <0.05 
Whole NOM M vs F 17,19 1.71 2.20 36 6.52 3.58 S <0.001 
Whole T2DM M vs F 14,24 1.79 2.13 38 2.95 2.72 S <0.01 
D of F= degrees of freedom (F-test, =n-1, t-test=n-2) 
Sig. = significance, NS = not significant, S= significant, P=probability level 
* Null hypothesis rejected 
The iron concentration in the whole blood of females was found to be statistically different to 
that of males by means of a two-tailed Mest (P<0.001 NDM, P<0.01 T2DM). It was found that 
in both the NDM and T2DM male groups, whole blood iron was higher than that of females. It 
was important to determine whether the outliers removed in section 6.8.1 influenced these 
significant findings, and therefore the F-test and Mest calculations were repeated on the male 
and female group of the T21DIVI-rejected group whole blood data. The group data are listed in 
Table 6.31, and the Rest and two-tailed Mest data in Table 6.32. 
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Table 6.31 Female (F) and male M T2DM-reiected arout) data for iron In serum. Wasma and whole blood. 
Fraction Group Gender n Mean / mg 1-1 SD / mg 1-1 Range / mg 1-1 
Whole T2DM-rejected F 17 464 57 360-579 
Whole T2DM-rejected M 21 688 150 411-1008 
SID = standard deviation, n=number of samples 
Table 6.32 F-test and two-tailed t-test results for evaluation of a statistical difference between iron 
concentrations in the serum, plasma and whole blood of the male (M) and female (F) group 
of the T2DM-rejected group. 
Fraction Group Relationship D of F Fcac Fcrft D of F 6C tcrk Sig. P (F-test) (Mest) 
Whole T2DM- M vs F 14,23 1.21 2.15 37 2.91 2.72 S <0.0 1 reiected 
D of F= degrees of freedom (F-test, =n-1, t-test=n-2) 
Sig. = significance, NS = not significant, S= significant, P=probability level 
* Null hypothesis rejected 
From the data in Tables 6.31 and 6.32 it can be seen that the removal of the statistical outliers 
did not alter the findings of the two-tailed Mest. It was found that the concentration of iron in 
whole blood is statistically higher in type 2 diabetic males than females (P<0.01). 
6.8.4 Diabetic Study - Iron: Discussion 
In comparing the NDM population data in Table 6.24 with the literature reference ranges in 
Table 6.12, it is clear that there is generally good agreement between the values. Considering 
the T2DM population data in Table 6.24, the mean value for iron in blood serum (0.736 mg 1-1) 
falls within the expected range of 0.692 - 1.240 mg 1-1 (Table 6.13) for the T2DM population. 
For blood plasma, values similar to those of blood serum are found. A reference mean value of 
427 mg 1-1 was found for a T2DM population, which compares well with the mean value (455 
mg 1-1) from this study. Only the iron levels for the serum of the NDIVI population were found to 
be normally distributed (Table 6.24). It was therefore important to investigate what may have 
influenced the lack of normality of their distribution for all other blood fractions. 
The iron content of serum and plasma (NDIVI population) and whole blood (T2DM population) 
was found to be negatively correlated with age (Table 6.28). 
The concentration of iron in whole blood is statistically lower in females compared with males 
(Tables 6.29 and 6.30), and therefore the proportion of males and females in the study 
population may affect the normality of the distribution. It also must be considered that the 
majority of iron present in whole blood is bound within erythrocytes, and as such the total iron 
status of an individual is in a constant state of flux. Consequently, serum iron concentrations 
are better indicators of the iron status of an individual (Ashwood et aL, 1998). 
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In summary, what can be seen is that iron in plasma is log-normally distributed in both 
populations, reflecting the fact that total iron in blood may not be the ideal media to use to 
determine iron concentrations in relation to health. Iron undergoes such extreme short term 
variations that its measurement in serum, plasma or whole blood is not a good indicator of iron 
status (Virtanen et al., 1999). However, some references refer to a gradual increase in the total 
iron status of both males and females (post menopausal) with age (Milman, 1996; Virtanen et 
al, 1999) while others cite a decreasing need for dietary iron absorption with age (Devlin, 
2002). This information, along with the log-normal distributions found, indicates that these 
findings should be noted with caution. The final iron blood fraction data sets used in statistical 
evaluation of the NIDIVI and T2DM populations are the complete data sets with no outliers 
removed 
6.9 Diabetic Study - Selenium 
6.9.1 Diabetic Study - Sample Population 
The serum, plasma and whole blood selenium concentrations of the NDM and T2DM 
populations were determined by SOLA lCP-MS (section 2.5). The data obtained relating to 
each of the two populations are listed in Table 6.33. 
Table 6.33 NDM and T2DM population data for selenium in serum. Diasma and whole blood. 






1 Ag I- 
Distribution SDI 
lig 1-1 
Range I pg 1-1 
Serum NDM 37 120 117 ill Log-normal 28 94-207 
Serum T2DM 40 146 142 144 Log-normal 34 89-224 
Plasma NDM 37 145 136 139 Log-normal 51 46-246 
Plasma T2DM 40 134 130 126 Log-normal 35 75-254 
Whole NDM 38 75 69 73 Normal 28 22-160 
Whole T2DM 39 86 75 82 Normal 40 9-181 
AM = arithmetic mean, GM = geometric mean, SID = standard deviation, n= number of samples 
The mean and standard deviation of the values of selenium levels in blood serum, plasma and 
whole blood of the NDM and T2DM populations were compared by using an Rest (Equation 
6.2) and a two-tailed Mest (Equation 6.3), and the data obtained are summarised in Table 6.34. 
Table 6.34 Nest and two-tailed Mest results for evaluation of a statistical difference between selenium In 
the serum, plasma and whole blood of the NDM and T2DM populations. 
Fraction Relationship D of F Fcaic Fcrft D of F tCAIC tcdt Sig. P (F-test) (t-test) 
Serum NOM vs T2DM 36.39 1.67 1.78 75 3.69 3.43 S <0.001 
Plasma NDM vs T2DM 36.39 2.14* 1.78 75 1.14 1.99 NS <0.05 
Whole NDM vs T2DM 37,38 1.49 1.72 75 1.47 1.99 NS <0.05 
D of F= degrees of freedom (F-test, =n-1, t-test=n-2) 
Sig. = significance, NS = not significant, S= significant, P=probability level 
Null hypothesis rejected 
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The data in Table 6.34 shows a statistical difference in the serum selenium concentrations of 
the NDM and T2DM populations (P<0.001). 
From Table 6.33, the distribution of selenium in blood serum and plasma of the NDM and 
T2DM populations was found to be log-normally distributed, whereas the selenium values of 
whole blood were normally distributed. Consequently, the serum and plasma data were 
inspected for statistical outliers by means of a Grubb's test (Equation 6.1). The outliers found 
were 207 ýLg 1-1 in NDM blood serum and 254 ýLg 1-1 in T2DM blood plasma. Removal of these 
outliers resulted in the serum NDM-rejected and plasma T2DM-rejected groups, for which the 
summary data are given in Table 6.35. 
Table 6.35 NDM-reiected and T2DM-reiected ciroup data for selenium in serum and plasma. 
Fraction Group n 
AM I GMI Median Distribution SD/ Range I ýtg 1-1 
lag I., go 1-1 1 lig 1-1 gg 1-1 
Serum NDIVI-rejected 36 117 115 115 Log-normal 24 94-184 
Plasma TWIVI-reiected 39 131 128 125 Loq-normal 30 75-218 
AM = arithmetic mean, GM = geometric mean, SID = standard deviation, n= number of samples 
The removal of the statistical outliers was not found to change the distribution of selenium for 
serum (NDM population) or plasma (T2DM population). Using the rejected populations, the F- 
test and two-tailed Mest were repeated. The values are summarised in Table 6.36. 
Table 6.36 Rest and two-tailed Mest results for evaluation of a statistical difference between selenium 
concentrations of the serum and plasma of the NDM-rejected and T2DM-rejectedgroups. 
Fraction Relationship D of F Feac Faft D of F tC&IC tCdt Sig. p (F-test) (West) 
Serum NDM-rejected vs 35 39 1.49 1.72 74 4.22 3.43 S <0.001 T2DM , 
Plasma NDM vs T2DM- 38 36 3.02* 1.73 74 1.51 1.99 NIS <0.05 
reiected , 
D of F= degrees of freedom (F-test, =n-1, t-test=n-2) 
Sig. = significance, NS = not significant, S= significant, P=probability level 
* Null hypothesis rejected 
Removal of the outliers did not affect the findings of the two-tailed Mest and a statistical 
difference in the serum selenium concentrations of the NDM and T2DM populations (P<0.001) 
was found where T2DM levels were found to be higher than NDM (Tables 6.34 and 6.36). 
6.9.2 Diabetic Study - Correlation of Blood Selenium with Age 
In order to determine whether the age of an individual affected the selenium concentration in 
serum, plasma or whole blood, correlation studies were conducted. The Pearson Product 
Moment Correlation Coefficient (r) (Equation 6.4) was calculated along with the significance of 
the correlation using a West (Equation 6.5) for the selenium concentrations of each fraction 
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versus age for both populations (NDM and T2DM) (Equation 6.4). The findings are listed in 
Table 6.37. 
Table 6.37 Correlation of serum, plasma and whole blood values of selenium with age In both the NDM and 
T2DM populations. 
Fraction Population n r tcalc tcrk Sig. p 
Serum NDM 37 0.233 1.57 2.03 NS <0.05 
Serum T2DM 36 0.090 0.55 2.03 NS <0.05 
Plasma NDM 37 0.063 0.38 2.03 NS <0.05 
Plasma T2DM 40 0.077 0.49 2.02 NS <0.05 
Whole NOM 38 -0.195 1.31 2.03 NS <0.05 Whole T2DM 39 -0.059 0.37 2.02 NS <0.05 
r= Pearson's Product Moment Correlation Coefficient, n= number of samples 
Sig. = significance, NS = not significant, S= significant, P=probability level 
Selenium was not found to correlate significantly with age in any blood fraction of the NDM and 
T2DM populations at the probability of P<. 0.05. 
6.9.3 Diabetic Study - Influence of Gender on Selenium Concentrations 
Blood selenium concentrations may be different in males and females, which has the potential 
to affect the normality of the distribution of selenium. Consequently, the data was statistically 
evaluated according to gender, and is shown in Table 6.38. 
Table 6.38 NDM and T2DM population data for selenium in serum, plasma and whole blood, resolved for 
females (F) and males (M). 
Fraction Population Gender n Mean I gg 1-1 SD / l. Lg 1-1 Range/ gg 1-1 
Serum NDM F 18 120 26 _ 94-184 
Serum NDM M 19 120 30 94-207 
Serum T2DM F 15 139 34 91-211 
Serum T2DM M 25 150 34 89-224 
Plasma NDM F 18 125 43 46-230 
Plasma NDM M 19 164 52 81-246 
Plasma T2DM F 15 133 36 93-218 
Plasma T2DM M 25 134 35 75-254 
Whole NDM F 18 65 20 22-91 
Whole NDM M 20 83 31 38-160 
Whole T2DM F 15 92 42 43-181 
Whole T2DM M 24 83 38 9-147 
SD = standard deviation, n= number of samples 
To test the significance of any difference, the data were again evaluated by means of an F-test 
and a two-tailed Mest. The values obtained are summarised in Table 6.39. The concentration 
of selenium in males and females was found to be statistically different in the whole blood and 
plasma of the NDM population (two-tailed Mest at a level of P<0.05), that was the 
concentration of selenium in plasma and whole blood of the NDM male group was higher than 
that of the female (Tables 6.38 and 6.39). 
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Table 6.39 F-test and two-tailed Mest results for evaluation of a statistical difference between selenium 
concentrations of the serum, plasma and whole blood of the male (M) and female (F) groups 
of the NDM and T2DM populations. 
Fraction Population Relationship D of F Fcaic Fedt D of F tcwc tedt Sig. P (F-test) (t-test) 
Serum NDM M vs F 17.18 1.77 2.23 35 0.01 2.03 NS <0.05 
Serum T2DM M vs F 14,24 1.99 2.13 38 0.10 2.02 NS <0.05 
Plasma NDM M vs F 17,18 1.67 2.23 35 2.45 2.03 S <0.05 
Plasma T2DM M vs F 14,24 1.07 2.13 38 0.14 2.02 NS <0.05 
Whole NDM M vs F 17,19 1.44 2.20 36 2.17 2.03 S <0.05 
Whole T2DM M vs F 14,23 1.67 2.15 37 0.67 2.03 NS <0-05 
D of F= degrees of freedom (F-test, =n-1, t-test--n-2) 
Sig. = significance, NS = not significant, S= significant, P=probability level 
6.9.4 Diabetic Study - Selenium: Discussion 
The data of the NDM population (Table 6.33) were found to be in generally good agreement 
with the reference values obtained from the literature (Table 6.12). The same was found for the 
T2DM population (Tables 6.33 and 6.13). The log-normal distribution of selenium in the serum 
and plasma of both study populations was not found to be affected by age (section 6.9.2), but 
was potentially affected by gender (section 6.9.3). 
The concentration of selenium in blood plasma and whole blood was found to be statistically 
higher in the male group of the NDM population compared to the female. The concentration of 
selenium in serum and plasma is reported to be similar (Versieck and Cornelis, 1989) so it is 
contradictory that no such difference is seen for serum. This confused representation is in 
agreement with the literature, where no specific relationship between selenium concentration 
and age or gender was found (McMaster et al., 1990; Barany et aL, 2002; Beckett and Arthur, 
2005; Ghayour-Mobarhan et al., 2005). The final selenium values for each blood fraction used 
in statistical evaluation of the NDM and T2DM populations are the complete data sets with no 
outliers removed. 
6.10 Diabetic Study -Zinc 
6.10.1 Diabetic Study- Sample Population 
The zinc concentrations of whole blood, serum and plasma samples are reported in Table 6.40. 
The mean standard deviations of the concentrations of zinc in blood serum, plasma and whole 
blood of the NDM and T2DM populations were compared by means of an Rest (Equation 6.2) 
and a two-tailed Mest (Equation 6.3). The values calculated are summarised in Table 6.41. 
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Table 6.40 NDM and T2DM DoDulation data for zinc in serum, Dlasma and whole blood. 






1 pq 1-1 
Distribution SD/ 
pg I., 
Range I gg 1-1 
Serum NDIVI 37 851 840 818 Log-normal 138 620-1126 
Serum T2DM 40 734 723 723 Log-normal 140 502-1360 
Plasma NDIVI 37 919 904 901 Log-normal 166 597-1255 
Plasma T2DM 40 729 712 717 Log-normal 165 425-1113 
Whole NDIVI 38 4734 4674 4597 Log-normal 742 2740-6152 
Whole T2DM 40 6145 5807 5278 Loa-normal 2492 4119-13715 
AM = arithmetic mean, GM = geometric mean, SID = standard deviation, n= number of samples 
Table 6.41 Rest and two-tailed t-test results for evaluation of a statistical difference between zinc 
concentrations of the serum, plasma and whole blood of the NDM and T2DM populations. 
Fraction Relationship D of F Fcoic Fcrft 'D of F LAIC tcrit Sig. p (F-test) (t-test) 
Serum NDM vs T2DM 36.39 1.17 1.72 75 3.68 3.43 S <0.001 
Plasma NDM vs T2DM 36,39 1.01 1.72 75 5.02 3.43 S <0.001 
Whole NDM vs T2DM 37,39 1.19 1.71 76 3.35 2.89 S <0.005 
D of F= degrees of freedom (F-test, =n-1, t-test=n-2) 
Sig. = significance, S= significant, P=probability level 
The data in Table 6.41 indicate that a statistical difference in zinc values of all blood fractions of 
the NDM and T2DM populations exists (P<0.001 serum and plasma, P<0.005 whole blood). In 
serum and plasma, the NDM population has higher zinc values, but in whole blood, the T2DM 
population has higher zinc values. This statistical difference may have arisen from the log- 
normal distributions of zinc in all fractions, or potentially from the presence of statistical outliers 
within the population. Consequently, the data was inspected for statistical outliers by means of 
a Grubb's test (Equation 6.1). Only one statistical outlier was found - the value of 1360 ýtg 1-1 in 
the serum of the T2DM population. Details of Z. Iý and Zcýt can be found in Appendix C. 
Removal of this outlier resulted in the serum T2DM-rejected group, for which the summary data 
is given in Table 6.42. 
Table 6.42 T2DM-rejected group data for zinc in serum, 
Fraction Group n 
AM I GM/ Median Distribution 
SDI 
Range I pg 1-1 
Ucl 1-1 UO 1-1 1 Ucl 1-1 liq V 
Serum T2DM-re*ected 39 718 712 713 Log-normal 98 502 - 923 AM = arithmetic mean, GM = geometric mean, SD = standard deviation, n= number of samples 
The removal of the statistical outlier was not found to change the distribution of zinc in the 
serum of the T2DM population, although it should be noted that the geometric mean, arithmetic 
mean and median values are all similar. The F-test and Mest were then repeated and the 
values calculated summarised in Table 6.43. 
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Table 6.43 Nest and two-tailed Mest results for evaluation of a statistical difference between zinc 
concentrations of the serum, plasma and whole blood of the NDM population and T2DM- 
rejected groups. 
Fraction Relationship D of F Fcaic Fcit D of F tcMIC tan Sig. P (F-test) (Mest) 
Serum NDM vs 36,38 2.00* 1.73 74 4.86 3.43 S <0.001 TWM-reiected 
D of F= degrees of freedom (F-test, =n-1, t-test=n-2) 
Sig. = significance, S= significant, P=probability level 
* Null hypothesis rejected 
The exclusion of the statistical outlier did not alter the finding of a statistical difference in the 
zinc values of all blood fractions of the NDM and T2DM populations (serum and plasma 
P<0.001, whole blood, P<0.005). 
6.10.2 Diabetic Study- Correlation of Zinc with Age 
In order to evaluate whether serum, plasma or whole blood zinc varied as a function of age, 
correlation studies were conducted. Any such relationship may alter the distribution of zinc from 
the normal. The Pearson Product Moment Correlation Coefficient (r) was calculated for the zinc 
concentrations of each fraction versus age for both populations (NDM and T2DM) (Equation 
6.4). The significance of the correlation was then evaluated using a Mest (Equation 6.5) and 
the findings are listed in Table 6.44. 
Table 6.44 Correlation of serum, plasma and whole blood values of zinc with age in both the NDM and 
T2DM populations. 
Fraction Population n r tcaic tcrn Sig. p 
Serum NDM 37 -0.317 2.27 2.03 S <0.05 
Serum T2DM 40 -0.117 0.77 2.02 NS <0.05 Plasma NDM 37 -0.344 2.52 2.03 S <0.05 Plasma T2DM 40 -0.117 0.76 2.02 NIS <0.05 Whole NDM 38 0.227 1.55 2.03 NS <0.05 
Whole T2DM 40 0.007 0.04 2.02 NS <0.05- 
r= Pearson's Product Moment Correlation Coefficient, n= number of 
Sig. = significance, NS = not significant, S= significant, P=probability 
From Table 6.44, blood zinc was found to negatively correlate with age in both the serum and 
plasma samples of. the NDM population (P<0.05). No such relationship was observed in any 
other blood samples. As a result, a bias in the age of the NDM population could cause the 
production of a log-normal distribution. 
6.10.3 Diabetic Study- Influence of Gender on Zinc Concentration 
The concentration of zinc in blood samples may be different in males and females, thus having 
the potential to influence the population distribution as a whole. To determine whether gender 
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did affect the population data (Table 6.45), the values were resolved according to gender. The 
summary data for females and males are shown in Table 6.43 and the corresponding results of 
the F-test and two-tailed Mest to determine any statistical difference between the males and 
females shown in Table 6.46. 
Table 6.45 NDM and T2DM group data for zinc in serum, plasma and whole blood for females (F) and males 
(M). 
Fraction Group Gender n Mean I gg 1-1 SID / gg 1-1 Range / ýtg 1-1 
Serum NDM F 18 791 106 620-791 
Serum NDM M 19 908 144 708-1126 
Serum T2DM F 15 913 87 583-862 
Serum T2DM M 25 747 164 502-1360 
Plasma NDM F 18 860 140 596-1108 
Plasma NDM M 19 974 173 725-1255 
Plasma T2DM F 15 725 174 425-1102 
Plasma T2DM M 25 731 163 493-1113 
Whole NDM F 18 4256 653 2470- 5892 
Whole NDM M 20 5165 528 4147- 6152 
Whole T20M F 15 6404 3047 4165 -13715 
Whole T2DM M 24 5990 2146 4119 -13140 
SD = standard deviation, n= number of samples 
Table 6.46 Rest and two-tailed Mest results for evaluation of a statistical difference between zinc 
concentrations of the serum, plasma and whole blood of the male (M) and female (F) groups 
of the NDM and T2DM populations. 
Fraction Population Relationship D of F Fcaic Fait D of F 61C tcdt Sig. P (F-test) (t-test) 
Serum NDM M vs F 17,18 1.52 2.23 35 2.79 2.72 S <0,01 
Serum T2DM M vs F 14,24 1.28 2.13 38 0.75 2.02 NS <0.05 
Plasma NDM M vs F 17,19 1.27 2.23 35 2.19 2.03 S <05 
Plasma T2DM M vs F 14,24 1.15 2.13 38 0.11 2.02 NS <0.05 
Whole NDM M vs F 17,19 1.53 2.20 36 4.73 3.58 S <0.001 
Whole T2DM M vs F 14,24 1.54 2.15 38 0.50 2.02 NS <0.05 
D of F= degrees of freedom 
Sig. = significance, NS = not significant, S= significant, P=probability level 
Null hypothesis rejected 
Tables 6.45 and 6.46 show that in all cases, the concentration of zinc in male blood fractions of 
the NDM population was statistically higher than the females - serum at the P<0.01 level, for 
plasma at the P<0.05 level and for whole blood at the P<0.001 level. 
As gender has been found to have a marked effect on zinc concentrations of all blood fractions 
of the NDM population, a bias in the gender mix of the NDM population can easily result in a 
log-normal distribution. However, for the T2DM population, no such relationship was found and 
therefore the log-normal distribution of zinc in all blood was not affected by gender. This 
suggests that the trend may be related to a reduced level of homeostatic regulation in diabetic 
individuals. 
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6.10.4 Diabetic Study- Zinc: Discussion 
The agreement of the NDM population values (Table 6.40) with the literature values (Table 
6.12) was found to be good. Considering the T2DM population, the values obtained (Table 
6.40) agreed well with the literature values (Table 6.13). 
In summary, the serum and plasma zinc levels of the NDM population were greater than those 
of the T2DM (P<0.001). The literature serves to confirm lower concentrations of zinc in the 
T2DM population (Walter et al., 1991; Elamri et A, 1994; Chen et aL, 1995; Quilliot et aL, 
2001). This finding is related to a diminished antioxidant status due to alterations in the Cu: Zn 
ratio. In whole blood, this study found that the zinc concentrations of diabetic whole blood were 
higher than that of the controls (P<0.005), which is corroborated by Ekmekcioglu et aL (2001). 
The log-normal distribution of zinc in the NDM population was found to be affected by both age 
and gender. The zinc concentration of blood serum and plasma was found to be negativ3ly 
correlated with age. A possible effect of this is to introduce a log-normal bias in an otherwise 
normal population. Zinc was also found to be significantly higher in all blood fractions of the 
male NDM group compared with the females. This was also consistent with the findings of 
previous studies (Bales et aL, 1986; Ghayour-Mobarhan et aL, 2005) 
The zinc population data used in further studies are the NDM and T2DM populations, that is all 
individuals sampled. 
6.11 Evaluation of Trace Elements in Relation to Serum Uric Acid 
For the purpose of evaluating whether -a relationship exists between the trace element 
concentrations of serum and serum uric acid, the data from both populations were pooled. The 
data can be found in Appendix C. The influence of serum uric acid on the trace element 
concentrations in blood were evaluated by means of calculating the Pearson Product Moment 
Correlation Coefficient (r) (Equation 6.4) and then calculating the significance of any correlation 
by determining a t-value (Equation 6.3). The data obtained are shown in Table 6.47 
Table 6.47 Pearson Product Moment Correlation Coefficients (r) for the correlation of serum uric acid 
- 
with copper, iron, selenium and zinc in serum of the pooled (NDM +T2DM population). 
Element Fraction n r tealc taft Sig. p 
CU Serum 78 0.083 0.71 1.99 NS <0.05 
Fe Serum 78 -0.119 1.01 1.99 NS <0.05 Se Serum 78 0.008 0.07 1.99 NS <0.05 
Zn Serum 78 0.149 1.28 1.99 NS <0.05 
r= Pearson's Product Moment Correlation Coefficient, n= number of samples 
Sig. = significance, NS = not significant, P=probability level 
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Table 6.47 shows that all values of 6, c were less than 6 at the P<0.05 level. Therefore no 
significant correlations were found between serum uric acid and serum copper, iron, selenium 
and zinc. This has not been investigated previously, and it can be concluded that there appears 
to be no significant relationship between copper, iron, selenium and'zinc in any blood fraction 
and serum uric acid. 
6.12 Trace Elements in Relation to Oxidation of Antioxidants 
The concentration of the trace elements in solution required to completely oxidise ascorbic and 
uric acids were determined in section 6.6, and relate to the work carried out in Chapter 5. 
These concentrations (from Table 6.14), along with the range of concentrations determined 
from the pooled NDM and T2DM populations (Appendix C) are shown in Table 6.48. 
Table 6.48 Concentration of metals in aqueous solution required to oxidise the ascorbic and uric acids, 
with the concentration rancie of metals in blood fractions obtained from this studv. 
Metal Concentration to oxidise 0.5 mM ascorbic acid 
Concentration to oxidise 
0.5 mM uric acid 
Range from this study 
(NDM + T2DM) 
Cu / mg 1-1 6 0.411 - 1.819 Mn / mg 1- 1 10 6 < LOD 
NV mg 1-1 5 6 < LOD 
Pb / mq 1-1 2 2 < LOD 
<LOD = lower than the limit of cletection 
For all samples manganese, nickel and lead were determined to be below the detection limit, 
which correspondingly is lower than the concentrations required to oxidise ascorbic or uric acid. 
For copper, the concentration range maximum is 1.636 mg 1-1 which is less than the 
concentration required to completely oxidise ascorbic acid (6 mg 1-1). 
6.13 Summary 
The aim of the work carried out in this chapter was to evaluate the trace element (Cr, Cu, Fe, 
Mn, Mo, Ni, Pb, Se, V and Zn) concentrations in the blood plasma, serum and whole blood of 
both healthy individuals and diabetics and their relationship to serum uric acid and glucose 
(YSI) with an end view to assessing the impact of both the trace elements and the uric acid on 
the blood glucose sensor (Ultralm). In terms of the ten trace elements chosen for investigation, 
Cr, Mn, Mo, Ni, Pb and V were found to be lower than the detection limit (section 2.5.5.3) of the 
instrumentation in all samples. As such, only data resulting from the analysis of Cu, Fe, Se and 
Zn in blood serum, plasma and whole blood have been reported here. The mean and range of 
values of each analyte in both populations are listed in Table 6.49. 
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Table 6.49 Summarv data for the NDM and T2DM DODUlations. 
Analyte (fraction) Units NDM Arithmetic Mean Range 
T2DM 
Arithmetic Mean Range 
Glucose (YSI) mm 5.63 3.37-9.79 8.59 4.00-18.50 
Glucose (UltraTm) RIM 5.48 3.67-10.2 8.59 4.00-19.10 
Uric Acid mm 0.312 0.126 - 0.583 0.326 0.140 - 0.666 
Cu (serum) vg P 1032 569-1478 1032 561-1598 
Fe (serum) mg H 1.075 0.295 - 2.315 0.736 0.267 - 1.398 
Se (serum) vg 11 120 94-207 146 89-224 
Zn (serum) vg 1-1 851 620-1126 734 502-1360 
Cu (plasma) lig 1-1 1029 561-1598 975 602-1819 
Fe (plasma) mg 1-1 0.858 0.159 -1.414 0.914 0.436 - 2.019 
Se (plasma) vg 1-1 145 46-246 134 75-254 
Zn (plasma) ltg 1-1 919 597-1255 729 425-1113 
Cu (whole) [Ig F, 784 497-1131 765 411-1433 
Fe (whole) mg 1-1 455 335-573 455 348-674 
Se (whole) Pg H 86 22-160 86 9-181 
Zn (whole) Pq FI 4734 2740-6152 6145 4119 - 13715 
Quality Control 
Quality control procedures involved the analysis of SeronormIm reference materials for serum 
and whole blood. Good agreement was found between measured and certified values (Paired 
West, P<0.05), and the methods described in sections 2.4 and 2.5 were validated for the 
measurement of trace elements in clinical samples (sections 6.2.5.1 and 6.2.5.2). An inter- 
method comparison was used to validate iron analysis by flame atomic absorption 
spectrometry (FAAS). This involved the comparison of data from a Perkin Elmer Elan DRC 11 
lCP-MS instrument with the Perkin Elmer AAnalyst 400 (FAAS). No statistical difference was 
found between the two methods (Paired Mest, P<0.05)(section 6.2.5.3). An inter-laboratory 
comparison was also conducted between the Perkin Elmer Elan DRC 11 lCP-MS (section 2.5.7) 
and the SOLA lCP-MS (section 2.5.4). The results from 12 samples (4 serum, 4 plasma and 4 
whole blood) were compared by means of a Paired West (P<0.05) and no statistical difference 
was found in the values from the two instruments (section 6.2.7). 
Blood Glucose Measurements 
Blood glucose data was determined by both the YSI and UltraTm blood glucose meters for both 
the NDM and T2DM populations (Table 6.5, section 6.3.1). Glucose was found to follow a 
normal distribution in the NDM population and a log-normal in the T2DM. This reflects the poor 
glycaemic control of the T2DM individuals. A two-tailed Mest was used to test for a difference 
between the NDM and T2DM population data generated by both analytical methods. The 
T2DM values were found to be significantly higher (P<0.05) than the NDM. Factors equally 
affecting the glucose levels of both the NDM and T2DM populations are the age and gender of 
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the population. Furthermore, glucose values of the NDM population were found to correlate 
positively with age and to be statistically lower in females compared with males (P<0.05) 
(sections 6.3.2 and 6.3.3). 
Comparison of Blood Glucose Analysis Techniques 
Once the NDM and T2DM glucose database values were established, the two methods of 
analysis - namely the YSI (section 2.1.8.1) and the UltraTM (section 2.1.8.2) - were compared 
(section 6.3.4). Firstly, a Paired t-test showed no statistical difference between the two methods 
at the P<0.05 level. Secondly, a statistically significant correlation (Pearson Product Moment 
Correlation Coefficient, P<0.05) was found between the glucose levels of both populations 
determined by the two methods. Thirdly, the Altman-Bland method was used (Bland and 
Altman, 1986) to test for any possible agreement between the two clinical methods, and 
evaluation of the data from the NDM and T2DM populations found that the two blood glucose 
measurement methods were found to agree well. Finally, the Parkes Error Grid was used to 
examine the degree of agreement between the two methods (Parkes et aL, 2000). It was found 
that 95% of the values fell within zone A of the Error Grid, which indicates a good level of 
agreement (section 6.3.4). 
Serum Uric Acid 
Serum uric acid measurements were found to be not statistically different between the NDM 
and T2DM populations (two-tailed West, P<0.05) and agree well with the literature values 
(Table 6.11) as discussed in section 6.4.1. The influence of serum uric acid on blood glucose 
measurements using the UltraTm meter was also evaluated by means of a partial least squares 
regression method. The Pearson Product Moment Correlation Coefficent value was r-0.991, 
indicating a highly significant correlation at the P<0.001 level Naic = 86,31, tcýt a 3.57,77 
degrees of freedom), and a correlation with an R2 value of 0.928 was obtained (section 6.3.2). 
Diabetic Study - Copper 
Copper was found to be log-normally distributed in the serum, plasma and whole blood data 
samples of both the NDM and T2DM individuals. The removal of statistical outliers resulted in 
change of the distribution in whole blood (T2DM population) to normal. This brings into 
question the 'normality of the control population (NDM). Consequently, the population data was 
evaluated with respect to both age and gender to determine whether these parameters affected 
the distribution (section 6.7.1). Copper was only found to be negatively correlated with age 
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(P<0.001) in all blood fractions (NDM population) (section 6.7.2). Considering gender, the 
concentration of copper in blood samples from males was found to be statistically lower than 
that of females for both the NDM and T2DM populations (section 6.7.3). Despite this 
information, the values obtained for the populations (as cited in Table 6.15) agree well with 
values reported in the literature (Tables 6.12 and 6.13). 
Diabetic Study - Iron 
Iron concentrations were found to be log-normally distributed in all blood fractions of both study 
populations, with the exception of serum (NDM population). This questions the 'normality' of the 
control population (NDM). Comparing the NDM and T2DM iron values, it was found that the 
only statistically different population values were for serum iron (two-tailed West, P<0.001). 
Data analysis was undertaken to evaluate whether this difference and the log-normal 
distributions of iron were an artefact of statistical outliers. The data were evaluated by means of 
a Grubb's test for outliers (Equation 6.1). The exclusion of some outliers did not change the 
outcome of the two-tailed Mest, and therefore the data was evaluated With respect to age and 
gender to determine whether these factors affected the blood iron values of both the NDM and 
T2DM populations (section 6.8.1). In terms of serum and plasma iron (NDM population) and 
whole blood iron (T2DM population), a negative correlation was found with respect to age 
(section 6.5.13.2). This was found to agree with previous studies (section 6.8.4). The 
concentration of iron in whole blood was found to be statistically higher (NDM N0.001, T2DM 
P<0.01) in the male groups of both populations (section 6.8.3). Generally, the values obtained 
for the populations (as cited in Table 6.24) agree well with values from the literature (Tables 
6.12 and 6.13). 
Diabetic Study - Selenium 
Selenium was found to be normally distributed in whole blood and log-normally distributed in 
the serum and plasma of both the NDM and T2DM populations. This once again questions the 
'normality of the control population (NDM). A statistically significant difference was observed 
between the values of selenium in serum of the NDM and T2DM populations (T2DM>NDM), 
and this relationship did not alter With exclusion of statistical outliers from the data set (section 
6.9.1). Statistical evaluation of the population data with respect to age yielded no significant 
correlations (section 6.9.2). Further statistical analysis considering the gender of the individuals 
showed that males (NDM population) were found to have statistically higher plasma and whole 
blood selenium concentrations (section 6.9.3). Considering the population data values 
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themselves, it was found that the values obtained for the two study populations (as cited in 
Table 6.33) agree well with the values from the literature (Tables 6.12 and 6.13). 
Diabetic Study - Zinc 
Zinc in all blood fractions of both populations was found to be log-normally distributed. Again 
there is the question of the 'normality of the control population (NDM). Evaluating the 
population data by means of a two-tailed West found that the serum and plasma of the NDIVI 
population had statistically higher zinc concentrations than the T2DM individuals. In the case of 
whole blood, the T2DM had statistically higher zinc concentrations than the NIDIVI cases. These 
findings were also confirmed after the exclusion of statistical outliers (section 6.10.1). 
Correlating the zinc concentrations of all blood fractions from both populations versus age 
revealed that zinc was correlated negatively with age in serum and plasma (NDIVI population). 
A further statistical analysis of the data resolved for gender showed that the zinc concentrations 
of the male group were found to be statistically higher (serum P<0.01, plasma P<0.05, whole 
blood P<0.001) than the female group (section 6.10.3). These findings were corroborated by a 
comparison with the findings of other studies (section 6.10.4). Evaluation of the concentrations 
obtained for both the NDIVI and T2DM populations with respect to literature values found that 
the levels obtained (as cited in Table 6.40) agree well With the values from the literature 
(Tables 6.12 and 6.13). 
Trace Element in Relation to Antioxidants 
Serum uric acid was found not to correlate to serum concentrations of copper, iron, selenium 
and zinc, therefore uric acid was not affected by the presence of these trace elements in 
serum. Information relating to the interaction of the metals of interest in a liquid form with the 
antioxidants ascorbic and uric acids indicates that the concentrations required to oxidise a 
sample at 0.5mM are 6 ýtg ml-I Cu (ascorbic acid only), 10 gg ml-I Mn, 6 gg ml-I Ni and 2 lag 
ml-I Pb (section 6.6.2). The data obtained from this study for both the NOM and T2DM 
populations showed that the concentration of these elements in any blood fraction was not 
found to exceed these values (section 6.12). Consequently, it is possible to conclude that the 
concentration of the antioxidants in the blood samples should not be affected by the trace 
element levels present in the blood. This was confirmed by the fact that no significant statistical 
difference (two-tailed Mest, Altman-Bland method, Parkes Error Grid) was found between the 
UltraTm and YSI data and therefore, the sensor is not significantly affected by the analytes 






Diabetes is a metabolic disorder caused by the inability of body tissues to produce insulin (type 
1) or to respond to any insulin present (type 2). This results in impaired control of blood glucose 
levels and in unmanaged cases is likely to cause hyperglycaemia. This exacerbates oxidative 
stress to such an extent that there is a significant chance of damage to body tissues (Marra et 
aL, 2002). 
Constant monitoring of blood glucose concentrations enables the diabetic to control their 
condition and to maintain optimum glucose levels, avoiding hyperglycaernia. Conventional 
blood glucose monitors - near-patient testing devices (section 1.1) - are highly susceptible to 
interference caused by electro-active species present in blood (section 1.4). Antioxidants; are a 
predominant cause of interference, and are also known to have markedly altered 
concentrations in metabolic disorders such as diabetes (Maxwell et aL, 1997; Marra et 8L, 
2002). Trace elements are also known to have altered levels in diabetes (Abou-Seif and 
Youssef, 2004). These constraints stimulated the evaluation of antioxidants and trace elements 
and their influence on blood glucose monitors utilising mediated electron transfer approaches 
undertaken in this study. 
The aim of this research was to elucidate the mechanisms through which common 
physiological antioxidants, can influence mediated electron transfer in amperometric 
biosensors, and develop protocols for their direct quantitation and/or exclusion, assessing the 
viability of these approaches with respect to blood glucose analysis for diabetics (section 1.7), 
The main objectives were: 
to investigate the electrochemistry of ascorbic acid, cysteine and glutathione and their 
interaction with the mediating species - potassium ferro/ferricyanide redox mediator; 
0 where appropriate, to develop a strategy for the electrochemical detection of thiol 
moieties; 
to assess the extent to which interferents (including uric acid) interfere and where 
relevant develop generic strategies using chemical (metal oxide) or physical 
(membrane) approaches to compensate; 
to investigate the properties of electrochemically generated nanoscale alloys and their 
activity in relation to glucose and the antioxidants of interest; 
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9 to determine the elemental concentrations of Cu, Cr, Fe Mn, Mo, Ni, Pb, Se, V, and Zn 
in biological media (serum, plasma and whole blood) of both diabetic and normal 
healthy individuals; and 
0 to determine the effect of Cu, Fe Mn, Mo, Ni, Pb, V, and Zn oxides on the antioxidants 
ascorbic and uric acid and the effect of these on blood glucose monitors, 
Both the aim and main objectives of the project have been achieved. The electrochemistry and 
associated electrochemical interference of the antioxidants ascorbic acid, cysteine, glutathione 
and uric acid have been evaluated from a perspective of both selective detection (chapters 3 
and 4) and interference removal (chapter 5). These are discussed further in sections 7.2,7.3 
and 7.4. The determination of the concentration of the trace elements and uric acid in both non 
diabetics and type 2 diabetics was also accomplished in relation to diabetic health and the 
effect of these trace elements on near-patient testing devices for blood glucose, as discussed 
in sections 7.5 and 7.6. The analytical techniques and methodology used in this work were 
mainly electrochemical and spectroscopic methods and are discussed below. 
7.1 Analytical Techniques and Methodology 
A wide variety of analytical techniques were used throughout this work; including 
electrochemical methods (voltammetry, amperometry and potentiometry) used to investigate 
the fundamental electrochemistry of the antioxidants (section 2.11); a standard three electrode 
system, with a platinum counter electrode, a AgjAgCl reference electrode and various working 
electrodes depending on the application; and blood plasma glucose measurements carried out 
using both the YSI standard reference method and the Ultra Tm blood glucose monitor. 
UVNis spectroscopy was used for two different assays - Ellman's chemical assay for the 
measurement of sulphydyl thiols (Ellman, 1959), kmax 410 nm, limit of detection = 0.4 ýW 
(section 2.2.3), and InfinityTM uric acid enzyme assay, kmax 520 nm, limit of detection = 0.07 
mM (section 2.2.4). 
For trace element measurements, appropriate sampling methodologies were developed 
following detailed consideration of trace element contamination - namely venous puncture with 
a Vacutainer@ 21 gauge straight through needle and then collection of blood directly into a LH 
PST Vacutainer@ for plasma, SST 11 Advance Vacutainer@ for serum, and a NH TE Vacutainer@ 
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for whole blood. The serum and plasma were then separated by centrifugation and all three 
fractions were transferred to metal-free ElkayTm tubes for storage at -200C until analysis 
(sections 2.6). 
Sample analysis was carded out by Flame Atomic Absorption Spectrometry (FAAS) and 
Inductively Coupled Plasma - Mass Spectrometry (ICP-MS). Blood plasma and serum were 
prepared by dilution using the alkali blood diluent developed for use on the SOLA lCP-MS and 
AAnalyst 400 FAAS instruments, comprised of 5g 1-125% ammonia solution, 5g 1-1 methanol, 
0.5 g 1-1 EDTA disodiurn salt and 0.5 g 1-1 Triton X-100. Whole blood samples were digested 
using a Kjeldhal flask open vessel digestion method with concentrated nitric acid and 30% 
hydrogen peroxide which was adapted from that established by Heales (2003). The final 
sample matrix was approximately 5% nitric acid which was nebullsed into the ICP-MS or FAAS. 
Sample dilution served to increase sample volume for analysis and to minimise matrix effects 
such as ionisation suppression, space charge effects, and sample viscosity effects (section 
2.5.3.2). Calibration standards and blanks were prepared in the same matrix as the sample. 
ICP-MS analysis is highly susceptible to both chemical and physical interferences (section 
2.5.3). To minimise spectroscopic interferences, isotopes with few isobaric and polyatomic 
interferences were chosen, namely 51V+, 53Cr+, 55Mn+, 58Ni+, 63CU+, 68Zn+, 82Se+, 98MO+, 206Pb+, 
207Pb+ and 208Pb+. Internal standards were used to correct for chemical, spectroscopic and 
matrix effects over the whole mass range. 59Co+ was used to correct for the mass range 51 - 
63,74Ge+ was used to correct for the mass range 68 - 82,1151n+ was used to correct for 98MO+, 
and 209Bi+ was used to correct the mass range 206 - 208. 
Instrumental drift affecting sample analysis was found to be present in both methods of 
instrumentation. In the case of FAAS this was corrected by the analysis of a mid range 
calibration standard (quality control standard), whereas for ICP-MS internal standard correction 
was used. Typical levels of precision for FAAS analysis were <2.5% RSID and for SOLA ICP- 
MS were <5% RSD. The accuracy of trace element analysis techniques was evaluated by the 
method of standard addition using a Paired West to evaluate the statistical difference between 
the concentration determined from the method of standard addition and from the calibration 
(Equation 2.9). In all cases the null hypothesis was accepted at the 95% confidence level 
(PO-05), and no statistical difference was found between the two methods (sections 2.4.5 and 
2.5.6.1). Spike recoveries were also used to evaluate accuracy of the methods and all values 
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were found to be within 90 - 110% (sections 2.4.8 and 2.5.6.2). The measured values for 
reference materials (Seronormlm Trace Elements in Serum Level 1 Lot No JL4409 and 
SeronorMTm Trace Elements in Whole Blood Level 1 Lot No OK0337) were also found to agree 
well with certified values by means of a Student Mest (section 6.3.5). Detailed comparison of 
certified values and measured values of the reference materials indicated that the copper and 
selenium values in whole blood were underestimated and their values in samples should be 
treated with caution. 
Inter-method and inter-laboratory comparisons were carried out between the Perkin Elmer Elan 
DRCII instrument, the SOLA ICP-MS and the AAnalyst 400 spectrometer (section 6.3.6). No 
statistical difference was observed between the values obtained for the same sample from 
each instrument (sections 6.2.6 and 6.2.7). 
7.2 Selective Detection of Antioxidants 
In this work the selective detection of antioxidants by electrochemical means has focused on 
thiol moieties. The standard methods for the detection of thiols in biological fluids rely upon 
chromatographic and/or spectrophotometric methods, which are both expensive and time- 
consuming. Recently, work considering the use of quinones for the enhanced detection of thiols 
by voltammetric and potentiometric methods has been published (White et at 2001,2002; 
Digga et at 2003), and the work in this thesis has considered the reactions of thiols with 
quinones amperometrically. Both cysteine and glutathione were found to give an enhanced 
electrochemical response in the presence of benzoquinone due to the M-nucleophillic addition 
of the thiol to the quinone ring and the subsequent electrochemical oxidation of the thiol- 
quinone adduct (section 3.2.1). 
It was found that the thiols cysteine and glutathione could easily be differentiated as there was 
a difference in the reaction stoichiometry, which was verified by both amperometric and 
potentiometric methods, and easily explained by the different reaction mechanism of the 
quinone with the two thiols (section 3.2.2). However, the oxidative signal of the benzoquinone 
was found to overlap with that of ascorbic acid, and hence would be highly susceptible to other 
electrochemical interferences (section 3.2.3). To overcome this potential interference the 
choice of quinone mediator was altered to naphthoquinone, which had a lower oxidation 
potential and avoided overlap from the ascorbic acid signal. The detection of both cysteine and 
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glutathione at screen printed electrodes was achieved with the limit of detection being 0.4 ýW 
(section 3.2.1). 
7.3 Manufacture of Selective Electrode Substrates 
Some transition metal elements are known to be electrocatalytic for the oxidation of 
biomolecules (Yeo and Johnson, 2000; 2001). For example, copper is known to oxidise 
glucose via the Cu(ll)/Cu(III) redox couple, and this property has been exploited for the 
amperometric detection of glucose and other sugars after electrophoretic or chromatographic 
separation (Colon et aL, 1993). Some transition metal alloys of electrocatalytic metals have 
also been generated and have been found to exhibit different properties to those of the 
component metals, and in many cases these properties are highly desirable (Mho and 
Johnson, 2001a, b). Screen printed electrodes were modified by the electrodeposition of copper 
and found to yield a catalytic response to glucose, just as the bulk copper disc electrode does 
(section 4.2.5). 
Screen printed carbon electrodes, by virtue of the properties of the ink in aqueous solution, 
have been proven to have a negatively charged surface upon which cations can be deposited. 
It was found that antimony, bismuth, copper and lead could be deposited on the electrode 
surface in this manner, and then removed by anodic stripping square wave voltammetry 
(section 4.2.3). The mixing of two of the metals was carried out and a separate stripping signal 
for a new species, an alloy, was found in the presence of copper and lead. No such signal was 
found for any other combination of antimony, bismuth, copper and lead (section 4.2.3). The 
passive deposition of the metals to generate the alloy was optimised and it was found that the 
greatest anodic stripping voltarnmetry signal for the alloy was obtained after 10 minutes 
immersion in the standard lead solution, followed by 10 minutes in the standard copper 
solution, where the metals were reduced on the electrode surface between each stage (section 
4.2.4). 
This copper-lead alloy was found to exhibit an electrocatalytic response to uric acid and 
cysteine, although a better response was seen to glucose, where a linear relationship was 
found over 2 to 5 mMol 1-1 (section 4.2.5). The passive alloy was also found to show a response 
better than that of passive copper, despite the fact that only copper, and not lead, catalysed 
glucose oxidation (section 4.2.4). 
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7.4 Antioxidants as Electrochemical Interferences 
The aims of this section of work were to enhance an understanding of antioxidants as 
electrochemical interferences and to develop strategies to prevent their influence in blood 
glucose sensors which utilise mediated electron transfer. Any developed technology should be 
readily transferable to mass manufactured screen printed electrodes. 
There are two methods used to exclude antioxidant based interferences present in biosensors. 
A membrane may be employed which excludes the antioxidant based on size or charge, or 
both. Alternatively transition metals have been used to either oxidise the interfering species or 
fix it in a complex so that it is not able to interfere. Membranes are not highly suited for 
incorporation into mass manufactured screen printed electrodes, and therefore this work 
considered only the use of pre-oxidation and complex formation. 
The interference of the antioxidants with mediated electron transfer in blood glucose monitors 
was evaluated by the use of a Parkes error grid. It was found that at normal physiological 
concentrations (0.15 - 0.43 mMol 1-1) uric acid caused sufficient electrochemical interference to 
blood glucose readings by Ultra TM to cause an altered clinical action. However, ascorbic acid 
generated a borderline value, and the presence of cysteine and glutathione caused no altered 
clinical action (as defined by Parkes et aL, 2000). Cysteine and glutathione were consequently 
excluded from the study as they have a higher oxidation potential than the pulse applied to the 
sensor for glucose measurement. Both thiols exhibit poor electrochemical activity and their 
detection requires signal enhancement (Chapter 3 and section 7.2). They were found not to 
produce statistically significant interference, with no altered clinical action. 
Screening of the interaction of the oxides of copper, iron, lead, manganese, molybdenum, 
nickel, lead, vanadium and zinc with ascorbic acid and uric acid was conducted by evaluating 
data from blood glucose monitors, cyclic voltarnmetry and FAAS. It was found that copper (1) 
and copper (11) oxide were able to oxidise ascorbic acid and manganese (IV), nickel (11) and 
lead (IV) oxides were able to oxidise both ascorbic and uric acid. 
In order to evaluate the possibility of transferring the metal oxides as a pre-oxidation 
technology to screen printed electrodes, any reactions between the metal and the mediator or 
the enzyme were investigated. Copper and nickel presented the most problems, as they were 
found to inhibit both the mediator and the enzyme (section 5.2.3.2). This was overcome by 
introducing citric acid as a chelation agent (5.2.3.3). The use of citric acid in this case does not 
require sensor modification as it is already incorporated in the patented screen printing ink as a 
buffering agent. Manganese did cause some signal suppression in the case of both the enzyme 
200 
and the mediator, due to the high potential applied which caused manganese oxide and 
hydroxide species to precipitate and 'foul" the electrode surface; whereas lead was found to 
have no effect on the mediator or the enzyme. 
Sensor modification was carried out by immobilising copper (11) oxide particles within a Melolin'D 
absorbent pad and fixing this at the end of the sample uptake capillary of the screen printed 
electrode. This was found to be highly efficient at removing ascorbic acid in simulated biofluid 
as an inteferent and was able to generate an interference-free genuine glucose measurement 
signal (section 5.2.5). However, copper (11) oxide was only able to oxidise ascorbic acid not uric 
acid. 
Manganese (IV) oxide was also evaluated using blood serum and plasma rather than simulated 
biofiuids (section 5.2.5). Blood plasma and serum samples were spiked with elevated 
physiological concentrations of ascorbic and uric acid, then treated with manganese (IV) oxide 
(Mn02) particles directly, which were then removed by filtration, the resulting supernatant was 
analysed by the blood glucose meter. There was no statistical difference seen between the un- 
spiked and spiked samples after Mn02 treatment (Pired West P<0,05), and the ascorbic acid 
and uric acid were effectively removed. For uric acid, this was confirmed by investigations 
using the InfinityTM uric acid assay verifying that the Mn02 particles oxidised uric acid 
efficiently. The stoichiometry of the ascorbic acid and uric acid reactions with the oxides was 
established and these were used to evaluate the influence of these as trace elements in blood 
(section 5.2.4). 
7.5 Influence of Trace Elements and Uric Acid on Glucose Sensing 
The aim of the clinical study carried out in Chapter 6 was to evaluate the trace element 
(chromium , copper, iron, manganese, molybdenum, nickel, lead, selenium, vanadium and 
zinc) concentrations in the blood plasma, serum and whole blood of both healthy individuals 
(NDM) and type 2 diabetics (T2DM) and their relationship to serum uric acid and plasma 
glucose (YSI), with an end view to assessing the impact of both the trace elements and the uric 
acid on the blood glucose sensor (Ultralm). 
Copper and zinc are known antioxidants with crucial importance in the onset of diabetic 
complications (Abou-Seif and Youssef, 2004), zinc is also needed for glycogen synthesis and 
hence deficiency impairs glucose metabolism (Reeves and O'Dell, 1984a, Reeves and O'Dell, 
1984b), as is also the case with manganese (Anderson et al. 1990). There is no information 
describing any relationship between molybdenum and diabetes, however it is an essential 
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component of xanthine oxidase which is required for correct uric acid metabolism (Devlin, 
2002). Selenium and Vanadium are insulin mimics with particular potency in type 2 diabetes 
(Mueller et al. 2003; Srivastava and Mehdi, 2005) and Cr is also essential as a key component 
of the glucose tolerance factor (chromodulin) (Devlin, 2002). Nickel and lead are not known to 
have any key role in the manifestation of diabetes. iron is only known to increase in the tissues 
of diabetics and this appears to be related to poor glycaemic control, which leads to haemolysis 
(Fraga and Oteiza, 2002). Uric acid is known to be lower in T2DM compared with NDM 
(Herman and Goldbourt, 1982). 
Of the 10 trace elements chosen for investigation, chromium, manganese, molybdenum, nickel, 
lead and vanadium were found to be lower than the detection limit of the instrumentation in all 
samples. As such, only data resulting from the analysis of copper, iron, selenium and zinc in 
blood serum, plasma and whole blood has been reported here. The arithmetic mean and range 
of values for each method of analysis is listed in Table 7.1. 
Table 7.1 Summary data for the NDM and T2DM populations. 
Analyte (fraction) Units NDM 
Arithmetic Mean Range 
T2DM 
Arithmetic Mean Range 
Glucose (YSI) mm 5.63 3.37-9.79 8.59 4.00-18.50 
Glucose (UltraTm) MM 5.48 3.67-10.2 8.59 4.00-19.10 
Uric Acid mm 0.312 0.126 - 0.583 0.326 0.140 - 0.666 
Cu (serum) n 1-1 1032 569-1478 1032 561-1598 
Fe (serum) mg 1-1 1.075 0.295 - 2.315 0.736 0.267 - 1.398 
Se (serum) Pg 1-1 120 94-207 146 89-224 
Zn (serum) Pg 1-1 851 620-1126 734 502-1360 
Cu (plasma) lig 1-1 1029 561-1598 975 602-1819 
Fe (plasma) mg 1-1 0.858 0.159 - 1.414 0.914 0.436 - 2.019 
Se (plasma) Pg 1-1 145 46-246 134 75-254 
Zn (plasma) Pg 1-1 919 597-1255 729 425-1113 
Cu (whole) Pg 1-1 784 497-1131 765 411-1433 
Fe (whole) mg 1-1 455 335-573 455 348-674 
Se (whole) Pg 1-1 86 22-160 86 9-181 
Zn (whole) Pg 1-1 4734 2740-6152 6145 4119-13715 
Quality control procedures involved the analysis of SeronorMTm reference materials and good 
agreement was seen between the measured and certified values. Glucose (measured by both 
TM the YSI and Ultra , section 2.1.8) was found to follow a normal distribution in the NDM and a 
log-normal distribution in the T2DM population, which relates to the poor glycaemic control in 
the T2DM individuals. A two-tailed Mest found that T2DM values were found to be significantly 
higher than the NDM (P<0.05). Glucose values of the NDM population were found to correlate 
positively with age, they were also found to be statistically lower in the females compared with 
males (P<0.05) (sections 6.3.2 and 6.3.3). 
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Comparison of the two methods, YSI and UltraTlý, firstly involved a paired Mest, which found no 
statistical difference was found between the two methods at the P<0.05 level. The Altman- 
Bland method was used (Bland and Altman, 1986) to test for agreement between two clinical 
methods, and the two methods were found to agree well. Finally, the Parkes error grid was 
used to examine the degree of agreement between the two methods (Parkes et al., 2000). It 
was found that 95% of the values fell within zone A of the error grid, which indicates good 
agreement (section 6.3.4). 
Serum uric acid measurements by the InfinityTM uric acid assay (section 2.2.4) were found to 
not be statistically different between the NDM and T2DM populations (two-tailed Mest, P<0.05) 
and to agree well with reference interval as discussed in section 6.4.1. The influence of serum 
uric acid on blood glucose measurements made by the UltraTM meter was also evaluated by 
means of multiple linear regression which revealed a direct dependence of UltraTM 
measurements on YSI measurements and uric acid concentratiow. 
Ultra =-0.04 + 0.959 YSI + 1.02 uric acid r=0.991 
The Pearson Product Moment Correlation Coefficent value was r=0.991, indicating a highly 
significant correlation at the P<0.001 level (6,; = 86.306, tcrit x 3.570,77 cl. ý., and a direct 
relationship with an r2 value of 0.928 was obtained (section 6.3.2). 
Copper was found to be log-normally distributed in the serum, plasma and whole blood data 
sets of both the NDM and T2DM populations, although the removal of statistical outliers 
resulted in changing the distribution in whole blood of the T2DM population to normal. Copper 
was only found to be negatively correlated with age (P<0.001) in the blood (all fractions) of the 
NDM population (section 6.7.2), and the concentration of copper in male blood (all fractions) 
was found to be statistically lower than that of females for both NDM and T2DM populations 
(section 6.7.3). Despite this information, the values obtained for the populations (as cited in 
Table 7.1) agree well with values from the literature (Tables 6.12 and 6.13) 
Iron concentrations were found to be log-normally distributed in all fractions of both populations 
except the serum of the NDM population regardless of the inclusion or exclusion of statistical 
outliers, thus questioning the 'normality' of the plasma and whole blood fractions control 
population (NDM). The levels of iron in serum and plasma of the NDM population and whole 
blood of the T2DM population were found to be negatively correlated with age (section 6.8.2), 
and this was found to agree with previous studies (section 6.8.4). The concentration of iron in 
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whole blood was found to be statistically higher (P<0.01) in males groups of both populations 
compared to females (section 6.8.3). Generally, the values obtained for the populations (as 
cited in Table 7.1) agree well with values from the literature (Tables 6.12 and 6.13). 
Selenium was found to be log-normally distributed in the serum and plasma of the NDM and 
T2DM populations but normally distributed in whole blood. A statistically significant difference 
was observed between the values of selenium in serum of the NDM and T2DM populations 
(T2DM>NDM), which was not altered by exclusion of statistical outliers from the data set 
(section 6.91). As with all elements, a log-normal distribution was expected for the T2DM 
population due to altered homeostasis. However, the log-normal distribution in the NDM 
population was evaluated to examine whether it was affected by age or gender. Resolving the 
population data with respect to age yielded no significant correlations (section 6.9.2). Males of 
the NDM population were found to have statistically higher plasma and whole blood selenium 
concentrations than females (section 6.9.3). Considering the population data values 
themselves, it was found that the values obtained for the populations (as cited in Table 7.1) 
agree well with values from the literature (Tables 6.12 and 6.13). 
Zinc in all blood fractions of both populations was found to be log-normally distributed and may 
therefore be affected by such factors as age and gender, Evaluating the population data with 
and without statistical outliers by means of a two-tailed Mest found that serum and plasma of 
the NDM population had statistically higher zinc concentrations than the T2DM, whereas in the 
case of whole blood the T2DM had statistically higher zinc concentrations than the NDM. Zinc 
correlated negatively with age in the serum and plasma of the NDM population and 
concentrations of the male group were found to be statistically higher (P<0.05) than the female 
(section 6.10.3). These findings were corroborated by comparison with the findings of previous 
studies (section 6.10.4). Evaluation of the findings with respect to literature values found that 
the values obtained (as cited in Table 7.1) agree well with values from the literature (Tables 
6.12 and 6.13). 
Although some of the elements in NDM blood fractions were found to be log-normally 
distributed, this may be due to the effect of age and gender. For the T2DM population the 
elements were not found to be so affected in this way, and the log-normal distribution may be 
attributed to the altered homeostasis found in diabetics, Serum uric acid concentration was not 
found to correlate to any trace elements in serum. 
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Background information relating to the interaction of the metals of interest in a liquid form with 
the antioxidants ascorbic and uric acids indicates that the concentrations required to oxidise 
typical physiological concentrations of them are 6 pg ml-I Cu (ascorbic acid only), 10 ýLg ml-1 
Mn, 6 ptg ml-I Ni and 2 pg ml-I Pb; and from the data obtained from the study of both healthy 
controls and type 2 diabetic subjects the concentration of these elements in any blood fraction 
was not found to exceed these values (section 6.12). Consequently, it is possible to conclude 
that the concentration of the antioxidants in the blood samples should not be affected by the 
trace element levels present in the blood. This is justified by the fact that no significant 
statistical difference (two-tailed Mest, Altman-Bland method, Parkes error grid) was found 
between the Ultra TM and YSI data, the sensor is not affected in a clinically significant way by 
the analytes measured in this study. 
7.6 Further Remarks 
The selective amperometdc detection of the thiols cysteine and glutathione has been achieved. 
It could be envisaged that further work could be conducted relating to the investigation of the 
reactions of thiols with different quinones and other physiologically relevant thiols (e. g. 
homocysteine). The potential incorporation of the quinone mediator into screen printed 
electrode ink layers would lead to the mass manufacture of thiol specific biosensors. This is of 
particular interest as the current methods for the measurement of plasma thiol moieties require 
extensive analytical methodologies (West 2000). However, the detection of thiols in genuine 
biofluids has the potential to be compromised through competing adverse side reactions of 
other biomolecules with the quinone (Gracheva et aL, 2005), and these should also be 
evaluated. 
A possible mode of construction for a third generation has been developed by the optimisation 
of a production of a catalytic lead-copper alloy for the electrochemical detection of glucose, 
ascorbic acid and uric acid. Unfortunately, this work did reveal that the passively deposited 
metal electrodes were not effective in biological media due to the fact that the sample matrix 
contained biomolecules capable of complexing copper and lead. Further work could investigate 
any viable media in which analysis would be suitable, including food and environmental 
samples. The creation of other alloys could also be investigated by considering other 
electrocatalytic transition metals. Finally, the large scale electroless deposition to generate 
mass manufactured screen printed passive alloy electrodes could be investigated. 
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Copper (11) oxide immobilisation as a pre-treatment methodology for blood glucose 
measurement at screen printed electrodes has been found to effectively remove ascorbic acid 
as an interferent. Manganese (IV) oxide has been found to oxidise both ascorbic acid and uric 
acid, and thus would provide a more effective interference removal strategy. Problems relating 
to excess metal (from the biofluid) and any interaction of the metal with the enzyme or the 
mediator commonly present in glucose biosensor screen printed electrodes have been 
investigated. As a result, further work would be to incorporate pre-oxidation of the sample by 
Mn02 into the screen printed electrode. This could either be done by incorporation of Mn02 
particles within the enzyme and mediator water soluble ink, or in it's own water soluble ink 
closer to the sample uptake end of the capillary (i. e. similar to the CuO arrangement developed 
in this work, section 5.6). This sensor modification should then be validated and, depending on 
the outcome of investigative studies, could then be mass manufactured and used to replace 
standard screen printed electrodes. 
The trace element and uric acid data obtained during the course of the diabetic clinical 
investigation has served well to nullify any possible effects of the trace elements on the blood 
glucose sensor, while in relation to uric aid, justifying the need for anti-interference strategies. 
The data obtained here agreed well with reference values from the literature. However the 
reference levels themselves are confusing as some workers report increased levels of a trace 
element in diabetics, whereas other workers report decreased. As diabetes is a metabolic 
disorder, much of this difference of opinion could be attributed to a loss of homeostatic 
regulation in diabetics compared to healthy individuals, and the values for one person over a 
period of time may vary widely. As such, further work would be to consider the trace element 
concentrations from an individual over time so as to eliminate any within person changes in 
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The arithmetic mean (x) of n measurements of x, is calculated as follows (Miller and Miller, 
2000): 
-= Ex, x n 
Geometric mean 






The median is the value of the V2 (n-I)th observation if n is odd; and the average of %n thamd 
the (1/2 n+l)thobservation if n is even (Miller and Miller, 2000). 
Nest 
An F- test compares the difference in the standard deviations of two samples. The value of F is 
calculated as follows (Miller and Miller, 2000): 
F=s, 
2 IS2 2 
where s, andS2are the standard deviations of the two populations, and they are allocated such 
that the value of F is always 2: 1. 
Grubb's Test for Outliers 
A Grubb's test is used to statistically test for outliers and is performed by calculating a value of 
Z and any values where Zcalc>Zcrit rejected as outliers (Barnett and Lewis, 1998): 
Z= 
S 
once all outliers had been removed, the remaining data formed the 'normalised population" and 
this was used in all subsequent calculations. 
A2 
Limit of Detection 
The limit of detection (LOD) of a method is calculated as concentration equivalent to the signal 
of the blank plus three times the standard deviation of the blank (Miller and Miller, 2000): 
LOD = yb + 3s, 
where s= standard deviation, )ý= x value 7= mean of x, n= number of values, Yb'2 signal of the 
blank and Sb = standard deviation of the blank. 
Rewession 
Least Squares Line Fit 
The regression line for the least squares line fit can be calculated as follows (Miller and Miller, 
2000): E ((x, - x-)(Y, -T)) 
Slope= m='E (xi -V 
Intercept =c -L T- tný 
where m=slope, x= x value, x= mean of x values, y, = y value, y= mean of y values and c 
intercept. 
Pearson Correlation of Least Squares Line Fit 
The Pearson's correlation coefficient of the line, R2, is the measure of the straightness of a line 
and is calculated as follows (Microsoft@ ExcelTm, 2003): 
Z (xi - YXY, - ý) 
(xi (yi 
where m= slope, xi =x value, 7= mean of x values, yl= y value, T= mean of y values c 
intercept and R2 = Pearson's correlation coefficient. 
Pearson Product Moment Correlation Coefficient 
Pearson's product moment correlation coefficient (r) is used to estimate how well experimental 
points fit to a straight line and is calculated as follows: 
Z {(x, - _XXY, - Y-» 




where )ý =x value, 7= mean of x values, yi= y value, and T= mean of y values. 
A3 
Recoverv 
Percentage recoveries are used to calculate the proportion of a spike sampled recovered 
following sample preparation methods, and is calculated as follows: 
% Recovery = ý! piked sample] - [sample] x 100 
[spike] 
where values close to 100% (90-110%) are desirable. 
Relative Standard Deviation 
Relative standard deviation (RSD), also known as the coefficient of variance, is used to 
measure the spread of a data set and is calculated as follows (Miller and Miller, 2000): 
%RSD=-IxIOO 
i 
where s= standard deviation and x= arithmetic mean of the data set. 
Standard Deviation 
The standard deviation s of n measurements is the measurement of the spread of data within a 
range, and is defined as follows (Miller and Miller, 2000): 
S (X y)2 In-I 
where xi =x value and x= arithmetic mean of x values. 
T-test 
Paired T-test 
The concentrations determined by the method of standard addition were evaluated versus the 
concentrations determined from the calibration by means of a paired t-test (Miller and Miller, 
2000): 
t= Un- / sd 
where t= Tcaic, mean of difference between pairs of values, n= number of values and Sd 
standard deviation of the difference between pairs of values. 
A4 
Student T-test 
A student T-test is used to calculate the significance of a difference between a certified value p 
and mean x measured value for a reference material (Miller and Miller, 2000): 
t= (X -, u), Fnls 
where n= no of values and s= standard deviation of the measurements. 
T-test for Linear Regression 
A T-test can also be used to calculate the significance of a correlation from the product moment 
correlation coefficient (r) of n measurements as follows: 
jrI'Jn-2 
If Tcalc is greater than the critical value of T (t has n-I degrees of freedom) then the null 
hypothesis is rejected and there is a significant difference (Miller and Miller, 2000). 
Two-Tailed T-test 





Where x, and x2 are the means of the two populations, ni and n2 are the number of values in 
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Clinical Study Protocol 
Evaluation of the effect of trace elements on blood glucose concentrations 
measured by electrochemical blood glucose monitors for the management 
of diabetes (054/QI909/54). 
Dr Callum Livingstone, Royal Surrey County Hospital, Guildford 
Dr Neil 1. Ward & Claire Stone, University of Surrey, Guildford 
Keywords: 
trace elements, diabetes, electrochemical sensor, blood glucose, blood components 
Objectives: 
To measure trace elements in diabetic and healthy control whole blood, plasma and serum 
using the following analytical techniques, available at the University of Surrey: Inductively 
Coupled Plasma Mass Spectrometry (to measure chromium, copper, iron, manganese, 
molybdenum, nickel, lead, selenium, vanadium and zinc) and Flame Atomic Absorption 
Spectrometry (to measure copper, iron and zinc). To evaluate the extent of interference by 
trace elements in blood glucose measurement. 
Background: 
Diabetes is a metabolic disorder which is known to affect homeostasis in the body. It causes 
changes in the distribution of macro- and micronutrients Within the body. 
In most diabetic patients, the macronutrient glucose, gives the greatest cause for concern, and 
is monitored frequently by the majority of patients. This'is carried out by measuring the blood 
glucose (13G) concentration, or level. The most convenient way to evaluate their BG is to use 
the widely available hand held meters (near patient testing devices). It is important to maintain 
a normal controlled BG concentration, because of the increased prevalence of diabetic 
complications in persons who exhibit poor glycaemic control. This means a diabetic patient 
should aim to keep their blood glucose in the range 4-8mmol/L. Diabetics therefore rely heavily 
upon the information their blood glucose monitors (BGMs) give them. 
However, electrochemical BGMs are highly susceptible to interference by other chemicals in 
the blood, this is particularly the case with ascorbic acid (vitamin C) and uric acid. When these 
antioxidants are present at elevated levels, an artificial increase in BGM BG concentration is 
recorded, due to the sensor responding to all three analytes. Ascorbic acid does not present a 
problem when the recommended daily allowance is not exceded and the concentrations are in 
the normal range. Uric acid yields more of a problem as it tends to increase in concentration in 
the blood of diabetics exhibiting diabetic nephropathy (kidney disease). 
Research at the University of Surrey has shown that blood glucose monitors are sensitive to 
the affects of certain trace elements. Trace elements (TE) are micro nutrients found In all 
tissues and fluids in the body. They can broadly be divided into essential TE - those necessary for optimum body function; and non-essential TE - those not necessary for optimum body function, which may possibly be harmful. The TE selected for this study are: chromium, 
copper, iron, manganese, molybdenum, nickel, lead, selenium, vanadium and zinc. The trace 
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element concentrations and glucose concentrations of blood fractions obtained from diabetic 
patients will be determined. 
Previous work 
One of the researchers, Dr N. 1. Ward has previously investigated the relationship between 
plasma trace element concentrations in diabetics undergoing intravenous glucose tolerance 
tests at the Radcliffe Infirmary, Oxford (1980-1982), several publications resulted [1 -3]. 
Other workers have considered diabetes in relation to particular biochemical changes and trace 
and macroelement concentration [4-7], including the affect on antioxidant status [4,8]. In 
particular, this work has shown the elements of interest to be chromium, magnesium, vanadium 
and zinc [3,5,6,9]. However, this work does not evaluate the affect of the trace elements on 
blood glucose sensors, nor does it investigate the relationship between the trace elements and 
diabetic complications. 
Methods 
All diabetic patients and control subjects need to be able to give informed written consent prior 
to the taking of samples. 
A. Diabetic patients will be categorised according to the following factors. 
1) Type of Diabetes - 
either (a) type 1 diabetic (insulin dependent - juvenile) or (b) type 2 (non insulin dependent - 
maturity onset). 
2) Whether they are suffering from diabetic complications - 
Retinopathy (eye disease), nephropathy (kidney disease), neuropathy (nerve disease), skin 
or cardiovascular complaints. 
3) Diabetic medication 
Oral hypoglycaernic agents, insulin. 
B. Control subjects will be recruited from the University of Surrey ICP-IVIS facility and samples 
will be taken as those for diabetic patients. 
Trace elements will be measured at the Department of Chemistry, University of Surrey. Blood 
glucose measurements will be determined by the instrumentation available in the RSCH 
Clinical Laboratory, and also by a commercial near patient testing device (electrochemical 
sensors). 
Research Site: 
Specimens will be collected at the Diabetic Lipid Clinic, Clinical Investigation Unit at the Royal 
Surrey County Hospital. 
The study population: 
The population used in the study will be approached by the physician and will be required to 
provide consent for a further 3 sample tubes containing 5ml blood samples to be taken at the 
time of obtaining hospital blood for tests. 
Each sampling will take 5-10 minutes, and a maximum of 3 samples will be taken from each 
patient over the period of 3 months, therefore, total duration of each participant = 30 minutes 
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The strategy is for the sample pýpulation to be a minimum of 25 and a maximum of 40 diabetic 
patients, regardless of their type of diabetes. A suitable control population will therefore be 5-10 
healthy non-diabetic individuals. 
Statistical evaluation 
Statistical analyses will be carried out in order to determine any statistical relationship between 
the various trace elements analysed and the diabetic complications reported. This will be 
evaluated using the following statistical tests: - F-Test for evaluating the differences in standard deviations. 
T-Test for the comparison of the means of sample populations. 
ANOVA - analysis of variance to eliminate random variations. Dixon's Q-Test - for rejection of outliers. Grubb's Test - to eliminate outliers from a normal population - as used by ISO. Chi squared - determine the frequency of measurement, according to the null hypothesis. Wilcoxon signed rank test - test for significance considering a reference population. Mann Whitney U-Test - non parametric test for 2 independent samples. Chevron's rejection test - based on a normal population. 
Publication 
All data is expected to be published in peer reviewed journals, and in a PhD thesis, thereby 
made available to the wider community. 
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Research Participant Information Sheet 
PARTNERSHIP PATHOLOGY SERVICES 
A Joint Venture of 
Royal Surrey County and Friinley Park 
Hospitals 
Title of Project: Evaluation of trace elements interference in blood glucose measurement 
in diabetes 
Nalnesof Researchers: DrC Livingstone, Dr Neil I Word 
RESEARCH PARTICIPANT INFORMATION SHEE'r 
You are being invited to take part in a research study. Before you decide, it is important for 
you to understand why the research is being done and what it will involve. Please take time to 
read the following information carefully and discuss it with friends, relatives and your GP if 
you wish. Ask us if there is anything which is not clear or if you would like more information. 
Consumers for Ethics in Research (CERES) publish a leaflet entitled 'Medical Research and 
You. ' This leaflet gives more information about medical research and looks at some questions 
you may want to ask. A copy may be obtained from CERES, PO Box 1365, London N16 
OBW. 
Thank you for reading this. 
What is the purpose of this study? 
Diabetes causes changes in the concentration in the blood of substances called trace elements and the 
antioxidants ascorbate and urate. Trace elements are classed as essential and non-csscntial in relation to 
their role in correct biochemical functioning of the body. Antioxidants are also essential for body 
function, they neutralise and remove toxins from the body. Ascorbatc is commonl) known as vitamin 
C and urate is a by-product of natural cell breakdown. Elevated levels of these antioxidants can cause 
problems with measuring the glucose level in blood using a hand held meter. However. a strategy to 
remove these problems from the sensor has been developed, and it has now become important to 
determine the concentrations of the trace elements in an effort to further improve the sensor's accuracy. 
For this reason these elements will be assessed in subjects with diabetes. It is hoped that this work will 
ultimately lead to the manufacture of a more accurate blood glucose sensor. 
Why have I been chosen? 
You have been chosen either because you have diabetes and are attending the Clinical Investigation 
Unit or alternatively are being approached as a non-diabctic control subject. 
Do I have to take part? 
No, it is up to you whether or not you wish to take part. If you decide to take part, you will he given 
this information sheet to keep and be asked to sign a consent form. You are still free to withdraw at any 
time without giving a reason. 
What will happen to me if I take part? 
You will have a sample of blood ( 15ml) taken to determine the concentrations ofthc above listed trace 
elements. This will be done on up to three occasions at separate visits. You will also have it blood 
glucose level measured both by the laboratory and by a near patient testing device. In the unlikel) 
event of unexpectedly abnonnal trace element levels being found, this will he confirmed by a repeat 
measurement and Dr Livingstone will contact you for appropriate assessment. 
What are the possible disadvantages of taking part? 
The only disadvantage of taking part is the discomfort ofhaving a blood sample taken. 
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What are the possible benefits of taking part? 
The test will not benefit individual patients at the present time. However, data resulting from the 
research may in the future benefit patients with diabetes by leading to the development of more 
accurate blood glucose meters. 
What if something goes wrong? 
If you are harmed by taking part in this study, there are no special compensation arrangements. If you 
are harmed due to someone's negligence, then you may have grounds for legal action. Regardless of 
this, if you wish to complain about any aspect of the way you have been approached or treated during 
the course of this study, the normal NHS complaints mechanisms are available to you. 
Will my taking part in this study be kept confidential? 
If you consent to take part in the research, your medical records may be inspected by those carrying out 
the study. They may also be looked at by regulatory authorities to check the study is being carried out 
correctly. Your name will not be disclosed outside the hospital. You will be assigned a research code 
number which will be used throughout all clinical measurements so that no scientist will be able to 
identify you directly. Data can if necessary be traced back to individual participants. 
What will happen to the results of the research study? 
It is anticipated that the results of the work will be published in a scientific journal within two years. If 
you wish, you can obtain a copy of the results from Dr Livingstone in due course. You will not be 
identified in any report or publication. 
Will I be compensated for taking part in this study? 
No, there is no payment for taking part in this study. 
Who is funding the research? 
This study is funded by the Engineering and Physical Sciences Research Council (EPSRC) and 
LifeScan Scotland Ltd.. The investigators will not be paid for including you in this study. 
Who has reviewed the study? 
The study has been reviewed by the South West Surrey Local Research Ethics Committee (LREC) 
which has raised no objections. 
Contact for further information 
Dr Livingstone, Clinical Investigation Unit, Royal Surrey County Hospital. (0 1483 46412 1). 
054/QI909/54 (Version 1) 
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Research Participant Consent Form 
PAIýTNFRSI-IIPPA"ff]O[-O(-, )YSE-k'\/I(-ý[-': ý v A joi. n., Venture of 
Rcyal' Surrey Councy and F-, -, nley Park Hospitals 
Centre Number: 
Study Number: 
Patient Identification Number for this trial- 
RESEARCH PARTICIPANT CONSENT FORM 
Title of Project: Evaluation of twace element interference in blood glucose 
measurement in diabetes 
Names of Researchers: Dr C Livingstone, Dr Neil I Ward 
Please 
initial box 
1.1 confirm that I have read and understand the infOrnation sheet dateld .... -..... . ...... (version .......... ) for the above study and have had the opportunity to ask questions. 
2.1 understand that my participation is voluntary and that I am free to withdraw at any time, 
without giving any reason. without my medical care or legal rights being affected. 
3.1 understand that sections of any of my medical notes may be looked at by responsible 
individuals from the Royal Surrey County HoMiial or from regulatory authorities where it 
is relevant to rny taking part in research. I give permisston for these individuals to have 
access to my records. 
4.1 agree to take part in the above study. 
Name of pat)ent Date Signature 
Narne of Person taking consent 






1 for patient: 1 for researcherý 1 to be kept with hospital notes 
054., *QI909. '54 (Version 1) CIAlay 2005 
Royal Sm-rey County HoVilal, Egolon Road. Guildfoid. Smyray, GU2 5XX 
Tolophome 014133 464121 
Fax 01493 464072 
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Research Participant Sample Information Form 
PARTNERSHIP PATHOLOGY SERVICES 
A To-, rt Vencure of 
Royal Surrey cowncy and Frimley Park 
Hosp. itals 
v oD 










Fasbngl Non Fasting Date 








System of Work: Blood Collection Protocol 
Approach the patient and obtain consent for the study, taking care to allow them 
time for questions, and then sign 3 copies of the consent form - one to be kept 
in their medical records, one to be kept by the patient, one to be kept in the 
researchers file. 
Ascertain whether the patient is providing a fasting/non fasting blood sample 
today - record on the patient information sheet. Make sure the correct hospital 
patient details are recorded on the form. 
3. Ascertain what dietary supplements the patient may be taking - record these on 
the patient information sheet. Record the Brand of supplement, the ingredient/s 
and the dose stated on the label. 
4. Examine the patient's medical records, and annotate the patient information 
form accordingly. 
5. Prepare a sample collection tray, taking care to complete the Pathology 
envelope form for blood glucose measurements. 
6. Carry out standard venipuncture using BDOEclipse Vacutainer TM collection 
needle system, taking care to follow the institutions approved safe system of 
work. 
7. Record the time of collection on the patient information sheet, along with the 
code numbers of the tubes used. 
8. Collect blood sample into 2ml grey capped VacutainerTm and send for glucose 
biochemistry 
9. Collect 3 subsequent blood samples into the following labelled VacutainerSTM 
provided by the ICP-MS Facility, University of Surrey. 





10. Carefully invert each tube 8 times to ensure thorough mixing of sample with 
anticoagulant/clot activator. 
1. Obtain patient revisiting date from patient, and record on patient information 
sheet. 
12. Decant the sample directly from ý 1234WB682005CGS __j the 
tube, and transfer to the correspondingly labelled plastic screw top ElkayTM tube 
and freeze. This is the whole blood sample. 
13. Leave the remaining two samples for >30 minutes, <2 hours, then centrifuge at 
200OG for 10 minutes. Record the time of centrifugation on the patient 
information sheet 
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14. Remove the supernatant from the 
tube using a sterile pipette, and transfer to the correspondingly labelled plastic 
screw top ElkayTM tube, and freeze. This is the blood serum sample. 
15. Remove the supernatant from 1234BPO82005CGS the 
tube using a sterile pipette, and transfer to the correspondingly labelled plastic 
screw top ElkayTM tube, and freeze. This is the blood plasma sample. 
16. Place all labelled samples into the sample collection bag provided and seal. 
Store in the freezer until delivery to the laboratory. 
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Grubb's Test Calculation Data 
Element I 
units 
Matrix Population Value Degrees of Freedom 
ZcaIc Zcrit (P=0.05) 
Cu / jag 1-1 Plasma T2DM 1819 37 3.16 3.01 
Cu / PLg 1-1 Plasma T2DM 1536 36 3.76 3.00 
Cu / gg 1-1 Whole T2DlVl 1433 37 3.15 3.01 
Fe / mg 1-1 Plasma T2DM 2.019 37 3.33 3.01 
Fe / mg 1-1 Whole T2DM 673 37 3.21 3.01 
Se/ jtg 1-1 Serum NDIVI 207 35 3.23 2.99 
Se/ gg 1-1 Whole NDIVI 160 37 3.10 3.01 
Se/ gg 1-1 Plasma T2DM 254 37 3.40 3.01 
Zn/ ua 1-1 Serum T2DM 1360 37 4.36 3.01 
NDM = non diabetic control sample population 
T2DM = type 2 diabetic sample population 
Data for NDM and T2DM Populations - Pooled 
Element Fraction Data Units n Average SD Range 
Cu Serum NDM + T2DM ýtg 1-1 77 1032 248 569-1636 
Cu Plasma NDM + T2DM ýLg 1-1 77 1001 282 561-1819 
Cu Whole NDM + T2DM ýIg 1-1 78 774 188 411-4133 
Fe Serum NDM + T2DM mg 1-1 74 0.901 0.401 0.267 - 2.315 
Fe Plasma NDM + T2DM mg 1-1 76 0.888 0.316 0.159 - 2.019 
Fe Whole NDM + T2DM mg 1-1 78 451 61 335-674 
Se Serum NDM + T2DM gg 1-1 77 133 33 89-224 
Se Plasma NDM + T2DM ptg 1-1 77 139 44 46-254 
Se Whole NDM + T2DM ptg 1-1 77 80 34 9-181 
Zn Serum NDM + T2DM gg 1-1 77 791 150 502-1360 
Zn Plasma NDM + T2DM ptg 1-1 77 820 190 425-1255 
Zn Whole NDM + T2DM Ua 1-1 78 5458 1978 2740-13715 
NDM non diabetic control sample population 
T2DM type 2 diabetic sample population 
C2 
Control Population (NDM) Data 
Sample Age M/F Copper Iron Selenium Zinc 
SPwSPwSPwSPw 
Al 43 F 908 852 656 0.912 0.616 409 157 90 51 696 597 2740 
A2 55 M NES NES 711 NES NES 462 NES NES 81 NES NES 4514 
A3 55 M 624 620 497 1.131 1.067 496 158 130 66 743 821 4147 
A4 51 F 1015 882 654 1.170 0.809 335 184 80 22 895 723 3742 
A5 62 M 922 933 671 0.796 0.629 470 113 87 92 818 784 5185 
A6 28 M 836 768 527 0.899 0.848 471 118 81 108 1000 985 4592 
A7 24 F 1418 1574 947 1.118 0.796 446 137 82 79 836 939 4451 
AB 43 F 978 899 766 1.208 1.054 383 115 92 28 939 923 4603 
A9 51 F 1047 1106 760 0.899 0,410 388 156 108 88 821 1100 4531 
AIO 28 M 759 834 676 1.157 0.912 398 176 97 105 1011 1122 4683 
All 24 F 1321 1239 890 NES NES 412 151 46 73 971 1108 4590 
A12 28 M 948 1055 809 1.427 0.732 466 100 91 77 919 1249 5385 
A13 62 M 859 857 1131 1.105 0.809 455 94 94 57 801 770 4852 
A14 28 M 825 782 602 0.687 0.578 573 126 246 67 998 1165 4906 
A15 28 M 1038 991 612 0.475 0.700 525 123 226 160 1126 1255 5303 
A16 51 F 1022 992 737 0.880 0.565 378 107 197 66 822 1015 4994 
A17 43 F 967 964 741 1.388 0.159 382 123 230 59 669 823 5892 
A18 62 M 969 916 689 0.758 0.565 438 207 231 109 809 950 5528 
SH-1 24 F 1478 1350 949 1.955 1.414 443 101 150 78 896 901 4106 
SH-2 24 F 1346 1533 1003 1.453 1.311 438 104 139 61 920 927 4208 
SH-3 24 F 1397 1381 968 2.315 1.363 440 98 140 86 784 863 3829 
SH-4 24 F 1456 1336 869 1.659 1.170 442 98 139 73 715 839 3462 
SH-5 24 F 1478 1474 936 1.414 1.015 441 102 135 57 816 926 3806 
NW-1 55 M 584 561 620 0.874 0.771 471 94 169 38 727 752 4223 
NW-2 55 M 569 609 583 0.738 0.886 472 105 175 56 708 820 5575 
NW-3 55 M 594 627 579 0.719 0.925 491 100 185 82 783 813 5352 
NW-4 55 M 654 619 591 0.488 0.681 478 101 173 64 763 822 6152 
NW-5 55 M 612 562 751 0.796 0.745 445 98 154 72 769 800 5287 
DD-1 28 M 1055 1020 790 1.324 0.989 505 114 200 50 1082 1171 5566 
DO-2 28 M 1054 898 761 1.749 1.285 530 107 195 53 1026 1009 5786 
DD-3 28 M 1023 948 701 1.260 1.285 504 114 194 87 1010 1079 5243 
DD-4 28 M 1011 959 747 1.375 1.298 465 111 195 105 1083 1047 5350 
DD-5 28 M 1002 1001 756 1.427 1.170 513 115 194 137 1069 1090 5662 
LM-1 25 F 1332 1341 1003 0.977 0.629 369 100 150 36 785 811 4175 
LM-2 25 F 1211 1111 1039 0.758 0.590 425 94 113 73 687 620 4508 
LM-3 25 F 1266 1438 1030 0.385 0.584 412 110 132 91 671 807 4308 
LM-4 25 F 1319 1457 1010 0.745 1.118 386 105 108 85 700 721 4321 
LM-5 25 F 1303 1598 1038 0.295 0.410 399 112 127 62 620 842 4350 
M/F = male or female 
S= serum 
P= plasma 
W= whole blood 
NES = not enough sample 
C3 
Type 2 Diabetic Population (T2DM) Data 
Sample Age M/F Copper Iron Selenium Zinc 
SPwSPwSPWSPw 
0001 47 M 973 882 660 0.691 1.006 531 161 177 100 100 705 1113 
0006 70 F 1472 1245 1070 0.478 0.436 504 158 194 47 47 844 764 
0007 70 M 855 787 499 0.989 1.023 488 170 142 22 22 812 918 
0008 71 M 897 826 625 0.989 1.346 496 159 116 103 103 691 1092 
0009 65 M 910 821 648 1.151 1.466 501 224 254 132 132 740 661 
0010 53 M 919 868 538 0.870 0.904 448 190 138 143 143 566 762 
0011 63 M 876 822 546 0.793 0.836 524 164 125 76 76 592 722 
0012 69 M 1383 1281 1008 0.563 0.776 406 142 107 113 113 502 657 
0013 53 F 1636 1536 1209 1.219 1.619 523 159 119 49 49 785 1102 
0014 58 M 932 857 494 0.802 0.895 674 192 163 134 134 695 874 
0015 52 M 974 871 804 0.640 0.691 534 189 144 39 39 645 812 
0016 60 M 724 602 443 0.784 0.912 549 141 99 40 40 585 700 
0017 30 M 956 844 736 0.710 0.462 482 110 107 59 59 741 753 
0018 57 M 999 853 782 1.387 1.195 579 146 132 112 112 829 964 
0019 62 F 1184 1051 876 0.877 0.809 490 153 148 81 81 583 725 
0020 72 M 780 636 411 0.832 0.681 495 113 124 9 9 574 667 
0021 74 F 1564 1346 1433 0.710 0.539 447 136 131 181 181 622 758 
0022 49 M 1398 1277 927 0.533 0.590 492 182 171 147 147 770 839 
0023 58 F 986 787 873 0.533 0.745 473 136 124 167 167 712 1010 
0024 76 F 1138 964 702 0.588 0.912 428 164 123 102 102 686 793 
0025 74 M 1057 861 705 0.267 0.874 454 132 104 64 64 857 744 
0026 70 F 1131 996 599 0.511 0.719 352 174 95 56 56 647 566 
0027 59 M 802 776 659 0.688 1.118 436 140 155 82 82 770 612 
0028 56 M 824 826 652 0.921 1.118 402 120 125 64 64 866 610 
0029 72 F 1065 937 783 0.611 1.182 434 154 146 91 91 862 560 
0030 60 M 695 664 621 NES 2.019 449 139 164 106 106 1360 729 
0031 51 M 1079 1077 842 0.500 0.796 445 89 101 78 78 671 527 
0032 61 F 1090 1072 907 0.466 0.488 348 104 94 128 128 625 565 
0033 47 M 907 906 617 0.588 0.668 480 113 116 26 26 749 659 
0034 80 F 1174 1319 953 0,677 0.861 374 95 93 43 43 791 799 
0035 72 M 897 901 786 1.398 1.401 375 171 127 92 92 763 659 
0036 50 F 1411 1413 lill 0.555 0.784 373 105 102 107 107 808 657 
0037 71 F 989 1036 738 0.821 0.874 371 136 163 113 113 702 811 
0038 71 F 1053 1181 835 0.455 0.758 378 103 129 80 80 695 629 
0039 68 F 983 1819 711 0.344 0.668 356 211 218 65 65 619 713 
0040 62 M 1015 993 765 0,355 0.565 360 108 117 88 88 734 565 
0041 42 M 1062 659 836 NES 1.067 480 109 75 NES NES 923 493 
0042 82 F 818 705 598 1.121 0.732 403 94 114 62 62 713 425 
0043 54 M 923 906 794 0.522 1.131 437 192 135 76 76 801 590 
0044 67 M 766 800 792 1.043 0.899 447 151 141 85 85 747 558 
M/F = male or female 
S= serum 
P= plasma 
W= whole blood 
NES = not enough sample 
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